concept_id	concept_synonym_name	language_concept_id
44802531	[D]Sinus bradycardia (situation)	4180186
44802533	[D]Poor urinary stream (situation)	4180186
44802534	[D]Right lower quadrant pain (situation)	4180186
44802539	[D]Senile tremor (situation)	4180186
44802542	[D]Musculoskeletal X-ray abnormal (situation)	4180186
44802543	Opportunistic verification of patient address (procedure)	4180186
44802544	Opportunistic verification of patient mobile telephone number (procedure)	4180186
44802546	Assessment status (finding)	4180186
44802547	Lymphoedema monitoring (regime/therapy)	4180186
44802550	CELVAPAN - first influenza A (H1N1v) 2009 vaccination given (procedure)	4180186
44802551	PANDEMRIX - second influenza A (H1N1v) 2009 vaccination given (procedure)	4180186
44802555	CELVAPAN - second influenza A (H1N1v) 2009 vaccination given by other healthcare provider (finding)	4180186
44802556	PANDEMRIX - second influenza A (H1N1v) 2009 vaccination given by other healthcare provider (finding)	4180186
44802557	No consent for influenza A (H1N1v) 2009 vaccination (finding)	4180186
44802558	howRu rating scale (assessment scale)	4180186
44802559	Apgar at 20 minutes (observable entity)	4180186
44802562	Pain or discomfort (observable entity)	4180186
44802563	Feeling low or worried (observable entity)	4180186
44802564	Limited in what you can do (observable entity)	4180186
44802565	Dependent on others (observable entity)	4180186
44802566	Seen by urgent care team (finding)	4180186
44802567	FMed133 form - medical history on release from Her Majesty's Forces (record artifact)	4180186
44802568	Cystic fibrosis monitoring (regime/therapy)	4180186
44802569	Cystic fibrosis annual review (regime/therapy)	4180186
44802571	Rheumatic disorder annual review invitation (procedure)	4180186
44802573	Does use easy wear clothing (finding)	4180186
44802575	Does collect medication (finding)	4180186
44802576	Does not collect medication (finding)	4180186
44802577	Care plan reviewed (situation)	4180186
44802578	Diabetic on subcutaneous treatment (finding)	4180186
44802580	Rehabilitation following brain surgery (regime/therapy)	4180186
44802587	Referral to dysphasia support service (procedure)	4180186
44802589	Jamar dynamometer scale (assessment scale)	4180186
44802591	Dynamometer pinch and gross grip scale (assessment scale)	4180186
44802593	Arthritis hand function test (assessment scale)	4180186
44802597	[D]Drowsiness (situation)	4180186
44802599	[D]Semicoma (situation)	4180186
44802601	[D]Hallucinations (situation)	4180186
44802602	[D]Hallucinations, auditory (situation)	4180186
44802604	[D]Visual hallucinations (situation)	4180186
44802605	[D]Blackout (situation)	4180186
44802607	[D]Vasovagal attack (situation)	4180186
44802610	[D]Fit (in non-epileptic) NOS	4180186
44802610	[D]Fit (situation)	4180186
44802611	[D]Other specified convulsion (situation)	4180186
44802612	[D]Dizziness (situation)	4180186
44802614	[D]Acute vertigo (situation)	4180186
44802616	[D]Sleep disturbance, unspecified (situation)	4180186
44802618	[D]Sleep rhythm inversion (situation)	4180186
44802619	[D]Sleep rhythm irregular (situation)	4180186
44802620	[D]Unsteady gait (situation)	4180186
44802621	[D]Impaired glucose tolerance (situation)	4180186
44802623	[D]Underweight (situation)	4180186
44802625	[D]Hyperuricuria (situation)	4180186
44802628	[D]Dysprosody (situation)	4180186
44802630	Born in Dominica (finding)	4180186
44802632	Invitation to participate in clinical trial (procedure)	4180186
44802633	Did not attend genitourinary medicine clinic (finding)	4180186
44802635	Deep vein thrombosis enhanced services administration stage 1 service level (finding)	4180186
44802639	SMR25b drug misuse follow up assessment form (record artifact)	4180186
44802641	Social prescribing for mental health (regime/therapy)	4180186
44802642	Family history of myocardial infarction in first degree relative less than 60 years (situation)	4180186
44802644	MED5 certificate requested	4180186
44802644	MED5 statement requested (finding)	4180186
44802645	Family history of total cholesterol greater than 6.7 millimoles per litre in child or sibling under 16 years of age (situation)	4180186
44802648	History of Parkinson disease	4180186
44802648	History of Parkinson's disease (situation)	4180186
44802650	No finger clubbing (situation)	4180186
44802653	Hepatitis A vaccination invitation (procedure)	4180186
44802655	GP24A - maternity claim (procedure)	4180186
44802656	No response to influenza vaccination invitation (finding)	4180186
44802657	Impaired glucose tolerance monitoring invitation (procedure)	4180186
44802659	Impaired glucose tolerance monitoring administration (finding)	4180186
44802661	Patient held care plan (record artifact)	4180186
44802663	No blanching on elevation of foot (situation)	4180186
44802665	Rectum injury without mention of open wound into cavity (disorder)	4180186
44802667	[D]Sleep dysfunction with sleep stage disturbance (situation)	4180186
44802668	[D]Sleep dysfunction with arousal disturbance (situation)	4180186
44802669	[D]Fever of unknown origin	4180186
44802669	[D]Pyrexia of unknown origin (situation)	4180186
44802677	[D]Tiredness (situation)	4180186
44802679	[D]Diaphoresis (situation)	4180186
44802680	[D]Excessive sweating (situation)	4180186
44802682	[D]Generalised hyperhidrosis (situation)	4180186
44802683	[D]Confusion (situation)	4180186
44802684	[D]Toxic confusional state (situation)	4180186
44802685	[D]Poor mobility (situation)	4180186
44802686	[D]Other general symptoms (situation)	4180186
44802687	[D]General aches and pains	4180186
44802687	[D]Pain, generalised (situation)	4180186
44802688	[D]Sedation (situation)	4180186
44802690	[D]Demoralisation and apathy (situation)	4180186
44802692	[D]Chronic intractable pain (situation)	4180186
44802693	[D]Restlessness and agitation (situation)	4180186
44802695	[D]Head movements abnormal (situation)	4180186
44802696	[D]Smell and taste disorder (situation)	4180186
44802697	ANC5/6/HC1 district health authority procedure (finding)	4180186
44802698	[D]Parosmia (situation)	4180186
44802699	[D]Ataxic gait (situation)	4180186
44802700	[D]Spastic gait (situation)	4180186
44802704	[D]Muscular incoordination (situation)	4180186
44802706	[D]Dupre's syndrome (situation)	4180186
44802709	Improving access to psychological therapies programme phobia scale - certain situations because of a fear of having a panic attack or other distressing symptoms (assessment scale)	4180186
44802710	Improving access to psychological therapies programme phobia scale - social situations due to a fear of being embarrassed or making a fool of myself (assessment scale)	4180186
44802712	Magnetic resonance imaging of brain volume (procedure)	4180186
44802712	MRI (magnetic resonance imaging) of brain volume	4180186
44802713	Magnetic resonance imaging of brain volume with contrast (procedure)	4180186
44802713	MRI (magnetic resonance imaging) of brain volume with contrast	4180186
44802715	Referral to gastroenterology clinical assessment service (procedure)	4180186
44802718	ABCD2 (age, blood pressure, clinical features, duration, diabetes 2) stroke risk score	4180186
44802718	Age, blood pressure, clinical features, duration, diabetes 2 stroke risk score (assessment scale)	4180186
44802719	Cancelled appointment at extended hours clinic (finding)	4180186
44802721	Did not attend for measles mumps rubella catch-up vaccination (finding)	4180186
44802722	Choice and booking letter reminder to make initial hospital appointment (procedure)	4180186
44802724	Health forecasting patient information pack given (procedure)	4180186
44802726	ADHD (attention deficit hyperactivity disorder) monitoring invitation first letter	4180186
44802726	Attention deficit hyperactivity disorder monitoring invitation first letter (procedure)	4180186
44802728	Referral to community nursing out of hours service (procedure)	4180186
44802730	Internal practice referral (procedure)	4180186
44802731	Declined consent for registration with Sure Start (finding)	4180186
44802733	Internal practice referral for cryotherapy (procedure)	4180186
44802736	Internal practice referral for minor surgery (procedure)	4180186
44802740	Payment of child health surveillance claim (procedure)	4180186
44802741	[D]Tetany (situation)	4180186
44802742	[D]Carpopedal spasm (situation)	4180186
44802744	[D]Posture abnormal (situation)	4180186
44802745	[D]Growing pains - limbs (situation)	4180186
44802746	[D]Musculoskeletal pain (situation)	4180186
44802750	[D]Skin sensation disturbance (situation)	4180186
44802755	[D]Hyperaesthesia (situation)	4180186
44802756	[D]Hypoaesthesia (situation)	4180186
44802760	[D]Rash and other nonspecific skin eruption (situation)	4180186
44802761	[D]Exanthem (situation)	4180186
44802763	[D]Mass, localised and superficial (situation)	4180186
44802764	[D]Lump, localised and superficial (situation)	4180186
44802766	[D]Localised swelling, mass and lump, lower limb (situation)	4180186
44802767	[D]Axillary lump (situation)	4180186
44802768	[D]Lump on back (situation)	4180186
44802769	[D]Shoulder lump (situation)	4180186
44802773	[D]Subungual swelling (situation)	4180186
44802774	[D]Buttock swelling (situation)	4180186
44802782	Chlamydia screening programme test kit issued (finding)	4180186
44802787	HIV (Human immunodeficiency virus) positive general health check service declined - enhanced services administration	4180186
44802787	Human immunodeficiency virus positive general health check service declined (situation)	4180186
44802788	Practice based commissioning administration (finding)	4180186
44802792	FP45 - training grant claim status (finding)	4180186
44802793	Osteoporosis enhanced services administration (procedure)	4180186
44802798	GP/CHS claim status (finding)	4180186
44802799	At medium risk of meticillin resistant staphylococcus aureus infection (finding)	4180186
44802799	At medium risk of MRSA (meticillin resistant staphylococcus aureus) infection	4180186
44802800	Preferred place of death: patient unable to express preference (finding)	4180186
44802804	Out of hours patient call detail received (finding)	4180186
44802807	Understands importance of blood pressure monitoring and control (finding)	4180186
44802807	Understands importance of BP (blood pressure) monitoring and control	4180186
44802812	Did not attend pneumococcal vaccination (finding)	4180186
44802813	Did not attend diphtheria, tetanus and acellular pertussis vaccination (finding)	4180186
44802815	Dialysate flow rate (observable entity)	4180186
44802816	Haemodialysis blood flow rate (observable entity)	4180186
44802818	Bicarbonate level setting on haemodialysis machine (observable entity)	4180186
44802824	Emergency treatment claim (procedure)	4180186
44802825	[D]Jaundice (not of newborn) (situation)	4180186
44802826	[D]Cyanosis (situation)	4180186
44802828	[D]Pale	4180186
44802828	[D]Pallor (situation)	4180186
44802829	[D]Flushing (situation)	4180186
44802830	[D]Excessive blushing (situation)	4180186
44802833	[D]Skin texture changes (situation)	4180186
44802834	[D]Induration of skin (situation)	4180186
44802837	[D]Anorexia (situation)	4180186
44802838	[D]Appetite loss (situation)	4180186
44802840	[D]Abnormal loss of weight (situation)	4180186
44802843	[D]Feeding problem in elderly (situation)	4180186
44802845	[D]Failure to thrive (situation)	4180186
44802846	[D]Short stature (situation)	4180186
44802847	[D]Short stature, constitutional (situation)	4180186
44802847	[D]Short stature, hereditary	4180186
44802849	[D]Bulimia NOS	4180186
44802849	[D]Excessive eating (situation)	4180186
44802851	[D]Hypometabolism (situation)	4180186
44802852	IG1/2/3 - improvement grant status (finding)	4180186
44802854	[D]Swelling, mass or lump in head	4180186
44802854	[D]Swelling, mass or lump in head and neck (situation)	4180186
44802854	[D]Swelling, mass or lump in neck	4180186
44802855	[D]Mass in head or neck (situation)	4180186
44802860	[D]Swelling of ear (situation)	4180186
44802864	Preferred place of care - hospital (finding)	4180186
44802866	Stop smoking face to face follow-up (finding)	4180186
44802867	Current smoker annual review (regime/therapy)	4180186
44802868	Non-smoker annual review (regime/therapy)	4180186
44802869	Ex-smoker annual review (regime/therapy)	4180186
44802872	Referral to weight management service declined (situation)	4180186
44802873	Health of the nation outcome scale for children and adolescents score (observable entity)	4180186
44802873	HoNOSCA (Health of the Nation Outcome Scale for Children and Adolescents) score	4180186
44802874	Advance supply of antibiotic medication (procedure)	4180186
44802876	Haitian Creole language	4180186
44802876	Haitian language (qualifier value)	4180186
44802879	FP1002 intrauterine contraceptive device insertion claim (procedure)	4180186
44802879	FP1002 IUCD (intrauterine contraceptive device) insertion claim	4180186
44802881	Referral to cognitive behavioural therapist (procedure)	4180186
44802882	Referral to community lymphoedema service (procedure)	4180186
44802889	Did not attend diphtheria, tetanus, acellular pertussis and polio vaccination (finding)	4180186
44802889	Did not attend DTaP (diphtheria, tetanus, acellular pertussis) and polio vaccination	4180186
44802891	Church Slavic language (qualifier value)	4180186
44802891	Church Slavonic	4180186
44802891	Old Bulgarian	4180186
44802891	Old Church Slavonic	4180186
44802891	Old Slavonic	4180186
44802894	Disease modifying antirheumatic drug therapy initiated (regime/therapy)	4180186
44802894	DMARD (disease modifying antirheumatic drug) therapy initiated	4180186
44802895	Sending of emergency treatment claim (procedure)	4180186
44802896	[D]Swelling of mandibular region (situation)	4180186
44802902	[D]Change in voice (situation)	4180186
44802907	[D]Other speech disturbance (situation)	4180186
44802908	[D]Dysarthria (situation)	4180186
44802911	[D]Other symbolic dysfunction (situation)	4180186
44802912	[D]Symbolic dysfunction, unspecified (situation)	4180186
44802913	[D]Alexia (situation)	4180186
44802914	[D]Alexia with agraphia (situation)	4180186
44802916	[D]Acalculia (situation)	4180186
44802917	[D]Agraphia (situation)	4180186
44802918	[D]Apraxia (situation)	4180186
44802920	[D]Foul breath	4180186
44802920	[D]Halitosis (situation)	4180186
44802921	[D]Nasal obstruction (situation)	4180186
44802922	[D]Cardiovascular system symptoms (situation)	4180186
44802922	[D]Heart symptoms	4180186
44802924	[D]Functional bruit	4180186
44802924	[D]Heart murmur, functional and undiagnosed (situation)	4180186
44802925	[D]Heart murmur, undiagnosed (situation)	4180186
44802926	[D]Heart murmur, benign (situation)	4180186
44802927	[D]Cardiac dullness increased (situation)	4180186
44802928	[D]Cardiac friction fremitus (situation)	4180186
44802934	[D]Widespread diabetic foot gangrene (situation)	4180186
44802935	[D]Failure of peripheral circulation (situation)	4180186
44802935	[D]Peripheral circulatory failure	4180186
44802937	Health of the nation outcome scale for learning disabilities score (observable entity)	4180186
44802937	HoNOS-LD (health of the nation outcome scale for learning disabilities) score	4180186
44802938	Health of the nation outcome scale for acquired brain injury score (observable entity)	4180186
44802938	HoNOS-ABI (health of the nation outcome scale - acquired brain injury) score	4180186
44802939	Specialist treatment area (environment)	4180186
44802940	Walsall community pressure sore risk score (observable entity)	4180186
44802943	Advice about meteorological health forecasting service (regime/therapy)	4180186
44802945	In-house general surgery (procedure)	4180186
44802946	Referral to community mothers programme (procedure)	4180186
44802950	Possible influenza A virus H1N1 subtype	4180186
44802950	Possible influenza due to Influenza A virus subtype H1N1 (situation)	4180186
44802950	Possible swine influenza	4180186
44802952	Rhesus and Kell blood group phenotype determination (procedure)	4180186
44802952	Rhesus and Kell blood group phenotyping	4180186
44802955	Recent travel to disease affected area (finding)	4180186
44802958	Deliberate overdose of prescribed medication	4180186
44802958	Intentional overdose of prescription only medication (disorder)	4180186
44802960	Has preferred out-patient nurse (finding)	4180186
44802961	Transport request agreed (finding)	4180186
44802962	Consent for educational use of medical photography given (finding)	4180186
44802964	Preferred place of care - learning disability unit (finding)	4180186
44802965	Preferred place of care - mental health unit (finding)	4180186
44802969	No symptomatic relief on limb elevation (finding)	4180186
44802970	Preferred place of death: discussed with family (finding)	4180186
44802972	Cause of learning disability (observable entity)	4180186
44802975	Gold standards framework supportive care stage 1 - advancing disease (finding)	4180186
44802976	Gold standards framework supportive care stage 2 - increasing decline (finding)	4180186
44802978	Rejection of emergency treatment claim (procedure)	4180186
44802980	[D]Endotoxic shock (situation)	4180186
44802982	[D]Hypovolaemic shock (situation)	4180186
44802983	[D]Septicaemic shock	4180186
44802983	[D]Septic shock (situation)	4180186
44802986	[D]Swollen glands (situation)	4180186
44802989	[D]Other cardiovascular symptoms (situation)	4180186
44802990	[D]Bruit, arterial (situation)	4180186
44802991	[D]Weak pulse (situation)	4180186
44802994	[D]Respiratory symptom, unspecified (situation)	4180186
44802995	[D]Hyperventilation (situation)	4180186
44802997	[D]Tachypnoea (situation)	4180186
44802999	[D]Cheyne-Stokes respiration (situation)	4180186
44803000	[D]Respiratory distress (situation)	4180186
44803002	[D]Yawning (situation)	4180186
44803004	[D]Haemoptysis (situation)	4180186
44803005	FP34D claim status (finding)	4180186
44803006	[D]Sputum abnormal - amount (situation)	4180186
44803007	[D]Sputum abnormal - odour (situation)	4180186
44803008	[D]Abnormal sputum - tenacious (situation)	4180186
44803009	[D]Chest pain (situation)	4180186
44803010	[D]Anterior chest wall pain (situation)	4180186
44803011	[D]Pleuritic pain (situation)	4180186
44803012	[D]Chest pressure (situation)	4180186
44803013	[D]Musculoskeletal chest pain (situation)	4180186
44803017	Name of pharmacy attended due to drug misuse (observable entity)	4180186
44803017	Pharmacy attended for drug misuse	4180186
44803018	LOC1/2/3 - notification of sickness status (finding)	4180186
44803019	Referral to minor injuries unit (procedure)	4180186
44803020	Primary reason for admission (observable entity)	4180186
44803021	Secondary reason for admission (observable entity)	4180186
44803022	Referral to minor surgery clinical assessment service (procedure)	4180186
44803023	Referral to ophthalmology clinical assessment service (procedure)	4180186
44803024	Unplanned local admission (finding)	4180186
44803027	Self-referral to accident and emergency department (procedure)	4180186
44803030	Planned local surgical admission (finding)	4180186
44803031	Planned local medical admission (finding)	4180186
44803033	Vestibular disorders activities of daily living scale score (observable entity)	4180186
44803034	Gold standards framework supportive care stage 3 - last days: category C - weeks prognosis (finding)	4180186
44803036	Referral for graded exercise therapy (procedure)	4180186
44803037	FP1003 contraceptive services claim for temporary resident (procedure)	4180186
44803040	History of diabetic complication (situation)	4180186
44803043	Finding of psychological and emotional need (finding)	4180186
44803045	Assisting with household management (procedure)	4180186
44803045	Help with household management	4180186
44803047	Dependent lymphoedema due to immobility (disorder)	4180186
44803048	Assisting with management of personal financial activities (procedure)	4180186
44803049	Did not attend haemophilus influenzae type B and meningitis C vaccination (finding)	4180186
44803049	Did not attend Hib (haemophilus influenzae type B) and meningitis C vaccination	4180186
44803051	Recommendation of multidisciplinary team (record artifact)	4180186
44803052	Nephropathy induced by ciclosporin (disorder)	4180186
44803052	Nephropathy induced by cyclosporin	4180186
44803054	Nephropathy induced by amphotericin (disorder)	4180186
44803058	British Sign Language (qualifier value)	4180186
44803059	Ischaemic nephropathy (disorder)	4180186
44803061	Czech (ethnic group)	4180186
44803063	GP102 form (record artifact)	4180186
44803064	PULHHEEMS - Eul (finding)	4180186
44803065	Community charge exemption status (finding)	4180186
44803067	Greenlandic language interpreter needed	4180186
44803067	Kalaallisut language interpreter needed (finding)	4180186
44803068	DS1500 Attendance allowance examination payment claim status (finding)	4180186
44803071	Resiting of prosthesis in organ NOC (procedure)	4180186
44803072	Removal of prosthesis from organ NOC (procedure)	4180186
44803074	Release of organ NOC (procedure)	4180186
44803076	Stereotactic biopsy of organ NOC (procedure)	4180186
44803077	Introduction of iridium wire into organ NOC (procedure)	4180186
44803078	Introduction of radium into organ NOC (procedure)	4180186
44803079	Late operations NOC (procedure)	4180186
44803081	PULHHEEMS - S (finding)	4180186
44803084	History relating to Royal Navy service (observable entity)	4180186
44803086	Accident to hang glider in collision with other aircraft (event)	4180186
44803088	BAAF (British Association for Adoption and Fostering) adult 1 examination payment claim status	4180186
44803088	British Association for Adoption and Fostering adult 1 examination payment claim status (finding)	4180186
44803090	Primary operation NOC (procedure)	4180186
44803093	On examination - right red reflex present (finding)	4180186
44803094	Esperanto language interpreter needed (finding)	4180186
44803096	Emigration medical payment claim status (finding)	4180186
44803099	Temporary resident claim status (finding)	4180186
44803100	GP24 paid by Health Board - overpaid (finding)	4180186
44803103	Estonian language interpreter needed (finding)	4180186
44803105	Family history: Endocrine disorder NOS	4180186
44803105	Family history: Endocrine disorder NOS (situation)	4180186
44803108	DS1500 Attendance allowance examination payment claim (procedure)	4180186
44803111	PULHHEEMS - P5R (finding)	4180186
44803112	NA52 order (procedure)	4180186
44803113	FP74 cervical cytology claim status (finding)	4180186
44803114	Shared care by other agency and general practitioner (finding)	4180186
44803115	Department of Social Security regional medical officer RM2 report status (finding)	4180186
44803115	DSS (Department of Social Security) RMO (regional medical officer) RM2 report status	4180186
44803122	Mental Health Act payment claim status Scotland (finding)	4180186
44803123	GP/RF registration claim form status (finding)	4180186
44803124	PULHHEEMS - U1 (finding)	4180186
44803126	GMS3 claim status (finding)	4180186
44803128	PULHHEEMS - U2 (finding)	4180186
44803129	Facilitating operations NOC (procedure)	4180186
44803132	Disciplinary status (finding)	4180186
44803135	GP19 - temporary resident registration (record artifact)	4180186
44803137	Mental Health Act procedure (procedure)	4180186
44803138	GP82 claim status (finding)	4180186
44803139	Incoming mail processing status (finding)	4180186
44803142	Procurator bonis certification payment claim status (finding)	4180186
44803144	Procurator bonis certification payment claim (procedure)	4180186
44803147	Attendance allowance examination payment claim status (finding)	4180186
44803148	Excision of lesion of organ NOC (procedure)	4180186
44803149	Partial excision of organ NOC (procedure)	4180186
44803151	Kinyarwanda language interpreter needed (finding)	4180186
44803158	Injection of inert substance into organ NOC (procedure)	4180186
44803159	Microvascular repair of organ NOC (procedure)	4180186
44803161	Aspiration of hematoma of organ NOC (procedure)	4180186
44803162	Xenoreplacement of organ NOC (procedure)	4180186
44803163	Re-exploration of organ and surgical arrest of postoperative bleeding NOC (procedure)	4180186
44803164	Re-exploration of organ and other repair of organ NOC (procedure)	4180186
44803170	Connection of organ NOC (procedure)	4180186
44803171	Maintenance of prosthesis in organ NOC (procedure)	4180186
44803173	Adjustment to prosthesis in organ NOC (procedure)	4180186
44803177	Laser excision of organ NOC (procedure)	4180186
44803179	PULHHEEMS - Eur4 (finding)	4180186
44803180	Manipulation of organ NOC (procedure)	4180186
44803181	Allograft to organ NOC (procedure)	4180186
44803184	To be seen by doctor on next attendance (finding)	4180186
44803186	Other method of operation on organ NOC (procedure)	4180186
44803187	PULHHEEMS - Eur6 (finding)	4180186
44803190	Ultrasonic destruction of organ NOC (procedure)	4180186
44803191	Ultrasonic destruction of lesion of organ NOC (procedure)	4180186
44803194	PULHHEEMS - L5 (finding)	4180186
44803195	PULHHEEMS - S4 (finding)	4180186
44803201	Monitoring of pressure in organ NOC (regime/therapy)	4180186
44803202	Injection of other destructive substance into lesion of organ NOC (procedure)	4180186
44803203	Immediate operation NOC (procedure)	4180186
44803206	PULHHEEMS - S6 (finding)	4180186
44803208	Child development assessment by questionnaire (regime/therapy)	4180186
44803212	Biopsy of organ NOC (procedure)	4180186
44803213	Biopsy of lesion of organ NOC (procedure)	4180186
44803214	PULHHEEMS - S2 (finding)	4180186
44803215	Laser destruction of lesion of organ NOC (procedure)	4180186
44803220	Biopsy of lesion of unspecified organ (procedure)	4180186
44803221	PULHHEEMS - HR2 (finding)	4180186
44803223	Attention to microvascular repair of organ NOC (procedure)	4180186
44803224	PULHHEEMS - HR4 (finding)	4180186
44803228	PULHHEEMS - M6 (finding)	4180186
44803229	PULHHEEMS - M8 (finding)	4180186
44803230	Hepatitis C screening negative (finding)	4180186
44803231	Bihari language interpreter needed (finding)	4180186
44803237	PULHHEEMS - HL1 (finding)	4180186
44803242	PULHHEEMS - S3 (finding)	4180186
44803248	PULHHEEMS - U7 (finding)	4180186
44803249	PULHHEEMS - U8 (finding)	4180186
44803250	PULHHEEMS - HL7 (finding)	4180186
44803251	Maternity booking before 16th week (procedure)	4180186
44803257	Partial postnatal care - one visit (procedure)	4180186
44803260	FW 8 - application for prescription exemption (record artifact)	4180186
44803260	FW 8-applic for presc exempt	4180186
44803260	Prescription exempt form-preg	4180186
44803260	Prescription exemption form - pregnancy	4180186
44803261	[V]Bone anchored hearing aid in situ (situation)	4180186
44803264	Obliteration of sinus track from organ NOC (procedure)	4180186
44803266	Partial postnatal care - five visits (procedure)	4180186
44803272	Excision of unspecified organ (procedure)	4180186
44803273	Excision of lesion of unspecified organ (procedure)	4180186
44803274	Other maternity service claim (procedure)	4180186
44803276	Total maternity service claim (procedure)	4180186
44803280	Trachea resection sample (specimen)	4180186
44803281	Irrigation of organ NOC (procedure)	4180186
44803284	Alloreplacement of organ NOC (procedure)	4180186
44803288	Attention to graft of organ NOC (procedure)	4180186
44803290	Complete maternity services claimed (finding)	4180186
44803291	Absent atrioventricular connection - single inlet ventricle (disorder)	4180186
44803293	Absent left sided atrioventricular connection - univentricular (disorder)	4180186
44803299	Concordant ventriculoarterial connection with parallel great arteries (disorder)	4180186
44803302	Double outlet ventriculoarterial connection (disorder)	4180186
44803304	Telehealth monitoring (regime/therapy)	4180186
44803308	Ebstein anomaly of left sided tricuspid valve with discordant atrioventricular connection	4180186
44803308	Ebstein's anomaly of left sided tricuspid valve with discordant atrioventricular connection (disorder)	4180186
44803310	Right superior vena cava connecting to coronary sinus and right sided atrium (disorder)	4180186
44803310	Right SVC (superior vena cava) connecting to coronary sinus and right sided atrium	4180186
44803315	Measurement of left anterior tibial doppler pressure (procedure)	4180186
44803317	Death administration (record artifact)	4180186
44803318	Audit administration (record artifact)	4180186
44803319	Mental health administration (record artifact)	4180186
44803320	Encounter administration (record artifact)	4180186
44803321	Medicolegal administration (record artifact)	4180186
44803322	Solicitors court attendance administration (record artifact)	4180186
44803323	Report administration (record artifact)	4180186
44803324	Request administration (record artifact)	4180186
44803329	Disease monitoring administration (record artifact)	4180186
44803331	Diabetes monitoring administration (record artifact)	4180186
44803332	Asthma monitoring administration (record artifact)	4180186
44803335	Educational standards (qualifier value)	4180186
44803337	Evidence based practice (qualifier value)	4180186
44803338	Excluded people (qualifier value)	4180186
44803339	Exercise referral scheme (qualifier value)	4180186
44803340	Food preparation (qualifier value)	4180186
44803341	Government office (qualifier value)	4180186
44803343	Health protection (qualifier value)	4180186
44803344	Healthy school (qualifier value)	4180186
44803346	Indicator (qualifier value)	4180186
44803347	Information need (qualifier value)	4180186
44803349	Life skill (qualifier value)	4180186
44803350	Local authority (qualifier value)	4180186
44803352	Measurement technique (qualifier value)	4180186
44803353	Medical research (qualifier value)	4180186
44803356	National aspect (qualifier value)	4180186
44803358	Non-verbal communication (qualifier value)	4180186
44803359	Non-vocational qualification (qualifier value)	4180186
44803360	Out of school activity (qualifier value)	4180186
44803361	Parenting skill (qualifier value)	4180186
44803363	People with hearing disability (qualifier value)	4180186
44803372	Completion of certificate of vision impairment form (procedure)	4180186
44803372	Completion of CVI (certificate of vision impairment) form	4180186
44803374	TAPVC (total anomalous pulmonary venous connection) of mixed type	4180186
44803374	Total anomalous pulmonary venous connection of mixed type (disorder)	4180186
44803376	Certified severely sight impaired (finding)	4180186
44803377	Congenital pulmonary venous confluence in vertical orientation (disorder)	4180186
44803379	Congenital pulmonary venous confluence in direct proximity to left atrium (disorder)	4180186
44803380	Hypothyroidism monitoring administration (record artifact)	4180186
44803382	Mental health monitoring administration (record artifact)	4180186
44803383	Stroke/transient ischaemic attack monitoring administration (record artifact)	4180186
44803385	Heart failure monitoring administration (record artifact)	4180186
44803387	Chronic kidney disease monitoring administration (record artifact)	4180186
44803388	Dementia monitoring administration (record artifact)	4180186
44803389	Depression monitoring administration (record artifact)	4180186
44803390	Lipid disorder monitoring administration (record artifact)	4180186
44803392	Clinic monitoring administration (record artifact)	4180186
44803397	Stop smoking clinic administration (record artifact)	4180186
44803399	Well man monitoring administration (record artifact)	4180186
44803402	Well woman clinic administration (record artifact)	4180186
44803403	Well adult clinic administration (record artifact)	4180186
44803404	Staff disciplinary administration (record artifact)	4180186
44803406	Staff statutory sick pay administration (record artifact)	4180186
44803406	Statutory sick pay - staff	4180186
44803407	Leave administration (record artifact)	4180186
44803409	Ancillary staff administration (record artifact)	4180186
44803411	Home visit administration (record artifact)	4180186
44803413	Appointment administration (record artifact)	4180186
44803417	Professional organisation (qualifier value)	4180186
44803419	Qualification (qualifier value)	4180186
44803421	Racism (qualifier value)	4180186
44803422	Research group (qualifier value)	4180186
44803423	Researcher (qualifier value)	4180186
44803429	Small and medium sized enterprises (qualifier value)	4180186
44803431	Socioeconomic policy (qualifier value)	4180186
44803432	Teaching material (qualifier value)	4180186
44803433	Tobacco industry (qualifier value)	4180186
44803434	Voluntary agencies regional policy (qualifier value)	4180186
44803436	Experiential learning (qualifier value)	4180186
44803437	Material design and development (qualifier value)	4180186
44803438	Violence (qualifier value)	4180186
44803443	Cluster (qualifier value)	4180186
44803445	Method (qualifier value)	4180186
44803447	Home oxygen order form completed (finding)	4180186
44803447	HOOF (home oxygen order form) completed	4180186
44803448	Cor triatriatum with all pulmonary veins to proximal chamber draining to left atrium	4180186
44803448	Divided left atrium with all pulmonary veins to proximal chamber draining to left atrium (disorder)	4180186
44803449	Cor triatriatum with all pulmonary veins to proximal chamber draining to left atrium with pulmonary venous chamber communication	4180186
44803449	Divided left atrium with all pulmonary veins to proximal chamber draining to left atrium with pulmonary venous chamber communication (disorder)	4180186
44803450	Cor triatriatum with pulmonary veins to proximal chamber draining to left atrium with pulmonary venous chamber communication to right atrium	4180186
44803450	Divided left atrium with all pulmonary veins to proximal chamber draining to left atrium with pulmonary venous chamber communication to right atrium (disorder)	4180186
44803452	Non-fenestrated atrial septal defect within oval fossa (disorder)	4180186
44803455	Restrictive interatrial communication septal defect (disorder)	4180186
44803456	Thoracoabdominal organ finding (finding)	4180186
44803457	Normal morphology of thoracoabdominal organ (finding)	4180186
44803458	Asylum seeker awaiting decision on refugee status (person)	4180186
44803459	Asylum seeker with application for asylum refused (person)	4180186
44803459	Failed asylum seeker	4180186
44803460	Asylum seeker with humanitarian protection status (person)	4180186
44803461	Carer from Black and minority ethnic group (finding)	4180186
44803468	Community charge exemption administration (record artifact)	4180186
44803470	Drug supply payments administration	4180186
44803470	Supply of drugs payment administration (record artifact)	4180186
44803472	Stock order GP10A administration (record artifact)	4180186
44803474	Improvement grant administration (record artifact)	4180186
44803478	Drug trial administration (record artifact)	4180186
44803486	Adult immunisation administration (record artifact)	4180186
44803487	Child immunisation administration (record artifact)	4180186
44803488	Rubella antibody screening administration (record artifact)	4180186
44803490	Pneumococcal vaccination administration (record artifact)	4180186
44803491	Diaphragm check administration (record artifact)	4180186
44803495	Child surveillance administration (record artifact)	4180186
44803498	Blood and immune disorder (qualifier value)	4180186
44803500	Causes of harm (qualifier value)	4180186
44803501	Community development (qualifier value)	4180186
44803502	Community health project (qualifier value)	4180186
44803506	County (qualifier value)	4180186
44803508	Drug policy (qualifier value)	4180186
44803509	Education, employment and skills (qualifier value)	4180186
44803510	Electoral region (qualifier value)	4180186
44803511	Email (qualifier value)	4180186
44803516	Focus group methodology (qualifier value)	4180186
44803517	Good practice (qualifier value)	4180186
44803519	Health behaviour (qualifier value)	4180186
44803521	Health economics (qualifier value)	4180186
44803523	Health information service (qualifier value)	4180186
44803524	Health services and their management (qualifier value)	4180186
44803525	Health target (qualifier value)	4180186
44803526	Hygiene (qualifier value)	4180186
44803527	Interprofessional working (qualifier value)	4180186
44803529	Local strategic partnership (qualifier value)	4180186
44803530	Ear examination - abnormal (finding)	4180186
44803531	Retro-aortic brachiocephalic vein (disorder)	4180186
44803531	Retro-aortic innominate vein	4180186
44803534	Main spoken language Chewa	4180186
44803534	Main spoken language Nyanja (finding)	4180186
44803535	Main spoken language Fulah	4180186
44803535	Main spoken language Fulani (finding)	4180186
44803536	Main spoken language Kikuyu (finding)	4180186
44803537	HALO (Hampshire assessment for living with others) score	4180186
44803537	Hampshire assessment for living with others score (observable entity)	4180186
44803539	Assessment using dynamometer pinch and gross grip scale (procedure)	4180186
44803540	Neuropathy assessment declined (situation)	4180186
44803541	Patient unsuitable for neuropathy assessment (finding)	4180186
44803544	Cervical cytology administration	4180186
44803544	Cervical smear screening administration (record artifact)	4180186
44803545	Adult health screening administration (record artifact)	4180186
44803553	Community disease modifying antirheumatic drug monitoring administration (record artifact)	4180186
44803553	Community DMARD (disease modifying antirheumatic drug) monitoring administration	4180186
44803555	Employment examination/report administration (record artifact)	4180186
44803556	Pre-employment examination/report administration (record artifact)	4180186
44803557	Free prescription administration (record artifact)	4180186
44803558	Medical examinations/reports administration (record artifact)	4180186
44803559	Special activities examination administration (record artifact)	4180186
44803563	Life assurance examination administration (record artifact)	4180186
44803563	Life insurance examination administration	4180186
44803565	Emigration medical administration (record artifact)	4180186
44803566	Boarded out child examination administration (record artifact)	4180186
44803567	Racing driver medical administration (record artifact)	4180186
44803568	Attendance allowance examination administration (record artifact)	4180186
44803569	Public service vehicle driver administration (record artifact)	4180186
44803572	Food poisoning notification administration (record artifact)	4180186
44803573	Infectious disease notification administration (record artifact)	4180186
44803574	Drug addict notification administration (record artifact)	4180186
44803578	Minor operation claim administration	4180186
44803578	Minor surgery claim administration (record artifact)	4180186
44803581	General practitioner out of hours service administration (record artifact)	4180186
44803581	GP OOH (general practitioner out of hours) service administration	4180186
44803582	Mass communication (qualifier value)	4180186
44803585	Open learning (qualifier value)	4180186
44803586	People with learning disability (qualifier value)	4180186
44803588	Policy evaluation (qualifier value)	4180186
44803590	Pressure group (qualifier value)	4180186
44803591	Pretesting (qualifier value)	4180186
44803592	Pricing (qualifier value)	4180186
44803596	Health research (qualifier value)	4180186
44803598	Service evaluation (qualifier value)	4180186
44803600	Social inequality (qualifier value)	4180186
44803601	Strategic health authority (qualifier value)	4180186
44803602	Systematic review (qualifier value)	4180186
44803604	United Kingdom health policy	4180186
44803604	United Kingdom health policy (qualifier value)	4180186
44803609	Youth work (qualifier value)	4180186
44803612	Ethics (qualifier value)	4180186
44803613	People with HIV or AIDS	4180186
44803613	People with human immunodeficiency virus or acquired immune deficiency syndrome (qualifier value)	4180186
44803614	Not eligible for chronic medication service (finding)	4180186
44803615	Treatment room services enhanced services administration (procedure)	4180186
44803619	Sexual orientation not given - patient refused (finding)	4180186
44803620	Eating disorder examination global score (observable entity)	4180186
44803620	EDE (eating disorder examination) global score	4180186
44803622	Post hospital discharge medication reconciliation with medical notes (procedure)	4180186
44803623	Upper limb volume excess (observable entity)	4180186
44803624	Lower limb volume excess (observable entity)	4180186
44803625	Hospital Discharge Notification to Social Care (record artifact)	4180186
44803626	Assessment Notification Under Section 2 of the Community Care (Delayed Discharges etc) Act 2003 (record artifact)	4180186
44803627	Assessment Notification Accept Response Under Section 2 of the Community Care (Delayed Discharges etc) Act 2003 (record artifact)	4180186
44803632	Cancellation Notification Under Section 3 of the Community Care (Delayed Discharges etc) Act 2003 (record artifact)	4180186
44803633	Cancellation of Section 5 Notification Under Section 3 of the Community Care (Delayed Discharges etc) Act 2003 (record artifact)	4180186
44803634	Assessment Notification Under Section 2 of the Community Care (Delayed Discharges etc) Act 2003 Document (record artifact)	4180186
44803635	Discharge Notification Under Section 5 of the Community Care (Delayed Discharges etc) Act 2003 Document (record artifact)	4180186
44803638	Cervical smear slide broken in transit (finding)	4180186
44803641	Exception reporting - asthma quality indicators (finding)	4180186
44803642	General practitioner computer system (environment)	4180186
44803644	Excepted from depression quality indicators - informed dissent (finding)	4180186
44803645	Examination findings (record artifact)	4180186
44803646	Test result (record artifact)	4180186
44803647	Exception reporting - palliative care quality indicators (finding)	4180186
44803648	Exception reporting - dementia quality indicators (finding)	4180186
44803651	Incoming mail (record artifact)	4180186
44803656	Socioeconomic status (qualifier value)	4180186
44803658	Relationship (qualifier value)	4180186
44803660	Ambulance service (qualifier value)	4180186
44803662	Behavioural change (qualifier value)	4180186
44803665	Community communicable diseases	4180186
44803665	Community communicable diseases (qualifier value)	4180186
44803669	Economic development (qualifier value)	4180186
44803670	Economic evaluation (qualifier value)	4180186
44803671	Economic system (qualifier value)	4180186
44803672	Education action zone (qualifier value)	4180186
44803673	Environmental policy (qualifier value)	4180186
44803676	Food and nutrition (qualifier value)	4180186
44803678	Government (qualifier value)	4180186
44803680	Habitual behaviour (qualifier value)	4180186
44803681	Health impact assessment (qualifier value)	4180186
44803682	Health promotion model (qualifier value)	4180186
44803684	Hotel and restaurant industry (qualifier value)	4180186
44803687	Epilepsy screening first invitation (procedure)	4180186
44803689	Excepted from diabetes quality indicators - informed dissent (finding)	4180186
44803690	Referral modes (record artifact)	4180186
44803692	Role views (record artifact)	4180186
44803694	Excepted from coronary heart disease quality indicators - informed dissent (finding)	4180186
44803696	Exception reporting - depression quality indicators (finding)	4180186
44803697	Excepted from dementia quality indicators - informed dissent (finding)	4180186
44803698	Exception reporting - thyroid quality indicators (finding)	4180186
44803699	Rx - Treatment	4180186
44803699	Treatment (record artifact)	4180186
44803700	Diagnostic imaging request (record artifact)	4180186
44803702	Atrial fibrillation monitoring third letter (procedure)	4180186
44803703	Exception reporting - cardiovascular disease quality indicators (finding)	4180186
44803704	Excepted from cardiovascular disease quality indicators - patient unsuitable (finding)	4180186
44803707	Patient encounter administration data (record artifact)	4180186
44803710	Registered general practitioner practice code (record artifact)	4180186
44803712	Excepted from chronic obstructive pulmonary disease quality indicators - informed dissent (finding)	4180186
44803715	Excepted from thyroid quality indicators - informed dissent (finding)	4180186
44803716	Exception reporting - stroke quality indicators (finding)	4180186
44803717	Excepted from dementia quality indicators - patient unsuitable (finding)	4180186
44803719	Diagnostic imaging summary report (record artifact)	4180186
44803721	Exception reporting - sexual health quality indicators (finding)	4180186
44803723	Depression monitoring telephone invitation (procedure)	4180186
44803725	Excepted from learning disability quality indicators - informed dissent (finding)	4180186
44803727	International law (qualifier value)	4180186
44803733	National policy (qualifier value)	4180186
44803734	Nature reserve (qualifier value)	4180186
44803736	Organisational change (qualifier value)	4180186
44803738	Outreach work (qualifier value)	4180186
44803740	People with physical disability (qualifier value)	4180186
44803743	Professional role (qualifier value)	4180186
44803744	Population projection (qualifier value)	4180186
44803745	Psychology (qualifier value)	4180186
44803749	Regional government (qualifier value)	4180186
44803751	Scenario planning (qualifier value)	4180186
44803753	Sites of special scientific interest (qualifier value)	4180186
44803754	Small group work (qualifier value)	4180186
44803755	Social determinant (qualifier value)	4180186
44803756	Social marketing (qualifier value)	4180186
44803757	Sociodemographic factor (qualifier value)	4180186
44803758	Strategic planning (qualifier value)	4180186
44803761	Lipid disorder monitoring verbal invitation (procedure)	4180186
44803763	Read code administration (record artifact)	4180186
44803764	Excepted from asthma quality indicators - informed dissent (finding)	4180186
44803766	Excepted from cancer quality indicators - patient unsuitable (finding)	4180186
44803767	Reason for repeat laboratory test (record artifact)	4180186
44803768	Patient registration data (record artifact)	4180186
44803769	Communication with patient/client	4180186
44803769	Participation (record artifact)	4180186
44803771	Past health characteristics (record artifact)	4180186
44803772	Referred encounter (record artifact)	4180186
44803773	Excepted from stroke quality indicators - patient unsuitable (finding)	4180186
44803774	Request types (record artifact)	4180186
44803775	Relevant supporting information for diagnostic imaging request (record artifact)	4180186
44803776	Clinical administration (record artifact)	4180186
44803777	Heart failure monitoring third letter (procedure)	4180186
44803779	Chronic kidney disease monitoring first letter (procedure)	4180186
44803782	Depression monitoring second letter (procedure)	4180186
44803783	Excepted from sexual health quality indicators - patient unsuitable (finding)	4180186
44803785	Patient miscellaneous administration data (record artifact)	4180186
44803786	Atrial fibrillation monitoring telephone invitation (procedure)	4180186
44803786	Atrial fibrillation monitoring telephone invite	4180186
44803789	Lipid disorder monitoring second letter (procedure)	4180186
44803790	Anonymised copy of record (record artifact)	4180186
44803791	Excepted from hypertension quality indicators - informed dissent (finding)	4180186
44803793	Exception reporting - cancer quality indicators (finding)	4180186
44803794	Excepted from epilepsy quality indicators - patient unsuitable (finding)	4180186
44803795	Epilepsy screening third invitation (procedure)	4180186
44803799	Past (record artifact)	4180186
44803803	Waiting time (qualifier value)	4180186
44803804	World Health Organisation region (qualifier value)	4180186
44803808	Asian people (qualifier value)	4180186
44803809	Colorectal cancer (qualifier value)	4180186
44803813	Sexual violence (qualifier value)	4180186
44803814	Travelling (qualifier value)	4180186
44803815	Gynaecology (qualifier value)	4180186
44803817	Action research (qualifier value)	4180186
44803818	Ageing population (qualifier value)	4180186
44803821	Biomedical science (qualifier value)	4180186
44803823	Care worker (qualifier value)	4180186
44803824	Case study (qualifier value)	4180186
44803825	Catering industry (qualifier value)	4180186
44803826	Community growing scheme (qualifier value)	4180186
44803827	Computer network (qualifier value)	4180186
44803831	Data (qualifier value)	4180186
44803833	Deprived area (qualifier value)	4180186
44803835	Chronic obstructive pulmonary disease monitoring telephone invitation (procedure)	4180186
44803836	Exception reporting - diabetes quality indicators (finding)	4180186
44803838	Record headings (record artifact)	4180186
44803839	Repeat medication (record artifact)	4180186
44803841	Heart failure monitoring first letter (procedure)	4180186
44803842	Atrial fibrillation monitoring second letter (procedure)	4180186
44803843	Dementia monitoring telephone invitation (procedure)	4180186
44803844	Caution - same name - check patient (record artifact)	4180186
44803845	Atrial fibrillation monitoring verbal invitation (procedure)	4180186
44803845	Atrial fibrillation monitoring verbal invite	4180186
44803847	Community disease modifying antirheumatic drug monitoring appointment (record artifact)	4180186
44803847	Community DMARD (disease modifying antirheumatic drug) monitoring appointment	4180186
44803849	Cervical smear slide lost in transit (finding)	4180186
44803852	Referral for falls risk assessment (procedure)	4180186
44803853	Falls risk assessment declined (finding)	4180186
44803855	History of	4180186
44803855	History (record artifact)	4180186
44803855	Presenting complaint	4180186
44803856	Health characteristics (record artifact)	4180186
44803857	Future (record artifact)	4180186
44803858	Outlook (record artifact)	4180186
44803861	Heart failure monitoring second letter (procedure)	4180186
44803862	Depression monitoring first letter (procedure)	4180186
44803863	Atrial fibrillation monitoring first letter (procedure)	4180186
44803865	Read code Scottish administration chapter (record artifact)	4180186
44803868	Excepted from left ventricular disease quality indicators - informed dissent (finding)	4180186
44803876	Department of Health or National Health Service local policy (qualifier value)	4180186
44803882	Food and drink industry (qualifier value)	4180186
44803883	Government and law (qualifier value)	4180186
44803885	Health indicator (qualifier value)	4180186
44803892	Library and information centre (qualifier value)	4180186
44803897	Organisation (qualifier value)	4180186
44803898	Personalised data (qualifier value)	4180186
44803901	Private sector (qualifier value)	4180186
44803902	Private transport (qualifier value)	4180186
44803905	Quantitative research (qualifier value)	4180186
44803907	Research project (qualifier value)	4180186
44803912	Fulfiller request details (record artifact)	4180186
44803912	Service order request details	4180186
44803916	Excepted from heart failure quality indicators - patient unsuitable (finding)	4180186
44803918	Heart failure monitoring verbal invitation (procedure)	4180186
44803919	Chronic kidney disease monitoring telephone invitation (procedure)	4180186
44803919	Chronic kidney disease monitoring telephone invite	4180186
44803921	Heart failure monitoring telephone invitation (procedure)	4180186
44803922	Exception reporting - myocardial infarction quality indicators (finding)	4180186
44803924	New appointment (record artifact)	4180186
44803927	Community disease modifying antirheumatic drug monitoring record returned to patient (finding)	4180186
44803927	Community DMARD (disease modifying antirheumatic drug) monitoring record returned to patient	4180186
44803929	At risk of (record artifact)	4180186
44803930	Registration information (record artifact)	4180186
44803932	Exception reporting - epilepsy quality indicators (finding)	4180186
44803933	Excepted from thyroid quality indicators - patient unsuitable (finding)	4180186
44803934	Relevant clinical information for diagnostic imaging request (record artifact)	4180186
44803935	Problems (record artifact)	4180186
44803937	Chronic kidney disease monitoring second letter (procedure)	4180186
44803938	Exception reporting - smoking quality indicators (finding)	4180186
44803950	Trainer (qualifier value)	4180186
44803953	Waiting area (qualifier value)	4180186
44803956	Disability equipment (qualifier value)	4180186
44803957	Illegal sale (qualifier value)	4180186
44803958	Knowledge (qualifier value)	4180186
44803959	Black people (qualifier value)	4180186
44803961	Community care (qualifier value)	4180186
44803965	Calorie (qualifier value)	4180186
44803967	Quality (qualifier value)	4180186
44803969	Social class (qualifier value)	4180186
44803970	Access to information (qualifier value)	4180186
44803972	Census environmental deprivation and output area (qualifier value)	4180186
44803973	GPC claim - registration examination signed (finding)	4180186
44803974	Bilateral trilobed lung (disorder)	4180186
44803976	Nepali (ethnic group)	4180186
44803977	Dysphagia screen completed (situation)	4180186
44803977	Dysphagia screening completed	4180186
44803980	Removal of subcutaneous contraceptive implant by other healthcare provider (situation)	4180186
44803985	Area based classification (qualifier value)	4180186
44803987	Biological composition (qualifier value)	4180186
44803988	Casual employment (qualifier value)	4180186
44803991	Community development worker (qualifier value)	4180186
44803992	Community health (qualifier value)	4180186
44803994	Census ward level (qualifier value)	4180186
44803997	Child development (qualifier value)	4180186
44803998	Climate (qualifier value)	4180186
44804000	Confidentiality (qualifier value)	4180186
44804001	Dieting for weight loss (qualifier value)	4180186
44804003	Distance learning (qualifier value)	4180186
44804004	Ecology (qualifier value)	4180186
44804005	Ecstasy (qualifier value)	4180186
44804008	Environmental impact assessment (qualifier value)	4180186
44804012	Health behaviour maintenance (qualifier value)	4180186
44804014	Healthy eating (qualifier value)	4180186
44804017	Indoor air pollution (qualifier value)	4180186
44804018	Information management (qualifier value)	4180186
44804019	Insulation (qualifier value)	4180186
44804021	Legislation (qualifier value)	4180186
44804023	Long term unemployment (qualifier value)	4180186
44804024	Migration (qualifier value)	4180186
44804026	GPC claim - registration examination sent to Health Board (finding)	4180186
44804027	Control group (qualifier value)	4180186
44804028	Cooking (qualifier value)	4180186
44804029	Crime (qualifier value)	4180186
44804030	Cultural identity (qualifier value)	4180186
44804031	Delphi method (qualifier value)	4180186
44804034	European organisation (qualifier value)	4180186
44804036	Food hygiene (qualifier value)	4180186
44804037	Food labelling (qualifier value)	4180186
44804039	Genetic modification (qualifier value)	4180186
44804041	Gypsies and travellers (qualifier value)	4180186
44804042	Health gain (qualifier value)	4180186
44804043	Health inequality (qualifier value)	4180186
44804044	Health intervention (qualifier value)	4180186
44804045	Health policy (qualifier value)	4180186
44804047	Health shop (qualifier value)	4180186
44804048	Impact assessment (qualifier value)	4180186
44804049	Industrial pollution (qualifier value)	4180186
44804051	Interagency working (qualifier value)	4180186
44804052	Job evaluation (qualifier value)	4180186
44804054	Management and policy (qualifier value)	4180186
44804055	Manufacturing industry (qualifier value)	4180186
44804056	Medicine (qualifier value)	4180186
44804058	National curriculum (qualifier value)	4180186
44804060	Patient advice (qualifier value)	4180186
44804061	Population size and density (qualifier value)	4180186
44804063	Preconception (qualifier value)	4180186
44804064	Public service (qualifier value)	4180186
44804065	Regional development (qualifier value)	4180186
44804067	Research design (qualifier value)	4180186
44804068	Safe sex (qualifier value)	4180186
44804069	School meal (qualifier value)	4180186
44804072	Shift work (qualifier value)	4180186
44804073	Small business (qualifier value)	4180186
44804074	Social issue (qualifier value)	4180186
44804075	Social study (qualifier value)	4180186
44804076	Supranational issue (qualifier value)	4180186
44804077	Survival rate (qualifier value)	4180186
44804078	Task force (qualifier value)	4180186
44804082	Frail older people (qualifier value)	4180186
44804085	Epidemiological measurement (qualifier value)	4180186
44804087	Living condition (qualifier value)	4180186
44804088	Lobbying (qualifier value)	4180186
44804089	Qualification requirement (qualifier value)	4180186
44804090	Seen in L.A. clinic-FPA (finding)	4180186
44804094	GMS3 claim - temporary contraceptive (non intrauterine contraceptive device) sent to health authority (finding)	4180186
44804096	Ophthalmic service (qualifier value)	4180186
44804098	Patient choice (qualifier value)	4180186
44804102	Personal safety (qualifier value)	4180186
44804104	Private health care (qualifier value)	4180186
44804110	Quality control (qualifier value)	4180186
44804112	Questionnaire (qualifier value)	4180186
44804113	Residential care (qualifier value)	4180186
44804114	School counselling (qualifier value)	4180186
44804116	Service development (qualifier value)	4180186
44804120	Socioeconomic factor (qualifier value)	4180186
44804122	Strategic plan (qualifier value)	4180186
44804123	Target group (qualifier value)	4180186
44804124	Training and enterprise council (qualifier value)	4180186
44804130	Inequality (qualifier value)	4180186
44804136	Child poverty (qualifier value)	4180186
44804137	Child welfare (qualifier value)	4180186
44804141	Cost effectiveness (qualifier value)	4180186
44804145	Developing country (qualifier value)	4180186
44804146	Developmental screening (qualifier value)	4180186
44804151	Ergonomic (qualifier value)	4180186
44804154	Fluoridation (qualifier value)	4180186
44804155	Food cooperative (qualifier value)	4180186
44804158	Geology and topography (qualifier value)	4180186
44804159	Hard to reach group (qualifier value)	4180186
44804161	Supervised consumption of medication (procedure)	4180186
44804162	Supervised consumption of buprenorphine (procedure)	4180186
44804165	Screening for sepsis (procedure)	4180186
44804165	Septic screening	4180186
44804166	Giving self-help leaflet (procedure)	4180186
44804167	Provision of information about PALS (Patient Advice and Liaison Service)	4180186
44804167	Provision of information about Patient Advice and Liaison Service (procedure)	4180186
44804169	Provision of monkey pole	4180186
44804169	Provision of over bed pole hoist (procedure)	4180186
44804170	Consent given for communication by telephone (finding)	4180186
44804171	Referral to Princess Royal Trust carers centre (procedure)	4180186
44804173	No wound discharge (situation)	4180186
44804174	Non-steroidal anti-inflammatory drug risk assessment completed (finding)	4180186
44804174	NSAID (non-steroidal anti-inflammatory drug) risk assessment completed	4180186
44804175	Removal of previous cemented total prosthetic replacement of hip joint (procedure)	4180186
44804179	Prostate specific antigen monitoring first letter (procedure)	4180186
44804179	PSA (prostate specific antigen) monitoring first letter	4180186
44804181	Prostate specific antigen monitoring third letter (procedure)	4180186
44804181	PSA (prostate specific antigen) monitoring third letter	4180186
44804183	Travel to work area (qualifier value)	4180186
44804184	Unitary authority (qualifier value)	4180186
44804185	Urban development (qualifier value)	4180186
44804187	Water quality (qualifier value)	4180186
44804191	Employment legislation (qualifier value)	4180186
44804192	Nursery school (qualifier value)	4180186
44804193	Social care (qualifier value)	4180186
44804194	Theory (qualifier value)	4180186
44804198	Personal relationship (qualifier value)	4180186
44804199	Sun protection (qualifier value)	4180186
44804200	Unemployed person (qualifier value)	4180186
44804201	Well neonate (qualifier value)	4180186
44804205	Emergency services (qualifier value)	4180186
44804206	Alcohol related harm (qualifier value)	4180186
44804207	All causes of morbidity and mortality (qualifier value)	4180186
44804208	Art (qualifier value)	4180186
44804212	Case control study (qualifier value)	4180186
44804213	Clinical network (qualifier value)	4180186
44804217	Healthy living centre (qualifier value)	4180186
44804222	Human rights (qualifier value)	4180186
44804226	International issue (qualifier value)	4180186
44804227	International organisation (qualifier value)	4180186
44804228	Leisure activity (qualifier value)	4180186
44804229	Leisure industry (qualifier value)	4180186
44804230	Leisure time (qualifier value)	4180186
44804233	Long term condition (qualifier value)	4180186
44804238	Outdoor air pollution (qualifier value)	4180186
44804239	Parish (qualifier value)	4180186
44804240	Parole work (qualifier value)	4180186
44804241	Performance indicator (qualifier value)	4180186
44804242	Performance monitoring (qualifier value)	4180186
44804244	Physiology (qualifier value)	4180186
44804245	Placebo (qualifier value)	4180186
44804248	Assessment using ODI (Oswestry disability index)	4180186
44804248	Assessment using Oswestry disability index (procedure)	4180186
44804250	Assessment using ACLS (Allen cognitive level screen)	4180186
44804250	Assessment using Allen cognitive level screen (procedure)	4180186
44804251	Assessment using AMPS (assessment motor and process skills)	4180186
44804251	Assessment using assessment of motor and process skills (procedure)	4180186
44804254	Assessment using model of human occupation screening tool version 2.0 (procedure)	4180186
44804254	Assessment using MOHOST (model of human occupation screening tool) version 2.0	4180186
44804255	Referral to ophthalmologist within 48 hours (procedure)	4180186
44804262	ACE-R (Addenbrooke's cognitive examination - revised) memory subscore	4180186
44804262	Addenbrooke's cognitive examination revised - memory subscore (observable entity)	4180186
44804263	GMS3 claim - temporary contraceptive (non IUCD) paid (finding)	4180186
44804266	Steroid treatment card issued (finding)	4180186
44804268	Notification of missing child	4180186
44804268	Notification to safeguarding service of missing child (finding)	4180186
44804270	Advance decision signed	4180186
44804270	Advance decision to refuse treatment signed (finding)	4180186
44804271	Leg pain on elevation (finding)	4180186
44804272	Osteoporosis resolved (finding)	4180186
44804273	Osteopenia resolved (finding)	4180186
44804274	Skull sample (specimen)	4180186
44804276	Community participation (qualifier value)	4180186
44804278	Dance (qualifier value)	4180186
44804281	Disability access (qualifier value)	4180186
44804282	Disadvantaged group (qualifier value)	4180186
44804284	Economics (qualifier value)	4180186
44804285	Employment (qualifier value)	4180186
44804287	Medical error (qualifier value)	4180186
44804288	Feminism (qualifier value)	4180186
44804290	Food regulation (qualifier value)	4180186
44804292	Frame of reference (qualifier value)	4180186
44804298	Health region (qualifier value)	4180186
44804299	Healthy life expectancy (qualifier value)	4180186
44804302	Life expectancy (qualifier value)	4180186
44804306	Microbicide (qualifier value)	4180186
44804308	Research method (qualifier value)	4180186
44804309	School travel plan (qualifier value)	4180186
44804311	Use level self care (qualifier value)	4180186
44804312	Self related health (qualifier value)	4180186
44804314	Social network (qualifier value)	4180186
44804315	Specific health measure (qualifier value)	4180186
44804316	Statistical data (qualifier value)	4180186
44804320	Traffic free route (qualifier value)	4180186
44804322	Voluntary agencies national policy (qualifier value)	4180186
44804323	Community action (qualifier value)	4180186
44804327	Internet (qualifier value)	4180186
44804328	Setting and place (qualifier value)	4180186
44804330	Accident and emergency service (qualifier value)	4180186
44804331	Genetics (qualifier value)	4180186
44804332	Donor (qualifier value)	4180186
44804340	Depression monitoring invitation (procedure)	4180186
44804341	Heart failure monitoring invitation (procedure)	4180186
44804342	Lipid disorder monitoring invitation (procedure)	4180186
44804343	Patient registered general practitioner (observable entity)	4180186
44804343	Patient's registered GP (general practitioner)	4180186
44804344	Epilepsy screening invitation (procedure)	4180186
44804345	Pain relieved by lowering leg (finding)	4180186
44804349	Cervical smear screening second letter (procedure)	4180186
44804351	Cervical smear screening third letter (procedure)	4180186
44804352	Cervical smear screening verbal invitation (procedure)	4180186
44804355	C-terminal telopeptide of type I collagen level	4180186
44804355	CTx (carboxy-terminal telopeptide) level	4180186
44804355	Measurement of carboxy-terminal telopeptide of type I collagen (procedure)	4180186
44804360	Carer not aware of prognosis	4180186
44804360	Carer unaware of prognosis (situation)	4180186
44804362	Notifiable disease (qualifier value)	4180186
44804365	Patient information (qualifier value)	4180186
44804366	Patient right (qualifier value)	4180186
44804367	Peer education (qualifier value)	4180186
44804371	Population change (qualifier value)	4180186
44804373	Professional practice (qualifier value)	4180186
44804375	Public health observatory (qualifier value)	4180186
44804377	Public sector (qualifier value)	4180186
44804378	Regional policy (qualifier value)	4180186
44804382	Self advocacy (qualifier value)	4180186
44804383	Service provision (qualifier value)	4180186
44804384	Social indicator (qualifier value)	4180186
44804385	Social service district (qualifier value)	4180186
44804386	Stroke and transient ischaemic attack (qualifier value)	4180186
44804387	Tobacco control policy (qualifier value)	4180186
44804389	Tropical disease (qualifier value)	4180186
44804391	Water accident (qualifier value)	4180186
44804392	Young adult (qualifier value)	4180186
44804393	Assessment using barriers to employment and coping efficacy scale (procedure)	4180186
44804393	Assessment using BECES (barriers to employment and coping efficacy scale)	4180186
44804394	GMS4 claim - contraception (non intrauterine contraceptive device) due next visit (finding)	4180186
44804394	GMS4 claim - contraception (non IUCD - intrauterine contraceptive device) due next visit	4180186
44804395	GMS4 claim - contraception (non intrauterine contraceptive device) forgot to claim (finding)	4180186
44804395	GMS4 claim - contraception (non IUCD - intrauterine contraceptive device) forgot to claim	4180186
44804404	GMS4 claim - immunisation (Rate A) sent to health authority (finding)	4180186
44804406	GMS4 claim - minor surgery sent to health authority (finding)	4180186
44804411	Lives in ground floor flat (finding)	4180186
44804413	GP/PS1 form requested from Health Board (finding)	4180186
44804414	GP/PS1 form sent to Health Board (finding)	4180186
44804417	GP/PS2 form not approved by Health Board (finding)	4180186
44804419	GP/PS2 form sent to Health Board (finding)	4180186
44804420	GP/PS3 form - notification of change of post holder (record artifact)	4180186
44804428	Assessment using Valpar 17 pre-vocational readiness battery (procedure)	4180186
44804433	Learning disability annual health check invitation third letter (procedure)	4180186
44804434	Bookstart pack given (procedure)	4180186
44804435	Referral for multidisciplinary review (procedure)	4180186
44804436	Practice based smoking cessation programme start date (observable entity)	4180186
44804440	Elective service (qualifier value)	4180186
44804443	Sun safe policy (qualifier value)	4180186
44804444	Disability care (qualifier value)	4180186
44804445	Prostitution (qualifier value)	4180186
44804448	Chiropody (qualifier value)	4180186
44804449	Aetiology (qualifier value)	4180186
44804458	Child health (qualifier value)	4180186
44804460	Community mental health service (qualifier value)	4180186
44804461	Community nursing (qualifier value)	4180186
44804462	Condom distribution (qualifier value)	4180186
44804463	Consumer information (qualifier value)	4180186
44804466	Dental health (qualifier value)	4180186
44804467	Determinant of health (qualifier value)	4180186
44804468	Disability housing (qualifier value)	4180186
44804469	Discrimination (qualifier value)	4180186
44804471	GP13 ex Her Majesty's forces registration form (record artifact)	4180186
44804472	GP22 deregistration - added in error (finding)	4180186
44804473	GP22 deregistration - death (finding)	4180186
44804477	GP22 deregistration - patient whereabouts known (finding)	4180186
44804478	Seen in day surgery unit (finding)	4180186
44804480	GP22 deregistration - removed at doctor's request (finding)	4180186
44804481	GP22 deregistration - transfer with doctor's consent (finding)	4180186
44804485	GP22 deregistration - removal from residential institute (finding)	4180186
44804489	GP22 deregistration - practice advise removal via vaccination data (finding)	4180186
44804492	GP22 deregistration - moved out of area (finding)	4180186
44804494	GP22 deregistration - internal transfer address change (finding)	4180186
44804495	GP22 deregistration - in psychiatric hospital (finding)	4180186
44804497	GP22 deregistration - adopted, re-registered with new name (finding)	4180186
44804501	Antacid therapy (procedure)	4180186
44804504	No history of vitrectomy (situation)	4180186
44804506	No history of laser eye surgery (situation)	4180186
44804507	No family history of renal disease (situation)	4180186
44804509	No history of diabetic nephropathy (situation)	4180186
44804510	No diabetic autonomic neuropathy (situation)	4180186
44804514	Lower risk alcohol drinking (finding)	4180186
44804515	Finding of alcohol drinking risk (finding)	4180186
44804516	No history of renal disease (situation)	4180186
44804517	HPV (human papillomavirus) vaccination invitation first SMS (short message service) text message sent	4180186
44804517	Human papillomavirus vaccination invitation first short message service text message sent (situation)	4180186
44804518	Reason for no contraception (observable entity)	4180186
44804520	Influenza vaccination invitation first short message service text message sent (finding)	4180186
44804520	Influenza vaccination invitation first SMS (short message service) text message sent	4180186
44804520	Influenza vaccination invitation first text message sent	4180186
44804524	Expectation of weight management programme (observable entity)	4180186
44804527	Well-being assessment for long term conditions not appropriate (finding)	4180186
44804528	Offer of well-being assessment for long term conditions accepted (finding)	4180186
44804529	Well-being assessment for long term conditions declined (situation)	4180186
44804532	Fundoplication status (finding)	4180186
44804534	On examination - Right diabetic foot at increased risk (finding)	4180186
44804535	Sending of discharge summary to general practitioner (procedure)	4180186
44804536	Lithium therapy record book completed (finding)	4180186
44804537	PBCL flag true: report, text, boolean (qualifier value)	4180186
44804538	General practitioner assessment of cognition informant score (observable entity)	4180186
44804538	GPCOG (general practitioner assessment of cognition) informant score	4180186
44804539	General practitioner assessment of cognition patient score (observable entity)	4180186
44804539	GPCOG (general practitioner assessment of cognition) patient score	4180186
44804547	Preferred place of death: patient declined discussion (finding)	4180186
44804550	Down's syndrome antenatal screening information leaflet given	4180186
44804550	Downs syndrome antenatal screening information leaflet given (situation)	4180186
44804558	Referral to walk in centre nurse (procedure)	4180186
44804559	National Health Service Continuing Healthcare (record artifact)	4180186
44804562	National Health Service Continuing Healthcare Request for Assessment (record artifact)	4180186
44804563	National Health Service Continuing Healthcare Request for Assessment Acceptance (record artifact)	4180186
44804570	Smoking status at 12 weeks (observable entity)	4180186
44804573	Previous general practitioner clinical record requested (finding)	4180186
44804578	Capable of work on work capability assessment criteria (finding)	4180186
44804579	Columelloplasty (procedure)	4180186
44804580	Referral for smoking cessation service offered (finding)	4180186
44804581	Referral to weight management service offered (finding)	4180186
44804582	Referral for management of impaired glucose tolerance (procedure)	4180186
44804587	Main spoken language Kannada (finding)	4180186
44804589	Treatment outcome expected by patient (observable entity)	4180186
44804590	Unable to do laundry (finding)	4180186
44804591	Able to do laundry (finding)	4180186
44804592	Legal guardian present at encounter (finding)	4180186
44804595	Percentage volume difference between lower limbs (observable entity)	4180186
44804596	Quantitative volume difference between lower limbs (observable entity)	4180186
44804600	Upper limb proximal segment volume (observable entity)	4180186
44804601	Quantitative volume difference between upper limbs (observable entity)	4180186
44804608	Impact of illness on lifestyle (observable entity)	4180186
44804611	Oak pollen RAST test	4180186
44804611	Quercus petraea specific immunoglobulin E antibody measurement (procedure)	4180186
44804611	Sessile oak RAST test	4180186
44804612	Referral to child protection service under section 47 of Children Act 1989 (procedure)	4180186
44804613	Elm pollen RAST test	4180186
44804613	English elm RAST test	4180186
44804613	Ulmus procera specific immunoglobulin E antibody measurement (procedure)	4180186
44804622	Education for transdermal contraceptive patch (procedure)	4180186
44804626	Declined consent for examination of cardiovascular system (finding)	4180186
44804628	Declined consent for examination of gastrointestinal system (finding)	4180186
44804632	Advice about food intake (procedure)	4180186
44804636	Insulin sensitivity factor - breakfast (observable entity)	4180186
44804639	Insulin/carbohydrate ratio - evening meal (observable entity)	4180186
44804639	Insulin/carbohydrate ratio - tea	4180186
44804640	Insulin/carbohydrate ratio - breakfast (observable entity)	4180186
44804641	Referral offered (finding)	4180186
44804642	Reason for initial weight gain (observable entity)	4180186
44804645	Declined consent to share clinical information with general practitioner (finding)	4180186
44804646	Initiation of partner notification (procedure)	4180186
44804648	Declined to perform inhaler technique (situation)	4180186
44804650	End of life advance care plan (record artifact)	4180186
44804651	Referral to community alcohol team declined (situation)	4180186
44804653	Minor surgery care management (procedure)	4180186
44804656	GPC claim - minor surgery returned unpaid (finding)	4180186
44804657	No family history of bowel cancer (situation)	4180186
44804658	No family history of ovarian cancer (situation)	4180186
44804659	Residential home acquired pressure ulcer (disorder)	4180186
44804661	Not eligible for bowel cancer screening programme (finding)	4180186
44804662	TAG (threshold assessment grid) score	4180186
44804662	Threshold assessment grid score (observable entity)	4180186
44804663	TAG (threshold assessment grid) domain score	4180186
44804663	Threshold assessment grid domain score (observable entity)	4180186
44804664	TAG (threshold assessment grid) total score	4180186
44804664	Threshold assessment grid total score (observable entity)	4180186
44804666	Carrier of Duchenne muscular dystrophy gene mutation (finding)	4180186
44804667	Carrier of Becker muscular dystrophy gene mutation (finding)	4180186
44804671	Multiple sclerosis monitoring administration (record artifact)	4180186
44804673	Multiple sclerosis monitoring first letter (procedure)	4180186
44804676	Multiple sclerosis monitoring telephone invitation (procedure)	4180186
44804677	Lipid disorder treatment started (situation)	4180186
44804680	TB (tuberculosis) screening chest X-ray declined	4180186
44804680	Tuberculosis screening chest X-ray declined (situation)	4180186
44804682	No family history of hip fracture in first degree relative (situation)	4180186
44804684	TB (tuberculosis) screening chest X-ray normal	4180186
44804684	Tuberculosis screening chest X-ray normal (finding)	4180186
44804687	History of bariatric operative procedure (situation)	4180186
44804691	Drug addiction maintenance therapy - naltrexone (regime/therapy)	4180186
44804692	All foot pulses palpable (finding)	4180186
44804693	Drug addiction maintenance therapy - lofexidine (regime/therapy)	4180186
44804694	Assessment for termination of pregnancy (procedure)	4180186
44804696	History of postcoital contraceptive usage (situation)	4180186
44804701	Last days of life discussed (situation)	4180186
44804704	Chester step test (procedure)	4180186
44804705	Consent given for treatment by student (finding)	4180186
44804706	Housing assessment completed (situation)	4180186
44804710	Beta-N-acetylhexosaminidase level (procedure)	4180186
44804712	Migraine induced by oestrogen contraceptive (disorder)	4180186
44804715	Measurement of rate of reabsorption of phosphate from renal tubule (procedure)	4180186
44804717	Over 75 health check invitation (procedure)	4180186
44804720	Referral to community perinatal mental health team (procedure)	4180186
44804721	Batch prescription amended (finding)	4180186
44804723	Batch prescription issued (finding)	4180186
44804724	Education about child health surveillance (procedure)	4180186
44804726	Education about chronic obstructive pulmonary disease (procedure)	4180186
44804727	Education about family support (procedure)	4180186
44804731	Education about registration of birth (procedure)	4180186
44804733	Right peroneal doppler pressure (procedure)	4180186
44804736	Worsening limb spasticity (finding)	4180186
44804738	Major complex surgery care management (procedure)	4180186
44804740	Outpatient care management (procedure)	4180186
44804741	Community care management (procedure)	4180186
44804743	GPC claim - anaesthetic signed (finding)	4180186
44804744	Referral to home oxygen service (procedure)	4180186
44804745	Congenital abnormality of leaflet of mitral valve (disorder)	4180186
44804747	At high risk of domestic violence (finding)	4180186
44804749	Did not attend spirometry clinic (finding)	4180186
44804751	Elongated mitral papillary muscle (disorder)	4180186
44804754	Atrioventricular septal defect with ventricular imbalance (disorder)	4180186
44804755	Gelatinous right atrioventricular valve leaflet (disorder)	4180186
44804756	Noncoapting right atrioventricular valve leaflet (disorder)	4180186
44804761	Noncoapting left atrioventricular valve leaflet (disorder)	4180186
44804763	Did not attend colposcopy clinic (finding)	4180186
44804766	Anomalous anterolateral muscle bands of left ventricle (disorder)	4180186
44804769	Subaortic left ventricular outflow tract obstruction (disorder)	4180186
44804770	Subpulmonary left ventricular outflow tract obstruction (disorder)	4180186
44804771	Ventricular septum intact (finding)	4180186
44804774	Left ventricular dysfunction due to right ventricular interaction (disorder)	4180186
44804775	Subaortic right ventricular outflow tract obstruction (disorder)	4180186
44804781	National Health Service continuing healthcare checklist completed (finding)	4180186
44804784	National Health Service continuing healthcare fast track funding refused (finding)	4180186
44804787	National Health Service continuing healthcare funding refused (finding)	4180186
44804789	Endurance shuttle walk test time taken (observable entity)	4180186
44804795	Hypogastric plexus block using fluoroscopic guidance (procedure)	4180186
44804797	Thoracic sympathetic plexus block using fluoroscopic guidance (procedure)	4180186
44804804	Insertion of gastrointestinal tonometer (procedure)	4180186
44804805	Post-resuscitation care management (procedure)	4180186
44804806	Safeguarding child case management (procedure)	4180186
44804808	Safeguarding vulnerable adult case management (procedure)	4180186
44804811	Biomechanical assessment (procedure)	4180186
44804812	Alcohol rehabilitation and detoxification care management (procedure)	4180186
44804813	Drug rehabilitation and detoxification care management (procedure)	4180186
44804814	Pulmonary artery catheter care assessment (procedure)	4180186
44804816	Critical care major surgery care management (procedure)	4180186
44804820	Visual impairment care management (procedure)	4180186
44804821	Progressing towards goal (finding)	4180186
44804822	Intraosseous device care management (procedure)	4180186
44804823	Discharge from primary healthcare team (procedure)	4180186
44804824	Referral for complex wound care (procedure)	4180186
44804825	Bilirubin fraction study (procedure)	4180186
44804826	Magnesium output measurement (procedure)	4180186
44804827	Antipsychotic medication review (procedure)	4180186
44804829	Non-invasive cardiac output monitoring (regime/therapy)	4180186
44804830	Measurement of ornithine output (procedure)	4180186
44804830	Ornithine output measurement	4180186
44804832	Improved exercise tolerance (finding)	4180186
44804833	Dynamometer pinch and gross grip scale score (observable entity)	4180186
44804836	Seen by emergency care practitioner (finding)	4180186
44804837	MEAMS (Middlesex elderly assessment of mental state) score	4180186
44804837	Middlesex elderly assessment of mental state score (observable entity)	4180186
44804838	Medical follow-up (record artifact)	4180186
44804841	H/O: beta blocker therapy	4180186
44804841	History of beta adrenoceptor blocking therapy (situation)	4180186
44804845	Generalised right ventricular dysfunction (disorder)	4180186
44804846	Regional right ventricular dysfunction (disorder)	4180186
44804847	Congenital abnormality of left atrioventricular valve papillary muscle (disorder)	4180186
44804847	Congenital abnormality of left AV (atrioventricular) valve papillary muscle	4180186
44804850	Obstruction of left ventricular inflow tract due to leftward displacement of interatrial septum (disorder)	4180186
44804852	Gelatinous mitral leaflet (disorder)	4180186
44804853	Noncoapting mitral leaflet (disorder)	4180186
44804858	Condolence letter sent (finding)	4180186
44804860	Medication review done by medicines management pharmacist (procedure)	4180186
44804861	Post-operative assessment at 6 weeks after secondary care discharge (regime/therapy)	4180186
44804862	Participant in Scottish Family Health Study (finding)	4180186
44804863	Repair of recurrent ventral hernia using insert of natural material (procedure)	4180186
44804865	Repair of recurrent ventral hernia using sutures (procedure)	4180186
44804867	Place of occurrence of accident or poisoning, recreational vehicle site	4180186
44804867	Place of occurrence of accident or poisoning, recreational vehicle site (environment)	4180186
44804868	Removal of fracture fixation device from spine (procedure)	4180186
44804871	Acquired hypotonia (finding)	4180186
44804871	[D]Acquired hypotonia	4180186
44804872	Copy of clinic correspondence declined (situation)	4180186
44804874	TOP (treatment outcomes profile)	4180186
44804874	Treatment outcomes profile (assessment scale)	4180186
44804876	Dissent for electronic record sharing overridden (finding)	4180186
44804878	Planned contraception method (finding)	4180186
44804879	Assessment using general practice physical activity questionnaire (procedure)	4180186
44804879	Assessment using GPPAQ (general practice physical activity questionnaire)	4180186
44804884	Referral to paediatric urologist (procedure)	4180186
44804885	Inappropriate use of accident and emergency service (procedure)	4180186
44804886	On examination - visual acuity right eye = 6/7.5 (finding)	4180186
44804888	Apolipoprotein B-100 measurement (procedure)	4180186
44804890	Protein output measurement (procedure)	4180186
44804891	Ketone measurement (procedure)	4180186
44804893	Copper output measurement (procedure)	4180186
44804895	Multidisciplinary care management (procedure)	4180186
44804896	Galactosyl transferase measurement (procedure)	4180186
44804897	CBT (cognitive behaviour therapy) care management	4180186
44804897	Cognitive behaviour therapy care management (procedure)	4180186
44804898	Optimal general body function (finding)	4180186
44804902	Goal not agreed (finding)	4180186
44804903	Cytoplasmic CD1a count (procedure)	4180186
44804904	CD2 count (procedure)	4180186
44804905	Cytoplasmic CD2 count (procedure)	4180186
44804908	Bed rail risk assessment (procedure)	4180186
44804910	Ovarian IgG antibody measurement	4180186
44804910	Ovarian immunoglobulin G antibody measurement (procedure)	4180186
44804911	Parathyroid IgG antibody measurement	4180186
44804911	Parathyroid immunoglobulin G antibody measurement (procedure)	4180186
44804912	Parietal cell immunoglobulin G antibody measurement (procedure)	4180186
44804915	Thiopentone specific immunoglobulin E antibody measurement (procedure)	4180186
44804917	Weight management service opportunity signposted (situation)	4180186
44804928	Grants (record artifact)	4180186
44804930	Procedure codes (community) (record artifact)	4180186
44804931	Coding schema (record artifact)	4180186
44804934	Bill sent (finding)	4180186
44804938	Mental health therapy follow-up (record artifact)	4180186
44804942	NHS Sickle Cell and Thalassaemia Screening Programme family origin South East Asia (Asian) (finding)	4180186
44804944	NHS Sickle Cell and Thalassaemia Screening Programme family origin Southern and other European (white) (finding)	4180186
44804949	NHS Sickle Cell and Thalassaemia Screening Programme India or African-Indian family origin (finding)	4180186
44804953	NHS Sickle Cell and Thalassaemia Screening Programme Thailand, Indonesia, Burma family origin (finding)	4180186
44804955	NHS Sickle Cell and Thalassaemia Screening Programme North Africa family origin (finding)	4180186
44804956	Lipofilling of breast (procedure)	4180186
44804957	Viscogonioplasty (procedure)	4180186
44804959	Chronic obstructive pulmonary disease 6 monthly review (regime/therapy)	4180186
44804959	COPD (chronic obstructive pulmonary disease) 6 monthly review	4180186
44804960	No longer housebound (finding)	4180186
44804967	Diagnostic endoscopic balloon examination of ileum (procedure)	4180186
44804970	Reconstruction of breast using free omental flap (procedure)	4180186
44804971	Percutaneous transluminal balloon dilation of interposition tube prosthesis between pulmonary artery and aorta (procedure)	4180186
44804972	Insertion of umbilical arterial catheter (procedure)	4180186
44804976	Night visit paid-higher rate	4180186
44804976	Night visit paid - higher rate (finding)	4180186
44804977	Group B streptococcus carrier (finding)	4180186
44804978	Insertion of central venous catheter using fluoroscopic guidance (procedure)	4180186
44804979	Sickle cell trait not suspected, no other haemoglobin or thalassaemia excluded (situation)	4180186
44804980	Screening incomplete as outside of area of current screening coverage (finding)	4180186
44804983	Fluoroscopic venogram of basilic vein using contrast with insertion of metallic stent graft	4180186
44804983	Fluoroscopic venography of basilic vein using contrast with insertion of metallic stent graft (procedure)	4180186
44804986	Seen by general practitioner with special interest in general surgery (finding)	4180186
44804987	History of diabetic ketoacidosis (situation)	4180186
44804990	Meropenem desensitisation therapy (regime/therapy)	4180186
44804992	Aztreonam desensitisation therapy (regime/therapy)	4180186
44804993	Referral to liver unit (procedure)	4180186
44804995	Stop smoking invitation short message service text message (procedure)	4180186
44804995	Stop smoking invitation text message	4180186
44804997	Stop smoking invitation second short message service text message (procedure)	4180186
44804997	Stop smoking invitation second text message	4180186
44804998	Stop smoking invitation third short message service text message (procedure)	4180186
44804998	Stop smoking invitation third text message	4180186
44804999	First tick-borne encephalitis vaccination (procedure)	4180186
44805003	Frequency of angina (observable entity)	4180186
44805005	Combined oral contraception leaflet given (situation)	4180186
44805006	Progestogen only oral contraception leaflet given (situation)	4180186
44805008	Diaphragm contraception leaflet given (situation)	4180186
44805011	CD41b count (procedure)	4180186
44805012	Cytoplasmic CD42b count (procedure)	4180186
44805015	NHS Sickle Cell and Thalassaemia Screening Programme Sardinia family origin (finding)	4180186
44805019	NHS Sickle Cell and Thalassaemia Screening Programme Scandinavia, Switzerland family origin (finding)	4180186
44805021	Patient declines to state family origin (finding)	4180186
44805023	Ndebele as a second language (finding)	4180186
44805024	Tswana as a second language (finding)	4180186
44805025	Zulu as a second language (finding)	4180186
44805026	Closure repair of cerebrospinal fluid leak from spinal cord (procedure)	4180186
44805027	Integrated Care and Support Plan - Continuing Health Care Funded (record artifact)	4180186
44805028	Integrated Care and Support Plan - Funded Nursing Care (record artifact)	4180186
44805029	Integrated Care and Support Plan - Local Authority Joint Funded (record artifact)	4180186
44805032	Advice given about lithium side-effects and toxicity (situation)	4180186
44805033	Congenital true tracheal bronchus (disorder)	4180186
44805033	Pig bronchus	4180186
44805033	Tracheal right upper lobe	4180186
44805034	Did not attend weight management special interest general practitioner clinic (finding)	4180186
44805040	Hepatitis C resolved (finding)	4180186
44805041	Able to adjust stoma bag (finding)	4180186
44805042	Able to change stoma bag (finding)	4180186
44805043	Able to cool home (finding)	4180186
44805050	Able to sense change in temperature (finding)	4180186
44805051	Able to swim (finding)	4180186
44805052	Able to use audiovisual appliance (finding)	4180186
44805053	Able to use personal computer (finding)	4180186
44805054	Adjusting to sensory loss (finding)	4180186
44805056	Requires assistance to adjust stoma bag (finding)	4180186
44805058	At risk of financial abuse (finding)	4180186
44805059	Refuses to attend dentist (finding)	4180186
44805060	Wears bone anchored hearing aid (finding)	4180186
44805063	Difficulty adjusting stoma bag (finding)	4180186
44805067	Difficulty sensing change in temperature (finding)	4180186
44805069	Application for disabled parking permit accepted (finding)	4180186
44805069	Blue Badge permit application accepted	4180186
44805071	Fluoroscopic venogram of brachial vein using contrast with insertion of metallic stent graft	4180186
44805071	Fluoroscopic venography of brachial vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805073	Fluoroscopic venogram of common femoral vein using contrast with insertion of metallic stent graft	4180186
44805073	Fluoroscopic venography of common femoral vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805079	Fluoroscopic venogram of popliteal vein using contrast with insertion of metallic stent graft	4180186
44805079	Fluoroscopic venography of popliteal vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805081	Fluoroscopic venogram of subclavian vein using contrast with insertion of metallic stent graft	4180186
44805081	Fluoroscopic venography of subclavian vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805085	Insulin/carbohydrate ratio (observable entity)	4180186
44805086	Insulin sensitivity factor (observable entity)	4180186
44805087	Asthma causes night time symptoms 1 to 2 times per week (finding)	4180186
44805089	Asthma causes symptoms most nights (finding)	4180186
44805091	Asthma limits activities 1 to 2 times per month (finding)	4180186
44805092	Asthma limits activities 1 to 2 times per week (finding)	4180186
44805094	National Health Service continuing healthcare process encounter type (record artifact)	4180186
44805095	Royal College of Physicians asthma assessment three questions score (observable entity)	4180186
44805098	CD45RO count (procedure)	4180186
44805099	Referral to community palliative care team declined (situation)	4180186
44805101	Repeat dispensing service declined (situation)	4180186
44805103	No evidence of diabetic nephropathy (situation)	4180186
44805104	Gadolinium specific immunoglobulin E antibody measurement (procedure)	4180186
44805105	Gadolinium specific immunoglobulin E (substance)	4180186
44805109	CD61 count (procedure)	4180186
44805110	CD58 count (procedure)	4180186
44805114	Depression care management (procedure)	4180186
44805115	Colistin desensitisation therapy (regime/therapy)	4180186
44805116	Amikacin desensitisation therapy (regime/therapy)	4180186
44805118	Antihistamine prophylaxis (procedure)	4180186
44805120	CD117 count (procedure)	4180186
44805123	Lung transplant planned (situation)	4180186
44805124	High sensitivity cardiac troponin T level	4180186
44805124	High sensitivity cardiac troponin T measurement (procedure)	4180186
44805125	Neutrophil phagocytosis test (procedure)	4180186
44805126	Safeguarding others case management (procedure)	4180186
44805127	Control and restraint management (procedure)	4180186
44805129	Percutaneous embolisation of lesion of kidney using fluoroscopic guidance (procedure)	4180186
44805130	O/E right dysplastic hip	4180186
44805130	On examination right dysplastic hip (disorder)	4180186
44805132	Referral to mental health in-reach team (procedure)	4180186
44805132	Referral to MHIT (mental health in-reach team)	4180186
44805133	Percutaneous embolisation of uterine vein using fluoroscopic guidance (procedure)	4180186
44805134	Telehealth monitoring declined (situation)	4180186
44805136	Biliary sepsis (disorder)	4180186
44805137	Farsi as a second language (finding)	4180186
44805137	Persian as a second language	4180186
44805145	Copy of referral letter offered to patient (finding)	4180186
44805146	Copy of referral letter not offered to patient (situation)	4180186
44805149	Coeliac disease monitoring invitation (procedure)	4180186
44805150	Coeliac disease monitoring telephone invitation (procedure)	4180186
44805153	Blue Badge permit holder	4180186
44805153	Holds disabled parking permit (finding)	4180186
44805156	Does cool home (finding)	4180186
44805158	Does heat home (finding)	4180186
44805162	Does not change stoma bag (finding)	4180186
44805164	Does not dress appropriately (finding)	4180186
44805165	Does not engage in mentally stimulating activity (finding)	4180186
44805167	Does not have pendant community alarm (finding)	4180186
44805169	Does not manage payment of bill (finding)	4180186
44805170	Does not sense change in temperature (finding)	4180186
44805171	Does not use audiovisual appliance (finding)	4180186
44805172	Does not use personal computer (finding)	4180186
44805173	Does sense change in temperature (finding)	4180186
44805174	Does use audiovisual appliance (finding)	4180186
44805175	Does use personal computer (finding)	4180186
44805176	Feels safe in own home (finding)	4180186
44805178	Has special cultural requirement (finding)	4180186
44805179	Has special spiritual requirement (finding)	4180186
44805180	Heating appliance suitable for living environment (finding)	4180186
44805181	In therapeutic work (finding)	4180186
44805183	Manages individual budget (finding)	4180186
44805184	Manages own care plan	4180186
44805184	Manages own support plan (finding)	4180186
44805185	Engages in mentally stimulating activity (finding)	4180186
44805186	Needs help managing payment of bill (finding)	4180186
44805187	No carbon monoxide monitor in home (finding)	4180186
44805188	Eats non food item (finding)	4180186
44805189	Wears pendant community alarm (finding)	4180186
44805192	Engages in social interaction (finding)	4180186
44805193	Unable to adjust stoma bag (finding)	4180186
44805195	Unable to dress appropriately (finding)	4180186
44805198	Magnetic resonance imaging of breast for screening (procedure)	4180186
44805201	Angina self management plan declined (situation)	4180186
44805202	Transthoracic echocardiography for complex congenital heart disease (procedure)	4180186
44805203	Transoesophageal echocardiography for complex congenital heart disease (procedure)	4180186
44805206	Dispensing review of use of medicines invitation (procedure)	4180186
44805208	On examination - epididymis normal	4180186
44805208	On examination - epididymis normal (finding)	4180186
44805210	On examination scrotum normal	4180186
44805210	On examination scrotum normal (finding)	4180186
44805212	Symptomatic diabetic peripheral neuropathy (disorder)	4180186
44805213	Implied consent for core Summary Care Record dataset upload (finding)	4180186
44805215	Admission to virtual ward (procedure)	4180186
44805217	Centromere immunoglobulin G antibody measurement (procedure)	4180186
44805218	Agaricus bisporus specific immunoglobulin E antibody measurement (procedure)	4180186
44805218	Button mushroom specific IgE antibody measurement	4180186
44805220	Advice about appropriate use of emergency appointment system (procedure)	4180186
44805221	Referral to primary care ophthalmology clinic (procedure)	4180186
44805224	Did not attend abdominal aortic aneurysm screening (finding)	4180186
44805228	Proteinase 3 immunoglobulin G antibody measurement (procedure)	4180186
44805231	Does not drive a vehicle (finding)	4180186
44805234	Measurement of keratin immunoglobulin G antibody (procedure)	4180186
44805238	Deterioration in ability to communicate (finding)	4180186
44805241	Home oxygen therapy review (procedure)	4180186
44805242	Ear syringing not completed (situation)	4180186
44805243	Referral for medication compliance support (procedure)	4180186
44805244	Percutaneous transluminal coil embolisation of fistula of coronary artery using fluoroscopic guidance (procedure)	4180186
44805247	Right ABPI (ankle brachial pressure index)	4180186
44805247	Right ankle brachial pressure index (procedure)	4180186
44805249	Lower limb percentage excess volume (observable entity)	4180186
44805251	Declined consent for follow-up evaluation after smoking cessation intervention (finding)	4180186
44805253	Use of inhaler device (procedure)	4180186
44805254	Registration transferred to practice pooled list (finding)	4180186
44805255	Has an informal carer (finding)	4180186
44805256	No longer has an informal carer (finding)	4180186
44805261	eMED3 (2010) new statement issued, not fit for work (finding)	4180186
44805262	Automated oto-acoustic emission test no clear response (finding)	4180186
44805266	eMED3 (2010) duplicate issued, not fit for work (finding)	4180186
44805267	eMED3 (2010) duplicate issued, may be fit for work (finding)	4180186
44805268	Unable to manage payment of bill (finding)	4180186
44805269	Unable to mobilise using mobility scooter (finding)	4180186
44805270	Unable to prepare snack (finding)	4180186
44805273	Unable to use audiovisual appliance (finding)	4180186
44805275	Uses visual aid (finding)	4180186
44805277	Did not attend congenital heart disease clinic (finding)	4180186
44805279	Referral to CDC (child development centre)	4180186
44805279	Referral to child development centre (procedure)	4180186
44805282	Seen by high intensity therapist (finding)	4180186
44805283	Coeliac disease monitoring (regime/therapy)	4180186
44805284	Common assessment framework for children and young people process initiated (finding)	4180186
44805287	Informal assessment for pressure ulcer risk (procedure)	4180186
44805287	Informal screening for pressure ulcer risk	4180186
44805289	Consent given for communication by telephone answer machine (finding)	4180186
44805291	Discharged from primary care mental health team (finding)	4180186
44805292	Initial case conference (procedure)	4180186
44805293	Review case conference (procedure)	4180186
44805294	Provision of local National Health Service service information (procedure)	4180186
44805296	Assessment using Cleveland Clinic constipation score (procedure)	4180186
44805300	Target serum total cholesterol level (observable entity)	4180186
44805302	Gynaecology major surgery inpatient care (regime/therapy)	4180186
44805303	Gynaecology minor surgery inpatient care (regime/therapy)	4180186
44805305	Liver failure support management (procedure)	4180186
44805306	Monitoring of blood loss per vagina (regime/therapy)	4180186
44805306	Monitoring of vaginal blood loss	4180186
44805312	Psychologically prepared to undergo surgery (finding)	4180186
44805313	Physically prepared to undergo surgery (finding)	4180186
44805316	Provision of copy of care plan (procedure)	4180186
44805318	Percutaneous transluminal insertion of metallic stent into coronary artery using fluoroscopic guidance (procedure)	4180186
44805320	Victim of sexual exploitation (finding)	4180186
44805321	Referral to atrial fibrillation clinic (procedure)	4180186
44805322	Referral for patch skin test (procedure)	4180186
44805324	Thyroid microsomal immunoglobulin G antibody measurement (procedure)	4180186
44805329	Myocardial immunoglobulin G antibody measurement (procedure)	4180186
44805330	Ribonucleoprotein immunoglobulin G antibody measurement (procedure)	4180186
44805333	Cryptococcus specific immunoglobulin E antibody measurement (procedure)	4180186
44805334	CD15 count (procedure)	4180186
44805335	CD18 count (procedure)	4180186
44805336	Immunoglobulin A subclass measurement (procedure)	4180186
44805337	Aquaporin-4 immunoglobulin G antibody measurement (procedure)	4180186
44805338	Frequent episodic tension-type headache (disorder)	4180186
44805340	Wishes to see money advisor (finding)	4180186
44805344	Referral to community dermatology service (procedure)	4180186
44805347	Does not have an informal carer (finding)	4180186
44805348	Automated auditory brainstem response test not done (situation)	4180186
44805350	MED3 (2010) issued by hand, may be fit for work (finding)	4180186
44805352	Diabetes monitoring invitation by short message service text messaging (procedure)	4180186
44805352	Diabetes monitoring invitation by SMS (short message service) text messaging	4180186
44805353	X-ray of sesamoid bone of foot (procedure)	4180186
44805356	Coeliac disease monitoring invitation third letter (procedure)	4180186
44805357	Advice given about prostate cancer screening (situation)	4180186
44805358	Referral to respiratory outreach team (procedure)	4180186
44805360	Revision of cardiac pacemaker electrode using fluoroscopic guidance (procedure)	4180186
44805361	History of buprenorphine misuse (situation)	4180186
44805362	Informed consent given for treatment (finding)	4180186
44805369	Accident and emergency department attendance avoided	4180186
44805369	A&E (accident and emergency) department attendance avoided	4180186
44805369	Determination of outcome, accident and emergency department attendance avoided (finding)	4180186
44805370	Short term drug therapy (procedure)	4180186
44805371	Severe lower urinary tract symptoms (finding)	4180186
44805372	Moderate lower urinary tract symptoms (finding)	4180186
44805373	Mild lower urinary tract symptoms (finding)	4180186
44805374	Peak expiratory flow rate after exercise (observable entity)	4180186
44805374	PEFR (peak expiratory flow rate) after exercise	4180186
44805375	Did not attend psychotherapy appointment (finding)	4180186
44805375	DNA (did not attend) psychotherapy appointment	4180186
44805377	Rarely has lunch (finding)	4180186
44805378	Usually has evening meal (finding)	4180186
44805379	Family history of thrombophilia (situation)	4180186
44805382	Self-referral to walk in centre (procedure)	4180186
44805384	Referral by out of hours general practitioner (procedure)	4180186
44805384	Referral by out of hours GP (general practitioner)	4180186
44805387	Subdermal etonogestrel implant insertion enhanced services administration (procedure)	4180186
44805391	Blood glucose range at bedtime (observable entity)	4180186
44805392	Seen in paediatric endocrinology clinic (finding)	4180186
44805393	Epidural catheter care education (procedure)	4180186
44805395	Gynaecology inpatient care plan (record artifact)	4180186
44805399	Gynaecology minor surgery inpatient care plan (record artifact)	4180186
44805402	Gynaecology unplanned inpatient care management (procedure)	4180186
44805404	Lower extremity ulcer care education (procedure)	4180186
44805405	Inpatient care plan (record artifact)	4180186
44805407	Minor surgery inpatient care plan (record artifact)	4180186
44805408	Unplanned inpatient care plan (record artifact)	4180186
44805409	Consultation where patient chose not to be involved encounter type (record artifact)	4180186
44805410	Advanced cardiovascular support management (procedure)	4180186
44805411	Basic cardiovascular support management (procedure)	4180186
44805412	Seen in paediatric otolaryngology clinic (finding)	4180186
44805413	Anorectal wound care management (procedure)	4180186
44805418	Attends regular retinal screening (finding)	4180186
44805425	Training grant received (finding)	4180186
44805428	Fasting blood test due (situation)	4180186
44805434	Optic cup disc ratio of left eye (observable entity)	4180186
44805436	Right quadriceps lag (observable entity)	4180186
44805439	Left straight leg raise test response (observable entity)	4180186
44805446	Breastfeeding assessment (procedure)	4180186
44805454	Included in Summary Care Record (record artifact)	4180186
44805458	Discharge summary sent to general practitioner (finding)	4180186
44805461	National Health Service Health Check annual review (procedure)	4180186
44805462	History of depot contraceptive injection usage (situation)	4180186
44805463	Percutaneous operation on heart (procedure)	4180186
44805465	Removal of male retropubic device (procedure)	4180186
44805467	Re-excision of skin margins (procedure)	4180186
44805468	Repair of recurrent hernia of abdominal wall (procedure)	4180186
44805471	Vacuum excision of lesion of organ (procedure)	4180186
44805472	Radiofrequency excision of lesion of organ (procedure)	4180186
44805473	Lipofilling injection into organ (procedure)	4180186
44805475	Occlusion of organ (procedure)	4180186
44805476	Introduction of substance into organ (procedure)	4180186
44805478	Destruction of organ NOC (procedure)	4180186
44805479	Coblation of organ (procedure)	4180186
44805482	Myelodysplastic syndrome drugs Band 1 (procedure)	4180186
44805483	Allergen immunotherapy drugs Band 1 (procedure)	4180186
44805484	First Haemophilus influenzae type B and meningitis C vaccination	4180186
44805484	First Haemophilus influenzae type B and Neisseria meningitidis serotype C combination vaccination (procedure)	4180186
44805485	Looked after child initial health assessment (procedure)	4180186
44805487	Investigations for male fertility (procedure)	4180186
44805488	Investigations for female fertility (procedure)	4180186
44805489	Self-medication with St John's wort (procedure)	4180186
44805490	History of diabetic nephropathy (situation)	4180186
44805497	Does not wear medical alert identification (finding)	4180186
44805499	Fitness for work record status (finding)	4180186
44805502	Fitness for work duplicate statement issued (finding)	4180186
44805503	Influenza A virus subtype H1N1 vaccination invitation short message service text message sent (finding)	4180186
44805505	At high risk of activity intolerance (finding)	4180186
44805506	At moderate risk of activity intolerance (finding)	4180186
44805507	At low risk of activity intolerance (finding)	4180186
44805513	Coronary sinus intact (finding)	4180186
44805515	Consent for communication by mail withdrawn (finding)	4180186
44805517	Exception reporting - osteoporosis quality indicators (finding)	4180186
44805518	Excepted from obesity quality indicators - patient unsuitable (finding)	4180186
44805519	Excepted from obesity quality indicators - informed dissent (finding)	4180186
44805520	Excepted from osteoporosis quality indicators - patient unsuitable (finding)	4180186
44805521	Excepted from osteoporosis quality indicators - informed dissent (finding)	4180186
44805525	Annual review of lithium therapy (procedure)	4180186
44805530	Assessment for syringing of ear (procedure)	4180186
44805535	History of chlamydia infection (situation)	4180186
44805536	History of gonorrhoea (situation)	4180186
44805537	CT guided coeliac plexus block	4180186
44805537	Neurolytic coeliac plexus block using computed tomography guidance (procedure)	4180186
44805538	Jugular venous pressure no abnormality detected (finding)	4180186
44805544	Single major depressive episode, severe (disorder)	4180186
44805546	Cervical spinal cord injury, without spinal bone injury, C5-7 (disorder)	4180186
44805549	Recurrent major depressive episodes, in partial remission (disorder)	4180186
44805554	Removal of stabilisation instrumentation from spine (procedure)	4180186
44805555	Female condom issued (finding)	4180186
44805558	Angina self management plan commenced (situation)	4180186
44805559	Angina self management plan completed (situation)	4180186
44805563	MED3 (2010) certificate issued to patient (finding)	4180186
44805564	MED3 (2010) certificate duplicate issued (finding)	4180186
44805565	MED3 (2010) certificate issued - recommend phased return to work (finding)	4180186
44805568	MED3 (2010) certificate issued - recommend workplace adaptation (finding)	4180186
44805571	Post exercise systolic blood pressure response normal (finding)	4180186
44805573	United Kingdom medical eligibility criteria for contraceptive use 2009 category 1 (finding)	4180186
44805574	United Kingdom medical eligibility criteria for contraceptive use 2009 category 3 (finding)	4180186
44805575	United Kingdom medical eligibility criteria for contraceptive use 2009 category 4 (finding)	4180186
44805576	GPC claim - immunisation sent to Health Board (finding)	4180186
44805579	180 minute plasma glucose level	4180186
44805579	180 minute plasma glucose measurement (procedure)	4180186
44805583	Grade 3 (Stage pTa) papillary urothelial/transitional cell carcinoma (morphologic abnormality)	4180186
44805584	Gold standards framework supportive care stage 3 - last days: category B - months prognosis (finding)	4180186
44805585	Referral to type 1 diabetes structured education programme	4180186
44805585	Referral to type I diabetes structured education programme (procedure)	4180186
44805586	Bence Jones protein/creatinine ratio measurement (procedure)	4180186
44805587	Bence Jones protein excretion level (procedure)	4180186
44805588	Blood ionised calcium level (procedure)	4180186
44805589	Rapid HIV (human immunodeficiency virus) antibody test	4180186
44805589	Rapid human immunodeficiency virus antibody test (procedure)	4180186
44805590	Carer annual health check (procedure)	4180186
44805591	Extended intervention for excessive alcohol consumption declined (situation)	4180186
44805596	Looked after child review meeting (procedure)	4180186
44805602	No history of contraceptive usage (situation)	4180186
44805607	Has mental capacity to give consent (finding)	4180186
44805608	Has mental capacity to give consent for assessment (finding)	4180186
44805609	Has mental capacity to decline consent (finding)	4180186
44805609	Has mental capacity to dissent	4180186
44805610	Has mental capacity to decline consent for assessment (finding)	4180186
44805610	Has mental capacity to dissent from assessment	4180186
44805612	Consent given by person with lasting power of attorney for personal welfare (finding)	4180186
44805613	History of hip replacement	4180186
44805613	History of hip replacement (situation)	4180186
44805615	History of knee replacement	4180186
44805615	History of knee replacement (situation)	4180186
44805616	History of in-vitro fertilisation (situation)	4180186
44805619	Referral to cardiac physiology (procedure)	4180186
44805620	Epistaxis care management (procedure)	4180186
44805622	Able to perform intermittent urethral self-catheterisation (finding)	4180186
44805625	Activity of daily living needs met (finding)	4180186
44805626	Adequate infection control measures (finding)	4180186
44805627	Referral to teenage pregnancy and parenting support service (procedure)	4180186
44805628	Diabetic retinopathy detected by national screening programme (disorder)	4180186
44805632	Disposal of offensive waste (procedure)	4180186
44805633	Disposal of cytotoxic or cytostatic sharps (procedure)	4180186
44805634	Disposal of non-cytotoxic or non-cytostatic sharps (procedure)	4180186
44805635	At high risk of tuberculosis infection (finding)	4180186
44805636	Referral to heart failure exercise programme declined (situation)	4180186
44805637	Referral to cardiac rehabilitation programme declined (situation)	4180186
44805638	Referral to heart failure exercise programme not indicated (situation)	4180186
44805641	Phosphodiesterase-5 inhibitor allergy (disorder)	4180186
44805643	Phosphodiesterase-5 inhibitor not indicated (situation)	4180186
44805646	Phosphodiesterase-5 inhibitor declined (situation)	4180186
44805647	Throat swab for chlamydia (procedure)	4180186
44805650	Conjugated bilirubin level	4180186
44805650	Conjugated bilirubin measurement (procedure)	4180186
44805652	45 minute plasma cortisol level	4180186
44805652	45 minute plasma cortisol measurement (procedure)	4180186
44805654	Patient accompanied at encounter (finding)	4180186
44805660	Vaginal vault smear action needed (situation)	4180186
44805661	Vaginal vault smear repeat at 6 months (situation)	4180186
44805665	Vaginal vault smear repeat at 18 months (situation)	4180186
44805667	Paranoid state in remission (disorder)	4180186
44805674	Has a parent carer (finding)	4180186
44805675	Diabetes structured education programme completed (situation)	4180186
44805677	Structural central nervous system abnormality (disorder)	4180186
44805679	Complies with bed rest (finding)	4180186
44805681	Problem solving (procedure)	4180186
44805682	Sex education (procedure)	4180186
44805684	Personal care needs met (finding)	4180186
44805685	Social care needs met (finding)	4180186
44805686	Total care needs met (finding)	4180186
44805687	Medically unfit for prison transfer (finding)	4180186
44805688	Management of multiple sclerosis (regime/therapy)	4180186
44805689	Incretin mimetic therapy management (procedure)	4180186
44805690	Renal itch	4180186
44805690	Uraemic pruritus (disorder)	4180186
44805691	Cholestatic pruritus (disorder)	4180186
44805692	Well man case management (procedure)	4180186
44805693	Well woman case management (procedure)	4180186
44805694	Advanced respiratory support management (procedure)	4180186
44805698	Medication discussed with pharmacist (situation)	4180186
44805706	Throat swab for gonorrhoea (procedure)	4180186
44805708	History of intrauterine system usage (situation)	4180186
44805708	H/O: IUS (intrauterine system) usage	4180186
44805709	Target serum non HDL (high density lipoprotein) cholesterol level	4180186
44805709	Target serum non high density lipoprotein cholesterol level (observable entity)	4180186
44805710	Phosphodiesterase-5 inhibitor adverse reaction (disorder)	4180186
44805714	Physical health assessment (procedure)	4180186
44805715	Substance misuse assessment (procedure)	4180186
44805717	Physical health assessment declined (situation)	4180186
44805719	Substance misuse assessment declined (situation)	4180186
44805722	Subject below age for reliable interpretation of test (finding)	4180186
44805723	Newborn blood spot screening programme incomplete as outside of area of current screening coverage (finding)	4180186
44805728	Mild wheeze (finding)	4180186
44805731	Very severe wheeze (finding)	4180186
44805735	Intravesical instillation of Bacillus Calmette-Guerin (procedure)	4180186
44805735	Intravesical instillation of BCG (Bacillus Calmette-Guerin)	4180186
44805739	Risk to health associated with overweight and obesity, at increased risk (finding)	4180186
44805741	Risk to health associated with overweight and obesity, at very high risk (finding)	4180186
44805745	Intervention for risk to health associated with overweight and obesity, advice about diet and physical activity, consider drugs, consider surgery (regime/therapy)	4180186
44805747	Double stranded deoxyribonucleic acid antibody detection using Crithidia luciliae	4180186
44805747	Measurement of double stranded deoxyribonucleic acid antibody using Crithidia luciliae (procedure)	4180186
44805748	Well-being assessment for long term conditions offered (finding)	4180186
44805749	HSV (herpes simplex virus) type 2 DNA (deoxyribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44805749	Measurement of Herpes simplex virus type 2 deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44805750	Burkholderia cepacia complex eradication therapy (procedure)	4180186
44805752	HAV (hepatitis A virus) RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44805752	Measurement of hepatitis A virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44805754	Assessment of tissue viability (procedure)	4180186
44805755	Horizontal osteotomy and proximal displacement of head of lesser metatarsal (procedure)	4180186
44805755	Weil osteotomy	4180186
44805758	Arthroscopic arthrodesis of ankle (procedure)	4180186
44805759	Methicillin resistant Staphylococcus aureus eradication therapy (regime/therapy)	4180186
44805759	MRSA (methicillin resistant Staphylococcus aureus) eradication therapy	4180186
44805763	Frequent changes of general practitioner (finding)	4180186
44805770	Unborn child subject to child protection plan (finding)	4180186
44805775	Fibroblast growth factor 23 measurement (procedure)	4180186
44805777	Measurement of disaccharidase (procedure)	4180186
44805778	Platelet nucleotide level	4180186
44805778	Platelet nucleotide measurement (procedure)	4180186
44805780	At risk of emergency hospital admission (finding)	4180186
44805782	Free homocysteine measurement (procedure)	4180186
44805783	Activated partial thromboplastin time mixing study (procedure)	4180186
44805783	APTT (activated partial thromboplastin time) mixing study	4180186
44805784	Amylase pancreatic isoenzyme measurement (procedure)	4180186
44805786	Cystine/creatinine ratio measurement (procedure)	4180186
44805787	Taurine/creatinine ratio measurement (procedure)	4180186
44805789	Tyrosine/creatinine ratio measurement (procedure)	4180186
44805791	Histidine/creatinine ratio measurement (procedure)	4180186
44805792	Aspartate/creatinine ratio	4180186
44805792	Aspartate/creatinine ratio measurement (procedure)	4180186
44805794	Haemosiderin screen	4180186
44805794	Haemosiderin screening test (procedure)	4180186
44805795	Homocystine/creatinine ratio measurement (procedure)	4180186
44805796	Cadmium/creatinine ratio measurement (procedure)	4180186
44805801	Proline/creatinine ratio measurement (procedure)	4180186
44805803	Linoleic acid level	4180186
44805803	Linoleic acid measurement (procedure)	4180186
44805804	Ischaemia modified albumin measurement (procedure)	4180186
44805805	Melanogen measurement (procedure)	4180186
44805807	Protein 14-3-3 measurement (procedure)	4180186
44805811	Human leucocyte antigen B3 antigen (substance)	4180186
44805814	LOC4/5 general practitioner confinement claim form (record artifact)	4180186
44805818	Human leucocyte antigen D antigen (substance)	4180186
44805819	Human leucocyte antigen DR3 antigen typing (procedure)	4180186
44805820	Human leucocyte antigen DR3 antigen (substance)	4180186
44805821	Human leucocyte antigen DR4 antigen typing (procedure)	4180186
44805822	Human leucocyte antigen DR4 antigen (substance)	4180186
44805823	Human leucocyte antigen B5701 antigen typing (procedure)	4180186
44805824	Human leucocyte antigen B5701 antigen (substance)	4180186
44805826	Ganglioside GM3 immunoglobulin M antibody measurement (procedure)	4180186
44805827	T cell receptor V-beta analysis (procedure)	4180186
44805828	Neutrophil adhesion marker study (procedure)	4180186
44805829	Signal recognition particle immunoglobulin G antibody measurement (procedure)	4180186
44805831	CD154 count (procedure)	4180186
44805833	Glycophagus domesticus specific immunoglobulin E (substance)	4180186
44805834	Ganglioside GM2 immunoglobulin G antibody measurement (procedure)	4180186
44805839	Debridement of skin using larvae (procedure)	4180186
44805839	Larvae therapy of skin	4180186
44805840	Provision of bariatric equipment (procedure)	4180186
44805843	Concealment of medication (finding)	4180186
44805846	Joint British Societies cardiovascular disease risk score (observable entity)	4180186
44805847	Joint British Societies cardiovascular disease risk assessment (assessment scale)	4180186
44805848	Main spoken language Aragonese (finding)	4180186
44805849	CAT (comprehensive aphasia test) score	4180186
44805849	Comprehensive aphasia test score (observable entity)	4180186
44805850	Referral to respiratory clinic (procedure)	4180186
44805851	Referral for epilepsy review (procedure)	4180186
44805854	Cervical smear test indicated but not done (situation)	4180186
44805858	Referral to epilepsy clinic (procedure)	4180186
44805860	Provision of information prescription (procedure)	4180186
44805861	Referral to coronary heart disease clinic (procedure)	4180186
44805864	Cervical smear repeat at 48 months (situation)	4180186
44805865	Victim of honour based violence (finding)	4180186
44805868	On examination visual acuity left eye = 6/20 (finding)	4180186
44805869	History of vocal problem (situation)	4180186
44805870	FRAX 10 year hip fracture probability score with bone mineral density	4180186
44805870	Ten year hip fracture probability score using World Health Organisation FRAX fracture risk assessment tool with bone mineral density (observable entity)	4180186
44805873	Eplerenone therapy declined (situation)	4180186
44805874	Hantavirus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44805874	Measurement of hantavirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44805881	HEV (hepatitis E virus) RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44805881	Measurement of hepatitis E virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44805884	Preferred place of death: usual place of residence (finding)	4180186
44805885	Reporting of significant event (procedure)	4180186
44805887	Review of significant event (procedure)	4180186
44805891	Weight management plan started (situation)	4180186
44805893	Participant in Scottish health research register (finding)	4180186
44805893	Participant in SHARE (Scottish health research register)	4180186
44805898	HIV (human immunodeficiency virus) RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44805898	Measurement of human immunodeficiency virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44805899	Measurement of Influenza A virus immunoglobulin G antibody (procedure)	4180186
44805900	Measurement of Influenza B virus immunoglobulin G antibody (procedure)	4180186
44805903	HIV (human immunodeficiency virus) type 2 IgG antibody measurement	4180186
44805903	Measurement of human immunodeficiency virus type 2 immunoglobulin G antibody (procedure)	4180186
44805906	National Health Service 111 Event (record artifact)	4180186
44805908	Haemoglobin heat stability study (procedure)	4180186
44805909	Arginosuccinate measurement (procedure)	4180186
44805910	Free protein S antigen level	4180186
44805910	Free protein S antigen measurement (procedure)	4180186
44805911	Glycogen brancher enzyme measurement	4180186
44805911	Glycogen branching enzyme measurement (procedure)	4180186
44805913	Primary closure of atrial septal defect (procedure)	4180186
44805914	Trihydroxycoprostanic acid measurement (procedure)	4180186
44805915	Sulphocysteine measurement (procedure)	4180186
44805916	Protein S binding protein level	4180186
44805916	Protein S binding protein measurement (procedure)	4180186
44805917	Uracil/creatinine ratio measurement (procedure)	4180186
44805918	Preferred place of care for next exacerbation of heart failure (finding)	4180186
44805919	Hospital at home patient (finding)	4180186
44805920	Preferred place of care for next exacerbation of chronic obstructive pulmonary disease (finding)	4180186
44805922	Difficult to rouse (finding)	4180186
44805923	Normal cervical canal (finding)	4180186
44805926	Receiving contributory employment and support allowance (finding)	4180186
44805927	Receiving disability living allowance (finding)	4180186
44805928	Receiving incapacity benefit (finding)	4180186
44805929	Receiving income-related employment and support allowance (finding)	4180186
44805930	Receiving income support (finding)	4180186
44805931	Receiving state pension (finding)	4180186
44805932	Able to get up from floor (finding)	4180186
44805933	Able to manage foot care (finding)	4180186
44805934	Referral by medium secure service (procedure)	4180186
44805938	LH (luteinising hormone)/FSH (follicle stimulating hormone) ratio measurement	4180186
44805938	Luteinising hormone/follicle stimulating hormone ratio measurement (procedure)	4180186
44805939	Assessment for admission to mental health service under the Mental Health Act 1983 (England and Wales) (procedure)	4180186
44805943	Continuous infusion of antithrombolytic (procedure)	4180186
44805944	Transluminal insertion of branched stent graft into aorta (procedure)	4180186
44805945	Transluminal insertion of fenestrated stent graft into aorta (procedure)	4180186
44805946	Percutaneous transluminal laser ablation of varicose vein of leg (procedure)	4180186
44805951	Primary suture of skin of head (procedure)	4180186
44805952	Primary suture of skin of neck (procedure)	4180186
44805953	Primary total prosthetic replacement of elbow joint (procedure)	4180186
44805959	Education for critical care (procedure)	4180186
44805961	Critical care medical care plan for major surgery (record artifact)	4180186
44805964	Assessment using cognitive linguistic quick test	4180186
44805964	Assessment using cognitive linguistic quick test (procedure)	4180186
44805965	Cognitive linguistic quick test score	4180186
44805965	Cognitive linguistic quick test score (observable entity)	4180186
44805966	ACCT (Assessment Care in Custody and Teamwork) post-closure	4180186
44805966	In Assessment Care in Custody and Teamwork post-closure phase (finding)	4180186
44805967	Consent given to leave telephone message with specified third party (finding)	4180186
44805969	Measurement of blood pressure using manual sphygmomanometer by auscultation over brachial artery (procedure)	4180186
44805970	CT guided placement of fiducial marker	4180186
44805970	Insertion of fiducial marker using computed tomography guidance (procedure)	4180186
44805971	Computed tomography of head, neck, thorax and abdomen (procedure)	4180186
44805972	Computed tomography of facial bones with contrast (procedure)	4180186
44805973	NA52 - fee not paid (finding)	4180186
44805975	Magnetic resonance imaging of parotid gland with contrast (procedure)	4180186
44805979	Epilepsy monitoring in secondary care (finding)	4180186
44805983	Removal of calculus from ureter using fluoroscopic guidance (procedure)	4180186
44805984	Magnetic resonance venogram of neck	4180186
44805984	Magnetic resonance venography of neck (procedure)	4180186
44805986	Cardiac medication review (procedure)	4180186
44805988	Large vessel vasculitis (disorder)	4180186
44805989	Clinical document descriptor (record artifact)	4180186
44805992	On examination visual acuity left eye = 6/10 (finding)	4180186
44805994	One stage osseointegrated implantation into jaw (procedure)	4180186
44805995	Lambdoid synostosis (disorder)	4180186
44805996	Kleefstra syndrome (disorder)	4180186
44805997	Measurement of Herpes simplex virus type 2 immunoglobulin G antibody (procedure)	4180186
44805999	Measurement of human herpes virus immunoglobulin G antibody (procedure)	4180186
44806006	HIV (human immunodeficiency virus) type 1 IgG antibody measurement	4180186
44806006	Measurement of human immunodeficiency virus type 1 immunoglobulin G antibody (procedure)	4180186
44806008	HBV (hepatitis B virus) e antigen IgG antibody measurement	4180186
44806008	Measurement of hepatitis B virus e antigen immunoglobulin G antibody (procedure)	4180186
44806009	Measurement of hepatitis D virus immunoglobulin G antibody (procedure)	4180186
44806011	Measurement of hepatitis D virus immunoglobulin M antibody (procedure)	4180186
44806013	Percutaneous transluminal radiofrequency sympathetic denervation of renal artery using fluoroscopic guidance (procedure)	4180186
44806016	Percutaneous microwave ablation of lesion of kidney using computed tomography guidance (procedure)	4180186
44806017	Teenage parent (finding)	4180186
44806019	Percutaneous stimulation of tibial nerve (procedure)	4180186
44806022	Corneal collagen crosslinking (procedure)	4180186
44806023	Negative pressure wound therapy to open abdomen (regime/therapy)	4180186
44806024	Hyperthermic intraoperative peritoneal chemotherapy (procedure)	4180186
44806027	Single shared assessment record (record artifact)	4180186
44806034	One of multiple birth (finding)	4180186
44806036	Nicotine replacement therapy using nicotine lozenge (procedure)	4180186
44806038	Pathologist report for secondary use (procedure)	4180186
44806040	Discussion about laboratory finding at unidisciplinary case conference (procedure)	4180186
44806041	Review of pathological material on behalf of clinical network (procedure)	4180186
44806043	Referral to drug worker (procedure)	4180186
44806045	1,25-dihydroxyvitamin D3 measurement (procedure)	4180186
44806049	Assessment for admission to adult intensive care (procedure)	4180186
44806052	Referral by housing service (procedure)	4180186
44806053	Erythrocyte plasmalogen level	4180186
44806053	Erythrocyte plasmalogen measurement (procedure)	4180186
44806057	Total protein S antigen level	4180186
44806057	Total protein S antigen measurement (procedure)	4180186
44806058	10-hydroxycarbazepine measurement (procedure)	4180186
44806059	A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 protease molecular detection (procedure)	4180186
44806060	Ammonium urate measurement (procedure)	4180186
44806064	Glutaric aciduria type 1 antibody measurement (procedure)	4180186
44806065	Alpha glucosidase measurement (procedure)	4180186
44806069	Complement 1q immunoglobulin G antibody measurement (procedure)	4180186
44806071	Cardiolipin immunoglobulin M antibody measurement (procedure)	4180186
44806072	Cyclic citrinullated peptide immunoglobulin G antibody measurement (procedure)	4180186
44806076	Tetrahydrocorticosterone output measurement (procedure)	4180186
44806077	Allo-tetrahydrocortisol output measurement (procedure)	4180186
44806078	Dehydroepiandrosterone output measurement (procedure)	4180186
44806080	Glycosaminoglycan profile (procedure)	4180186
44806081	Ganglioside M3 immunoglobulin G antibody measurement (procedure)	4180186
44806083	Count of cells positive for both CD19 and lambda light chain (procedure)	4180186
44806084	Rabbit blood specific immunoglobulin E antibody measurement (procedure)	4180186
44806087	Bactericidal permeability-increasing protein immunoglobulin G antibody measurement (procedure)	4180186
44806089	Fusion of joint with extra-articular bone graft (procedure)	4180186
44806090	On examination - mid-systolic ejection murmur (finding)	4180186
44806092	On examination - late systolic murmur (finding)	4180186
44806094	16 Alpha hydroxy dehydroepiandrosterone output measurement (procedure)	4180186
44806096	Tape closure of skin of neck (procedure)	4180186
44806100	Episodic dry cough (finding)	4180186
44806104	Self-completed Leeds assessment of neuropathic symptoms and signs pain scale (assessment scale)	4180186
44806104	S-LANSS (self-completed Leeds assessment of neuropathic symptoms and signs) pain scale	4180186
44806105	Self-completed Leeds assessment of neuropathic symptoms and signs pain score (observable entity)	4180186
44806105	S-LANSS (self-completed Leeds assessment of neuropathic symptoms and signs) pain score	4180186
44806106	Assessment using self-completed Leeds assessment of neuropathic symptoms and signs pain scale (procedure)	4180186
44806106	Assessment using S-LANSS (self-completed Leeds assessment of neuropathic symptoms and signs) pain scale	4180186
44806108	Police report received - no action required (situation)	4180186
44806109	Coronary microvascular disease (disorder)	4180186
44806112	Child no longer safeguarding concern (finding)	4180186
44806113	Language read not given - patient refused (finding)	4180186
44806114	Date of foreign travel (observable entity)	4180186
44806115	Magnetic resonance imaging of liver for assessment of hepatic iron load (procedure)	4180186
44806116	Magnetic resonance imaging of heart for assessment of cardiac iron load (procedure)	4180186
44806119	Referral to counselling assessment referral advice and throughcare drug service (procedure)	4180186
44806121	Deactivation of automatic implantable cardioverter defibrillator (procedure)	4180186
44806124	Diabetes self-management plan review (procedure)	4180186
44806125	Heart failure self-management plan review (procedure)	4180186
44806127	Stroke self-management plan review (procedure)	4180186
44806128	Common Assessment Framework for children and young people process initiated for unborn child (finding)	4180186
44806130	Has UK (United Kingdom) student visa	4180186
44806130	Has United Kingdom student visa (finding)	4180186
44806131	Fluoroscopy of arteriovenous fistula (procedure)	4180186
44806132	Microwave ablation of lesion of liver using fluoroscopic guidance (procedure)	4180186
44806133	Pre-admission assessment record (record artifact)	4180186
44806134	Self assessment record (record artifact)	4180186
44806135	Medical assessment record (record artifact)	4180186
44806137	Social services assessment record (record artifact)	4180186
44806138	Measurement of sapovirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806138	Sapovirus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44806143	Growth chart (record artifact)	4180186
44806144	Measurement of Rickettsial immunoglobulin G antibody (procedure)	4180186
44806145	Allotransplantation of hand (procedure)	4180186
44806149	Inpatient medical note (record artifact)	4180186
44806153	Chemotherapy record (record artifact)	4180186
44806156	Depression intensity scale circles (assessment scale)	4180186
44806156	DISCs - depression intensity scale circles	4180186
44806157	Assessment using depression intensity scale circles (procedure)	4180186
44806157	Assessment using DISCs (depression intensity scale circles)	4180186
44806162	Laparoscopic helium plasma coagulation of endometriosis (procedure)	4180186
44806165	Nursing note (record artifact)	4180186
44806167	Nutritional record (record artifact)	4180186
44806169	Phosphorylase A measurement (procedure)	4180186
44806176	Equivocal immunology finding (finding)	4180186
44806178	Expert patient programme declined (situation)	4180186
44806179	Screen for JAK (Janus kinase) 2 gene mutation	4180186
44806179	Screen for Janus kinase 2 gene mutation (procedure)	4180186
44806180	Textarin clotting time (procedure)	4180186
44806182	Rehabilitation for brain injury (regime/therapy)	4180186
44806183	Rehabilitation for pain syndrome (regime/therapy)	4180186
44806184	Rehabilitation for respiratory disorder (regime/therapy)	4180186
44806187	Ecarin clotting time (procedure)	4180186
44806189	Red blood cell glucose-6-phosphate dehydrogenase level	4180186
44806189	Red blood cell glucose-6-phosphate dehydrogenase measurement (procedure)	4180186
44806189	Red cell G6PD (glucose-6-phosphate dehydrogenase) level	4180186
44806191	Androstenedione output measurement (procedure)	4180186
44806195	JAK (Janus kinase) 2 exon 12 variant analysis	4180186
44806195	Janus kinase 2 exon 12 mutation analysis (procedure)	4180186
44806196	Alpha cortolone measurement (procedure)	4180186
44806197	Oestriol output measurement (procedure)	4180186
44806198	Beta cortolone measurement (procedure)	4180186
44806200	Cytomegalovirus immunoglobulin M antibody negative (finding)	4180186
44806203	Orotate/creatinine ratio measurement (procedure)	4180186
44806207	LOC5 general practitioner confinement form (record artifact)	4180186
44806209	Open repair of extra-articular ligament (procedure)	4180186
44806210	Plastic repair of extra-articular ligament (procedure)	4180186
44806211	Open debridement of joint (procedure)	4180186
44806213	Reimplantation of inferior mesenteric artery (procedure)	4180186
44806214	Reimplantation of superior mesenteric artery (procedure)	4180186
44806216	Education for vaginal blood loss (procedure)	4180186
44806217	Complies with fluid balance management (finding)	4180186
44806219	Urinary flow time (observable entity)	4180186
44806220	Intravitreal injection (procedure)	4180186
44806221	Repair of penetrating eye injury (procedure)	4180186
44806224	Excision of lump of neck (procedure)	4180186
44806226	Porphyria deoxyribonucleic acid screening test (procedure)	4180186
44806228	Referral to spinal surgeon (procedure)	4180186
44806232	Opiate level	4180186
44806232	Opiate measurement (procedure)	4180186
44806239	Surgical biopsy of shaft of penis (procedure)	4180186
44806241	Computed tomography sinogram of abdomen (procedure)	4180186
44806247	Referral to re-enablement service (procedure)	4180186
44806251	Biliary acute pancreatitis (disorder)	4180186
44806252	Use of out of hours service letter sent (finding)	4180186
44806253	Breast screening disclaimer received (finding)	4180186
44806258	Acetoacetate level	4180186
44806258	Measure of acetoacetate (procedure)	4180186
44806259	Percutaneous insertion of stent using mobile image intensifier guidance (procedure)	4180186
44806261	Quantitative ultrasonography of upper limb (procedure)	4180186
44806261	Quantitative ultrasound scan of upper limb	4180186
44806262	Quantitative ultrasonography of lower limb (procedure)	4180186
44806262	Quantitative ultrasound scan of lower limb	4180186
44806264	Nasopharyngeal virology swab taken (situation)	4180186
44806265	Endoscopy record (record artifact)	4180186
44806266	Blood spot acetyl carnitine (procedure)	4180186
44806267	Under care of non-National Health Service physiotherapist (finding)	4180186
44806268	Refractory anaemia with multilineage dysplasia (disorder)	4180186
44806270	Has involved healthcare professional in discussion about advance decision to refuse treatment (Mental Capacity Act 2005) (finding)	4180186
44806276	Chloride/creatinine ratio measurement	4180186
44806276	Measurement of mass ratio of chloride to creatinine (procedure)	4180186
44806277	Supplemental pneumococcal conjugated vaccination (procedure)	4180186
44806278	Measurement of mass ratio of homocysteine to creatinine	4180186
44806278	Measurement of mass ratio of homocysteine to creatinine (procedure)	4180186
44806283	Multiple endocrine neoplasia mutation study (procedure)	4180186
44806285	Measurement of respiratory syncytial virus immunoglobulin G antibody (procedure)	4180186
44806286	Bronchoscopic lung volume reduction using airway valve (procedure)	4180186
44806288	Detection of respiratory syncytial virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806288	Respiratory syncytial virus RNA (ribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44806289	Rubella virus immunoglobulin G avidity test (procedure)	4180186
44806293	Trunk lateral leaning gait (finding)	4180186
44806297	Glycine/creatinine ratio measurement (procedure)	4180186
44806299	Threonine/creatinine ratio measurement (procedure)	4180186
44806301	Isoleucine/creatinine ratio measurement (procedure)	4180186
44806303	Alanine/creatinine ratio	4180186
44806303	Alanine/creatinine ratio measurement (procedure)	4180186
44806305	Arginine/creatinine ratio measurement (procedure)	4180186
44806306	Ornithine/creatinine ratio measurement (procedure)	4180186
44806308	Porphobilinogen deaminase measurement (procedure)	4180186
44806311	Total uroporphyrin measurement (procedure)	4180186
44806314	Porphyrin abnormality study (procedure)	4180186
44806316	In-house general surgery first appointment (procedure)	4180186
44806319	Rockall acute upper gastrointestinal haemorrhage risk score (observable entity)	4180186
44806320	In-house general surgery follow-up appointment (procedure)	4180186
44806321	Total uroporphyrin/creatinine ratio measurement (procedure)	4180186
44806324	Under care of drug misuse service (finding)	4180186
44806326	Under care of prison service (finding)	4180186
44806327	Under care of psychiatric service (finding)	4180186
44806328	Under care of Sure Start service (finding)	4180186
44806329	Neural tube defect risk level calculation (procedure)	4180186
44806332	Diethylene glycol measurement (procedure)	4180186
44806333	Repair of paraumbilical hernia using suture (procedure)	4180186
44806334	Primary repair of paraumbilical hernia using suture (procedure)	4180186
44806335	Repair of recurrent paraumbilical hernia using suture (procedure)	4180186
44806336	Laparoscopic repair of paraumbilical hernia using suture (procedure)	4180186
44806337	Human chorionic gonadotropin output measurement (procedure)	4180186
44806339	Butyrylcholinesterase measurement (procedure)	4180186
44806340	Bleeding symptom (finding)	4180186
44806342	Curry spice mix specific immunoglobulin E antibody measurement (procedure)	4180186
44806347	Brushings sample	4180186
44806347	Specimen obtained by brushing (specimen)	4180186
44806348	Lloyd George record destroyed (finding)	4180186
44806349	Canary faeces specific immunoglobulin G antibody measurement (procedure)	4180186
44806351	Prosthetic reinforcement of ligament (procedure)	4180186
44806352	Continuous intravenous infusion of therapeutic substance (procedure)	4180186
44806354	Injection of anaesthetic agent (procedure)	4180186
44806355	Injection of cytotoxic substance (procedure)	4180186
44806356	Conversion from total prosthetic replacement of shoulder joint (procedure)	4180186
44806358	Identifying barriers to goal achievement (procedure)	4180186
44806360	Severity of roughness of voice (observable entity)	4180186
44806362	Severity of asthenia of voice (observable entity)	4180186
44806363	Health and social care plan agreed (finding)	4180186
44806365	Oral reading observation (observable entity)	4180186
44806366	Angina self-management plan agreed (finding)	4180186
44806371	Heart failure self-management plan agreed (finding)	4180186
44806372	Hypertension self-management plan agreed (finding)	4180186
44806374	Dietary caffeine intake in 24 hours (observable entity)	4180186
44806375	Percutaneous transluminal stent assisted coil embolisation of aneurysm (procedure)	4180186
44806377	Mobility allowance report completed (finding)	4180186
44806385	Knee hyperextension gait (finding)	4180186
44806388	Patient on maximum tolerated diuretic therapy (finding)	4180186
44806389	Difficulty accessing toilet (finding)	4180186
44806391	Liaison with intermediate care team (procedure)	4180186
44806393	Liaison with midwife (procedure)	4180186
44806394	Liaison with nurse (procedure)	4180186
44806395	Liaison with medical practitioner (procedure)	4180186
44806399	Active range of left elbow pronation (observable entity)	4180186
44806400	Liaison with physiotherapist (procedure)	4180186
44806401	Liaison with carer (procedure)	4180186
44806404	Liaison with surgeon (procedure)	4180186
44806405	Active range of left elbow extension (observable entity)	4180186
44806408	Insulin passport checked (finding)	4180186
44806413	EQ-5D-5L (EuroQol five dimension five level) self-care score	4180186
44806413	EuroQol five dimension five level self-care score (observable entity)	4180186
44806414	EQ-5D-5L (EuroQol five dimension five level) pain discomfort score	4180186
44806414	EuroQol five dimension five level pain discomfort score (observable entity)	4180186
44806415	Augmentation of vocal cord by injection of collagen (procedure)	4180186
44806415	Augmentation of vocal cords	4180186
44806416	Transaxial interbody lumbosacral fusion using fluoroscopic guidance (procedure)	4180186
44806419	Blood screening test (procedure)	4180186
44806421	N-acetylglucosamine/creatinine ratio measurement (procedure)	4180186
44806422	Opiate screening test (procedure)	4180186
44806423	Cocaine screening test (procedure)	4180186
44806430	Efavirenz measurement (procedure)	4180186
44806433	Base deficit in umbilical cord venous blood (observable entity)	4180186
44806433	Cord venous blood base excess	4180186
44806435	Chlorophacinone measurement (procedure)	4180186
44806437	Lofepramine measurement (procedure)	4180186
44806439	IGH (immunoglobulin heavy) chain locus mutation screening test	4180186
44806439	Immunoglobulin heavy chain locus mutation screening test (procedure)	4180186
44806445	Cytopathology test (procedure)	4180186
44806446	Seen by spinal surgery service (finding)	4180186
44806449	Insulin receptor immunoglobulin G antibody measurement (procedure)	4180186
44806450	Lead output measurement (procedure)	4180186
44806451	Calculated osmolarity measurement (procedure)	4180186
44806455	Anti heparin/platelet factor 4 antibody screening test (procedure)	4180186
44806456	Conversion from previous hybrid prosthetic replacement of hip joint using cement (procedure)	4180186
44806458	Leukaemia/lymphoma cell marker test (procedure)	4180186
44806461	Outpatient Clinic Attendance - General Practitioner Letter (record artifact)	4180186
44806463	Outpatient Clinic Attendance - Maxillofacial and Tertiary Letter (record artifact)	4180186
44806464	Outpatient Clinic Attendance - Results Letter (record artifact)	4180186
44806465	Outpatient Clinic Attendance - No Patient Copy Letter (record artifact)	4180186
44806466	Outpatient Clinic Attendance - Safeguarded Letter (record artifact)	4180186
44806467	Outpatient Clinic Attendance - Administration Letter (record artifact)	4180186
44806468	Outpatient Clinic Attendance - Private Practice Letter (record artifact)	4180186
44806469	Factor VIII intron 22 inversion molecular screen (procedure)	4180186
44806469	Intron 22 inversion molecular screen	4180186
44806472	Activated partial thromboplastin time using lupus anticoagulant insensitive reagent (procedure)	4180186
44806472	Lupus insensitive APTT (activated partial thromboplastin time)	4180186
44806474	On examination - wound necrotic (finding)	4180186
44806475	Factor XI deficiency study (procedure)	4180186
44806480	Macroprolactin screening test (procedure)	4180186
44806483	Specimen collection by brushing (procedure)	4180186
44806484	Catheter sample	4180186
44806484	Specimen collection from catheter (procedure)	4180186
44806486	Collection of fluid (procedure)	4180186
44806487	Collection of drain fluid (procedure)	4180186
44806488	Cycle of change stage, physical activity (qualifier value)	4180186
44806489	Traumatic amputation below knee (disorder)	4180186
44806492	Died in accident and emergency department (finding)	4180186
44806493	Injury of muscle of upper back (disorder)	4180186
44806497	Administration of antiemetic (procedure)	4180186
44806499	Gastrostomy tube care education (procedure)	4180186
44806503	Reduction in lymphoedema (finding)	4180186
44806507	Thin puree dysphagia diet (finding)	4180186
44806509	Pre-mashed dysphagia diet (finding)	4180186
44806512	Injury of muscle of hand (disorder)	4180186
44806516	Injury of muscle of foot (disorder)	4180186
44806517	Degloving injury of face (disorder)	4180186
44806518	Traumatic injury of forearm (disorder)	4180186
44806519	Replacement of pump of inflatable penile prosthesis (procedure)	4180186
44806521	Replacement of reservoir of inflatable penile prosthesis (procedure)	4180186
44806522	One stage urethroplasty for stricture with free graft (procedure)	4180186
44806523	Two stage urethroplasty for stricture with free graft (procedure)	4180186
44806524	Revision of second stage urethroplasty (procedure)	4180186
44806526	Unsuitable for meteorological health forecasting service (finding)	4180186
44806529	Family history of medium chain acyl coenzyme A dehydrogenase deficiency (situation)	4180186
44806532	6 minute walk test distance (observable entity)	4180186
44806533	Determination of sapovirus genotype by ribonucleic acid analysis (procedure)	4180186
44806533	Sapovirus genotype determination by RNA (ribonucleic acid) analysis	4180186
44806534	Determination of rotavirus genotype by ribonucleic acid analysis (procedure)	4180186
44806534	Rotavirus genotype determination by RNA (ribonucleic acid) analysis	4180186
44806535	Measurement of rabies virus immunoglobulin G antibody (procedure)	4180186
44806536	Measurement of rabies virus immunoglobulin M antibody (procedure)	4180186
44806537	Ulcerative oral mucositis (disorder)	4180186
44806539	Detection of Ross river virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806539	Ross river virus RNA (ribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44806541	Endoscopic biopsy of lymph node (procedure)	4180186
44806548	Bone-anchored cystourethropexy (procedure)	4180186
44806549	Determination of torovirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806549	Torovirus RNA (ribonucleic acid) determination by NAAT (nucleic acid amplification test)	4180186
44806550	Endoscopic excision of axillary lymph node (procedure)	4180186
44806551	Acute encephalitis (disorder)	4180186
44806553	West Nile fever (disorder)	4180186
44806557	Haemophilus influenzae type b infection (disorder)	4180186
44806557	Hib (Haemophilus influenzae type b) infection	4180186
44806559	Cryoablation of endometrium using ultrasound guidance (procedure)	4180186
44806559	Ultrasound guided cryoablation of endometrium	4180186
44806561	Albumin output measurement (procedure)	4180186
44806562	Chloride output measurement (procedure)	4180186
44806563	Arginine output measurement (procedure)	4180186
44806564	Arsenic output measurement (procedure)	4180186
44806566	Lesion of face (disorder)	4180186
44806567	ADAMTS-13 protease activity level	4180186
44806567	A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 protease activity measurement (procedure)	4180186
44806571	Percutaneous transluminal closure of defect of interventricular septum (procedure)	4180186
44806576	Primary anterior excision of body of thoracic vertebra with reconstruction (procedure)	4180186
44806577	Revision anterior excision of body of thoracic vertebra with reconstruction (procedure)	4180186
44806578	Revision anterior excision of body of lumbar vertebra with reconstruction (procedure)	4180186
44806582	Galactocerebrosidase measurement (procedure)	4180186
44806583	Palmitoyl protein thioesterase measurement (procedure)	4180186
44806584	Tripeptidyl-peptidase I measurement (procedure)	4180186
44806585	C26 very long chain fatty acid measurement (procedure)	4180186
44806586	C22 very long chain fatty acid measurement (procedure)	4180186
44806587	C24 very long chain fatty acid measurement (procedure)	4180186
44806590	Mercury output measurement (procedure)	4180186
44806594	Specimen collection from partial resection (procedure)	4180186
44806595	Detection of Aspergillus galactomannan antigen (procedure)	4180186
44806596	Specimen collection by mid-stream sampling (procedure)	4180186
44806599	European pressure ulcer advisory panel grade 1 ulcer left foot (disorder)	4180186
44806602	Good bone alignment following treatment (finding)	4180186
44806606	European pressure ulcer advisory panel grade 3 ulcer left foot (disorder)	4180186
44806607	European pressure ulcer advisory panel grade 3 ulcer right foot (disorder)	4180186
44806608	European pressure ulcer advisory panel grade 4 ulcer left foot (disorder)	4180186
44806609	European pressure ulcer advisory panel grade 4 ulcer right foot (disorder)	4180186
44806612	Child protection category neglect (finding)	4180186
44806617	Suitable for in-possession medication (finding)	4180186
44806618	Not suitable for in-possession medication (finding)	4180186
44806620	Management of administration of blood product (procedure)	4180186
44806621	Cardiovascular assessment (procedure)	4180186
44806622	TMAO (trimethylamine-N-oxide) level	4180186
44806622	Trimethylamine-N-oxide level	4180186
44806622	Trimethylamine-N-oxide measurement (procedure)	4180186
44806623	Factor VIII inhibitor level	4180186
44806623	Factor VIII inhibitor measurement (procedure)	4180186
44806625	Thyroid stimulating hormone suppression therapy (procedure)	4180186
44806625	TSH (thyroid stimulating hormone) suppression therapy	4180186
44806627	Partial orchidectomy (procedure)	4180186
44806629	Traumatic amputation of nose (disorder)	4180186
44806630	Mobility allowance report sent off (finding)	4180186
44806631	Injury of tendon of elbow joint (disorder)	4180186
44806633	Injury of tendon of finger (disorder)	4180186
44806638	Injury of tendon of foot (disorder)	4180186
44806639	Injury of tendon of toe (disorder)	4180186
44806644	Rhabdomyolysis associated with burn (disorder)	4180186
44806646	Submucosal injection of polydimethylsiloxane bulking agent to female bladder neck (procedure)	4180186
44806647	Submucosal injection of polydimethylsiloxane bulking agent to male bladder neck (procedure)	4180186
44806648	Injury of muscle of lower back (disorder)	4180186
44806650	Cystoscopy and cauterisation of prostate (procedure)	4180186
44806651	Rigid check cystoscopy and cystodiathermy (procedure)	4180186
44806652	Flexible check cystoscopy and cystodiathermy (procedure)	4180186
44806654	Foreign body associated with burn (disorder)	4180186
44806655	Suprapubic cystoscopy (procedure)	4180186
44806660	Liaison with community nurse (procedure)	4180186
44806661	Liaison with practice nurse (procedure)	4180186
44806662	Liaison with mental health nurse (procedure)	4180186
44806665	On examination visual acuity left eye = 6/7 (finding)	4180186
44806666	Extracorporeal shockwave destruction of lesion of penis (procedure)	4180186
44806667	MRI (magnetic resonance imaging) guided percutaneous laser ablation of uterine fibroid	4180186
44806667	Percutaneous laser ablation of uterine fibroid using magnetic resonance imaging guidance (procedure)	4180186
44806668	Percutaneous radiofrequency catheter ablation for arrhythmia using fluoroscopic guidance (procedure)	4180186
44806669	On examination visual acuity right eye = 6/7 (finding)	4180186
44806672	Infection resistant to methicillin (disorder)	4180186
44806673	Liaison with public health service (procedure)	4180186
44806674	Liaison with public health physician (procedure)	4180186
44806676	Liaison with safeguarding adult team (procedure)	4180186
44806679	Pre-operative check (procedure)	4180186
44806680	Cyanoacrylate injection of parotid cutaneous fistula (procedure)	4180186
44806681	Endoscopic injection of bulking agent to gastro-oesophageal junction (procedure)	4180186
44806683	Epidural infusion care (regime/therapy)	4180186
44806687	Returning patient valuables (procedure)	4180186
44806693	QRISK cardiovascular disease risk assessment declined (situation)	4180186
44806695	Education about listeria precautions during pregnancy (procedure)	4180186
44806699	Excepted from peripheral arterial disease quality indicators - patient unsuitable (finding)	4180186
44806701	Operation on dural arteriovenous fistula (procedure)	4180186
44806703	Operation on fixture for nasal prosthesis (procedure)	4180186
44806705	Therapeutic percutaneous operation on bile duct (procedure)	4180186
44806707	Therapeutic endoscopic operation on urinary diversion (procedure)	4180186
44806709	X-ray of elbow for bone age (procedure)	4180186
44806717	Administration of intramuscular vitamin K prophylaxis (procedure)	4180186
44806718	Education for liver failure (procedure)	4180186
44806719	Pathology request and result management (procedure)	4180186
44806720	Pregnancy detection care management (procedure)	4180186
44806723	Assessment of vulnerable child (procedure)	4180186
44806726	Open repair of ventral hernia (procedure)	4180186
44806727	Open repair of obstructed ventral hernia with prosthesis (procedure)	4180186
44806735	Application of conical pressure bandage to amputation stump (procedure)	4180186
44806737	Vulnerable child on progressive care pathway (finding)	4180186
44806739	Vulnerable child no longer on progressive care pathway (finding)	4180186
44806743	Glucose galactose intolerance (disorder)	4180186
44806744	Bone fracture healed (finding)	4180186
44806749	Open operation on intra-articular structure (procedure)	4180186
44806753	Androgen deprivation therapy (procedure)	4180186
44806754	Closed rhinoplasty (procedure)	4180186
44806756	Closed rhinoseptoplasty (procedure)	4180186
44806757	Blood grouping and crossmatch (procedure)	4180186
44806758	Red cell phenotyping (procedure)	4180186
44806759	Cell free fetal deoxyribonucleic acid typing (procedure)	4180186
44806760	Flucloxacillin measurement (procedure)	4180186
44806761	GP/UMS Undergraduate teach claim administration (record artifact)	4180186
44806770	Flexible ureteroscopy and collection of ureteral washings (procedure)	4180186
44806773	Secondary malignant neoplasm of liver and intrahepatic bile duct (disorder)	4180186
44806776	Ascending ureterogram of lower moiety of duplex kidney (procedure)	4180186
44806777	Cervical smear epithelial cells absent (situation)	4180186
44806779	Patient reported description of own voice (observable entity)	4180186
44806780	Rigid cystoscopy and intravesical injection of botulinum toxin into detrusor muscle (procedure)	4180186
44806781	Flexible cystoscopy and intravesical injection of botulinum toxin into detrusor muscle (procedure)	4180186
44806784	Determination of cellularity of bone marrow (procedure)	4180186
44806785	Laryngeal dysfunction (finding)	4180186
44806786	Cytogenetic study (procedure)	4180186
44806787	Severity of dysphonia (observable entity)	4180186
44806788	Severe binocular visual impairment (disorder)	4180186
44806790	Moderate binocular visual impairment (disorder)	4180186
44806791	Moderate monocular visual impairment (disorder)	4180186
44806793	Spastic hemiplegic cerebral palsy (disorder)	4180186
44806795	Ten year hip fracture probability score using World Health Organisation FRAX fracture risk assessment tool with body mass index (observable entity)	4180186
44806797	Learning disability screening questionnaire declined (situation)	4180186
44806800	Percutaneous transluminal balloon angioplasty with insertion of stent into pulmonary vein using fluoroscopic guidance with contrast (procedure)	4180186
44806801	Excepted from peripheral arterial disease quality indicators - informed dissent (finding)	4180186
44806803	Has authorisation for medication under patient specific direction (finding)	4180186
44806804	Has authorisation for medication under patient group direction (finding)	4180186
44806807	Patient preferences record (record artifact)	4180186
44806808	Pulmonary investigation record (record artifact)	4180186
44806809	Vascular investigation record (record artifact)	4180186
44806810	Cardiac investigation record (record artifact)	4180186
44806811	Gastroenterology investigation record (record artifact)	4180186
44806812	Neurological investigation record (record artifact)	4180186
44806813	Echography report (record artifact)	4180186
44806814	Audiology investigation record (record artifact)	4180186
44806816	Seasonal influenza vaccination given by other healthcare provider (finding)	4180186
44806820	Seasonal influenza vaccination declined (situation)	4180186
44806821	Seasonal influenza vaccination contraindicated (situation)	4180186
44806823	Consent given for seasonal influenza vaccination (finding)	4180186
44806824	Endoscopic submucosal dissection of lesion of oesophagus (procedure)	4180186
44806824	ESD (endoscopic submucosal dissection) of lesion of oesophagus	4180186
44806825	Infectious systemic inflammatory response syndrome without organ failure (disorder)	4180186
44806829	Assessment using WHO (World Health Organisation) (five) well being-index	4180186
44806829	Assessment using World Health Organisation (five) well-being index (procedure)	4180186
44806831	BAAF (British Association for Adoption and Fostering) adult 2 fee unpaid	4180186
44806831	British Association for Adoption and Fostering adult 2 fee unpaid (finding)	4180186
44806836	Revisional anterior lumbar discectomy (procedure)	4180186
44806837	Implied consent for emergency care summary upload (finding)	4180186
44806841	Total 25-Hydroxyvitamin D level	4180186
44806841	Total vitamin D, 25-hydroxy measurement (procedure)	4180186
44806844	Counselling for end of life issues (procedure)	4180186
44806846	Infant weaning intervention declined (situation)	4180186
44806850	3-Methoxytyramine output measurement (procedure)	4180186
44806853	5-Aminolaevulinic acid output measurement (procedure)	4180186
44806855	Coproporphyrin I and coproporphyrin III isomer measurement (procedure)	4180186
44806856	Total coproporphyrin output measurement (procedure)	4180186
44806857	Total uroporphyrin output measurement (procedure)	4180186
44806858	Specimen obtained by timed collection (procedure)	4180186
44806860	Specimen collection by surface wipe (procedure)	4180186
44806861	Specimen collection by surgical resection (procedure)	4180186
44806863	Cell sample (specimen)	4180186
44806864	Device tip sample (specimen)	4180186
44806865	Plasma specimen with ethylenediaminetetraacetic acid (specimen)	4180186
44806866	Plasma specimen with citrate (specimen)	4180186
44806870	Reticulocyte haemoglobin content	4180186
44806870	Reticulocyte haemoglobin content measurement (procedure)	4180186
44806872	Duration of sexual abstinence (observable entity)	4180186
44806874	Carer to be contacted to make appointment (finding)	4180186
44806878	Patient participation group member (finding)	4180186
44806879	Requires slow verbal communication (finding)	4180186
44806882	Professional voice user (finding)	4180186
44806888	Referral for high intensity cognitive behavioural therapy (procedure)	4180186
44806891	Referral to postnatal depression group (procedure)	4180186
44806895	Checking unit expiry date of blood component for transfusion (procedure)	4180186
44806896	Visual inspection of blood product for any irregular appearance (procedure)	4180186
44806897	Epidural infusion care management (procedure)	4180186
44806898	Treponema pallidum deoxyribonucleic acid detection (procedure)	4180186
44806901	Screening declined (situation)	4180186
44806903	Test declined (situation)	4180186
44806906	Retrograde cutting balloon endopyelotomy and insertion of stent using fluoroscopic guidance (procedure)	4180186
44806909	Radiotherapy for palmar fibromatosis (procedure)	4180186
44806911	Provision of infant weaning leaflet (procedure)	4180186
44806913	Unilateral oedema of arm (finding)	4180186
44806914	Has voluntary carer (finding)	4180186
44806916	EuroQol VAS (visual analogue score)	4180186
44806916	EuroQol visual analogue score (observable entity)	4180186
44806918	Referral to admission prevention service (procedure)	4180186
44806920	Pre-operative assessment record (record artifact)	4180186
44806921	Scored assessment record (record artifact)	4180186
44806925	Observation chart (record artifact)	4180186
44806926	Out of hours note (record artifact)	4180186
44806927	Allied health professional note (record artifact)	4180186
44806928	Clinical note (record artifact)	4180186
44806930	Outpatient letter (record artifact)	4180186
44806938	One leg stand test time (observable entity)	4180186
44806942	Hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalised ratio, elderly over 65, and drugs/alcohol concomitantly bleeding risk score (observable entity)	4180186
44806943	Assessment using hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalised ratio, elderly over 65, and drugs/alcohol concomitantly score (procedure)	4180186
44806945	Systemic psychotherapy (regime/therapy)	4180186
44806946	Seen in early pregnancy unit (finding)	4180186
44806950	Allograft of amniotic membrane (procedure)	4180186
44806954	Dissent for key information summary upload overridden, patient unaware (finding)	4180186
44806955	Creatine kinase MB activity (procedure)	4180186
44806956	Radionuclide yttrium 90 somatostatin analogue scan (procedure)	4180186
44806958	Support available in first 24 hours post discharge (finding)	4180186
44806962	Repeat prescription for glasses (procedure)	4180186
44806963	Repeat prescription for medication (procedure)	4180186
44806964	FP10MDA prescription	4180186
44806964	Issue of FP10MDA prescription (procedure)	4180186
44806966	Community disease modifying antirheumatic drug monitoring invitation	4180186
44806966	Community disease modifying antirheumatic drug monitoring invitation (procedure)	4180186
44806967	Laboratory test due date (observable entity)	4180186
44806968	Blood test due date (observable entity)	4180186
44806969	GP/UMS sent to Health Board (finding)	4180186
44806975	Malabsorption due to intolerance to cow milk protein (disorder)	4180186
44806977	Presbyphonia (disorder)	4180186
44806984	Anaplastic lymphoma kinase positive anaplastic large cell lymphoma (disorder)	4180186
44806986	Bullous aphakic keratopathy following cataract surgery (disorder)	4180186
44806987	Keratopathy following cataract surgery (disorder)	4180186
44806988	Attendance allowance form completed (finding)	4180186
44806990	Follicular lymphoma grade 3a (morphologic abnormality)	4180186
44806993	Measurement of Molluscum contagiosum virus deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806993	Molluscum contagiosum virus DNA (deoxyribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44806995	Measurement of poliovirus 2 immunoglobulin G antibody/total antibody (procedure)	4180186
44806997	Measurement of poliovirus 1, 2 and 3 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806997	Poliovirus 1, 2 and 3 ribonucleic acid measurement by nucleic acid amplification test	4180186
44806998	Measurement of Parvovirus B19 deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806998	Parvovirus B19 deoxyribonucleic acid measurement by nucleic acid amplification test	4180186
44806999	Measurement of Polyomavirus BK immunoglobulin G antibody (procedure)	4180186
44807002	Measurement of poliovirus 3 immunoglobulin G antibody/total antibody (procedure)	4180186
44807004	Measurement of Parainfluenza virus type 2 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807004	Parainfluenza virus type 2 ribonucleic acid measurement by nucleic acid amplification test	4180186
44807005	Measurement of Parainfluenza virus type 2 immunoglobulin G antibody (procedure)	4180186
44807006	Measurement of Parainfluenza virus type 3 immunoglobulin G antibody (procedure)	4180186
44807007	Measurement of Parainfluenza virus type 1, 2 and 3 immunoglobulin G antibody (procedure)	4180186
44807008	Measurement of parainfluenza virus type 1,2 and 3 antigen (procedure)	4180186
44807010	Membership of patient participation group ended (situation)	4180186
44807012	Measurement of mumps virus type V immunoglobulin G antibody (procedure)	4180186
44807013	Measurement of mumps virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807013	Mumps virus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807014	Measurement of Murray Valley encephalitis virus immunoglobulin G antibody (procedure)	4180186
44807015	Social Services letter (record artifact)	4180186
44807016	Transfer of care letter (record artifact)	4180186
44807019	Administrative letter (record artifact)	4180186
44807021	Multidisciplinary team letter (record artifact)	4180186
44807022	Repair of hallux valgus using fluoroscopy guidance (procedure)	4180186
44807027	Discharge from hospital admission prevention service (procedure)	4180186
44807028	Forensic autopsy report (record artifact)	4180186
44807028	Forensic post mortem report	4180186
44807030	AHP (allied health professional) investigation record	4180186
44807030	Allied health professional investigation record (record artifact)	4180186
44807033	Private provider note (record artifact)	4180186
44807035	Adult incapacity report (record artifact)	4180186
44807036	Referral to memory assessment service (procedure)	4180186
44807038	Education for delirium (procedure)	4180186
44807044	Magnetic resonance imaging of cervicothoracic spine with contrast (procedure)	4180186
44807047	Traumatic dislocation of intercarpal joint (disorder)	4180186
44807048	Recurrent deep vein thrombosis (disorder)	4180186
44807049	Attention to sutures (procedure)	4180186
44807051	Measurement of Coxiella burnetii immunoglobulin G antibody/total antibody (procedure)	4180186
44807052	Liaison with occupational therapist (procedure)	4180186
44807053	Liaison with podiatrist (procedure)	4180186
44807056	Liaison with psychologist (procedure)	4180186
44807057	Anaphylaxis care (regime/therapy)	4180186
44807058	On examination - cyanosis (finding)	4180186
44807059	On examination cyanosis not present (situation)	4180186
44807060	Annual health review (procedure)	4180186
44807061	Attention to hybrid prosthetic replacement of shoulder joint using cement (procedure)	4180186
44807065	Attention to total knee replacement (procedure)	4180186
44807066	Attention to hybrid total knee replacement (procedure)	4180186
44807068	Attention to total prosthetic replacement of elbow joint (procedure)	4180186
44807069	Attention to total prosthetic replacement of joint (procedure)	4180186
44807071	Attention to prosthetic interposition arthroplasty (procedure)	4180186
44807073	Attention to hybrid prosthetic replacement of hip joint using cement (procedure)	4180186
44807074	Attention to prosthetic replacement of head of radius (procedure)	4180186
44807075	Implantation of endoprosthetic replacement of bone (procedure)	4180186
44807076	Secondary open reduction of fracture dislocation of joint and internal fixation (procedure)	4180186
44807080	Conversion to hybrid prosthetic replacement of shoulder joint using cement (procedure)	4180186
44807081	Pneumococcal serotype 1 antibody measurement (procedure)	4180186
44807082	Issue of fitness certificate (procedure)	4180186
44807083	Issue of incapacity certificate (procedure)	4180186
44807085	Chronic obstructive pulmonary disease monitoring due date (observable entity)	4180186
44807085	COPD (chronic obstructive pulmonary disease) monitoring due date	4180186
44807089	Transfer of care from hospital (procedure)	4180186
44807090	Provision of transport to accommodate oversized wheelchair (procedure)	4180186
44807092	Urine screening due date (observable entity)	4180186
44807093	Immunisation due date (observable entity)	4180186
44807095	Insulin alert patient information booklet given (situation)	4180186
44807101	Hypoglycaemic management discussed (situation)	4180186
44807102	Insulin passport completed (finding)	4180186
44807104	GP/UMS okayed by Health Board (finding)	4180186
44807105	On examination - tongue normal colour (finding)	4180186
44807106	Not suitable for Liverpool care pathway for the dying (finding)	4180186
44807109	Measurement of metapneumovirus antigen (procedure)	4180186
44807110	Measurement of metapneumovirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807110	Metapneumovirus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807113	Daytime faecal incontinence (finding)	4180186
44807115	Measurement of Orthopoxvirus deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807115	Orthopoxvirus deoxyribonucleic acid measurement by nucleic acid amplification test	4180186
44807117	Measurement of Parechovirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807117	Parechovirus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807120	Measurement of Norovirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807120	Norovirus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807122	Measurement of Poliovirus type 1 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807122	Poliovirus type 1 ribonucleic acid measurement by nucleic acid amplification test	4180186
44807123	Measurement of Poliovirus type 2 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807123	Poliovirus type 2 ribonucleic acid measurement by nucleic acid amplification test	4180186
44807124	Ulcer associated with end of life skin failure (disorder)	4180186
44807127	Asthma trigger - wind (finding)	4180186
44807129	Measurement of Parainfluenza virus type 1 immunoglobulin G antibody (procedure)	4180186
44807130	Measurement of Mumps virus immunoglobulin G antibody (procedure)	4180186
44807132	Shared decision making with patient decision aid (procedure)	4180186
44807135	Shared decision making without decision support (procedure)	4180186
44807138	Nuchal translucency MoM (multiple of median)	4180186
44807138	Nuchal translucency multiple of median (observable entity)	4180186
44807139	Measurement of ribonucleic acid immunoglobulin G antibody (procedure)	4180186
44807139	RNA (ribonucleic acid) IgG antibody measurement	4180186
44807140	CD62L count (procedure)	4180186
44807143	Ablation of nail bed using phenol (procedure)	4180186
44807146	Liaison with pathology service (procedure)	4180186
44807147	Liaison with person with property and affairs lasting power of attorney (procedure)	4180186
44807150	Local anaesthesia care (regime/therapy)	4180186
44807151	Checking blood group and donation number of blood component for transfusion (procedure)	4180186
44807153	Inpatient final discharge letter (record artifact)	4180186
44807154	Immediate inpatient discharge letter (record artifact)	4180186
44807155	Magnetic resonance imaging of thigh with contrast (procedure)	4180186
44807157	Carer of person with dementia (finding)	4180186
44807158	Referral for ambulatory blood pressure monitoring (procedure)	4180186
44807159	Non-traumatic haematoma (disorder)	4180186
44807162	Bronchodilator used infrequently (finding)	4180186
44807164	Email address of informal carer (observable entity)	4180186
44807166	Mobile telephone number of informal carer (observable entity)	4180186
44807167	Work telephone number of informal carer (observable entity)	4180186
44807168	Confusion assessment method short version score (observable entity)	4180186
44807168	Short CAM (confusion assessment method) score	4180186
44807172	Request for individual funding (procedure)	4180186
44807179	Pneumococcal serotype 6B antibody measurement (procedure)	4180186
44807180	Pneumococcal serotype 7F antibody measurement (procedure)	4180186
44807181	Pneumococcal serotype 8 antibody measurement (procedure)	4180186
44807182	Pneumococcal serotype 9N antibody measurement (procedure)	4180186
44807185	Diagnostic endoscopic examination of ureter and biopsy of lesion of ureter (procedure)	4180186
44807187	Distant subcutaneous pedicle flap, fasciocutaneous (procedure)	4180186
44807188	Distant subcutaneous pedicle flap, myocutaneous (procedure)	4180186
44807189	Pneumococcal serotype 10A antibody measurement (procedure)	4180186
44807190	Electrodessication of lesion of skin (procedure)	4180186
44807191	Pneumococcal serotype 11A antibody measurement (procedure)	4180186
44807193	Pneumococcal serotype 14 antibody measurement (procedure)	4180186
44807194	Pneumococcal serotype 15B antibody measurement (procedure)	4180186
44807196	Pneumococcal serotype 18C antibody measurement (procedure)	4180186
44807197	Pneumococcal serotype 19F antibody measurement (procedure)	4180186
44807198	Pneumococcal serotype 20 antibody measurement (procedure)	4180186
44807203	Canary specific immunoglobulin G antibody measurement (procedure)	4180186
44807205	Requires contact by telephone (finding)	4180186
44807208	FP1001 claim due date (observable entity)	4180186
44807209	Bronchiolitis obliterans syndrome after lung transplantation (disorder)	4180186
44807209	Post-transplant bronchiolitis obliterans syndrome	4180186
44807210	Glyceryl trinitrate administration education (procedure)	4180186
44807211	Home access information (finding)	4180186
44807214	Not suitable for end of life advance care plan (finding)	4180186
44807215	Offer of end of life advance care plan review (finding)	4180186
44807216	End of life advance care plan review declined (situation)	4180186
44807217	Diabetes UK (United Kingdom) diabetes risk score	4180186
44807217	Diabetes United Kingdom diabetes risk score (assessment scale)	4180186
44807218	Safeguarding children and young people toolkit for general practice (2009 revision) (assessment scale)	4180186
44807219	Assessment using National Institute for Health and Clinical Excellence criteria for ICD (implantable cardioverter defibrillator)	4180186
44807219	Assessment using National Institute for Health and Clinical Excellence criteria for implantable cardioverter defibrillator (procedure)	4180186
44807220	Able to manage ureterostomy (finding)	4180186
44807221	Patient transfer to coronary care unit (procedure)	4180186
44807223	Referral to ureterostomy nurse (procedure)	4180186
44807225	Request for end of life advance care plan (procedure)	4180186
44807227	Referral to domiciliary phlebotomy service (procedure)	4180186
44807228	Provision of end of life patient information record (procedure)	4180186
44807229	Biopsychosocial assessment (assessment scale)	4180186
44807231	Planned stop date for anticoagulation therapy (observable entity)	4180186
44807232	Requires lifelong warfarin therapy (finding)	4180186
44807234	International normalised ratio target range (observable entity)	4180186
44807237	Measurement of unconjugated oestriol multiple of median (procedure)	4180186
44807239	Measurement of serum unconjugated oestriol multiple of median (procedure)	4180186
44807240	hCG (human chorionic gonadotrophin) multiple of median measurement	4180186
44807240	Measurement of human chorionic gonadotrophin multiple of median (procedure)	4180186
44807241	Measurement of plasma inhibin A multiple of median (procedure)	4180186
44807242	Measurement of serum inhibin A multiple of median (procedure)	4180186
44807243	Measurement of alpha fetoprotein multiple of median (procedure)	4180186
44807244	Measurement of free beta human chorionic gonadotrophin multiple of median (procedure)	4180186
44807246	Measurement of plasma pregnancy associated plasma protein A multiple of median (procedure)	4180186
44807246	Plasma PAPP-A MoM (pregnancy associated plasma protein A multiple of median) measurement	4180186
44807248	Injection of local anaesthetic and steroid into shoulder joint (procedure)	4180186
44807249	Injection of local anaesthetic and steroid into greater trochanteric bursa (procedure)	4180186
44807251	BAAF (British Association for Adoption and Fostering) adult 1 fee to patient	4180186
44807251	British Association for Adoption and Fostering adult 1 fee to patient (finding)	4180186
44807256	CD42b count (procedure)	4180186
44807257	CD8 count (procedure)	4180186
44807262	Oral fluid cannabis level	4180186
44807262	Oral fluid cannabis measurement (procedure)	4180186
44807264	Sleeping position (observable entity)	4180186
44807267	Management of gestational diabetes mellitus (procedure)	4180186
44807270	Has advance decision to refuse treatment (Mental Capacity Act 2005)	4180186
44807270	Has advance decision to refuse treatment (Mental Capacity Act 2005) (finding)	4180186
44807275	Active range of right hip flexion (observable entity)	4180186
44807276	Passive range of left hip flexion (observable entity)	4180186
44807279	Active range of right hip extension (observable entity)	4180186
44807281	Passive range of right hip extension (observable entity)	4180186
44807284	Passive range of left hip abduction (observable entity)	4180186
44807287	Active range of right hip adduction (observable entity)	4180186
44807290	Passive range of left hip internal rotation (observable entity)	4180186
44807291	Passive range of right hip internal rotation (observable entity)	4180186
44807292	Dynamic interpersonal therapy (regime/therapy)	4180186
44807295	Active range of left hip external rotation (observable entity)	4180186
44807296	Active range of right hip external rotation (observable entity)	4180186
44807297	Passive range of left hip external rotation (observable entity)	4180186
44807298	Passive range of right hip external rotation (observable entity)	4180186
44807303	Active range of left knee extension (observable entity)	4180186
44807307	Passive range of right ankle flexion (observable entity)	4180186
44807308	Active range of right ankle eversion (observable entity)	4180186
44807309	Passive range of left ankle eversion (observable entity)	4180186
44807311	Active range of right ankle inversion (observable entity)	4180186
44807316	Endovascular insertion of drug eluting stent (procedure)	4180186
44807319	Endovascular insertion of plastic stent (procedure)	4180186
44807321	Neutrophil chemotaxis study	4180186
44807321	Neutrophil chemotaxis test (procedure)	4180186
44807328	Ganglia immunoglobulin G antibody measurement (procedure)	4180186
44807329	Education for care planning (procedure)	4180186
44807330	Assessment for constipation care (procedure)	4180186
44807335	Home oxygen therapy management (procedure)	4180186
44807336	Major complex care management (procedure)	4180186
44807338	Tr immunoglobulin G antibody measurement (procedure)	4180186
44807339	Muscle-specific receptor tyrosine kinase immunoglobulin G antibody measurement (procedure)	4180186
44807343	Enterocyte immunoglobulin G antibody measurement (procedure)	4180186
44807344	Glutamic acid decarboxylase immunoglobulin G antibody measurement (procedure)	4180186
44807345	Requires information in Easyread (finding)	4180186
44807346	Ganglioside B1a immunoglobulin G antibody measurement (procedure)	4180186
44807350	Excepted from osteoarthritis quality indicators - informed dissent (finding)	4180186
44807352	Excepted from rheumatoid arthritis quality indicators - patient unsuitable (finding)	4180186
44807353	Excepted from rheumatoid arthritis quality indicators - informed dissent (finding)	4180186
44807354	Provision of advice about aerobic exercise (procedure)	4180186
44807355	Provision of advice about muscle strengthening exercise (procedure)	4180186
44807362	Raloxifene not tolerated (situation)	4180186
44807366	Phosphate/creatinine ratio	4180186
44807366	Phosphate/creatinine ratio measurement (procedure)	4180186
44807368	Manganese/creatinine ratio	4180186
44807368	Manganese/creatinine ratio measurement (procedure)	4180186
44807370	High cost cardiovascular drugs (procedure)	4180186
44807371	Review of end of life advance care plan (procedure)	4180186
44807372	Closure of skin wound (procedure)	4180186
44807373	Has appointed person with health and welfare lasting power of attorney with authority for life sustaining decisions	4180186
44807373	Has appointed person with personal welfare lasting power of attorney with authority for life sustaining decisions (Mental Capacity Act 2005) (finding)	4180186
44807373	Has appointed person with personal welfare LPA (lasting power of attorney) with authority for life sustaining decisions (Mental Capacity Act 2005)	4180186
44807375	Chronic disease annual review (regime/therapy)	4180186
44807377	Suspected dementia (situation)	4180186
44807380	Insertion of subcutaneous contraceptive claim (procedure)	4180186
44807384	Reconstruction of medial patellofemoral ligament (procedure)	4180186
44807386	History of dizziness (situation)	4180186
44807387	Relevant medical information (record artifact)	4180186
44807388	Hobbies and interests (record artifact)	4180186
44807391	Gestational diabetes mellitus annual review (regime/therapy)	4180186
44807394	Care of patient following epidural anaesthesia (regime/therapy)	4180186
44807398	Measurement of Flavivirus immunoglobulin G antibody/total antibody (procedure)	4180186
44807399	Astrovirus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807399	Measurement of astrovirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807401	Open Brethren	4180186
44807401	Open Brethren, follower of religion (person)	4180186
44807402	Measurement of Coxiella burnetii phase 2 immunoglobulin G antibody/total antibody (procedure)	4180186
44807404	Measurement of Chikungunya virus immunoglobulin G antibody/total antibody (procedure)	4180186
44807405	Passive range of left ankle inversion (observable entity)	4180186
44807407	Active range of left ankle extension (observable entity)	4180186
44807407	Active range of left ankle plantar flexion	4180186
44807408	Active range of right ankle extension (observable entity)	4180186
44807408	Active range of right ankle plantar flexion	4180186
44807411	Capillary filling time of left extremity (observable entity)	4180186
44807411	Capillary refill time of left extremity	4180186
44807413	Diabetes care plan declined (situation)	4180186
44807414	Central corneal thickness of left eye (observable entity)	4180186
44807415	Central corneal thickness of right eye (observable entity)	4180186
44807422	Inferior neuroretinal rim width of left eye (observable entity)	4180186
44807423	Inferior neuroretinal rim width of right eye (observable entity)	4180186
44807427	Nasal neuroretinal rim width of right eye (observable entity)	4180186
44807428	Temporal neuroretinal rim width of left eye (observable entity)	4180186
44807429	Temporal neuroretinal rim width of right eye (observable entity)	4180186
44807430	Abstinent from drug misuse (finding)	4180186
44807431	Environmental risk assessment (procedure)	4180186
44807434	Surgery care management (procedure)	4180186
44807437	Provision of specialist static seating (procedure)	4180186
44807439	Lack of mental capacity to make decision (Mental Capacity Act 2005) (finding)	4180186
44807442	Pyruvate dehydrogenase immunoglobulin G antibody measurement (procedure)	4180186
44807445	Myelin associated glycoprotein immunoglobulin G antibody measurement (procedure)	4180186
44807448	Lactoferrin immunoglobulin G antibody measurement (procedure)	4180186
44807449	Mitochondrial immunoglobulin A antibody measurement (procedure)	4180186
44807451	Endovascular insertion of stent for aneurysm of aortic bifurcation (procedure)	4180186
44807453	Mouse serum protein specific immunoglobulin E antibody measurement (procedure)	4180186
44807454	Canary serum protein specific immunoglobulin E antibody measurement (procedure)	4180186
44807456	Left dorsalis pedis pulse monophasic (finding)	4180186
44807459	Referral to prosthetic service (procedure)	4180186
44807460	Education for respite care (procedure)	4180186
44807462	Left dorsalis pedis pulse biphasic (finding)	4180186
44807465	Urinary retention care management (procedure)	4180186
44807467	Left dorsalis pedis pulse triphasic (finding)	4180186
44807471	Left posterior tibial pulse monophasic (finding)	4180186
44807472	Right posterior tibial pulse monophasic (finding)	4180186
44807474	Right posterior tibial pulse biphasic (finding)	4180186
44807476	Left posterior tibial pulse absent (finding)	4180186
44807477	Normal light touch sensation right foot (finding)	4180186
44807484	Ovarian hyperstimulation syndrome inpatient care plan (record artifact)	4180186
44807486	Ovarian hyperstimulation syndrome care (regime/therapy)	4180186
44807487	Ovarian hyperstimulation syndrome care management (procedure)	4180186
44807489	Education for epistaxis care (procedure)	4180186
44807492	Termination of pregnancy inpatient care plan (record artifact)	4180186
44807493	Termination of pregnancy inpatient care management (procedure)	4180186
44807496	Miscarriage care plan (record artifact)	4180186
44807497	Miscarriage care management (procedure)	4180186
44807501	Physically prepared to undergo procedure (finding)	4180186
44807502	Psychologically prepared to undergo procedure (finding)	4180186
44807505	Blood product administered safely (finding)	4180186
44807507	Care of urinary catheter (regime/therapy)	4180186
44807507	Urinary catheter care	4180186
44807508	Verification of RhD (Rhesus D) antibody status	4180186
44807508	Verification of Rhesus D antibody status (procedure)	4180186
44807509	Verification of date of last menstrual period (procedure)	4180186
44807511	Checking position of nasogastric tube using X-ray (procedure)	4180186
44807514	Provision of infusion pump for enteral feeding (procedure)	4180186
44807516	Measurement of Bartonella quintana immunoglobulin G antibody/total antibody (procedure)	4180186
44807517	Measurement of Bartonella henselae immunoglobulin G antibody/total antibody (procedure)	4180186
44807520	Measurement of human coxsackie A virus immunoglobulin M antibody (procedure)	4180186
44807522	Measurement of human coxsackie A virus immunoglobulin G antibody (procedure)	4180186
44807526	Measurement of flavivirus immunoglobulin M antibody (procedure)	4180186
44807530	Primary excision of ganglion of hand (procedure)	4180186
44807532	Arthroscopic excision of recurrent ganglion of wrist (procedure)	4180186
44807534	BAAF (British Association for Adoption and Fostering) adult 1 fee to referral agency	4180186
44807534	British Association for Adoption and Fostering adult 1 fee to referral agency (finding)	4180186
44807539	Measurement of Ascaris lumbricoides immunoglobulin G antibody/total antibody (procedure)	4180186
44807540	Measurement of alphavirus immunoglobulin M antibody (procedure)	4180186
44807545	Reconstruction of scapholunate ligament (procedure)	4180186
44807548	Measurement of Barmah Forest virus immunoglobulin G antibody/total antibody (procedure)	4180186
44807549	Measurement of Eastern equine encephalitis virus immunoglobulin G antibody/total antibody (procedure)	4180186
44807550	Measurement of Ebola virus immunoglobulin G antibody/total antibody (procedure)	4180186
44807551	Bocavirus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807551	Measurement of bocavirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807554	Lysis of adhesions of flexor tendon of hand (procedure)	4180186
44807555	Release of first extensor compartment of wrist (procedure)	4180186
44807556	Highest brachial systolic pressure (observable entity)	4180186
44807558	Medication monitoring first letter (procedure)	4180186
44807559	Medication monitoring second letter (procedure)	4180186
44807560	Medication monitoring third letter (procedure)	4180186
44807561	Interpreter booked (finding)	4180186
44807562	LDSQ - learning disability screening questionnaire	4180186
44807562	Learning disability screening questionnaire (assessment scale)	4180186
44807563	Estimated date of delivery by antenatal ultrasound scan (observable entity)	4180186
44807568	Diagnostic caudal epidural bolus injection of anaesthetic substance (procedure)	4180186
44807569	Therapeutic caudal epidural bolus injection of anaesthetic substance (procedure)	4180186
44807573	Screening for solvent abuse (procedure)	4180186
44807576	Pyridinium cross-links measurement (procedure)	4180186
44807577	Measurement of N-acetylneuraminic acid (procedure)	4180186
44807578	Aminoisobutyric acid measurement (procedure)	4180186
44807579	Beta aminoisobutyric acid measurement (procedure)	4180186
44807580	Impaired light touch sensation right foot (finding)	4180186
44807582	Absent light touch sensation right foot (finding)	4180186
44807583	Left ankle reflex normal (finding)	4180186
44807586	Left ankle reflex reduced (finding)	4180186
44807587	Right ankle reflex reduced (finding)	4180186
44807592	Informed of reason for referral (situation)	4180186
44807594	Attention to dressing of skin of neck (procedure)	4180186
44807595	Transfer of distant skin flap to neck (procedure)	4180186
44807599	21-hydroxypregnenolone measurement (procedure)	4180186
44807601	MDA (methylenedioxyamphetamine) screening test	4180186
44807601	Methylenedioxyamphetamine screening test (procedure)	4180186
44807602	MDEA (methylenedioxyethylamphetamine) measurement	4180186
44807602	Methylenedioxyethylamphetamine measurement (procedure)	4180186
44807603	Confirming patient has passed urine prior to discharge (procedure)	4180186
44807604	Sending of discharge letter to general practitioner (procedure)	4180186
44807606	Haemoglobin O Arab level	4180186
44807606	Haemoglobin O Arab measurement (procedure)	4180186
44807608	Referred for part 3 accommodation (finding)	4180186
44807614	HIV (human immunodeficiency virus) type 2 RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807614	Measurement of human immunodeficiency virus type 2 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807615	Management of irritable bowel syndrome (regime/therapy)	4180186
44807618	Copy of clinical record sent to insurance company (finding)	4180186
44807620	Copy of clinical record sent to patient (finding)	4180186
44807623	Sample taken before recall period (finding)	4180186
44807628	Reason for discontinuation of care plan (observable entity)	4180186
44807630	HTLV (human T cell lymphotropic virus) type 2 RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807630	Measurement of human T-cell lymphotropic virus type 2 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807631	Radionuclide destruction of synovium using yttrium 90 (procedure)	4180186
44807632	Chlamydia trachomatis detection by NAAT (nucleic acid amplification test)	4180186
44807632	Detection of Chlamydia trachomatis by nucleic acid amplification test (procedure)	4180186
44807633	Influenza A virus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807633	Measurement of Influenza A virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807634	Influenza B virus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807634	Measurement of Influenza B virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807635	Measurement of JC virus immunoglobulin M antibody (procedure)	4180186
44807641	Release of collateral ligament of DIPJ (distal interphalangeal joint)	4180186
44807641	Release of collateral ligament of distal interphalangeal joint (procedure)	4180186
44807644	Laparoscopic repair of ventral hernia with prosthesis (procedure)	4180186
44807646	Laparoscopic repair of recurrent ventral hernia with prosthesis (procedure)	4180186
44807648	Tetrahydrocortisone output measurement (procedure)	4180186
44807649	Seen in community treatment room (finding)	4180186
44807660	Diagnostic endoscopic examination of ileoanal pouch using rigid sigmoidoscope (procedure)	4180186
44807661	Excision of pilonidal sinus and primary closure (procedure)	4180186
44807664	Glycogen measurement (procedure)	4180186
44807668	Peroxisomal immunoglobulin G antibody measurement (procedure)	4180186
44807672	Fowl specific immunoglobulin G antibody measurement (procedure)	4180186
44807674	Pemphigus immunoglobulin G antibody measurement (procedure)	4180186
44807676	Parakeet specific immunoglobulin G antibody measurement (procedure)	4180186
44807679	Ri immunoglobulin G antibody measurement (procedure)	4180186
44807680	Carbohydrate antigen 72-4 measurement (procedure)	4180186
44807683	Ursodeoxycholic acid measurement (procedure)	4180186
44807683	Ursodiol measurement	4180186
44807684	Cytoplasmic kappa measurement (procedure)	4180186
44807685	Ro (Sjögren's syndrome A) immunoglobulin G antibody measurement (procedure)	4180186
44807685	Ro SSA (Sjögren's syndrome A) IgG antibody measurement	4180186
44807688	Count of cells positive for both CD33 antigen and CD34 antigen (procedure)	4180186
44807693	CD4/CD5 (T helper/T cell) ratio measurement (procedure)	4180186
44807697	Single stranded deoxyribonucleic acid immunoglobulin G antibody measurement (procedure)	4180186
44807698	Complement component 3 breakdown products assay (procedure)	4180186
44807700	Oligoclonal immunoglobulin G measurement (procedure)	4180186
44807702	CD71 count (procedure)	4180186
44807703	CD79a count (procedure)	4180186
44807704	Cytoplasmic CD8 count (procedure)	4180186
44807705	Cytoplasmic CD13 count (procedure)	4180186
44807707	Cytoplasmic CD14 count (procedure)	4180186
44807710	Referral to rectal bleeding clinic (procedure)	4180186
44807711	Scalp dysaesthesia (finding)	4180186
44807715	Lassa fever virus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807715	Measurement of Lassa fever virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807717	Not socially isolated (finding)	4180186
44807717	Not socially isolated (situation)	4180186
44807718	Detection of human papilloma virus deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807718	HPV (human papilloma virus) DNA (deoxyribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44807722	Determination of human immunodeficiency virus 1 genotype by ribonucleic acid analysis (procedure)	4180186
44807722	HIV (human immunodeficiency virus) 1 genotype determination by RNA (ribonucleic acid) analysis	4180186
44807723	Determination of hepatitis E virus genotype by ribonucleic acid analysis (procedure)	4180186
44807723	Hepatitis E virus genotype determination by RNA (ribonucleic acid) analysis	4180186
44807724	Detection of human herpes virus 6 deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807724	HHV (human herpes virus) 6 DNA (deoxyribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44807725	Detection of human herpes virus 7 deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807725	HHV (human herpes virus) 7 DNA (deoxyribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44807727	Has a paid carer (finding)	4180186
44807728	BAAF (British Association for Adoption and Fostering) adult 1 fee paid	4180186
44807728	British Association for Adoption and Fostering adult 1 fee paid (finding)	4180186
44807730	Percentage of predicted vital capacity after bronchodilation (observable entity)	4180186
44807731	Detection of hepatitis B virus deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807731	HBV (hepatitis B virus) DNA (deoxyribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44807732	Pseudomonas aeruginosa eradication therapy (procedure)	4180186
44807733	Asthma trigger - perfume (finding)	4180186
44807734	Determination of hepatitis B virus genotype by deoxyribonucleic acid analysis (procedure)	4180186
44807734	HBV (hepatitis B virus) genotype determination by DNA (deoxyribonucleic acid) analysis	4180186
44807735	HDV (hepatitis D virus) RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807735	Measurement of hepatitis D virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807736	HCV (hepatitis C virus) RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807736	Measurement of hepatitis C virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807737	On LCP (Liverpool care pathway) for the dying	4180186
44807737	On Liverpool care pathway for the dying (finding)	4180186
44807738	On ICP (integrated care pathway)	4180186
44807738	On integrated care pathway (finding)	4180186
44807739	Determination of hepatitis C virus genotype by ribonucleic acid analysis (procedure)	4180186
44807739	HCV (hepatitis C virus) genotype determination by RNA (ribonucleic acid) analysis	4180186
44807741	Positron emission tomography myocardial stress imaging using rubidium 82 (procedure)	4180186
44807742	Positron emission tomography myocardial rest imaging using rubidium 82 (procedure)	4180186
44807745	HIV (human immunodeficiency virus) type 1 antiviral resistance measurement by RNA (ribonucleic acid) analysis	4180186
44807745	Measurement of human immunodeficiency virus type 1 antiviral resistance by ribonucleic acid analysis (procedure)	4180186
44807746	Delayed reconstruction of breast with myocutaneous flap of latissimus dorsi muscle and pectoralis major muscle and insertion of prosthesis (procedure)	4180186
44807749	Immediate reconstruction of breast with pedicled TRAM (transverse rectus abdominis myocutaneous) flap	4180186
44807749	Immediate reconstruction of breast with pedicled transverse rectus abdominis myocutaneous flap (procedure)	4180186
44807751	Delayed reconstruction of breast with pedicled TRAM (transverse rectus abdominis myocutaneous) flap and insertion of prosthesis	4180186
44807751	Delayed reconstruction of breast with pedicled transverse rectus abdominis myocutaneous flap and insertion of prosthesis (procedure)	4180186
44807752	Reconstruction of breast with free TRAM (transverse rectus abdominis myocutaneous) flap and insertion of prosthesis	4180186
44807752	Reconstruction of breast with free transverse rectus abdominis myocutaneous flap and insertion of prosthesis (procedure)	4180186
44807753	Delayed reconstruction of breast with free TRAM (transverse rectus abdominis myocutaneous) flap and insertion of prosthesis	4180186
44807753	Delayed reconstruction of breast with free transverse rectus abdominis myocutaneous flap and insertion of prosthesis (procedure)	4180186
44807754	Immediate reconstruction of breast with free TRAM (transverse rectus abdominis myocutaneous) flap and insertion of prosthesis	4180186
44807754	Immediate reconstruction of breast with free transverse rectus abdominis myocutaneous flap and insertion of prosthesis (procedure)	4180186
44807757	Immediate reconstruction of breast with free flap (procedure)	4180186
44807761	Reconstruction of breast with submuscular implant (procedure)	4180186
44807765	Immediate reconstruction of breast with submuscular implant and reconstructive tissue matrix (procedure)	4180186
44807767	Delayed reconstruction of breast with local muscle flap and insertion of prosthesis (procedure)	4180186
44807769	Measurement of prothrombin immunoglobulin M antibody (procedure)	4180186
44807770	Measurement of antibody to A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 (procedure)	4180186
44807772	Coagulation factor V antigen level	4180186
44807772	Measurement of coagulation factor V antigen (procedure)	4180186
44807775	Coagulation factor X antigen level	4180186
44807775	Measurement of coagulation factor X antigen (procedure)	4180186
44807777	Measurement of kallikrein activity (procedure)	4180186
44807778	Measurement of protein S activity (procedure)	4180186
44807779	Measurement of procollagen II amino-terminal propeptide (procedure)	4180186
44807779	PIINP (procollagen II amino-terminal propeptide) measurement	4180186
44807779	Procollagen II N-terminal propeptide measurement	4180186
44807783	Laparoscopic extended right hemicolectomy converted to open (procedure)	4180186
44807786	Laparoscopically assisted extended left hemicolectomy (procedure)	4180186
44807787	Laparoscopic extended left hemicolectomy (procedure)	4180186
44807788	Laparoscopic extended left hemicolectomy converted to open (procedure)	4180186
44807789	Active range of right shoulder external rotation (observable entity)	4180186
44807790	Active range of left shoulder external rotation (observable entity)	4180186
44807792	Frequent attender of accident and emergency department	4180186
44807792	Frequent attendance of emergency department	4180186
44807792	Frequent attender of accident and emergency department (finding)	4180186
44807793	Open transverse colectomy (procedure)	4180186
44807795	Laparoscopic transverse colectomy converted to open (procedure)	4180186
44807800	Open subtotal colectomy (procedure)	4180186
44807807	BAAF (British Association for Adoption and Fostering) B1 fee to adoption agency	4180186
44807807	British Association for Adoption and Fostering B1 fee to adoption agency (finding)	4180186
44807809	Laparoscopic total colectomy converted to open (procedure)	4180186
44807810	Panproctocolectomy (procedure)	4180186
44807814	Laparoscopic panproctocolectomy converted to open (procedure)	4180186
44807817	Dissent withdrawn for secondary use of general practitioner patient identifiable data (finding)	4180186
44807818	Supply of medication available at home (finding)	4180186
44807819	Former sex worker (situation)	4180186
44807821	Provision of written information about hypotension (procedure)	4180186
44807821	Provision of written information about low blood pressure	4180186
44807823	Provision of practice information leaflet (procedure)	4180186
44807824	Provision of written information about chronic obstructive pulmonary disease (procedure)	4180186
44807824	Provision of written information about COPD (chronic obstructive pulmonary disease)	4180186
44807825	Provision of written information about epilepsy (procedure)	4180186
44807826	Provision of written information about contraception (procedure)	4180186
44807827	Provision of written information about emergency contraception (procedure)	4180186
44807829	Provision of written information about subcutaneous contraceptive implant (procedure)	4180186
44807830	Provision of written information about long acting reversible contraception (procedure)	4180186
44807831	Provision of written information about intrauterine system (procedure)	4180186
44807831	Provision of written information about IUS (intrauterine system)	4180186
44807832	Provision of written information about minor surgery (procedure)	4180186
44807833	Provision of written information about mental health (procedure)	4180186
44807835	Provision of written information about lithium therapy (procedure)	4180186
44807837	Provision of written information about combined oral contraception (procedure)	4180186
44807838	Provision of written information about health care services (procedure)	4180186
44807840	Provision of written information about screening for cancer (procedure)	4180186
44807841	Provision of written information about safer sex (procedure)	4180186
44807845	Provision of written information about minor injury (procedure)	4180186
44807846	Provision of written information about coronary heart disease (procedure)	4180186
44807847	Provision of written information about smoking cessation (procedure)	4180186
44807850	Provision of written information about antenatal screening for Down's syndrome	4180186
44807850	Provision of written information about antenatal screening for Down syndrome (procedure)	4180186
44807853	Provision of written information about oedema (procedure)	4180186
44807855	Provision of written information about foreign travel (procedure)	4180186
44807856	Diabetes quality of life questionnaire (assessment scale)	4180186
44807859	Assessment of artificial airway (procedure)	4180186
44807862	Major vascular surgery inpatient care plan (record artifact)	4180186
44807863	Urological surgery inpatient care plan (record artifact)	4180186
44807865	Minor urological surgery inpatient care plan (record artifact)	4180186
44807867	Hyperglycaemia education (procedure)	4180186
44807869	Education about diabetic neuropathy (procedure)	4180186
44807870	Aneurysm of superficialised artery of dialysis arteriovenous fistula (disorder)	4180186
44807874	Aneurysm of dialysis arteriovenous fistula (disorder)	4180186
44807877	Aneurysm of anastomotic site of dialysis arteriovenous fistula (disorder)	4180186
44807880	Under care of renal service (finding)	4180186
44807883	Baseline BMI (body mass index)	4180186
44807883	Baseline body mass index (observable entity)	4180186
44807885	General Practitioner Referral Document (record artifact)	4180186
44807887	General Practitioner Referral Reject Response (record artifact)	4180186
44807888	Radionuclide localisation of tumour using methoxyisobutyl isonitrile (procedure)	4180186
44807888	Radionuclide localisation of tumour using MIBI (methoxyisobutyl isonitrile)	4180186
44807890	Injection of Botulinum toxin using ultrasonography guidance (procedure)	4180186
44807890	Ultrasound guided Botulinum toxin injection	4180186
44807894	Balloon dilatation of bronchus using fluoroscopic guidance (procedure)	4180186
44807896	Cutting balloon dilatation of bronchus using fluoroscopic guidance (procedure)	4180186
44807901	Provision of written information about hallucinations (procedure)	4180186
44807902	Complex community care (regime/therapy)	4180186
44807904	General document section types (record artifact)	4180186
44807905	Consent section (record artifact)	4180186
44807909	Referral to voluntary sector advocacy service (procedure)	4180186
44807911	Limbal stem cell allograft transplantation (procedure)	4180186
44807912	Does not engage in substance misuse (situation)	4180186
44807914	Insertion of biventricular implantable cardioverter defibrillator lead using fluoroscopic guidance (procedure)	4180186
44807916	Transport needs met by service (finding)	4180186
44807919	Doppler ultrasonography of multiple pregnancy (procedure)	4180186
44807919	Doppler ultrasound scan of multiple pregnancy	4180186
44807922	Medical Research Council muscle power score of shoulder internal rotation (observable entity)	4180186
44807928	Medical Research Council muscle power score of ankle plantar flexion (observable entity)	4180186
44807931	Medical Research Council muscle power score of ankle inversion (observable entity)	4180186
44807934	Laparoscopic low anterior resection converted to open	4180186
44807934	Laparoscopic low anterior resection of rectum converted to open (procedure)	4180186
44807935	Medical Research Council muscle power score of ankle dorsiflexion (observable entity)	4180186
44807936	Open low anterior resection	4180186
44807936	Open low anterior resection of rectum (procedure)	4180186
44807937	Open abdominoperineal resection (procedure)	4180186
44807939	Laparoscopic abdominoperineal resection converted to open (procedure)	4180186
44807941	Band neutrophil percent differential count (procedure)	4180186
44807941	Percent band cell count	4180186
44807943	Addiction service (qualifier value)	4180186
44807945	Anticoagulant service (qualifier value)	4180186
44807947	Community learning disability nursing (qualifier value)	4180186
44807950	Living will and advance directive record (record artifact)	4180186
44807953	Medical Research Council muscle power score of shoulder abduction (observable entity)	4180186
44807954	Medical Research Council muscle power score of shoulder flexion (observable entity)	4180186
44807955	Medical Research Council muscle power score of wrist abduction (observable entity)	4180186
44807959	Medical Research Council muscle power score of hip abduction (observable entity)	4180186
44807968	Target BMI (body mass index)	4180186
44807968	Target body mass index (observable entity)	4180186
44807972	Percutaneous transluminal coil embolisation using fluoroscopic guidance (procedure)	4180186
44807973	Keeps essential information in Message in a Bottle (finding)	4180186
44807973	Keeps essential information in MIAB (Message in a Bottle)	4180186
44807974	Heart rate walking speed index (assessment scale)	4180186
44807975	Percutaneous transluminal balloon angioplasty using fluoroscopic guidance (procedure)	4180186
44807979	Human papillomavirus vaccination invitation second letter (procedure)	4180186
44807980	Human papillomavirus vaccination invitation third letter (procedure)	4180186
44807982	Participant in research study (finding)	4180186
44807984	EQ-5D (EuroQol five dimension) self-report questionnaire	4180186
44807984	EuroQol five dimension self-report questionnaire (assessment scale)	4180186
44807985	Assessment using EQ-5D (EuroQol five dimension) self-report questionnaire	4180186
44807985	Assessment using EuroQol five dimension self-report questionnaire (procedure)	4180186
44807989	Referral to community diabetes specialist nurse declined (situation)	4180186
44807990	Measurement of inosine pranobex (procedure)	4180186
44807993	Measurement of amantadine hydrochloride (procedure)	4180186
44807994	Contraceptive sheath offered (finding)	4180186
44807995	Measurement of oseltamivir (procedure)	4180186
44807996	Measurement of zanamivir (procedure)	4180186
44807999	Biopsychosocial assessment declined (situation)	4180186
44808000	Unsuitable for biopsychosocial assessment (finding)	4180186
44808001	Unsuitable for QRISK2 cardiovascular disease risk assessment (finding)	4180186
44808006	Ibandronic acid contraindicated (situation)	4180186
44808007	Calcitonin contraindicated (situation)	4180186
44808008	Zoledronic acid monohydrate contraindicated (situation)	4180186
44808010	Fluoroscopy guided insertion of nontunnelled central venous catheter via internal jugular vein	4180186
44808010	Insertion of non-tunnelled central venous catheter via internal jugular vein using fluoroscopic guidance (procedure)	4180186
44808017	Insertion of non-tunnelled central venous catheter via internal jugular vein using ultrasonography guidance (procedure)	4180186
44808017	Ultrasound guided insertion of nontunnelled central venous catheter via internal jugular vein	4180186
44808018	Insertion of non-tunnelled central venous catheter via external jugular vein using ultrasonography guidance (procedure)	4180186
44808018	Ultrasound guided insertion of nontunnelled central venous catheter via external jugular vein	4180186
44808020	Insertion of non-tunnelled central venous catheter via subclavian vein using ultrasonography guidance (procedure)	4180186
44808020	Ultrasound guided insertion of nontunnelled central venous catheter via subclavian vein	4180186
44808021	Intra-arterial infusion of chemotherapy agent using fluoroscopic guidance with contrast	4180186
44808021	Intra-arterial infusion of antineoplastic agent using fluoroscopic guidance with contrast (procedure)	4180186
44808022	Percutaneous removal of calculus from urinary bladder using fluoroscopic guidance (procedure)	4180186
44808026	Atrial fibrillation care pathway (regime/therapy)	4180186
44808027	Infusion of chemotherapy agent into cerebral artery using fluoroscopic guidance with contrast	4180186
44808027	Infusion of antineoplastic agent into cerebral artery using fluoroscopic guidance with contrast (procedure)	4180186
44808028	Follicular lymphoma grade 3 (disorder)	4180186
44808030	Medical Research Council muscle power score of hip external rotation (observable entity)	4180186
44808033	Adaptation - intent (qualifier value)	4180186
44808035	Habilitation - intent (qualifier value)	4180186
44808036	Late onset male hypogonadism (finding)	4180186
44808039	Paediatric burns care (qualifier value)	4180186
44808040	Paediatric cystic fibrosis service (qualifier value)	4180186
44808041	Paediatric dermatology (qualifier value)	4180186
44808042	Non-healing leg ulcer (disorder)	4180186
44808044	Paediatric diabetic medicine (qualifier value)	4180186
44808046	Paediatric maxillofacial surgery (qualifier value)	4180186
44808047	Paediatric cardiac surgery (qualifier value)	4180186
44808049	Recurrent leg ulcer (disorder)	4180186
44808050	Paediatric neurosurgery (qualifier value)	4180186
44808053	Audiometry (qualifier value)	4180186
44808054	Dental and maxillofacial radiology (qualifier value)	4180186
44808055	Paediatric interventional radiology (qualifier value)	4180186
44808057	Dental hygiene service (qualifier value)	4180186
44808061	Diagnostic imaging - specialty (qualifier value)	4180186
44808062	Eating disorders service (qualifier value)	4180186
44808063	ECG (electrocardiography) service	4180186
44808063	Electrocardiography service (qualifier value)	4180186
44808066	Learning disability nursing (qualifier value)	4180186
44808067	Medical photography (qualifier value)	4180186
44808068	Mental health nursing (qualifier value)	4180186
44808071	Measurement of cidofovir (procedure)	4180186
44808072	Plasma specimen with fluoride oxalate (specimen)	4180186
44808073	Consent given for deactivation of automatic implantable cardioverter defibrillator (finding)	4180186
44808075	Whole blood specimen with edetic acid	4180186
44808075	Whole blood specimen with ethylenediaminetetraacetic acid (specimen)	4180186
44808077	Whole blood specimen with fluoride oxalate (specimen)	4180186
44808079	Pre-dose sample (finding)	4180186
44808080	Fasting sample (finding)	4180186
44808081	Post mortem sample (finding)	4180186
44808083	Sample from ambulatory subject (finding)	4180186
44808087	Collection of specimen by catheter (procedure)	4180186
44808089	Collection of calculus specimen (procedure)	4180186
44808093	Endoscopic mastectomy (procedure)	4180186
44808095	Collection of food specimen (procedure)	4180186
44808096	Collection of hair specimen (procedure)	4180186
44808098	Specimen obtained by cone biopsy	4180186
44808098	Specimen obtained by cone biopsy (specimen)	4180186
44808099	Collection of specimen by curettage (procedure)	4180186
44808099	Specimen collection by curetting	4180186
44808100	Measurement of didanosine (procedure)	4180186
44808103	Measurement of stavudine (procedure)	4180186
44808104	Endoscopic biopsy sample	4180186
44808104	Specimen obtained by endoscopic biopsy (specimen)	4180186
44808106	Thoracoscopic exclusion of left atrial appendage (procedure)	4180186
44808107	Measurement of zidovudine (procedure)	4180186
44808109	Measurement of fosamprenavir (procedure)	4180186
44808110	Measurement of indinavir (procedure)	4180186
44808112	Collection of specimen by needle aspiration (procedure)	4180186
44808113	Lopinavir level	4180186
44808113	Measurement of lopinavir (procedure)	4180186
44808114	Needle biopsy sample	4180186
44808114	Specimen obtained by needle biopsy (specimen)	4180186
44808119	Percutaneous transluminal insertion of stent into cerebral artery using fluoroscopic guidance (procedure)	4180186
44808121	Percutaneous transluminal glue embolisation of vein using fluoroscopic guidance (procedure)	4180186
44808122	Diffuse large B-cell lymphoma (disorder)	4180186
44808124	Reduction mastopexy by vertical scar technique (procedure)	4180186
44808127	Rupture of vein of transplanted kidney (disorder)	4180186
44808128	Acute renal failure due to traumatic rhabdomyolysis (disorder)	4180186
44808130	EPUAP (European pressure ulcer advisory panel) grade of pressure ulcer of right foot	4180186
44808130	European pressure ulcer advisory panel grade of pressure ulcer of right foot (observable entity)	4180186
44808131	EPUAP (European pressure ulcer advisory panel) grade of pressure ulcer of left foot	4180186
44808131	European pressure ulcer advisory panel grade of pressure ulcer of left foot (observable entity)	4180186
44808133	EPUAP (European pressure ulcer advisory panel) grade of pressure ulcer of left knee	4180186
44808133	European pressure ulcer advisory panel grade of pressure ulcer of left knee (observable entity)	4180186
44808134	EPUAP (European pressure ulcer advisory panel) grade of pressure ulcer of right hip	4180186
44808134	European pressure ulcer advisory panel grade of pressure ulcer of right hip (observable entity)	4180186
44808140	Assessment using post-traumatic stress disorder impact of events scale (procedure)	4180186
44808141	Post-traumatic stress disorder impact of events scale score (observable entity)	4180186
44808142	Zoledronic acid monohydrate declined (situation)	4180186
44808143	Operator unfamiliar with equipment (finding)	4180186
44808145	Special care dentistry (qualifier value)	4180186
44808146	School nursing (qualifier value)	4180186
44808149	Prosthetics (qualifier value)	4180186
44808152	Electroencephalography (qualifier value)	4180186
44808153	Foreign travel risk assessment (procedure)	4180186
44808154	Oral medicine (qualifier value)	4180186
44808156	National Health Service Direct (qualifier value)	4180186
44808158	Obstetrics - antenatal (qualifier value)	4180186
44808162	Medical Research Council muscle power score of hip extension (observable entity)	4180186
44808163	Suspected acrodysostosis (situation)	4180186
44808166	Medical Research Council muscle power score of left hip extension (observable entity)	4180186
44808167	Medical Research Council muscle power score of right elbow extension (observable entity)	4180186
44808168	Medical Research Council muscle power score of knee extension (observable entity)	4180186
44808170	Medical Research Council muscle power score of right knee extension (observable entity)	4180186
44808171	Medical Research Council muscle power score of knee flexion (observable entity)	4180186
44808172	Medical Research Council muscle power score of left knee flexion (observable entity)	4180186
44808175	Adolescent psychiatry service (qualifier value)	4180186
44808176	Dental therapy (qualifier value)	4180186
44808177	Diagnostic radiography (qualifier value)	4180186
44808179	Intensive care medicine (qualifier value)	4180186
44808184	Punch biopsy sample	4180186
44808184	Specimen obtained by punch biopsy (specimen)	4180186
44808185	Measurement of nelfinavir (procedure)	4180186
44808187	Collection of specimen by scraping (procedure)	4180186
44808191	Measurement of tipranavir (procedure)	4180186
44808196	Collection of spontaneous specimen (procedure)	4180186
44808197	Collection of induced specimen (procedure)	4180186
44808200	Discharge from in-house cardiology (procedure)	4180186
44808203	Discharge from in-house gynaecology (procedure)	4180186
44808206	Falls risk assessment tool (assessment scale)	4180186
44808206	FRAT - falls risk assessment tool	4180186
44808207	Computed tomography arthrography of lumbar facet joint with contrast (procedure)	4180186
44808207	Computed tomography arthrography of lumbar zygapophyseal joint with contrast	4180186
44808207	CT arthrogram of lumbar facet joint with contrast	4180186
44808209	Computed tomography arthrography of thoracic facet joint with contrast (procedure)	4180186
44808209	Computed tomography arthrography of thoracic zygapophyseal joint with contrast	4180186
44808209	CT arthrogram of thoracic facet joint with contrast	4180186
44808210	Assessment using falls risk assessment tool (procedure)	4180186
44808210	Assessment using FRAT (falls risk assessment tool)	4180186
44808212	Laparoscopic cryoablation of neoplasm of kidney (procedure)	4180186
44808213	Computed tomography arthrography of ankle with contrast (procedure)	4180186
44808213	CT arthrogram of ankle with contrast	4180186
44808214	Computed tomography arthrography of elbow with contrast (procedure)	4180186
44808214	CT arthrogram of elbow with contrast	4180186
44808216	Computed tomography arthrography of knee with contrast (procedure)	4180186
44808216	CT arthrogram of knee with contrast	4180186
44808217	Computed tomography arthrography of metacarpophalangeal joint with contrast (procedure)	4180186
44808217	CT arthrogram of metacarpophalangeal joint with contrast	4180186
44808218	Computed tomography arthrography of metatarsophalangeal joint with contrast (procedure)	4180186
44808218	CT arthrogram of metatarsophalangeal joint with contrast	4180186
44808219	Computed tomography arthrography of midtarsal joint with contrast (procedure)	4180186
44808219	CT arthrogram of midtarsal joint with contrast	4180186
44808220	Computed tomography arthrography of subtalar joint with contrast (procedure)	4180186
44808220	CT arthrogram of subtalar joint with contrast	4180186
44808221	Endoscopic transluminal debridement of pancreatic necrosis (procedure)	4180186
44808222	Computed tomography arthrography of wrist with contrast (procedure)	4180186
44808222	CT arthrogram of wrist with contrast	4180186
44808224	Fluoroscopic arthrogram of metacarpophalangeal joint with contrast	4180186
44808224	Fluoroscopic arthrography of metacarpophalangeal joint with contrast (procedure)	4180186
44808225	Denosumab declined (situation)	4180186
44808226	Calcitonin declined (situation)	4180186
44808229	Denosumab not tolerated (situation)	4180186
44808232	Ibandronic acid not indicated (situation)	4180186
44808233	Zoledronic acid monohydrate not indicated (situation)	4180186
44808235	Denosumab not indicated (situation)	4180186
44808236	Adverse incident possibly preventable within current resource (finding)	4180186
44808238	Chronic obstructive pulmonary disease care pathway (regime/therapy)	4180186
44808238	COPD (chronic obstructive pulmonary disease) care pathway	4180186
44808240	Bowels not opened in last 24 hours (finding)	4180186
44808241	History of zoledronic acid monohydrate allergy (situation)	4180186
44808242	History of denosumab allergy (situation)	4180186
44808245	Healthy skin (finding)	4180186
44808246	Referral to multidisciplinary heart failure team (procedure)	4180186
44808247	Chaperone not offered (situation)	4180186
44808249	Adverse incident probably preventable with reasonable extra resource (finding)	4180186
44808251	QCancer risk calculator (assessment scale)	4180186
44808252	QCancer lung cancer risk calculator (assessment scale)	4180186
44808254	Adverse incident preventability (observable entity)	4180186
44808258	Assessment using QCancer colorectal cancer risk calculator (procedure)	4180186
44808259	Therapeutic role play (regime/therapy)	4180186
44808260	Postprocedural play (regime/therapy)	4180186
44808263	CAF (common assessment framework) for children and young people process completed	4180186
44808263	Common assessment framework for children and young people process completed (finding)	4180186
44808264	Declines information about services for carers (finding)	4180186
44808267	Chronic obstructive pulmonary disease written self management plan declined (situation)	4180186
44808267	COPD (chronic obstructive pulmonary disease) written self management plan declined	4180186
44808268	Chronic obstructive pulmonary disease self management plan not appropriate (finding)	4180186
44808268	COPD (chronic obstructive pulmonary disease) self management plan not appropriate	4180186
44808272	Education about tobacco use cessation (procedure)	4180186
44808280	Microwave ablation using ultrasonography guidance (procedure)	4180186
44808280	Ultrasound guided microwave ablation	4180186
44808281	Respiratory disease medication review (procedure)	4180186
44808283	Local authority care package declined (situation)	4180186
44808286	Does not adhere to medication regimen (finding)	4180186
44808288	Partial adherence to medication regimen (finding)	4180186
44808289	Nutrition and Diet Resources United Kingdom stage 2 thickened fluid diet (finding)	4180186
44808290	Nutrition and Diet Resources United Kingdom stage 3 thickened fluid diet (finding)	4180186
44808292	BAAF (British Association for Adoption and Fostering) B1 fee unpaid	4180186
44808292	British Association for Adoption and Fostering B1 fee unpaid (finding)	4180186
44808293	Needs assistance with medication regimen adherence (finding)	4180186
44808294	Paediatric immunology and allergy (qualifier value)	4180186
44808296	Prosthetics or orthotics (qualifier value)	4180186
44808298	Inpatient nursing note (record artifact)	4180186
44808300	Medical Research Council muscle power score of left hip flexion (observable entity)	4180186
44808303	Patient narrative (record artifact)	4180186
44808305	Application of low adherence dressing (procedure)	4180186
44808305	Application of low adherent dressing	4180186
44808306	Application of absorbent dressing (procedure)	4180186
44808309	Application of soft polymer dressing (procedure)	4180186
44808310	Application of hydrocolloid dressing (procedure)	4180186
44808311	Application of capillary action dressing (procedure)	4180186
44808312	Application of odour absorbent dressing (procedure)	4180186
44808314	Application of silicone keloid dressing (procedure)	4180186
44808316	Fluoroscopic arthrogram of subtalar joint with contrast	4180186
44808316	Fluoroscopic arthrography of subtalar joint with contrast (procedure)	4180186
44808318	Fluoroscopic arthrogram of temporomandibular joint with contrast	4180186
44808318	Fluoroscopic arthrography of temporomandibular joint with contrast (procedure)	4180186
44808322	Intervention (record artifact)	4180186
44808323	Intervention on development of symptoms (record artifact)	4180186
44808325	Acute medical intervention on development of symptoms (record artifact)	4180186
44808326	Acute surgical intervention on development of symptoms (record artifact)	4180186
44808327	Oncology intervention on development of symptoms (record artifact)	4180186
44808329	Fluoroscopic angiography of thoracic aorta using contrast with insertion of fenestrated tapered stent graft (procedure)	4180186
44808334	Establishing focus of care (procedure)	4180186
44808335	Establishing focus of care with specialist cancer team (procedure)	4180186
44808336	Planned supportive care for terminal illness (record artifact)	4180186
44808338	Acute renal failure induced by aminoglycoside (disorder)	4180186
44808341	Insulinoma-associated antigen-2 antibody level	4180186
44808341	Measurement of insulinoma-associated antigen-2 antibody (procedure)	4180186
44808342	Percutaneous endoscopic laser excision of cervical intervertebral disc (procedure)	4180186
44808344	Adverse incident items (finding)	4180186
44808346	Assessment using QCancer renal cancer risk calculator (procedure)	4180186
44808347	Assessment using QCancer ovarian cancer risk calculator (procedure)	4180186
44808348	Assessment using QCancer pancreatic cancer risk calculator (procedure)	4180186
44808350	QCancer colorectal cancer risk (observable entity)	4180186
44808352	QCancer lung cancer risk (observable entity)	4180186
44808353	QCancer ovarian cancer risk (observable entity)	4180186
44808355	Shortage of beds in HDU (high dependency unit)	4180186
44808355	Shortage of beds in high dependency unit (finding)	4180186
44808355	Shortage of level 2 beds	4180186
44808356	QCancer renal cancer risk (observable entity)	4180186
44808358	QKidney disease risk calculator score (observable entity)	4180186
44808360	QThrombosis risk calculator (assessment scale)	4180186
44808361	Assessment using QThrombosis risk calculator (procedure)	4180186
44808362	Admission to HDU (high dependency unit) or ITU (intensive therapy unit) following anaesthetic adverse event	4180186
44808362	Admission to high dependency unit or intensive therapy unit following anaesthetic adverse event (procedure)	4180186
44808362	Admission to level 2 or 3 bed following anaesthetic adverse event	4180186
44808363	QThrombosis risk calculator score (observable entity)	4180186
44808367	High grade dysplasia of colon (disorder)	4180186
44808371	Measurement of creatine output (procedure)	4180186
44808375	Seasonal influenza vaccination given by pharmacist (finding)	4180186
44808377	CHI-ESQ - Commission for Health Improvement experience of service questionnaire	4180186
44808377	Commission for Health Improvement experience of service questionnaire (assessment scale)	4180186
44808379	Ultrasonography of stent graft of aorta (procedure)	4180186
44808379	Ultrasound scan of aortic stent graft	4180186
44808380	ECG (electrocardiography) gated CT of chest	4180186
44808380	Electrocardiography gated computed tomography of thorax (procedure)	4180186
44808381	Family history of peripheral vascular disease (situation)	4180186
44808382	Informing patient of test result process (procedure)	4180186
44808384	Insertion of tunnelled drain using ultrasonography guidance (procedure)	4180186
44808384	Ultrasound guided insertion of tunnelled drain	4180186
44808385	Pre-diabetes (disorder)	4180186
44808387	Positron emission tomography using fluorodeoxyglucose with computed tomography myocardial stress imaging (procedure)	4180186
44808390	Discussion about liver transplantation (procedure)	4180186
44808392	Intravenous steroid prophylaxis (procedure)	4180186
44808395	Removal of subcutaneous contraceptive implant using ultrasonography guidance (procedure)	4180186
44808395	Removal of subcutaneous contraceptive implant using ultrasound guidance	4180186
44808396	Safe sleeping assessment (procedure)	4180186
44808398	Born in Montenegro (finding)	4180186
44808399	No family history of hypercholesterolaemia (situation)	4180186
44808401	Application of topical negative pressure therapy (procedure)	4180186
44808405	Provision of diabetes clinical summary (procedure)	4180186
44808406	Medical Research Council muscle power score of left shoulder adduction (observable entity)	4180186
44808407	Medical Research Council muscle power score of right shoulder adduction (observable entity)	4180186
44808409	Neoadjuvant chemotherapy (procedure)	4180186
44808412	Short uterine cervix (finding)	4180186
44808413	Agreeing on leg ulcer treatment plan (procedure)	4180186
44808415	History of hepatitis C antiviral drug therapy (situation)	4180186
44808416	Injection of marker into breast using fluoroscopic guidance (procedure)	4180186
44808417	Insertion of fiducial marker into liver using computed tomography guidance (procedure)	4180186
44808418	On hepatitis C treatment plan (finding)	4180186
44808421	Insertion of fiducial marker into spine using computed tomography guidance (procedure)	4180186
44808422	Microscopic polyangiitis (disorder)	4180186
44808423	CT guided insertion of fiducial marker into lung	4180186
44808423	Insertion of fiducial marker into lung using computed tomography guidance (procedure)	4180186
44808424	Insertion of fiducial marker using ultrasonography guidance (procedure)	4180186
44808424	Ultrasound guided insertion of fiducial marker	4180186
44808428	Ageing males' symptoms score (observable entity)	4180186
44808428	AMS (ageing males' symptoms) score	4180186
44808430	Out of hours service (qualifier value)	4180186
44808432	Medical microbiology and virology (qualifier value)	4180186
44808434	FICB - fascia iliaca compartment block	4180186
44808434	Local anaesthetic block of fascia iliaca compartment (procedure)	4180186
44808435	Canaloplasty	4180186
44808435	Circumferential viscodilation and tensioning of Schlemm canal (procedure)	4180186
44808436	Transabdominal implantation of artificial anal sphincter (procedure)	4180186
44808437	Insertion of implant to sinus tarsi (procedure)	4180186
44808437	Subtalar arthroereisis	4180186
44808440	Laparoscopic augmentation cystoplasty (procedure)	4180186
44808441	Endoscopic augmentation of lower oesophageal sphincter using hydrogel implant (procedure)	4180186
44808442	Post-dose sample (finding)	4180186
44808443	Random sample (finding)	4180186
44808445	Random sample - dose details unknown (finding)	4180186
44808446	Random sample - recent activity details unknown (finding)	4180186
44808447	Provision of written information about chemotherapy (procedure)	4180186
44808448	Measurement of nevirapine (procedure)	4180186
44808449	Measurement of enfuvirtide (procedure)	4180186
44808450	Measurement of maraviroc (procedure)	4180186
44808453	Measurement of entecavir (procedure)	4180186
44808458	Measurement of telaprevir (procedure)	4180186
44808459	Laparoscopic cerclage of cervix (procedure)	4180186
44808460	Sneezing incontinence of urine (finding)	4180186
44808463	Measurement of boceprevir (procedure)	4180186
44808468	Accepts altered body image (finding)	4180186
44808469	Interstitial photodynamic therapy of malignant tumour of parotid gland (procedure)	4180186
44808470	Rupture of rectus femoris muscle (disorder)	4180186
44808471	Long term condition care (regime/therapy)	4180186
44808478	Measurement of cytoplasmic kappa light chain (procedure)	4180186
44808479	Laparoscopic distal pancreatectomy (procedure)	4180186
44808480	Risedronate sodium declined (situation)	4180186
44808481	Disodium etidronate not tolerated (situation)	4180186
44808484	Risedronate sodium not tolerated (situation)	4180186
44808485	Disodium etidronate not indicated (situation)	4180186
44808488	Adverse incident preventabilities (finding)	4180186
44808489	History of disodium etidronate allergy (situation)	4180186
44808490	History of alendronic acid allergy (situation)	4180186
44808491	History of risedronate sodium allergy (situation)	4180186
44808492	Disodium etidronate contraindicated (situation)	4180186
44808494	Adverse incident possibly preventable with reasonable extra resource (finding)	4180186
44808495	Risedronate sodium contraindicated (situation)	4180186
44808497	Acute bacterial laryngitis (disorder)	4180186
44808500	Duodenal ulcer with obstruction (disorder)	4180186
44808501	Operator unfamiliar with technique (finding)	4180186
44808502	Peptic ulcer with obstruction (disorder)	4180186
44808505	Percutaneous transluminal angioplasty of trunk of pulmonary artery using fluoroscopic guidance (procedure)	4180186
44808506	Congenital absence of lesser toe (disorder)	4180186
44808508	Open intra-articular fracture of distal radius (disorder)	4180186
44808509	PBCL flag true (attribute)	4180186
44808511	Endorectal ultrasonography of prostate (procedure)	4180186
44808511	Endorectal ultrasound scan of prostate	4180186
44808513	Obtaining consent for clinical photography for educational purposes (procedure)	4180186
44808516	Obtaining consent using form 2 (parental agreement to investigation or treatment for a child or young person) (procedure)	4180186
44808518	Education about stroke rehabilitation (procedure)	4180186
44808520	Check of inhaler technique not appropriate (finding)	4180186
44808522	Insertion of EOTTS (extraosseous talotarsal stabilisation) device	4180186
44808522	Insertion of extraosseous talotarsal stabilisation device (procedure)	4180186
44808523	Pregnancy of unknown location (disorder)	4180186
44808524	Dermatology assessment (procedure)	4180186
44808526	Administration of diuretic (procedure)	4180186
44808529	Provision of written information about generalised anxiety disorder (procedure)	4180186
44808531	Mental health care plan (record artifact)	4180186
44808537	Assessment of ileostomy (regime/therapy)	4180186
44808543	Single photon emission computed tomography with computed tomography of liver using technetium 99m macroaggregated albumin (procedure)	4180186
44808543	SPECT CT of liver using Tc99m MAA (technetium 99m macroaggregated albumin)	4180186
44808544	Single photon emission computed tomography of whole body (procedure)	4180186
44808545	Assessment using Medical Research Council dyspnoea scale	4180186
44808545	Assessment using Medical Research Council dyspnoea scale (procedure)	4180186
44808545	Assessment using MRC (Medical Research Council) dyspnoea scale	4180186
44808546	Single photon emission computed tomography with computed tomography of whole body (procedure)	4180186
44808547	Medical Research Council dyspnoea scale	4180186
44808547	Medical Research Council dyspnoea scale (assessment scale)	4180186
44808547	MRC (Medical Research Council) dyspnoea scale	4180186
44808550	National early warning score	4180186
44808550	RCP (Royal College of Physicians) NEWS (national early warning score)	4180186
44808550	Royal College of Physicians national early warning score (assessment scale)	4180186
44808550	Royal College of Physicians NEWS (national early warning score)	4180186
44808551	Education about arterial cannula care (procedure)	4180186
44808552	Multidisciplinary mental health case management (procedure)	4180186
44808554	Complex community care plan (record artifact)	4180186
44808557	Speech video fluoroscopy (procedure)	4180186
44808558	Measurement of yellow fever virus immunoglobulin M antibody (procedure)	4180186
44808562	Determination of thiopurine methyltransferase phenotype (procedure)	4180186
44808562	TPMT (thiopurine methyltransferase) phenotype	4180186
44808563	7-aminoclonazepam level	4180186
44808563	Measurement of 7-aminoclonazepam (procedure)	4180186
44808567	5-Hydroxyindoleacetic acid output	4180186
44808567	Measurement of 5-hydroxyindoleacetic acid output (procedure)	4180186
44808569	Measurement of normetadrenaline output (procedure)	4180186
44808569	Normetadrenaline output	4180186
44808570	Measurement of urea output (procedure)	4180186
44808570	Urea output	4180186
44808573	Measurement of red blood cell G6PD (glucose-6-phosphate dehydrogenase) activity	4180186
44808573	Measurement of red blood cell glucose-6-phosphate dehydrogenase activity (procedure)	4180186
44808573	Red blood cell glucose-6-phosphate dehydrogenase activity	4180186
44808577	Measurement of beta-glucuronidase activity (procedure)	4180186
44808578	Measurement of glutamate dehydrogenase activity (procedure)	4180186
44808580	Measurement of asparaginase activity (procedure)	4180186
44808582	Measurement of dihydropyrimidine dehydrogenase activity (procedure)	4180186
44808585	Measurement of 5' nucleotidase activity	4180186
44808585	Measurement of 5' nucleotidase activity (procedure)	4180186
44808591	Measurement of deoxyribonuclease B immunoglobulin G antibody (procedure)	4180186
44808592	Measurement of adenosine deaminase activity (procedure)	4180186
44808594	Measurement of hexosaminidase A activity (procedure)	4180186
44808596	Count of cells positive for cytoplasmic myeloperoxidase (procedure)	4180186
44808597	Measurement of Aspergillus terreus specific immunoglobulin E antibody (procedure)	4180186
44808601	Cytoplasmic TdT (terminal deoxyribonucleotidyl transferase) measurement	4180186
44808601	Measurement of cytoplasmic terminal deoxyribonucleotidyl transferase (procedure)	4180186
44808602	Percutaneous transluminal embolisation of uterine artery using ultrasonography guidance (procedure)	4180186
44808602	Ultrasound guided percutaneous transluminal embolisation of uterine artery	4180186
44808603	Referral to community diabetes clinic (procedure)	4180186
44808604	Referral to community paediatric clinic (procedure)	4180186
44808605	Referral to community musculoskeletal service (procedure)	4180186
44808606	Bacterial 16S rRNA (ribosomal ribonucleic acid) detection and sequencing by NAAT (nucleic acid amplification test)	4180186
44808606	Detection and sequencing of bacterial 16S ribosomal ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808607	Detection and sequencing of fungal 18S ribosomal ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808607	Fungal 18S rRNA (ribosomal ribonucleic acid) detection and sequencing by NAAT (nucleic acid amplification test)	4180186
44808609	Country of origin high risk for blood-borne virus (finding)	4180186
44808611	Measurement of Pneumocystis jiroveci antigen (procedure)	4180186
44808613	Procurement of drugs for chemotherapy for neoplasm for regimens in band 2 (procedure)	4180186
44808614	Procurement of drugs for chemotherapy for neoplasm for regimens in band 3 (procedure)	4180186
44808615	Procurement of drugs for chemotherapy for neoplasm for regimens in band 4 (procedure)	4180186
44808617	Procurement of drugs for chemotherapy for neoplasm for regimens in band 6 (procedure)	4180186
44808618	Procurement of drugs for chemotherapy for neoplasm for regimens in band 7 (procedure)	4180186
44808628	Measurement of Coccidioides immitis immunoglobulin G antibody (procedure)	4180186
44808629	Detection of Pneumocystis jiroveci deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808629	Pneumocystis jiroveci DNA (deoxyribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44808631	Obtaining consent using form 4 (adults who are unable to consent to investigation or treatment) (procedure)	4180186
44808633	Invitation for Electronic Prescription Service (procedure)	4180186
44808634	Endoscopic fine needle aspiration biopsy of mediastinal lymph node using ultrasonography guidance (procedure)	4180186
44808634	Endoscopic ultrasound guided fine needle aspiration of mediastinal lymph node	4180186
44808635	Endoscopic core needle biopsy of mediastinal lymph node using ultrasonography guidance (procedure)	4180186
44808635	Endoscopic ultrasound guided core biopsy of mediastinal lymph node	4180186
44808636	Endoscopic fine needle aspiration biopsy of stomach using ultrasonography guidance (procedure)	4180186
44808636	Endoscopic ultrasound guided fine needle aspiration of stomach	4180186
44808637	Endoscopic core needle biopsy of stomach using ultrasonography guidance (procedure)	4180186
44808637	Endoscopic ultrasound guided core biopsy of stomach	4180186
44808639	Endoscopic fine needle aspiration biopsy of duodenum using ultrasonography guidance (procedure)	4180186
44808639	Endoscopic ultrasound guided fine needle aspiration of duodenum	4180186
44808640	Endoscopic core needle biopsy of duodenum using ultrasonography guidance (procedure)	4180186
44808640	Endoscopic ultrasound guided core needle biopsy of duodenum	4180186
44808641	Kamath and Stothard carpal tunnel syndrome questionnaire score (observable entity)	4180186
44808642	Assessment using Kamath and Stothard carpal tunnel syndrome questionnaire (procedure)	4180186
44808643	Pelvic organ prolapse symptom score (assessment scale)	4180186
44808643	POP-SS - pelvic organ prolapse symptom score	4180186
44808644	Endoscopic core needle biopsy of pancreas using ultrasonography guidance (procedure)	4180186
44808644	Endoscopic ultrasound guided core biopsy of pancreas	4180186
44808645	Referral to hip fracture programme (procedure)	4180186
44808646	Assessment using pelvic organ prolapse symptom score (procedure)	4180186
44808646	Assessment using POP-SS (pelvic organ prolapse symptom score)	4180186
44808647	Endoscopic fine needle aspiration biopsy using ultrasonography guidance (procedure)	4180186
44808647	Endoscopic ultrasound guided fine needle aspiration	4180186
44808649	Endoscopic core needle biopsy using ultrasonography guidance (procedure)	4180186
44808649	Endoscopic ultrasound guided core biopsy	4180186
44808650	Provision of written information about hip fracture (procedure)	4180186
44808651	Provision of written information about heart failure (procedure)	4180186
44808653	Provision of written information about glaucoma (procedure)	4180186
44808654	Endoscopic ethanol ablation using ultrasonography guidance (procedure)	4180186
44808654	Endoscopic ultrasound guided alcohol ablation	4180186
44808658	Provision of written information about dementia (procedure)	4180186
44808660	Endoscopic retrograde cholangiopancreatography with balloon dilatation of sphincter of Oddi using fluoroscopic guidance (procedure)	4180186
44808661	Orthogeriatric assessment (procedure)	4180186
44808666	MoCA - Montreal cognitive assessment	4180186
44808666	Montreal cognitive assessment (assessment scale)	4180186
44808667	Assessment using MoCA (Montreal cognitive assessment)	4180186
44808667	Assessment using Montreal cognitive assessment (procedure)	4180186
44808668	MoCA (Montreal cognitive assessment) score	4180186
44808668	Montreal cognitive assessment score (observable entity)	4180186
44808669	Discharge from mental health inreach service (procedure)	4180186
44808670	Seen by primary care mental health team (finding)	4180186
44808672	Placing in supine position (procedure)	4180186
44808673	Chronic obstructive pulmonary disease care assessment (procedure)	4180186
44808673	COPD (chronic obstructive pulmonary disease) care assessment	4180186
44808674	Review of child protection plan (regime/therapy)	4180186
44808676	Extra-oral photography (procedure)	4180186
44808678	Provision of patient satisfaction questionnaire (procedure)	4180186
44808686	Assessment for risk of dehydration (procedure)	4180186
44808687	Liaison with intensive care specialist (procedure)	4180186
44808688	Minimal scarring of skin (finding)	4180186
44808689	Lives with biological parent and step parent (finding)	4180186
44808690	Endoscopy report received (finding)	4180186
44808691	Able to manage anxiety (finding)	4180186
44808692	Education about administration of blood product (procedure)	4180186
44808694	Education about ileostomy (procedure)	4180186
44808698	Cytoplasmic CD79a count (procedure)	4180186
44808700	Measurement of reducing substance (procedure)	4180186
44808703	Measurement of cytomegalovirus antigen (procedure)	4180186
44808708	Measurement of galactocerebrosidase activity (procedure)	4180186
44808712	Measurement of galactose-6-sulphatase activity (procedure)	4180186
44808718	British Association for Adoption and Fostering B2 fee sent to social services (finding)	4180186
44808719	Thoracoscopic epicardial radiofrequency ablation (procedure)	4180186
44808720	Measurement of Histoplasma capsulatum immunoglobulin G antibody (procedure)	4180186
44808723	Blastomyces dermatiditis DNA (deoxyribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44808723	Detection of Blastomyces dermatiditis deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808724	Cladophialophora bantiana DNA (deoxyribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44808724	Detection of Cladophialophora bantiana deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808725	Laparoscopic prostatectomy (procedure)	4180186
44808727	Community nurse first visit (procedure)	4180186
44808728	Education about complementary therapy (procedure)	4180186
44808729	Care of open wound (regime/therapy)	4180186
44808730	Major orthopaedic surgery care management (procedure)	4180186
44808732	Antenatal physiological assessment of mother (procedure)	4180186
44808732	Maternal physiological assessment	4180186
44808734	Measurement of Histoplasma capsulatum antigen (procedure)	4180186
44808735	Glaucoma care management (procedure)	4180186
44808736	Assessment using BMI (body mass index)	4180186
44808736	Assessment using body mass index (procedure)	4180186
44808738	Verification of activity of daily living needs (procedure)	4180186
44808741	Staphylococcal peritonitis (disorder)	4180186
44808742	Provision of chemotherapy alert card (procedure)	4180186
44808746	Occlusion of ulnar artery (disorder)	4180186
44808751	Endoscopic retrograde cholangiopancreatography with replacement of biliary stent using fluoroscopic guidance (procedure)	4180186
44808755	Endoscopic retrograde cholangiopancreatography with incision of pancreatic sphincter using fluoroscopic guidance (procedure)	4180186
44808757	Self management of epilepsy (procedure)	4180186
44808759	Endoscopic retrograde cholangiopancreatography with insertion of plastic stent into pancreatic duct using fluoroscopic guidance (procedure)	4180186
44808760	Epilepsy self-management plan review (procedure)	4180186
44808762	Assessment using sexual health inventory for men (procedure)	4180186
44808763	Endoscopic retrograde cholangiopancreatography with replacement of pancreatic stent using fluoroscopic guidance (procedure)	4180186
44808765	Endoscopic retrograde cholangiopancreatography with insertion of nasopancreatic drain using fluoroscopic guidance (procedure)	4180186
44808769	Bronchoscopy care plan (record artifact)	4180186
44808772	Cardiac surgery inpatient care plan (record artifact)	4180186
44808774	Endoscopic insertion of tracheobronchial stent using fluoroscopic guidance (procedure)	4180186
44808775	Endoscopic insertion of metallic colorectal stent using fluoroscopic guidance (procedure)	4180186
44808776	Endoscopic balloon dilatation of colon and rectum using fluoroscopic guidance (procedure)	4180186
44808779	Percentage count of lymphocytes positive for CD18 antigen (procedure)	4180186
44808781	Offshore medical examination (procedure)	4180186
44808782	Level of physical activity (observable entity)	4180186
44808783	Patient choice of equipment (finding)	4180186
44808786	Intermediate care bed not available (finding)	4180186
44808787	Brief intervention for substance misuse (procedure)	4180186
44808788	Seen by assistant psychologist (finding)	4180186
44808793	Influenza vaccination second telephone invitation (finding)	4180186
44808795	Influenza vaccination third telephone invitation (finding)	4180186
44808797	Day of cycle	4180186
44808797	Day of menstrual cycle (observable entity)	4180186
44808800	Chronic pain review (regime/therapy)	4180186
44808801	Does comply with safety precautions (finding)	4180186
44808802	Seen by specialty doctor (finding)	4180186
44808804	Commission for Health Improvement experience of service questionnaire score (observable entity)	4180186
44808806	Children's global assessment scale score (observable entity)	4180186
44808807	BAAF (British Association for Adoption and Fostering) B2 fee to adoption agency	4180186
44808807	British Association for Adoption and Fostering B2 fee to adoption agency (finding)	4180186
44808809	Assessment of Year of Care goal importance (procedure)	4180186
44808812	Clippings	4180186
44808812	Specimen obtained by clipping (specimen)	4180186
44808815	Education about stroke (procedure)	4180186
44808818	Semen specimen (specimen)	4180186
44808820	Cystine screening test (procedure)	4180186
44808822	Acute renal failure induced by plant toxin (disorder)	4180186
44808824	Measurement of neurokinin A (procedure)	4180186
44808828	Assessment using MEMS (modified elderly mobility scale)	4180186
44808828	Assessment using modified elderly mobility scale (procedure)	4180186
44808829	MEMS (modified elderly mobility scale) score	4180186
44808829	Modified elderly mobility scale score (observable entity)	4180186
44808830	Screening test for reducing substances (procedure)	4180186
44808831	Chronic pericardial effusion (disorder)	4180186
44808832	Occlusion of anterior tibial artery (disorder)	4180186
44808833	Occlusion of posterior tibial artery (disorder)	4180186
44808834	Mapping of lower limb ulcer (procedure)	4180186
44808835	Lower limb ulcer care management (procedure)	4180186
44808840	Sample from orthostatic subject (finding)	4180186
44808840	Sample from standing subject	4180186
44808841	Sample from supine subject (finding)	4180186
44808844	Osteoarthritis of sternoclavicular joint (disorder)	4180186
44808846	CD3-/HLA-DR+ percentage of lymphocytes	4180186
44808846	Percentage count of lymphocytes negative for CD3 antigen and positive for human leucocyte antigen DR (procedure)	4180186
44808847	History of acute hypoxaemic respiratory failure (situation)	4180186
44808847	History of acute type I respiratory failure	4180186
44808848	Combined Predictive Model (assessment scale)	4180186
44808848	CPM - Combined Predictive Model	4180186
44808851	Assessment using Combined Predictive Model (procedure)	4180186
44808851	Assessment using CPM (Combined Predictive Model)	4180186
44808853	Has Social Services care manager (finding)	4180186
44808856	Cholesterol level (observable entity)	4180186
44808862	Heart failure initial assessment (regime/therapy)	4180186
44808865	Reduction mastopexy by lateralising technique (procedure)	4180186
44808869	Endoscopic retrograde cholangiopancreatography with aspiration of pseudocyst of pancreas using fluoroscopic guidance (procedure)	4180186
44808871	Developmental behaviour checklist score (observable entity)	4180186
44808872	Assessment using Sheffield learning disabilities outcome measure (procedure)	4180186
44808872	Assessment using SLDOM (Sheffield learning disabilities outcome measure)	4180186
44808873	Provision of written information about reducing risk of deep vein thrombosis (procedure)	4180186
44808873	Provision of written information about reducing risk of DVT (deep vein thrombosis)	4180186
44808875	Assessment using NCBRF (Nisonger child behaviour rating form)	4180186
44808875	Assessment using Nisonger child behaviour rating form (procedure)	4180186
44808876	Private referral to allergy specialist (procedure)	4180186
44808880	Education about depression (procedure)	4180186
44808881	Stabilisation of ACJ (acromioclavicular joint)	4180186
44808881	Stabilisation of acromioclavicular joint (procedure)	4180186
44808882	Dark green sputum (finding)	4180186
44808884	Provision of written information about bowel cancer screening programme (procedure)	4180186
44808887	Provision of written information about general anaesthesia (procedure)	4180186
44808888	Referral to anticoagulation clinic (procedure)	4180186
44808892	Endoscopy of larynx, pharynx and oesophagus (procedure)	4180186
44808892	Panendoscopy	4180186
44808893	Posterolateral corner of knee joint (body structure)	4180186
44808895	Seafarer medical examination (procedure)	4180186
44808896	Pressure ulcer care plan (record artifact)	4180186
44808897	Did not complete pulmonary rehabilitation programme (situation)	4180186
44808899	Provision of written information about weight reduction diet (procedure)	4180186
44808901	Pre-discharge education (procedure)	4180186
44808902	Decision support tool for National Health Service continuing healthcare (assessment scale)	4180186
44808903	Stabilisation of acromioclavicular joint by transfer of coracoacromial ligament (procedure)	4180186
44808903	Weaver-Dunn procedure	4180186
44808905	BAAF (British Association for Adoption and Fostering) B2 fee paid	4180186
44808905	British Association for Adoption and Fostering B2 fee paid (finding)	4180186
44808906	Post exposure diphtheria, tetanus, acellular pertussis and inactivated polio vaccination (procedure)	4180186
44808906	Post exposure DTaP/IPV (diphtheria, tetanus, acellular pertussis and inactivated polio vaccination)	4180186
44808908	Multidisciplinary case management (procedure)	4180186
44808910	Safe disposal of hazardous waste (procedure)	4180186
44808911	Emergency hospital admission from walk-in centre (procedure)	4180186
44808916	Education about human papillomavirus (procedure)	4180186
44808920	Magnetic resonance imaging enteroclysis (procedure)	4180186
44808922	Insertion of spinal cord stimulator using fluoroscopic guidance (procedure)	4180186
44808923	Percutaneous study of upper urinary tract (procedure)	4180186
44808926	Provision of written information about medication (procedure)	4180186
44808928	Does report signs and symptoms (finding)	4180186
44808929	Management of cancer (procedure)	4180186
44808931	Education for venous ulcer of lower limb (procedure)	4180186
44808933	Provision of information about abdominal aortic aneurysm screening programme (procedure)	4180186
44808938	Haemodialysis care (regime/therapy)	4180186
44808939	Application for National Health Service funded nursing care (procedure)	4180186
44808941	Referral to emergency medical service (procedure)	4180186
44808942	Stroke care plan (record artifact)	4180186
44808943	Respite care plan (record artifact)	4180186
44808947	Chemotherapy care plan (record artifact)	4180186
44808949	Has self management plan (finding)	4180186
44808956	Diabetes clinical pathway (regime/therapy)	4180186
44808957	Heart failure clinical pathway (regime/therapy)	4180186
44808960	Continence care equipment available at home (finding)	4180186
44808971	Removal of intraosseous device (procedure)	4180186
44808972	Referral to lesbian, gay, bisexual and transgender service (procedure)	4180186
44808973	Hake RAST test	4180186
44808973	Merluccius merluccius specific immunoglobulin E antibody measurement (procedure)	4180186
44808975	Percentage count of lymphocytes positive for cytoplasmic CD22 antigen (procedure)	4180186
44808978	Percentage count of lymphocytes positive for cytoplasmic CD3 antigen (procedure)	4180186
44808981	Antenatal 31 week examination (procedure)	4180186
44808982	Post-exercise pulse oximetry (procedure)	4180186
44808984	Acquired absence of spleen (disorder)	4180186
44808986	Education about neurological care (procedure)	4180186
44808991	Diabetic foot screening invitation (procedure)	4180186
44808992	Diabetic foot screening invitation first letter (procedure)	4180186
44808996	Education about anxiety (procedure)	4180186
44808997	Provision of copy of outpatient summary to patient (procedure)	4180186
44809000	Loosening of tension free vaginal tape obturator (procedure)	4180186
44809000	Loosening of TVT-O (tension free vaginal tape obturator)	4180186
44809005	Endoscopic banding of oesophageal varices using fluoroscopic guidance (procedure)	4180186
44809006	Endoscopic insertion of gastric band using fluoroscopic guidance (procedure)	4180186
44809007	Absence of signs and symptoms of tissue damage (situation)	4180186
44809008	Cleaning periwound skin (procedure)	4180186
44809009	Fine needle aspiration biopsy of chest wall using ultrasonography guidance (procedure)	4180186
44809009	Ultrasound guided fine needle aspiration biopsy of chest wall	4180186
44809014	Urological complication of renal transplant (disorder)	4180186
44809015	Management of glaucoma (procedure)	4180186
44809016	Calibration of equipment (procedure)	4180186
44809017	Body position comfortable (finding)	4180186
44809020	Assessment of arterial ulcer of lower limb (procedure)	4180186
44809021	Assessment of arterial lower leg ulcer (procedure)	4180186
44809022	Assessment of lower limb ulcer (procedure)	4180186
44809025	Assessment of diabetic ulcer of lower leg (procedure)	4180186
44809026	Stage 1 hypertension	4180186
44809026	Stage 1 hypertension (National Institute for Health and Clinical Excellence 2011) (disorder)	4180186
44809027	Severe hypertension	4180186
44809027	Severe hypertension (National Institute for Health and Clinical Excellence 2011) (disorder)	4180186
44809029	Laparoscopic gastrectomy (procedure)	4180186
44809030	Thoracoscopic excision of mediastinal parathyroid tumour (procedure)	4180186
44809032	Radial pulse rate (observable entity)	4180186
44809033	Catheterisation of epidural space using ultrasonography guidance (procedure)	4180186
44809033	Ultrasound guided catheterisation of epidural space	4180186
44809035	Arteriovenous extracorporeal carbon dioxide removal (procedure)	4180186
44809039	Equipment in working order (finding)	4180186
44809041	Demonstrates knowledge of who to contact in medical emergency (finding)	4180186
44809042	Wellness promotion in long term condition (regime/therapy)	4180186
44809044	Minor orthopaedic surgery inpatient care plan (record artifact)	4180186
44809047	Minor ophthalmic surgery inpatient care plan (record artifact)	4180186
44809049	Major neurosurgery inpatient care plan (record artifact)	4180186
44809050	Interventional cardiology inpatient care plan (record artifact)	4180186
44809051	Miscarriage inpatient care plan (record artifact)	4180186
44809052	Has spiritual and cultural support (finding)	4180186
44809054	Has social care assessor (finding)	4180186
44809056	Infectious disease care plan (record artifact)	4180186
44809060	Obesity and weight loss quality of life score (observable entity)	4180186
44809060	OWLQOL (obesity and weight loss quality of life) score	4180186
44809062	Acute kidney injury stage 2 (disorder)	4180186
44809065	Hypoglycaemia fear survey score (observable entity)	4180186
44809066	Clarke hypoglycaemia awareness questionnaire score (observable entity)	4180186
44809067	Diabetes quality of life questionnaire score (observable entity)	4180186
44809068	Under care of physician (finding)	4180186
44809070	Minimal breathlessness (finding)	4180186
44809073	Respiratory support (navigational concept)	4180186
44809076	Conversion to hybrid prosthetic replacement of hip joint using cement (procedure)	4180186
44809077	Revision of hybrid prosthetic replacement of hip joint using cement (procedure)	4180186
44809081	Personal Health Plan-based care stopped (situation)	4180186
44809081	PHP (Personal Health Plan)-based care stopped	4180186
44809083	Laparoscopic repair of epigastric hernia (procedure)	4180186
44809085	Laparoscopic repair of epigastric hernia with prosthesis (procedure)	4180186
44809086	Laparoscopic repair of recurrent epigastric hernia with prosthesis (procedure)	4180186
44809088	Finding of legal status under Children (Scotland) Act 1995 (finding)	4180186
44809089	Subject to care order under Children (Scotland) Act 1995 (finding)	4180186
44809090	Modified Weaver-Dunn procedure	4180186
44809090	Stabilisation of acromioclavicular joint by transfer of coracoacromial ligament - modified procedure (procedure)	4180186
44809091	Subject to interim care order under Children (Scotland) Act 1995 (finding)	4180186
44809092	Provision of written information about Care Programme Approach (procedure)	4180186
44809092	Provision of written information about CPA (Care Programme Approach)	4180186
44809094	Withdrawn from drug detoxification programme (finding)	4180186
44809095	Subject to supervision requirement with condition of residence under Section 70 of Children (Scotland) Act 1995 (finding)	4180186
44809097	History of syphilis (situation)	4180186
44809100	History of epididymo-orchitis (situation)	4180186
44809104	Overview assessment (procedure)	4180186
44809107	Unusual variability in blood pressure (finding)	4180186
44809109	Seen by community human immunodeficiency virus nurse (finding)	4180186
44809110	Ureterostomy present (finding)	4180186
44809112	Massive haemoptysis (disorder)	4180186
44809113	In-house follow-up (procedure)	4180186
44809115	[V]Personal history of mild cervical dysplasia (situation)	4180186
44809118	[V]Personal history of moderate cervical dysplasia (situation)	4180186
44809119	On solids at 5 months (finding)	4180186
44809122	Modified Rankin scale score (observable entity)	4180186
44809125	Agreeing on health and social care plan (procedure)	4180186
44809126	Referral to orthopaedic triage service (procedure)	4180186
44809129	Declined consent for communication by email (finding)	4180186
44809131	Sexually transmitted infection screening offered (situation)	4180186
44809132	Did not attend Mantoux reading (finding)	4180186
44809133	Sun damaged skin (disorder)	4180186
44809135	Abandoned baby (finding)	4180186
44809136	Arterial cannula in situ (finding)	4180186
44809137	Care management of arterial ulcer of limb (procedure)	4180186
44809140	Periwound skin care (regime/therapy)	4180186
44809141	Equipment available (finding)	4180186
44809142	Autologous transplantation of pancreatic islet cells (procedure)	4180186
44809145	Assessment of arterial ulcer of limb (procedure)	4180186
44809148	Therapeutic body position (finding)	4180186
44809150	Healed lower limb ulcer (finding)	4180186
44809156	Dependant of current serving member of British Armed Forces (finding)	4180186
44809157	Dependant of former serving member of British Armed Forces (finding)	4180186
44809158	Mean arterial pressure within target range (finding)	4180186
44809159	Cancer survivorship care plan (record artifact)	4180186
44809161	Employment support indicated (finding)	4180186
44809162	ASCA (anti-Saccharomyces cerevisiae antibody) measurement	4180186
44809162	Measurement of Saccharomyces cerevisiae specific antibody (procedure)	4180186
44809162	Saccharomyces cerevisiae antibody specificity	4180186
44809163	Measurement of Saccharomyces cerevisiae specific immunoglobulin A antibody (procedure)	4180186
44809163	Saccharomyces cerevisiae IgA antibody specificity	4180186
44809165	Able to make informed choice (finding)	4180186
44809168	Agreeing on patient actions in care plan (procedure)	4180186
44809169	Ratio of voiceless sound s to voiced sound z (finding)	4180186
44809170	Acute renal failure induced by poison (disorder)	4180186
44809174	Personal Health Plan-based care started (situation)	4180186
44809174	PHP (Personal Health Plan)-based care started	4180186
44809175	Major plastic surgery inpatient care plan (record artifact)	4180186
44809176	Primary open reduction of fracture of neck of femur and open fixation using proximal femoral nail antirotation (procedure)	4180186
44809177	Demonstrates understanding of discharge plan (finding)	4180186
44809179	Laryngectomy surgery inpatient care plan (record artifact)	4180186
44809180	Personal Health Plan declined (situation)	4180186
44809180	PHP (Personal Health Plan) declined	4180186
44809184	Minimum weight (observable entity)	4180186
44809186	Target pulse rate (observable entity)	4180186
44809188	Minimum pulse rate (observable entity)	4180186
44809191	Minimum carboxyhaemoglobin level (observable entity)	4180186
44809192	Maximum cholesterol level (observable entity)	4180186
44809193	Minimum cholesterol level (observable entity)	4180186
44809202	Activated partial thromboplastin time (observable entity)	4180186
44809202	APTT - activated partial thromboplastin time	4180186
44809203	Maximum activated partial thromboplastin time (observable entity)	4180186
44809205	Maximum forced expired volume in 1 second (observable entity)	4180186
44809208	Maximum body temperature (observable entity)	4180186
44809209	Target blood glucose concentration (observable entity)	4180186
44809211	Minimum blood glucose concentration (observable entity)	4180186
44809212	Target peripheral oxygen saturation (observable entity)	4180186
44809213	Minimum peripheral oxygen saturation (observable entity)	4180186
44809218	Education for post anaesthesic (procedure)	4180186
44809219	Magnetic resonance imaging of spine for radiotherapy planning (procedure)	4180186
44809220	Magnetic resonance imaging angiography of head with contrast (procedure)	4180186
44809221	Fluoroscopic angiography using carbon dioxide contrast (procedure)	4180186
44809221	Fluoroscopic angiography with CO2 (carbon dioxide) contrast	4180186
44809222	Fluoroscopic angiography of thoracic aorta using contrast with insertion of stent graft (procedure)	4180186
44809225	Percutaneous embolisation of branch of superior mesenteric artery using fluoroscopic guidance (procedure)	4180186
44809226	Magnetic resonance angiogram of neck vessel with contrast	4180186
44809226	Magnetic resonance angiography of neck vessel with contrast (procedure)	4180186
44809227	Drug administration chart (record artifact)	4180186
44809228	Prescription and administration record (record artifact)	4180186
44809229	Front sheet	4180186
44809229	Patient master index sheet (record artifact)	4180186
44809230	Infection as complication of fracture (disorder)	4180186
44809231	Infection as complication of dislocation (disorder)	4180186
44809234	Hepatitis C genotype 2 (disorder)	4180186
44809236	Hepatitis C genotype 3 (disorder)	4180186
44809237	Hepatitis C genotype 4 (disorder)	4180186
44809240	Declined consent to include carer details in clinical record (finding)	4180186
44809241	Copeptin immunofluorescent assay (procedure)	4180186
44809241	C-terminal provasopressin immunofluorescent assay	4180186
44809245	Bronchodilator not used in last month (finding)	4180186
44809246	Ethanol ablation of lesion of parathyroid using ultrasonography guidance (procedure)	4180186
44809246	Ultrasound guided parathyroid ablation	4180186
44809248	Traumatic dislocation of tarsometatarsal joint (disorder)	4180186
44809251	Medical Research Council muscle power score of right shoulder abduction (observable entity)	4180186
44809252	Active range of right wrist abduction (observable entity)	4180186
44809257	Wound of anorectal region (disorder)	4180186
44809258	Referral to employability service (procedure)	4180186
44809261	At high risk of falls (finding)	4180186
44809262	Employment and support allowance status (finding)	4180186
44809266	Employment and support allowance 113 form paid (finding)	4180186
44809271	Hepatitis B vaccination invitation third letter (procedure)	4180186
44809274	Infusion device in situ (finding)	4180186
44809280	Referred by lymphoedema service (finding)	4180186
44809284	Insertion of fiducial marker into pelvis using computed tomography guidance (procedure)	4180186
44809285	Supportive care on development of symptoms (record artifact)	4180186
44809287	Percutaneous transhepatic insertion of central venous catheter using fluoroscopic guidance (procedure)	4180186
44809289	Occlusion of bronchopleural fistula using fluoroscopic guidance (procedure)	4180186
44809290	Occlusion of oesophageal-pleural fistula using fluoroscopic guidance (procedure)	4180186
44809291	GnRH (gonadotrophin releasing hormone) analogue prophylaxis	4180186
44809291	Gonadotrophin releasing hormone analogue prophylaxis (procedure)	4180186
44809293	History of vocal cord haematoma (situation)	4180186
44809294	Replacement of intrauterine system (procedure)	4180186
44809294	Replacement of IUS (intrauterine system)	4180186
44809296	Influenza vaccination invitation email (procedure)	4180186
44809297	Influenza vaccination invitation first email (procedure)	4180186
44809300	Patient held palliative care record (record artifact)	4180186
44809301	Healthcare professional would not be surprised (Gold Standards Framework surprise question) (finding)	4180186
44809303	Provision of written information about thrombolytic therapy (procedure)	4180186
44809305	Management of chronic obstructive pulmonary disease (procedure)	4180186
44809306	Management of exacerbation of chronic obstructive pulmonary disease (procedure)	4180186
44809307	Provision of written information about personal cancer journey (procedure)	4180186
44809308	Not aware of DNACPR (do not attempt cardiopulmonary resuscitation) clinical decision	4180186
44809308	Not aware of do not attempt cardiopulmonary resuscitation clinical decision (finding)	4180186
44809309	At risk of cardiovascular disease (finding)	4180186
44809310	Referral to community geriatrician (procedure)	4180186
44809315	Target forced vital capacity (observable entity)	4180186
44809316	Intramedullary distraction for lower limb lengthening (procedure)	4180186
44809320	Ear care follow-up assessment (procedure)	4180186
44809322	Assessment of medical fitness to drive (procedure)	4180186
44809323	Lower gastrointestinal tract endoscopy care plan (record artifact)	4180186
44809324	Major burn inpatient care plan (record artifact)	4180186
44809327	Right upper limb total volume (observable entity)	4180186
44809328	Left upper limb proximal segment volume (observable entity)	4180186
44809331	Right upper limb distal segment volume (observable entity)	4180186
44809336	Aneurysm of vein of transplanted kidney (disorder)	4180186
44809338	Percentage volume difference between distal segments of upper limbs (observable entity)	4180186
44809341	Right upper limb volume proximal to distal segment ratio (observable entity)	4180186
44809343	Liposuction and excision of gynaecomastia (procedure)	4180186
44809344	Education about health risks associated with air travel (procedure)	4180186
44809345	Left lower limb proximal segment volume (observable entity)	4180186
44809349	Right lower limb distal segment volume (observable entity)	4180186
44809351	Revision of reduction mastopexy (procedure)	4180186
44809352	Left lower limb total volume (observable entity)	4180186
44809355	Active range of right elbow supination (observable entity)	4180186
44809359	Active range of left wrist extension (observable entity)	4180186
44809361	Medical Research Council muscle power score of right elbow flexion (observable entity)	4180186
44809362	Active range of left wrist flexion (observable entity)	4180186
44809363	Medical Research Council muscle power score of left elbow flexion (observable entity)	4180186
44809367	Medical Research Council muscle power score of left shoulder internal rotation (observable entity)	4180186
44809368	Active range of right wrist extension (observable entity)	4180186
44809369	Medical Research Council muscle power score of left elbow supination (observable entity)	4180186
44809370	Active range of left wrist adduction (observable entity)	4180186
44809377	Medical Research Council muscle power score of right hip external rotation (observable entity)	4180186
44809378	Active range of right shoulder extension (observable entity)	4180186
44809379	Active range of left shoulder extension (observable entity)	4180186
44809380	Medical Research Council muscle power score of right elbow supination (observable entity)	4180186
44809382	Medical Research Council muscle power score of right wrist pronation (observable entity)	4180186
44809388	Medical Research Council muscle power score of right wrist abduction (observable entity)	4180186
44809389	At risk of dehydration (finding)	4180186
44809390	British Association for Adoption and Fostering form C/D fee sent to social services (finding)	4180186
44809391	Assessment using heart rate walking speed index (procedure)	4180186
44809392	Heart rate walking speed index score (observable entity)	4180186
44809394	History of arterial surgery (situation)	4180186
44809395	Under care of family nurse partnership team (finding)	4180186
44809396	Referral to teledermatology service (procedure)	4180186
44809397	Percutaneous insertion of drug eluting stent using fluoroscopic guidance (procedure)	4180186
44809399	Percutaneous insertion of biodegradable stent using fluoroscopic guidance (procedure)	4180186
44809400	Percutaneous insertion of branched bifurcated stent graft using fluoroscopic guidance (procedure)	4180186
44809404	Seen by general practitioner with special interest in rheumatology (finding)	4180186
44809407	GOS18 form forwarded to optometrist (finding)	4180186
44809409	Computed tomography of tube device with contrast (procedure)	4180186
44809409	CT tubogram	4180186
44809412	Cervical smear screening invitation second short message service text (procedure)	4180186
44809412	Cervical smear screening invitation second SMS (short message service) text	4180186
44809412	Cervical smear screening invitation second text message	4180186
44809415	Generalised anxiety disorder 2 scale	4180186
44809415	Generalised anxiety disorder 2 scale (assessment scale)	4180186
44809416	Assessment using generalised anxiety disorder 2 scale (procedure)	4180186
44809417	Map of Medicine pathway (regime/therapy)	4180186
44809419	Opportunistic verification of patient email address (procedure)	4180186
44809421	Measurement of recombinant Ara h1 Arachis hypogaea specific immunoglobulin E antibody (procedure)	4180186
44809421	Recombinant Ara h1 peanut specific IgE antibody level	4180186
44809423	Assessment using Lindop Parkinson's assessment scale (procedure)	4180186
44809424	Lindop Parkinson's assessment scale score (observable entity)	4180186
44809426	Referral to peripheral joint orthopaedic triage service (procedure)	4180186
44809428	Left atrial catheter in situ (finding)	4180186
44809430	Reads Welsh (finding)	4180186
44809431	Three dimensional rotational fluoroscopic angiography of liver with contrast (procedure)	4180186
44809431	3D (three dimensional) rotational fluoroscopic angiogram of liver with contrast	4180186
44809432	Three dimensional rotational fluoroscopic angiography of abdomen with contrast (procedure)	4180186
44809432	3D (three dimensional) rotational fluoroscopic angiogram of abdomen with contrast	4180186
44809436	Three dimensional rotational fluoroscopic angiography of pelvis with contrast (procedure)	4180186
44809436	3D (three dimensional) rotational fluoroscopic angiogram of pelvis with contrast	4180186
44809439	Assessment using gold standards framework prognostic indicator (procedure)	4180186
44809441	Three dimensional rotational fluoroscopic angiography of head with contrast (procedure)	4180186
44809441	3D (three dimensional) rotational fluoroscopic angiogram of head with contrast	4180186
44809443	Gold standards framework prognostic indicator stage A (blue) - year plus prognosis (finding)	4180186
44809449	Injection of platelet-rich plasma (procedure)	4180186
44809449	Injection of PRP (platelet-rich plasma)	4180186
44809450	Referral to cardiology multidisciplinary team (procedure)	4180186
44809452	Lipofilling of subcutaneous tissue of reconstructed breast (procedure)	4180186
44809453	Immediate reconstruction of breast with latissimus dorsi flap and insertion of prosthesis (procedure)	4180186
44809454	Immediate reconstruction of breast with latissimus dorsi mini-flap and insertion of prosthesis (procedure)	4180186
44809457	Reconstruction of breast with extended latissimus dorsi flap and insertion of prosthesis (procedure)	4180186
44809463	Percentage volume difference between proximal segments of lower limbs (observable entity)	4180186
44809464	Percentage volume difference between distal segments of lower limbs (observable entity)	4180186
44809466	Right lower limb volume proximal to distal segment ratio (observable entity)	4180186
44809468	Immediate reconstruction of breast with myocutaneous flap of latissimus dorsi muscle and pectoralis major muscle and insertion of prosthesis (procedure)	4180186
44809469	Breast reconstruction with pedicled TRAM (transverse rectus abdominis myocutaneous) flap and insertion of prosthesis	4180186
44809469	Reconstruction of breast with pedicled transverse rectus abdominis myocutaneous flap and insertion of prosthesis (procedure)	4180186
44809473	Balloon dilatation of systemic to pulmonary artery shunt using fluoroscopic guidance with contrast (procedure)	4180186
44809474	Referral to Angina Plan self-management programme (procedure)	4180186
44809475	Percutaneous balloon valvuloplasty of pulmonary valve using fluoroscopic guidance (procedure)	4180186
44809477	Laser sheath removal of cardiac pacemaker lead using fluoroscopic guidance (procedure)	4180186
44809478	Laparoscopic live donor nephrectomy (procedure)	4180186
44809479	Stenosis of dialysis vascular access (disorder)	4180186
44809481	Infusion line swab (specimen)	4180186
44809482	Medical Research Council muscle power score of left ankle dorsiflexion (observable entity)	4180186
44809483	Medical Research Council muscle power score of left wrist abduction (observable entity)	4180186
44809484	Medical Research Council muscle power score of left wrist extension (observable entity)	4180186
44809487	Medical Research Council muscle power score of right wrist flexion (observable entity)	4180186
44809491	Medical Research Council muscle power score of shoulder external rotation (observable entity)	4180186
44809492	Medical Research Council muscle power score of left shoulder external rotation (observable entity)	4180186
44809493	Medical Research Council muscle power score of left hip adduction (observable entity)	4180186
44809494	Medical Research Council muscle power score of right hip adduction (observable entity)	4180186
44809497	Active range of left wrist supination (observable entity)	4180186
44809498	Active range of right wrist supination (observable entity)	4180186
44809499	Active range of left shoulder adduction (observable entity)	4180186
44809504	Active range of right elbow extension (observable entity)	4180186
44809506	Medical Research Council muscle power score of shoulder extension (observable entity)	4180186
44809508	Active range of right shoulder flexion (observable entity)	4180186
44809509	Active range of right shoulder internal rotation (observable entity)	4180186
44809511	Infection due to carbapenemase producing Enterobacteriacea (disorder)	4180186
44809513	Unable to provide sample (finding)	4180186
44809515	Assessment for nebuliser therapy (procedure)	4180186
44809516	Declines to give mobile telephone number (situation)	4180186
44809519	Ischaemic leg pain at rest	4180186
44809519	Ischaemic lower limb pain at rest (finding)	4180186
44809521	Letter received from relative (finding)	4180186
44809522	National Cancer Institute breast cancer risk assessment tool (assessment scale)	4180186
44809523	Assessment using National Cancer Institute breast cancer risk assessment tool (procedure)	4180186
44809524	National Cancer Institute breast cancer risk assessment score (observable entity)	4180186
44809526	Assessment using Edmonton frail scale (procedure)	4180186
44809528	Does not have mobile telephone (finding)	4180186
44809534	Cardiac resynchronisation therapy indicated (situation)	4180186
44809538	Healthy Start programme (regime/therapy)	4180186
44809539	History of acute coronary syndrome (situation)	4180186
44809540	BAAF (British Association for Adoption and Fostering) form C/D fee to adoption agency	4180186
44809540	British Association for Adoption and Fostering form C/D fee to adoption agency (finding)	4180186
44809542	Compression bandaging contraindicated (situation)	4180186
44809543	Provision of information about antenatal screening (procedure)	4180186
44809545	Referral for hysteroscopy (procedure)	4180186
44809546	Not eligible for Keep Well health check (finding)	4180186
44809550	Consent given for injection (finding)	4180186
44809551	Discharge from Social Services (procedure)	4180186
44809553	Breast surgery inpatient care plan (record artifact)	4180186
44809558	No history of hypoglycaemia (situation)	4180186
44809559	Provision of written information about carpal tunnel syndrome (procedure)	4180186
44809560	Palliative care handover form completed (finding)	4180186
44809562	Incomplete patient record received (finding)	4180186
44809563	Dabigatran not indicated (situation)	4180186
44809566	Dabigatran not tolerated (situation)	4180186
44809568	No history of skin ulcer (situation)	4180186
44809572	Hepatitis B screening not offered (situation)	4180186
44809577	Compression therapy for ulcer healing (regime/therapy)	4180186
44809583	Has healthcare support worker (finding)	4180186
44809585	Laparoscopic radical prostatectomy (procedure)	4180186
44809586	Percutaneous insertion of peritoneal-amniotic shunt using ultrasonography guidance (procedure)	4180186
44809586	Ultrasound guided percutaneous insertion of peritoneal-amniotic shunt	4180186
44809588	High intensity focused ultrasound ablation of left atrium (procedure)	4180186
44809589	Percutaneous laser ablation of lesion of fetus using ultrasonography guidance (procedure)	4180186
44809589	Ultrasound guided percutaneous laser ablation of lesion of fetus	4180186
44809590	Tonsillectomy using ultrasonic scalpel	4180186
44809590	Tonsillectomy using ultrasonic scalpel (procedure)	4180186
44809591	High risk HPV (human papillomavirus) genotyping test not indicated	4180186
44809591	High risk human papillomavirus genotyping test not indicated (situation)	4180186
44809592	Fractional excretion of phosphate	4180186
44809592	Measurement of fractional excretion of phosphate (procedure)	4180186
44809593	Catheterisation of right side of heart for assessment of pulmonary vascular resistance using fluoroscopic guidance (procedure)	4180186
44809595	Combined laparoscopically assisted endoscopic removal of lesion of stomach	4180186
44809595	Combined laparoscopically assisted gastroscopic removal of lesion of stomach (procedure)	4180186
44809597	Percutaneous reduction of myocardial septum by injection of alcohol using fluoroscopic guidance (procedure)	4180186
44809598	Endoscopic free circulating saline thermal ablation of endometrium (procedure)	4180186
44809598	Endoscopic free heated circulating saline ablation of endometrium	4180186
44809598	Hysteroscopic free heated circulating saline ablation of endometrium	4180186
44809599	Percutaneous transluminal laser ablation of long saphenous vein using ultrasonography guidance (procedure)	4180186
44809599	Ultrasound guided percutaneous transluminal laser ablation of long saphenous vein	4180186
44809600	Open microwave ablation of atrioventricular node (procedure)	4180186
44809603	Ambulance service notified of patient on end of life care register (finding)	4180186
44809608	Thrombus in peritoneal dialysis catheter (disorder)	4180186
44809611	Measurement of 11 deoxycortisol output (procedure)	4180186
44809612	Delayed reconstruction of breast with latissimus dorsi flap and insertion of prosthesis (procedure)	4180186
44809616	Laparoscopic left hemicolectomy (procedure)	4180186
44809617	Laparoscopic left hemicolectomy converted to open (procedure)	4180186
44809618	Size of incontinence sheath (observable entity)	4180186
44809619	Open right hemicolectomy (procedure)	4180186
44809620	Risk information (record artifact)	4180186
44809621	Acute nephropathy induced by heavy metals (disorder)	4180186
44809622	Intrauterine contraceptive device threads seen (finding)	4180186
44809623	Intervention record (record artifact)	4180186
44809624	Miscellaneous record (record artifact)	4180186
44809625	Exemption form (record artifact)	4180186
44809626	Refusal form (record artifact)	4180186
44809630	Obstetric magnetic resonance imaging of pelvis (procedure)	4180186
44809631	Gynaecological magnetic resonance imaging of pelvis (procedure)	4180186
44809632	Measurement of wedge pressure of hepatic vein using fluoroscopic guidance (procedure)	4180186
44809634	Mental Health Act notice (record artifact)	4180186
44809636	Notification and legal document (record artifact)	4180186
44809638	Radionuclide myocardial perfusion rest and redistribution study using thallium 201 (procedure)	4180186
44809639	Radionuclide electrocardiography gated myocardial perfusion rest and redistribution study using thallium 201 (procedure)	4180186
44809640	Radionuclide myocardial perfusion stress and redistribution study using thallium 201 (procedure)	4180186
44809641	Magnetic resonance imaging of craniofacial structure with contrast (procedure)	4180186
44809649	Assessment using LFQ (lung function questionnaire)	4180186
44809649	Assessment using lung function questionnaire (procedure)	4180186
44809654	Total bone mass (observable entity)	4180186
44809655	Seen in injection clinic (finding)	4180186
44809656	High risk of cardiovascular disease (finding)	4180186
44809658	High risk of diabetes mellitus (finding)	4180186
44809659	Proctoscopy normal (finding)	4180186
44809661	Provision of continence pad	4180186
44809661	Provision of incontinence pad (procedure)	4180186
44809662	Screening for risk of falls (procedure)	4180186
44809663	History of intermittent claudication (situation)	4180186
44809664	Review of supportive care plan (procedure)	4180186
44809666	Application for standard authorisation of deprivation of liberty under Mental Capacity Act 2005 (procedure)	4180186
44809669	Under care of universal level of health visiting service (finding)	4180186
44809669	Under care of universal level of health visiting service	4180186
44809670	Under care of health visiting service - Universal partnership plus (finding)	4180186
44809672	Provision of written information about diabetes (procedure)	4180186
44809680	Paediatric trauma and orthopaedics service (qualifier value)	4180186
44809681	Paediatric transplantation surgery service (qualifier value)	4180186
44809682	Paediatric thoracic surgery service (qualifier value)	4180186
44809683	Neonatal critical care service (qualifier value)	4180186
44809685	Electrocauterisation of organ NOC (procedure)	4180186
44809688	Paediatric plastic surgery service (qualifier value)	4180186
44809689	Paediatric pain management service (qualifier value)	4180186
44809691	Destruction of lesion of organ NOC (procedure)	4180186
44809694	Paediatric neurodisability service (qualifier value)	4180186
44809697	Paediatric interventional radiology service (qualifier value)	4180186
44809698	Paediatric infectious diseases service (qualifier value)	4180186
44809699	Paediatric gastrointestinal surgery service (qualifier value)	4180186
44809700	Paediatric gastroenterology service (qualifier value)	4180186
44809702	Paediatric dermatology service (qualifier value)	4180186
44809703	Paediatric cardiology service (qualifier value)	4180186
44809705	Paediatric burns care service (qualifier value)	4180186
44809708	Removal of diagnostic device from subcutaneous tissue (procedure)	4180186
44809712	Sample from paediatric patient (specimen)	4180186
44809714	Anterior opercular syndrome (disorder)	4180186
44809714	Foix-Chavany-Marie syndrome	4180186
44809716	Referral by CMHN (community mental health nurse)	4180186
44809716	Referral by community mental health nurse (procedure)	4180186
44809717	Sexually transmitted infection in-house follow-up (procedure)	4180186
44809718	Recommendation to have child immunised against poliomyelitis (procedure)	4180186
44809720	Recommendation to have child immunised against tetanus (procedure)	4180186
44809728	Preference for National Health Service care provider (finding)	4180186
44809729	111 contact disposition	4180186
44809729	111 contact disposition finding (finding)	4180186
44809730	111 contact disposition to general practitioner (finding)	4180186
44809731	111 contact disposition to pharmacist (finding)	4180186
44809732	111 contact disposition to out of hours service (finding)	4180186
44809735	111 contact disposition to 999 transfer (finding)	4180186
44809737	Mobilisation of rectum (procedure)	4180186
44809739	Tibiotalocalcaneal arthrodesis (procedure)	4180186
44809739	TTC (tibiotalocalcaneal) fusion	4180186
44809740	Change of suprapubic catheter over guide wire (procedure)	4180186
44809743	QCancer testicular cancer risk (observable entity)	4180186
44809745	QCancer endometrial cancer risk (observable entity)	4180186
44809748	QCancer breast cancer risk (observable entity)	4180186
44809751	Provision of written information about primary care out of hours service (procedure)	4180186
44809757	Percutaneous transluminal balloon occlusion of internal carotid artery using fluoroscopic guidance (procedure)	4180186
44809758	Percutaneous transluminal balloon occlusion of vertebral artery using fluoroscopic guidance (procedure)	4180186
44809759	Health visitor antenatal visit (procedure)	4180186
44809761	Discussion about relationship (procedure)	4180186
44809763	Carotid bruit absent (situation)	4180186
44809765	Renal bruit absent (situation)	4180186
44809767	Vulval rash (finding)	4180186
44809768	Consent given for telemedicine consultation (finding)	4180186
44809771	Continence treatment plan agreed (finding)	4180186
44809773	Diagnostic history - oncology (record artifact)	4180186
44809774	Oncology treatment (record artifact)	4180186
44809776	Bowel scope (flexible sigmoidoscopy) screen: referred for colonoscopy (finding)	4180186
44809777	Bowel scope (flexible sigmoidoscopy) screen: cancer detected (finding)	4180186
44809778	Bowel scope (flexible sigmoidoscopy) screen: suspected cancer detected (finding)	4180186
44809779	Bowel scope (flexible sigmoidoscopy) screen: other abnormality detected (finding)	4180186
44809781	Referral to equipment loan service (procedure)	4180186
44809782	Referral to neurological rehabilitation service (procedure)	4180186
44809783	Referral to assistive technology service (procedure)	4180186
44809784	Excision of Mullerian duct remnant (procedure)	4180186
44809785	Excision of lesion of Mullerian duct remnant (procedure)	4180186
44809787	Excision of gonad from inguinal canal (procedure)	4180186
44809789	Excision of gonad from abdomen (procedure)	4180186
44809791	In-house substance misuse treatment (procedure)	4180186
44809792	Operations for disorders of sex development (navigational concept)	4180186
44809793	Diagnostic endoscopic examination of nasal cavity and biopsy of lesion of nasal cavity (procedure)	4180186
44809796	Disposable device used (finding)	4180186
44809801	No longer on integrated care pathway (finding)	4180186
44809804	Human immunodeficiency virus infection monitoring first telephone invitation (procedure)	4180186
44809805	Cholera vaccination declined (situation)	4180186
44809810	Human immunodeficiency virus infection monitoring second telephone invitation (procedure)	4180186
44809811	Ultrasonography of urethra (procedure)	4180186
44809811	Ultrasound scan of urethra	4180186
44809813	First hepatitis B junior vaccination (procedure)	4180186
44809814	Second hepatitis B junior vaccination (procedure)	4180186
44809817	Fourth hepatitis B junior vaccination (procedure)	4180186
44809818	Percutaneous endoscopic retroperitoneal debridement of pancreatic necrosis (procedure)	4180186
44809819	First combined paediatric hepatitis A and B vaccination (procedure)	4180186
44809823	Application of thumb spica splint (procedure)	4180186
44809824	Seen by trainee psychotherapist (finding)	4180186
44809825	Provision of information about needle and syringe exchange scheme (procedure)	4180186
44809828	Osteotomy of first metatarsal by scarf technique (procedure)	4180186
44809835	Pertussis vaccination programme for pregnant women enhanced service administration (procedure)	4180186
44809837	Internal valvuloplasty of vein (procedure)	4180186
44809840	Percutaneous endoscopic cold knife pyelotomy and insertion of stent using fluoroscopic guidance (procedure)	4180186
44809841	Percutaneous endoscopic diathermy probe pyelotomy and insertion of stent using fluoroscopic guidance (procedure)	4180186
44809843	Postoperative radiocephalic arteriovenous fistula at anatomical snuff box (morphologic abnormality)	4180186
44809843	Radial-cephalic snuff box fistula	4180186
44809844	Did not respond to bowel scope (flexible-sigmoidoscopy) screening invitation	4180186
44809844	Did not respond to bowel scope (flexible-sigmoidoscopy) screening invitation (finding)	4180186
44809845	Did not attend bowel scope (flexible-sigmoidoscopy) appointment (finding)	4180186
44809846	Bowel scope (flexible-sigmoidoscopy) screening: attended but not screened (finding)	4180186
44809847	Unsuitable for bowel scope (flexible sigmoidoscope) screening invitation at this time (finding)	4180186
44809849	Administration of second intranasal pandemic influenza vaccination (procedure)	4180186
44809850	Administration of first intranasal seasonal influenza vaccination (procedure)	4180186
44809852	First intranasal pandemic influenza vaccination given by other healthcare provider (finding)	4180186
44809853	Epilepsy limits activities (finding)	4180186
44809854	Second intranasal pandemic influenza vaccination given by other healthcare provider (finding)	4180186
44809856	Second intranasal seasonal influenza vaccination given by other healthcare provider (finding)	4180186
44809861	School entrant hearing screening left ear - no clear response (situation)	4180186
44809863	Dementia screening questionnaire declined (situation)	4180186
44809865	Child and Adolescent Mental Health Service partnership appointment cancelled by patient (finding)	4180186
44809867	Child and Adolescent Mental Health Service appointment cancelled by clinician (finding)	4180186
44809875	Endoscopic extirpation of lesion of nasal cavity (navigational concept)	4180186
44809877	Delay in care due to missed communication (finding)	4180186
44809878	Referral to multidisciplinary obesity clinic (procedure)	4180186
44809879	Neuromuscular disorder drugs Band 1 (procedure)	4180186
44809882	Retinal disorder drugs Band 1 (procedure)	4180186
44809883	Skin condition drugs Band 1 (procedure)	4180186
44809884	Antibacterial drugs Band 1 (procedure)	4180186
44809889	Health of the Nation Outcome Scale for Children and Adolescents item 2 - overactivity, attention and concentration (observable entity)	4180186
44809891	Health of the Nation Outcome Scale for Children and Adolescents item 4 - alcohol, substance/solvent misuse (observable entity)	4180186
44809892	Health of the Nation Outcome Scale for Children and Adolescents item 5 - scholastic or language skills (observable entity)	4180186
44809893	Macular translocation with three hundred and sixty degree retinotomy (procedure)	4180186
44809894	Endoscopic brush biopsy of lesion of pancreas using ultrasonography guidance (procedure)	4180186
44809894	Endoscopic ultrasound guided brush biopsy of lesion of pancreas	4180186
44809895	Endoscopic retrograde cholangiopancreatography with brush biopsy of bile duct using fluoroscopic guidance (procedure)	4180186
44809896	Endoscopic retrograde cholangiopancreatography with forceps biopsy of lesion of ampulla of Vater using fluoroscopic guidance (procedure)	4180186
44809897	Revision rhinoseptoplasty (procedure)	4180186
44809902	Miscarriage surgical management care plan (record artifact)	4180186
44809903	Application of high arm sling (procedure)	4180186
44809904	Occlusion of dialysis vascular access (disorder)	4180186
44809905	Infection of dialysis vascular access (disorder)	4180186
44809906	Haemorrhage of dialysis vascular access (disorder)	4180186
44809908	Stenosis of dialysis arteriovenous graft (disorder)	4180186
44809909	Stenosis of dialysis arteriovenous shunt (disorder)	4180186
44809910	Pertussis vaccination in pregnancy invitation (procedure)	4180186
44809911	Norovirus screening test (procedure)	4180186
44809912	Save sample for serum virology (situation)	4180186
44809913	Save sample for later serum analysis (situation)	4180186
44809915	Thrombosis of dialysis arteriovenous fistula (disorder)	4180186
44809917	Occlusion of dialysis arteriovenous graft (disorder)	4180186
44809922	Pertussis vaccination in pregnancy invitation first letter (procedure)	4180186
44809925	Conversion to insulin in secondary care (regime/therapy)	4180186
44809926	Conversion to insulin by diabetes specialist nurse (regime/therapy)	4180186
44809927	Shared care - secondary care and tertiary care (regime/therapy)	4180186
44809931	Requires course of Japanese encephalitis vaccination (finding)	4180186
44809932	Natural killer (bright) cell absolute count (procedure)	4180186
44809932	NK (natural killer) (bright) cell absolute count	4180186
44809934	Suspected multiple sclerosis (situation)	4180186
44809942	Antipsychotic medication physical health check (procedure)	4180186
44809946	Dementia screening questionnaire completed (finding)	4180186
44809947	Referral to paediatric allergy service (procedure)	4180186
44809949	No history of ectopic pregnancy (situation)	4180186
44809951	Warwick-Edinburgh Mental Well-being Scale (assessment scale)	4180186
44809953	Assessment using Warwick-Edinburgh Mental Well-being Scale (procedure)	4180186
44809957	Admission to school medical centre (procedure)	4180186
44809959	Able to participate in telemedicine consultation (finding)	4180186
44809961	Serial prescription issued (finding)	4180186
44809963	Choreoathetoid cerebral palsy (disorder)	4180186
44809963	Choreo-athetotic cerebral palsy	4180186
44809965	Health of the Nation Outcome Scale for Children and Adolescents item 8 - non-organic somatic symptoms (observable entity)	4180186
44809968	Health of the Nation Outcome Scale for Children and Adolescents item 11 - self care and independence (observable entity)	4180186
44809971	Health of the Nation Outcome Scale for Children and Adolescents item 14 - lack of knowledge - nature of difficulties (observable entity)	4180186
44809973	Discharge notification (record artifact)	4180186
44809974	Admission notification (record artifact)	4180186
44809975	Stercoral perforation of colon (disorder)	4180186
44809976	Intracervical injection of local anaesthetic (procedure)	4180186
44809977	Substance misuse treatment programme delivered by other healthcare provider (finding)	4180186
44809979	Cannulation site irritation (disorder)	4180186
44809980	Dietary advice to maximise nutritional intake	4180186
44809980	Dietary education to maximise nutritional intake (procedure)	4180186
44809981	Inappropriate use of walk-in centre (procedure)	4180186
44809983	Clinical Institute Withdrawal Assessment for Alcohol scale, revised (assessment scale)	4180186
44809986	Assessment using CIWA-Ar (Clinical Institute Withdrawal Assessment of Alcohol Scale, revised)	4180186
44809986	Assessment using Clinical Institute Withdrawal Assessment of Alcohol Scale, revised (procedure)	4180186
44809988	CIWA-Ar (Clinical Institute Withdrawal of Alcohol Scale, revised) score	4180186
44809988	Clinical Institute Withdrawal of Alcohol Scale, revised score (observable entity)	4180186
44809990	Unscheduled care report (record artifact)	4180186
44809993	Time since last episode of diarrhoea (observable entity)	4180186
44809996	Uses assistance dog (finding)	4180186
44809997	PASI - psoriasis area and severity index	4180186
44809997	Psoriasis area and severity index (assessment scale)	4180186
44810000	Did not attend pertussis vaccination in pregnancy (finding)	4180186
44810002	Recurrent anaemia (disorder)	4180186
44810003	Seen by community drug team (finding)	4180186
44810004	INR (international normalised ratio) percentage TTR (time in therapeutic range)	4180186
44810004	International normalised ratio time in therapeutic range expressed as percentage (observable entity)	4180186
44810005	Ultrasonography to determine estimated date of confinement (procedure)	4180186
44810006	Facilitating creative expression (procedure)	4180186
44810007	Carpometacarpal bossing (disorder)	4180186
44810009	Supplier reported volume of supplemental oxygen prescribed per day (observable entity)	4180186
44810013	History of fever (situation)	4180186
44810013	H/O: pyrexia	4180186
44810014	Peripheral blood oxygen saturation on room air at rest (observable entity)	4180186
44810015	Peripheral blood oxygen saturation on room air on exertion (observable entity)	4180186
44810019	Cone beam computed tomography of facial bone (procedure)	4180186
44810020	Cone beam computed tomography of internal auditory meatus (procedure)	4180186
44810023	Right knee reflex reduced (finding)	4180186
44810024	Left knee reflex absent (finding)	4180186
44810026	Left biceps reflex normal (finding)	4180186
44810031	Right triceps reflex normal (finding)	4180186
44810033	Right triceps reflex absent (finding)	4180186
44810035	Left plantar reflex normal (finding)	4180186
44810038	Integrated care pathway declined (situation)	4180186
44810040	Coeliac United Kingdom member (finding)	4180186
44810041	Excision of exostosis of head of fifth metacarpal (procedure)	4180186
44810044	Bilateral profound sensorineural hearing loss (disorder)	4180186
44810044	Profound BSNHL (bilateral sensorineural hearing loss)	4180186
44810046	Hoffman reflex equivocal (finding)	4180186
44810046	Hoffman's reflex equivocal	4180186
44810048	Seen in drug misuse clinic (finding)	4180186
44810049	Paediatric outpatient care plan (record artifact)	4180186
44810051	Paediatric community care plan (record artifact)	4180186
44810053	Existing patient paper record available (finding)	4180186
44810054	Paediatric orthopaedic surgery inpatient care plan (record artifact)	4180186
44810057	Lung transplant recipient (finding)	4180186
44810058	Cornea transplant recipient (finding)	4180186
44810061	Rotavirus vaccine allergy (disorder)	4180186
44810062	Diabetes structured education programme not available (situation)	4180186
44810065	First intranasal seasonal influenza vaccination declined (situation)	4180186
44810067	Did not attend stroke clinic (finding)	4180186
44810067	DNA (did not attend) stroke clinic	4180186
44810068	Second intranasal seasonal influenza vaccination declined (situation)	4180186
44810069	Second intranasal pandemic influenza vaccination declined (situation)	4180186
44810071	Did not attend first intranasal pandemic influenza vaccination (finding)	4180186
44810072	Did not attend second intranasal pandemic influenza vaccination (finding)	4180186
44810073	Vitamin advice	4180186
44810073	Vitamin education (procedure)	4180186
44810075	Fluid restriction advice	4180186
44810075	Fluid restriction education (procedure)	4180186
44810076	Domestic Abuse, Stalking and Harassment and Honour Based Violence (2009) Risk Identification and Assessment and Management Model Checklist (assessment scale)	4180186
44810077	Assessment using Domestic Abuse, Stalking and Harassment and Honour Based Violence (2009) Risk Identification and Assessment and Management Model Checklist (procedure)	4180186
44810078	Multi-professional risk assessment declined (finding)	4180186
44810079	Automatic implantable cardioverter defibrillator check (procedure)	4180186
44810080	Domestic Abuse, Stalking and Harassment and Honour Based Violence (2009) Risk Identification and Assessment and Management Model Checklist - initial risk classification (observable entity)	4180186
44810081	Advice to carer about side effects of child immunisation	4180186
44810081	Education to carer about side effects of child immunisation (procedure)	4180186
44810082	History obtained from person with parental responsibility (finding)	4180186
44810083	Delayed union of joint of ankle (disorder)	4180186
44810087	Sure Start registered (finding)	4180186
44810088	Preferred place of care - patient undecided (finding)	4180186
44810090	General Practice Physical Activity Questionnaire declined (situation)	4180186
44810090	GPPAQ (General Practice Physical Activity Questionnaire) declined	4180186
44810091	Measurement of recombinant Bet v 2 Betula verrucosa specific immunoglobulin E antibody level (procedure)	4180186
44810091	Recombinant Bet v 2 birch specific IgE antibody level	4180186
44810092	Fire ant specific IgE antibody level	4180186
44810092	Measurement of Solenopsis invicta venom specific immunoglobulin E antibody (procedure)	4180186
44810093	Herpes zoster vaccination invitation first letter (procedure)	4180186
44810093	Shingles vaccination invitation first letter	4180186
44810098	No family history of breast cancer meeting National Institute of Health and Care Excellence Clinical Guideline 126 referral criteria (situation)	4180186
44810099	Poor upper body strength (finding)	4180186
44810100	Variable upper body strength (finding)	4180186
44810101	Good upper body strength (finding)	4180186
44810102	Test Your Memory test (assessment scale)	4180186
44810103	Primary total prosthetic replacement of ankle joint (procedure)	4180186
44810104	Conversion to total prosthetic replacement of ankle joint (procedure)	4180186
44810105	Revision of total prosthetic replacement of ankle joint (procedure)	4180186
44810106	Holds EHIC (European Health Insurance Card)	4180186
44810106	Holds European Health Insurance Card (finding)	4180186
44810111	Presacral paracoccygeal approach to spine (qualifier value)	4180186
44810112	Exclusion of left atrial appendage (procedure)	4180186
44810113	Drainage of frontal sinus (procedure)	4180186
44810114	Follow-up appointment offered (situation)	4180186
44810116	Cone beam computed tomography of nasal sinus (procedure)	4180186
44810122	Haemorrhage of dialysis arteriovenous graft (disorder)	4180186
44810130	Length of stay, acuity of admission, comorbidities and emergency department visits index scoring tool for death or readmission risk assessment (assessment scale)	4180186
44810131	No asthma trigger identified by subject (finding)	4180186
44810134	Probable familial hypercholesterolaemia (situation)	4180186
44810135	Day case care management (procedure)	4180186
44810137	Care of laryngectomy stoma (regime/therapy)	4180186
44810138	Emergency contraception indicated (situation)	4180186
44810139	Child immunisation invitation third short message service text message (procedure)	4180186
44810139	Child immunisation invitation third SMS (short message service) text message	4180186
44810141	Paediatric intensive care plan (record artifact)	4180186
44810142	Inadequate dietary intake of pantothenic acid (finding)	4180186
44810143	Inadequate dietary intake of biotin (finding)	4180186
44810145	Excessive dietary intake of biotin (finding)	4180186
44810146	Inadequate dietary intake of fluoride (finding)	4180186
44810148	Review of inhaler technique using inhaler checking device (regime/therapy)	4180186
44810149	Inadequate dietary intake of iodine (finding)	4180186
44810151	Inadequate dietary intake of manganese (finding)	4180186
44810154	No family history of malignant neoplasm of lung (situation)	4180186
44810156	Excessive dietary intake of fluoride (finding)	4180186
44810157	Application for naturalisation as British citizen - referee declaration signed (finding)	4180186
44810159	Excessive dietary intake of copper (finding)	4180186
44810160	Excessive dietary intake of iodine (finding)	4180186
44810162	Inadequate dietary intake of chromium (finding)	4180186
44810163	Excessive dietary intake of chromium (finding)	4180186
44810166	Rectal lymphogranuloma venereum (disorder)	4180186
44810168	User of electronic cigarette (finding)	4180186
44810169	Mitochondrial 1555 A to G mutation analysis (procedure)	4180186
44810175	On non-stimulant drug therapy for attention deficit hyperactivity disorder (situation)	4180186
44810176	Assessment of psychotic and behavioural symptoms of dementia (procedure)	4180186
44810179	Vitamin D deficiency monitoring invitation (procedure)	4180186
44810180	Vitamin D deficiency monitoring first letter (procedure)	4180186
44810181	Vitamin D deficiency monitoring second letter (procedure)	4180186
44810184	Vitamin D deficiency monitoring telephone invitation (procedure)	4180186
44810185	Telehealth monitoring not appropriate (finding)	4180186
44810186	Prisoner constant watch commenced (situation)	4180186
44810187	Prisoner constant watch ended (situation)	4180186
44810190	Suspected genetic disease	4180186
44810190	Suspected hereditary disease (situation)	4180186
44810191	Non-diabetic hyperglycaemia (disorder)	4180186
44810193	Referral details (record artifact)	4180186
44810194	Patient demographics (record artifact)	4180186
44810195	Special requirements (record artifact)	4180186
44810197	Expectation of referral (record artifact)	4180186
44810198	Patient's expectation of referral (record artifact)	4180186
44810199	Admission details (record artifact)	4180186
44810200	Outpatient details (record artifact)	4180186
44810205	Patient's reason for referral (record artifact)	4180186
44810206	Presenting complaints or issues (record artifact)	4180186
44810207	Medications and devices (record artifact)	4180186
44810209	Brachial-basilic fistula	4180186
44810209	Postoperative brachiobasilic arteriovenous fistula (morphologic abnormality)	4180186
44810210	Imbalanced dietary intake of fat (finding)	4180186
44810212	Transplantation of stomach (procedure)	4180186
44810214	Declined to see school nurse (situation)	4180186
44810216	Qualitative detection test for oxycodone in urine specimen (procedure)	4180186
44810216	Urine oxycodone detection test	4180186
44810218	Patient died in community hospital (finding)	4180186
44810222	Measurement of ratio of cystine to creatinine in urine specimen (procedure)	4180186
44810222	Urine cystine:creatinine ratio	4180186
44810223	Measurement of ratio of arginine to creatinine in urine specimen (procedure)	4180186
44810223	Urine arginine:creatinine ratio	4180186
44810224	Measurement of ratio of methylmalonic acid to creatinine in urine specimen (procedure)	4180186
44810224	Urine methylmalonic acid:creatinine ratio	4180186
44810226	Measurement of ratio of isoleucine to creatinine in urine specimen (procedure)	4180186
44810226	Urine isoleucine:creatinine ratio	4180186
44810227	Measurement of ratio of glutamine to creatinine in urine specimen (procedure)	4180186
44810227	Urine glutamine:creatinine ratio	4180186
44810228	Measurement of ratio of homocystine to creatinine in urine specimen (procedure)	4180186
44810228	Urine homocystine:creatinine ratio	4180186
44810230	Measurement of ratio of methionine to creatinine in urine specimen (procedure)	4180186
44810230	Urine methionine:creatinine ratio	4180186
44810232	Measurement of ratio of phenylalanine to creatinine in urine specimen (procedure)	4180186
44810232	Urine phenylalanine:creatinine ratio	4180186
44810233	Measurement of ratio of taurine to creatinine in urine specimen (procedure)	4180186
44810233	Urine taurine:creatinine ratio	4180186
44810236	Measurement of ratio of tyrosine to creatinine in urine specimen (procedure)	4180186
44810236	Urine tyrosine:creatinine ratio	4180186
44810237	Measurement of ratio of alanine to creatinine in urine specimen (procedure)	4180186
44810237	Urine alanine:creatinine ratio	4180186
44810238	Measurement of ratio of aspartate to creatinine in urine specimen (procedure)	4180186
44810238	Urine aspartate:creatinine ratio	4180186
44810239	Measurement of ratio of homocysteine to creatinine in urine specimen (procedure)	4180186
44810239	Urine homocysteine:creatinine ratio	4180186
44810240	Substance misuse monitoring annual review (regime/therapy)	4180186
44810241	Referral to Child and Adolescent Mental Health Service occupational therapy service	4180186
44810241	Referral to Child and Adolescent Mental Health Service occupational therapy service (procedure)	4180186
44810242	Measurement of recombinant Ves v 5 Vespula vulgaris venom specific immunoglobulin E antibody (procedure)	4180186
44810242	Recombinant Ves v 5 common wasp specific IgE antibody level	4180186
44810245	Percutaneous endoscopic laser pyelotomy and insertion of stent using fluoroscopic guidance (procedure)	4180186
44810246	Assessment using length of stay, acuity of admission, comorbidities and emergency department visits index (procedure)	4180186
44810249	Supplier reported percentage variance between prescribed and used supplemental oxygen per day (observable entity)	4180186
44810252	First primary immunisation invitation third letter (procedure)	4180186
44810253	Second primary immunisation invitation first letter (procedure)	4180186
44810255	Second primary immunisation invitation third letter (procedure)	4180186
44810258	Third primary immunisation invitation third letter (procedure)	4180186
44810259	Agreeing on mental health care plan (procedure)	4180186
44810260	Review of mental health care plan (procedure)	4180186
44810261	Erectile dysfunction due to diabetes mellitus (disorder)	4180186
44810263	12-13 month immunisation invitation first letter (procedure)	4180186
44810266	Second measles mumps rubella immunisation invitation first letter (procedure)	4180186
44810270	Pulmonary rehabilitation review (procedure)	4180186
44810271	Family history of pre-eclampsia (situation)	4180186
44810272	Mitochondrial 1555 A to G mutation negative (finding)	4180186
44810274	Unborn child is cause for safeguarding concern (finding)	4180186
44810277	Suspected coronavirus infection (situation)	4180186
44810280	Requires oxygen therapy during exercise (finding)	4180186
44810281	Predicted excessive nutrient intake (finding)	4180186
44810282	Verification of postoperative vaginal blood loss within expected range (procedure)	4180186
44810284	Management of cystoscopy (procedure)	4180186
44810286	Management of bronchoscopy (procedure)	4180186
44810289	No family history of malignant tumour of urinary bladder (situation)	4180186
44810292	Left knee reflex exaggerated (finding)	4180186
44810293	Right knee reflex exaggerated (finding)	4180186
44810294	Right ankle reflex exaggerated (finding)	4180186
44810295	Left biceps reflex reduced (finding)	4180186
44810296	Right biceps reflex reduced (finding)	4180186
44810300	Risks to others (record artifact)	4180186
44810303	Mental capacity assessment (record artifact)	4180186
44810305	Organ and tissue donation (record artifact)	4180186
44810309	Safeguarding issues (record artifact)	4180186
44810311	Type 1 Bartter syndrome (disorder)	4180186
44810313	Type 3 Bartter syndrome (disorder)	4180186
44810316	Family history (record artifact)	4180186
44810321	Diagnoses (record artifact)	4180186
44810322	Procedures (record artifact)	4180186
44810323	Clinical summary (record artifact)	4180186
44810325	Plan and requested actions (record artifact)	4180186
44810328	Person completing record (record artifact)	4180186
44810330	Person receiving handover (record artifact)	4180186
44810338	Forced expiratory volume in 1 second/forced expiratory volume in 6 seconds ratio (observable entity)	4180186
44810340	On parenteral nutrition (situation)	4180186
44810341	Under care of homeless advocacy service (finding)	4180186
44810345	Herb mix specific IgE antibody level	4180186
44810345	Measurement of herb mix specific immunoglobulin E antibody measurement (procedure)	4180186
44810346	Carer perception of problem (record artifact)	4180186
44810348	Suspected binge eating disorder (situation)	4180186
44810352	Shared care chronic obstructive pulmonary disease monitoring (regime/therapy)	4180186
44810352	Shared care COPD (chronic obstructive pulmonary disease) monitoring	4180186
44810353	Haemophilus influenzae type b and meningitis C vaccination contraindicated (situation)	4180186
44810353	Hib (haemophilus influenzae type b) and meningitis C vaccination contraindicated	4180186
44810354	Diphtheria, tetanus, acellular pertussis, inactivated polio vaccination contraindicated (situation)	4180186
44810354	DTaP/IPV (diphtheria, tetanus, acellular pertussis, inactivated polio) vaccination contraindicated	4180186
44810355	Measurement of ratio of chromium to creatinine in urine specimen (procedure)	4180186
44810355	Urine chromium:creatinine ratio	4180186
44810356	Measurement of ratio of cobalt to creatinine in urine specimen (procedure)	4180186
44810356	Urine cobalt:creatinine ratio	4180186
44810360	Measurement of ratio of zinc to creatinine in urine specimen (procedure)	4180186
44810360	Urine zinc:creatinine ratio	4180186
44810364	Faecal hexaporphyrin content	4180186
44810364	Measurement of hexaporphyrin content in faeces specimen (procedure)	4180186
44810365	Faecal isocoproporphyrin content	4180186
44810365	Measurement of isocoproporphyrin content in faeces specimen (procedure)	4180186
44810366	Preferred place of death: nursing home (finding)	4180186
44810367	Faecal pentaporphyrin content	4180186
44810367	Measurement of pentaporphyrin content in faeces specimen (procedure)	4180186
44810369	Cancer hormonal treatment drugs Band 1 (procedure)	4180186
44810370	Cancer supportive drugs Band 1 (procedure)	4180186
44810371	Faecal coproporphyrin III:coproporphyrin I ratio	4180186
44810371	Measurement of ratio of coproporphyrin III to coproporphyrin I in faeces specimen (procedure)	4180186
44810375	Pre-school booster immunisation invitation third letter (procedure)	4180186
44810376	Hepatitis C antiviral treatment completed (situation)	4180186
44810378	Recurrent genital warts (disorder)	4180186
44810379	Cardiovascular stress test using Bruce protocol (procedure)	4180186
44810382	Removal of oesophageal stent using fluoroscopic guidance (procedure)	4180186
44810383	Recanalisation of artery using fluoroscopic guidance (procedure)	4180186
44810385	No consent for seasonal influenza vaccination (finding)	4180186
44810386	Herpes zoster vaccination given by other health care provider (finding)	4180186
44810388	No consent for herpes zoster vaccination (finding)	4180186
44810391	Rotavirus vaccination contraindicated (situation)	4180186
44810392	No consent for rotavirus vaccination (finding)	4180186
44810398	Measurement of recombinant Cor a 8 Corylus avellana specific immunoglobulin E antibody (procedure)	4180186
44810400	Lupus anticoagulant negative (finding)	4180186
44810401	Lupus anticoagulant positive (finding)	4180186
44810403	Does not have driving licence (finding)	4180186
44810407	HPV (human papillomavirus) screening	4180186
44810407	Human papillomavirus screening (procedure)	4180186
44810410	Anti-CRMP-5 (collapsin-responsive mediator protein-5) IgG antibody measurement	4180186
44810410	Anti-CV2 IgG antibody level	4180186
44810410	Measurement of crossveinless-2 specific immunoglobulin G antibody (procedure)	4180186
44810413	Bench surgery resection of liver	4180186
44810413	Extracorporeal resection of liver (procedure)	4180186
44810414	Measurement of paraneoplastic Ma antigen 2 specific immunoglobulin G antibody (procedure)	4180186
44810414	Paraneoplastic Ma antigen 2 IgG antibody level	4180186
44810416	Suspected child neglect	4180186
44810416	Suspected victim of child neglect (situation)	4180186
44810417	Percutaneous transluminal coil embolisation of unruptured cerebral aneurysm using fluoroscopic guidance (procedure)	4180186
44810418	Screening for Serratia infection (procedure)	4180186
44810419	Primary osteoarthritis of ankle (disorder)	4180186
44810420	Secondary osteoarthritis of ankle (disorder)	4180186
44810421	Osteoarthritis of ankle secondary to trauma (disorder)	4180186
44810423	Cervical smear - high grade dyskaryosis (moderate) (finding)	4180186
44810424	Cervical smear - high grade dyskaryosis (severe) (finding)	4180186
44810428	Seen by child and adolescent psychologist (finding)	4180186
44810429	Cervical smear - features of endocervical type glandular neoplasia (finding)	4180186
44810431	National Health Service 111 report received (finding)	4180186
44810435	Referral to haematuria clinic (procedure)	4180186
44810436	Anxiety about breathlessness (finding)	4180186
44810437	Medically unexplained symptoms (finding)	4180186
44810438	Education about lifestyle for risk of diabetes (procedure)	4180186
44810439	Patient died in usual place of residence (finding)	4180186
44810440	Chronic disease management annual review invitation (procedure)	4180186
44810441	Diabetes Year of Care annual review (regime/therapy)	4180186
44810444	Percentage count of lymphocytes and blast cells positive for HLA-DR	4180186
44810444	Percentage count of lymphocytes and blast cells positive for human leucocyte antigen DR (procedure)	4180186
44810447	Wishes to donate body to medical research (finding)	4180186
44810448	No history of exposure to occupational risk factor (situation)	4180186
44810450	Care Programme Approach recovery assessment (procedure)	4180186
44810453	Measurement of red blood cell zinc protoporphyrin concentration (procedure)	4180186
44810453	Red blood cell zinc protoporphyrin concentration	4180186
44810454	Measurement of ratio of delta-aminolaevulinic acid to creatinine in urine specimen (procedure)	4180186
44810454	Urine delta-aminolaevulinic acid:creatinine ratio	4180186
44810455	Urine porphyrin profile (procedure)	4180186
44810457	Repositioning of lead of subcutaneous cardioverter defibrillator (procedure)	4180186
44810457	Resiting of lead of subcutaneous cardioverter defibrillator	4180186
44810461	Remote care monitoring ended (situation)	4180186
44810463	Partial meal replacement programme ended (situation)	4180186
44810464	Obesity multidisciplinary case review (procedure)	4180186
44810465	Benign anorectal disease	4180186
44810465	Benign anorectal disorder (disorder)	4180186
44810466	Congenital cholestatic syndrome (disorder)	4180186
44810470	Bilateral mild sensorineural hearing loss (disorder)	4180186
44810470	Mild BSNHL (bilateral sensorineural hearing loss)	4180186
44810475	Endoscopic operation on pharyngeal pouch (procedure)	4180186
44810476	Pulsed dose rate brachytherapy (procedure)	4180186
44810480	Sample microscopy for clue cells (procedure)	4180186
44810485	Insertion of drain using cone beam computed tomography guidance (procedure)	4180186
44810488	Biopsy of head using cone beam computed tomography guidance (procedure)	4180186
44810490	Biopsy of abdomen using cone beam computed tomography guidance (procedure)	4180186
44810492	Biopsy of upper limb using cone beam computed tomography guidance (procedure)	4180186
44810492	Cone beam CT guided biopsy of arm	4180186
44810493	Biopsy of lower limb using cone beam computed tomography guidance (procedure)	4180186
44810493	Cone beam CT guided biopsy of leg	4180186
44810497	Aspiration of abdomen using cone beam computed tomography guidance (procedure)	4180186
44810500	Aspiration of lower limb using cone beam computed tomography (procedure)	4180186
44810500	Cone beam CT guided aspiration of leg	4180186
44810501	Aspiration of spine using cone beam computed tomography guidance (procedure)	4180186
44810502	Predicted inadequate energy intake (finding)	4180186
44810503	Insertion of drain into neck using cone beam computed tomography guidance (procedure)	4180186
44810505	Cone beam CT guided insertion of drain into thorax	4180186
44810505	Insertion of drain into chest using cone beam computed tomography guidance (procedure)	4180186
44810506	Mental Health Act 1983 (England and Wales) form 2 fee unpaid (finding)	4180186
44810507	Predicted excessive energy intake (finding)	4180186
44810508	Insertion of drain into abdomen using cone beam computed tomography guidance (procedure)	4180186
44810511	Drug misuse clinic administration (procedure)	4180186
44810513	Cone beam CT guided insertion of drain into leg	4180186
44810513	Insertion of drain into lower limb using cone beam computed tomography guidance (procedure)	4180186
44810514	Insertion of drain into spine using cone beam computed tomography guidance (procedure)	4180186
44810515	Recanalisation of vein using fluoroscopic guidance (procedure)	4180186
44810518	Percutaneous mechanical thrombectomy of renal artery using fluoroscopic guidance with contrast (procedure)	4180186
44810520	Biopsy of lymph node using ultrasonography guidance (procedure)	4180186
44810520	Ultrasound guided biopsy of lymph node	4180186
44810526	Osteoarthritis of subtalar joint secondary to inflammatory arthritis (disorder)	4180186
44810530	Secondary osteoarthritis of calcaneocuboid joint (disorder)	4180186
44810532	Osteoarthritis of calcaneocuboid joint secondary to trauma (disorder)	4180186
44810533	Osteoarthritis of midfoot (disorder)	4180186
44810534	Midfoot (body structure)	4180186
44810535	Primary osteoarthritis of midfoot (disorder)	4180186
44810539	Primary osteoarthritis of first metatarsophalangeal joint (disorder)	4180186
44810539	Primary osteoarthritis of first MTPJ (metatarsophalangeal joint)	4180186
44810542	Osteoarthritis of first metatarsophalangeal joint secondary to trauma (disorder)	4180186
44810542	Osteoarthritis of first MTPJ (metatarsophalangeal joint) secondary to trauma	4180186
44810543	Referral to community Parkinson's service (procedure)	4180186
44810544	Charcot arthropathy of hindfoot (disorder)	4180186
44810545	Charcot arthropathy of midfoot (disorder)	4180186
44810546	Charcot arthropathy of forefoot (disorder)	4180186
44810548	Acute rupture of Achilles tendon (disorder)	4180186
44810550	Excision of dermatofibroma (procedure)	4180186
44810551	Achilles tendinopathy (disorder)	4180186
44810558	Cervical smear - human papillomavirus negative (finding)	4180186
44810563	Type 1 diabetes mellitus in remission	4180186
44810563	Type I diabetes mellitus in remission (disorder)	4180186
44810569	Moderate cognitive impairment (finding)	4180186
44810570	Transfer to Care Programme Approach (procedure)	4180186
44810571	Severe cognitive impairment (finding)	4180186
44810572	Measurement of renin activity in plasma specimen (procedure)	4180186
44810572	Plasma renin activity	4180186
44810573	Lymphoedema Quality of Life Tool - leg (assessment scale)	4180186
44810574	Lymphoedema Quality of Life Tool score - leg (observable entity)	4180186
44810575	Assessment using Lymphoedema Quality of Life Tool - leg (procedure)	4180186
44810576	Transfer to Single Assessment Process (procedure)	4180186
44810578	Statement of special educational needs stopped (finding)	4180186
44810579	Chronic disease management annual review completed (situation)	4180186
44810584	Left Hoffman reflex positive (finding)	4180186
44810585	Right Hoffman reflex positive (finding)	4180186
44810587	Noncompliance with food fortification regimen (finding)	4180186
44810591	Johns Hopkins Adjusted Clinical Groups - Resource Utilization Band category (assessment scale)	4180186
44810591	RUB (Resource Utilization Band) category	4180186
44810592	Assessment using Johns Hopkins Adjusted Clinical Groups - Resource Utilization Band category (procedure)	4180186
44810592	Assessment using RUB (Resource Utilization Band) category	4180186
44810593	Johns Hopkins Adjusted Clinical Groups - Resource Utilization Band category (observable entity)	4180186
44810593	RUB (Resource Utilization Band) category	4180186
44810594	Single photon emission computed tomography of dopamine receptor sites of brain using 123I-ioflupane (procedure)	4180186
44810596	Consent given for educational use of video recording (finding)	4180186
44810598	Acquired swallowing difficulty (finding)	4180186
44810599	Developmental chewing difficulty (finding)	4180186
44810602	Glamorgan paediatric pressure ulcer risk assessment scale (assessment scale)	4180186
44810604	Glamorgan paediatric pressure ulcer risk assessment scale score (observable entity)	4180186
44810605	Acquired chewing difficulty (finding)	4180186
44810606	Parenteral nutrition not optimised to requirements (finding)	4180186
44810607	Under care of educational psychologist (finding)	4180186
44810608	Fluoroscopy guided PAE (prostate arterial embolisation) with contrast	4180186
44810608	Arterial embolisation of prostate using fluoroscopic guidance with contrast (procedure)	4180186
44810609	Percutaneous radiofrequency ablation of renal artery using fluoroscopic guidance (procedure)	4180186
44810611	Fluoroscopy guided OCT (optical coherence tomography) of oesophagus	4180186
44810611	Optical coherence tomography of oesophagus using fluoroscopic guidance (procedure)	4180186
44810612	Left toe brachial pressure index (procedure)	4180186
44810614	Blood sample taken from patient registered at other general practice (procedure)	4180186
44810616	Care pathway contraindicated (situation)	4180186
44810620	Peripheral intravenous cannula (physical object)	4180186
44810621	Removal of peripheral intravenous cannula (procedure)	4180186
44810622	Advised to discontinue carrying adrenaline preloaded injection pen (situation)	4180186
44810623	Assessment of peripheral intravenous cannula site (procedure)	4180186
44810625	Peripheral intravenous cannula care (regime/therapy)	4180186
44810629	On ear microsuction care pathway (situation)	4180186
44810631	Anticoagulation care pathway (regime/therapy)	4180186
44810633	Community cardiac care pathway (regime/therapy)	4180186
44810635	Gallstone care pathway (regime/therapy)	4180186
44810636	Urinary tract infection care pathway (regime/therapy)	4180186
44810637	Procedure in progress (situation)	4180186
44810639	Dementia care plan (record artifact)	4180186
44810641	Biopsy of spine using cone beam computed tomography guidance (procedure)	4180186
44810644	Colposcopy normal (finding)	4180186
44810646	Gastrostomy tube in situ (finding)	4180186
44810648	Colposcopy abnormal (finding)	4180186
44810652	Liaison with referrer (procedure)	4180186
44810656	Referral to Children's Centre (procedure)	4180186
44810657	Victim of domestic abuse (finding)	4180186
44810658	Tendinopathy of peroneal tendon (disorder)	4180186
44810660	Chronic instability of ankle (finding)	4180186
44810664	Optical coherence tomography of retina (procedure)	4180186
44810665	Talar osteochondral defect of ankle (disorder)	4180186
44810668	Did not attend Child and Adolescent Mental Health Service choice appointment (finding)	4180186
44810669	Did not attend Child and Adolescent Mental Health Service partnership appointment (finding)	4180186
44810670	Did not attend Child and Adolescent Mental Health Service return appointment (finding)	4180186
44810672	Osteomyelitis of ankle (disorder)	4180186
44810673	Osteomyelitis of hindfoot (disorder)	4180186
44810675	Osteomyelitis of forefoot (disorder)	4180186
44810678	SIS (Stroke Impact Scale) version 3.0 physical domain score	4180186
44810678	Stroke Impact Scale version 3.0 physical domain score (observable entity)	4180186
44810679	SIS (Stroke Impact Scale) version 3.0 strength score	4180186
44810679	Stroke Impact Scale version 3.0 strength score (observable entity)	4180186
44810682	Left ankle clonus absent (situation)	4180186
44810683	Right ankle clonus absent (situation)	4180186
44810684	Left ankle clonus present (situation)	4180186
44810685	Right ankle clonus present (situation)	4180186
44810686	On Delivering Assisted Living Lifestyles at Scale programme (finding)	4180186
44810688	Borderline respiratory obstruction on spirometry (finding)	4180186
44810692	Club foot	4180186
44810692	Talipes equinocavovarus (disorder)	4180186
44810695	Discharge from care in accordance with professional advice (procedure)	4180186
44810697	Unsuitable for ASSIGN2 cardiovascular disease risk assessment (finding)	4180186
44810698	Filing toenails (procedure)	4180186
44810702	ARFID - avoidant restrictive food intake disorder	4180186
44810702	Avoidant restrictive food intake disorder (disorder)	4180186
44810703	Record contains third party information (finding)	4180186
44810705	Screening for child sexual abuse (procedure)	4180186
44810709	HCL-32-R1 (hypomania checklist 32 item revised) score	4180186
44810709	Hypomania checklist 32 item revised score (observable entity)	4180186
44810715	Measurement of concentration of tacrolimus in whole blood specimen (procedure)	4180186
44810715	Whole blood tacrolimus concentration	4180186
44810717	Radionuclide myocardial perfusion stress study using technetium Tc-99m methoxyisobutylisonitrile normal (finding)	4180186
44810721	Health Plan Indicator (National Health Service Scotland) - intensive (finding)	4180186
44810723	Retrograde urethral sphincterometry (procedure)	4180186
44810724	Urine methadone metabolites positive (finding)	4180186
44810726	Urine methadone metabolites negative (finding)	4180186
44810728	Seen by occupational therapy technician (finding)	4180186
44810729	Seen by occupational therapy technical instructor higher level (finding)	4180186
44810730	Postoperative wound management generated from secondary care done by practice (situation)	4180186
44810731	Sexual health screening (procedure)	4180186
44810732	End of life care management (procedure)	4180186
44810733	Did not attend child and adolescent mental health service appointment (finding)	4180186
44810733	DNA (did not attend) CAMHS (child and adolescent mental health service) appointment	4180186
44810734	EuroQol five dimension self-report questionnaire declined	4180186
44810734	EuroQol five dimension self-report questionnaire declined (situation)	4180186
44810735	SIS (Stroke Impact Scale) version 3.0 ADL (activities of daily living) score	4180186
44810735	Stroke Impact Scale version 3.0 activities of daily living score (observable entity)	4180186
44810736	SIS (Stroke Impact Scale) version 3.0 emotion score	4180186
44810736	Stroke Impact Scale version 3.0 emotion score (observable entity)	4180186
44810737	SIS (Stroke Impact Scale) version 3.0 memory score	4180186
44810737	Stroke Impact Scale version 3.0 memory score (observable entity)	4180186
44810739	SIS (Stroke Impact Scale) version 3.0 social participation score	4180186
44810739	Stroke Impact Scale version 3.0 social participation score (observable entity)	4180186
44810740	Haemoglobin electrophoresis normal (finding)	4180186
44810742	MST - Multisystemic Therapy	4180186
44810742	Multisystemic Therapy (regime/therapy)	4180186
44810743	Management plan for shared care (record artifact)	4180186
44810744	Repeat dispensing service offered (finding)	4180186
44810745	Application of focused rigidity cast (procedure)	4180186
44810746	Antibiotic prophylaxis not indicated (situation)	4180186
44810747	Referral to Social Services declined (situation)	4180186
44810748	Management of lower gastrointestinal tract endoscopy (procedure)	4180186
44810750	Postnatal examination invitation (procedure)	4180186
44810751	Postnatal examination third invitation (procedure)	4180186
44810754	Postnatal examination first invitation (procedure)	4180186
44810756	School entrant hearing screening status (situation)	4180186
44810757	School entrant hearing screening not tested (situation)	4180186
44810758	School entrant hearing screening incomplete - declined screening (situation)	4180186
44810759	School entrant hearing screening clear response - no follow-up required (situation)	4180186
44810760	School entrant hearing screening no clear response - unilateral referral (situation)	4180186
44810764	School entrant hearing screening incomplete - behavioural issues (situation)	4180186
44810766	MTFC - Multidimensional Treatment Foster Care	4180186
44810766	Multidimensional Treatment Foster Care (regime/therapy)	4180186
44810767	Video interaction guidance (regime/therapy)	4180186
44810767	VIG - video interaction guidance	4180186
44810768	Post-micturition ultrasound scan of bladder	4180186
44810768	Ultrasonography of urinary bladder for post-void residual volume (procedure)	4180186
44810768	Ultrasound scan of bladder for PVR (post-void residual) volume	4180186
44810769	Irish Traveller - ethnic category 2001 census (finding)	4180186
44810770	Adiponectin level	4180186
44810770	Measurement of adiponectin (procedure)	4180186
44810772	Lutein level	4180186
44810772	Measurement of lutein (procedure)	4180186
44810773	Lycopene level	4180186
44810773	Measurement of lycopene (procedure)	4180186
44810775	Measurement of pyruvate kinase isoenzyme type M2 (procedure)	4180186
44810775	Pyruvate kinase isoenzyme type M2 level	4180186
44810776	Traveller - ethnic category 2001 census (finding)	4180186
44810778	Carer understands care plan (finding)	4180186
44810779	Carer does not understand care plan (finding)	4180186
44810780	Measurement of zeaxanthin (procedure)	4180186
44810780	Zeaxanthin level	4180186
44810782	Scottish Physical Activity Screening Questions (assessment scale)	4180186
44810783	Gypsy/Romany - ethnic category 2001 census (finding)	4180186
44810785	Care home visit for initial patient assessment (procedure)	4180186
44810788	Acid phosphatase activity	4180186
44810788	Measurement of acid phosphatase activity (procedure)	4180186
44810789	Alanine transaminase activity	4180186
44810789	Measurement of alanine transaminase activity (procedure)	4180186
44810790	Alkaline phosphatase activity	4180186
44810790	Measurement of alkaline phosphatase activity (procedure)	4180186
44810792	Alkaline phosphatase bone isoenzyme activity	4180186
44810792	Measurement of alkaline phosphatase bone isoenzyme activity (procedure)	4180186
44810793	Amylase activity	4180186
44810793	Measurement of amylase activity (procedure)	4180186
44810795	Aspartate transaminase activity	4180186
44810795	Measurement of aspartate transaminase activity (procedure)	4180186
44810796	Beta-galactosidase activity	4180186
44810796	Measurement of beta-galactosidase activity (procedure)	4180186
44810798	Disaccharidase activity	4180186
44810798	Measurement of disaccharidase activity (procedure)	4180186
44810799	Glycoasparaginase activity	4180186
44810799	Measurement of glycoasparaginase activity (procedure)	4180186
44810802	Glycogen brancher enzyme activity	4180186
44810802	Measurement of glycogen branching enzyme activity (procedure)	4180186
44810804	Measurement of myeloperoxidase activity (procedure)	4180186
44810804	Myeloperoxidase activity	4180186
44810805	Measurement of palmitoyl protein thioesterase activity (procedure)	4180186
44810805	Palmitoyl protein thioesterase activity	4180186
44810808	Measurement of steroid sulphatase activity (procedure)	4180186
44810808	Steroid sulphatase activity	4180186
44810810	Under care of community learning disability team (finding)	4180186
44810814	Ages and stages questionnaires social-emotional (assessment scale)	4180186
44810815	In-house diabetic foot screening follow-up appointment (procedure)	4180186
44810817	Removal of arterial cannula (procedure)	4180186
44810818	Discharge from CAMHS (child and adolescent mental health service)	4180186
44810818	Discharge from child and adolescent mental health service (procedure)	4180186
44810820	Assessment using Eron severity classification system for skin and soft tissue infections (procedure)	4180186
44810821	Eron severity classification for skin and soft tissue infections (observable entity)	4180186
44810822	National Health Service Health Check raising awareness about dementia and memory clinics (procedure)	4180186
44810825	Finding of Eron severity classification for skin and soft tissue infections (finding)	4180186
44810826	Eron class 1 skin and soft tissue infection	4180186
44810826	Eron class I skin and soft tissue infection (finding)	4180186
44810831	Health Plan Indicator (National Health Service Scotland) - additional, medium risk (finding)	4180186
44810832	Vulnerable child case management (procedure)	4180186
44810833	Invitation to participate in research study (procedure)	4180186
44810834	IBAIP - Infant Behavioral Assessment and Intervention Program	4180186
44810834	Infant Behavioral Assessment and Intervention Program (procedure)	4180186
44810836	Paediatric inpatient care management (procedure)	4180186
44810837	Paediatric surgery care management (procedure)	4180186
44810838	Failure of implant of foot and ankle (disorder)	4180186
44810840	Maternity care plan (record artifact)	4180186
44810841	Referral to maternity service (procedure)	4180186
44810846	Cervical smear - low grade dyskaryosis (finding)	4180186
44810848	Parent-infant psychotherapy (regime/therapy)	4180186
44810849	Referral to MAST (multi-agency support team)	4180186
44810849	Referral to multi-agency support team (procedure)	4180186
44810851	Doppler ultrasonography of thoracodorsal artery (procedure)	4180186
44810851	Doppler ultrasound scan of thoracodorsal artery	4180186
44810856	Referral for free early education place (procedure)	4180186
44810857	Request for individual funding granted (finding)	4180186
44810859	Left triceps reflex reduced (finding)	4180186
44810860	Right triceps reflex brisk (finding)	4180186
44810861	Left triceps reflex brisk (finding)	4180186
44810862	Looked after child annual dental health assessment completed (situation)	4180186
44810863	Referral to voluntary support service for carers (procedure)	4180186
44810864	Family history of long QT syndrome (situation)	4180186
44810865	Child health 24-30 months review (regime/therapy)	4180186
44810866	At high risk of sexually transmitted infection (finding)	4180186
44810869	Adverse reaction to herpes zoster vaccine (disorder)	4180186
44810871	Measurement of uridine diphosphate glucose-4-epimerase activity (procedure)	4180186
44810871	Uridine diphosphate (UDP) glucose-4-epimerase activity	4180186
44810872	Alpha-2 antiplasmin activity	4180186
44810872	Measurement of alpha-2 antiplasmin activity (procedure)	4180186
44810875	Measurement of protein C activity (procedure)	4180186
44810875	Protein C activity	4180186
44810877	Albanian - ethnic category 2001 census (finding)	4180186
44810878	Alpha-L-iduronidase activity	4180186
44810878	Measurement of alpha-L-iduronidase activity (procedure)	4180186
44810882	Multiple and complex disability with physical disability (finding)	4180186
44810884	Serbian - ethnic category 2001 census (finding)	4180186
44810885	ADHD/ADD (attention deficit hyperactivity disorder/attention deficit disorder), inattentive presentation (restrictive)	4180186
44810885	Attention deficit hyperactivity disorder, inattentive presentation (restrictive)	4180186
44810885	Attention deficit hyperactivity disorder, inattentive presentation (restrictive) (disorder)	4180186
44810886	Assessment using Scot-PASQ (Scottish Physical Activity Screening Questions)	4180186
44810886	Assessment using Scottish Physical Activity Screening Questions (procedure)	4180186
44810889	Hearing examination not completed (situation)	4180186
44810891	Advice on risks of harm to fetus from maternal medication during pregnancy (procedure)	4180186
44810892	Jewish - ethnic category 2001 census (finding)	4180186
44810893	Meets criteria for referral to paediatric neurology epilepsy specialist (finding)	4180186
44810894	Meets criteria for referral to CESS (Children's Epilepsy Surgery Service)	4180186
44810894	Meets criteria for referral to Children's Epilepsy Surgery Service (finding)	4180186
44810895	Management of antenatal education (procedure)	4180186
44810896	Pre-admission assessment for major surgery (procedure)	4180186
44810897	Provision of parent held PCHR (Personal Child Health Record)	4180186
44810897	Provision of parent held Personal Child Health Record (procedure)	4180186
44810898	Percutaneous transluminal intrasaccular ellipsoid braided-wire assisted embolisation of cerebral aneurysm using fluoroscopic guidance (procedure)	4180186
44810899	Percutaneous transluminal temporary balloon occlusion of subclavian artery using fluoroscopic guidance (procedure)	4180186
44810900	Percutaneous transluminal temporary balloon occlusion of subclavian vein using fluoroscopic guidance (procedure)	4180186
44810901	Terminal ileum visualised (finding)	4180186
44810902	Dietary education for bowel preparation	4180186
44810902	Dietary education for bowel preparation for procedure (procedure)	4180186
44810905	Measurement of concentration of chlorpromazine in serum specimen (procedure)	4180186
44810905	Serum chlorpromazine concentration	4180186
44810906	Measurement of concentration of darunavir in serum specimen (procedure)	4180186
44810906	Serum darunavir concentration	4180186
44810907	Measurement of concentration of disopyramide (procedure)	4180186
44810907	Serum disopyramide concentration	4180186
44810910	Measurement of concentration of fentanyl in serum specimen (procedure)	4180186
44810910	Serum fentanyl concentration	4180186
44810914	Unintentional weight gain (finding)	4180186
44810917	Measurement of Helianthus annuus seed specific immunoglobulin E antibody (procedure)	4180186
44810917	Sunflower seed RAST test	4180186
44810918	Measurement of Helianthus annuus pollen specific immunoglobulin E antibody (procedure)	4180186
44810918	Sunflower pollen RAST test	4180186
44810920	Withdrawn from research study (finding)	4180186
44810922	Participation in research study completed (finding)	4180186
44810923	Lost to research study follow-up (finding)	4180186
44810926	Second intranasal influenza vaccination declined (situation)	4180186
44810930	Referral to smoking cessation service declined (situation)	4180186
44810931	Referral to smoking cessation service (procedure)	4180186
44810932	Heart failure monitoring (regime/therapy)	4180186
44810934	Social prescribing declined (situation)	4180186
44810938	Administration of second intranasal influenza vaccination (procedure)	4180186
44810940	On examination lymphorrhoea (finding)	4180186
44810941	On examination right brachial pulse present (finding)	4180186
44810943	On examination right brachial pulse absent (finding)	4180186
44810944	At low risk of sexually transmitted infection (finding)	4180186
44810947	GMFCS (Gross Motor Function Classification System) for Cerebral Palsy	4180186
44810947	Gross Motor Function Classification System for Cerebral Palsy (assessment scale)	4180186
44810948	Assessment using GMFCS (Gross Motor Function Classification System) for Cerebral Palsy	4180186
44810948	Assessment using Gross Motor Function Classification System for Cerebral Palsy (procedure)	4180186
44810949	GMFCS (Gross Motor Function Classification System) for Cerebral Palsy level finding	4180186
44810949	Gross Motor Function Classification System for Cerebral Palsy level finding (finding)	4180186
44810950	GMFCS (Gross Motor Function Classification System) for Cerebral Palsy level I	4180186
44810950	GMFCS (Gross Motor Function Classification System) level I	4180186
44810950	Gross Motor Function Classification System for Cerebral Palsy level I (finding)	4180186
44810953	Dissent withdrawn from disclosure of personal confidential data by Health and Social Care Information Centre (finding)	4180186
44810953	Dissent withdrawn from disclosure of personal confidential data by HSCIC (Health and Social Care Information Centre)	4180186
44810959	Power of myotome of first thoracic nerve (observable entity)	4180186
44810960	Power of myotome of fourth cervical nerve (observable entity)	4180186
44810963	Power of myotome of second lumbar nerve (observable entity)	4180186
44810964	Power of myotome of second sacral nerve (observable entity)	4180186
44810966	Aspirin not tolerated (situation)	4180186
44810968	Power of myotome of third cervical nerve (observable entity)	4180186
44810971	Power of left myotome of fifth cervical nerve (observable entity)	4180186
44810974	Power of left myotome of first sacral nerve (observable entity)	4180186
44810978	Power of left myotome of fourth cervical nerve (observable entity)	4180186
44810979	Power of right myotome of fourth cervical nerve (observable entity)	4180186
44810980	Effective bowel preparation for procedure (finding)	4180186
44810981	Effective bowel preparation for surgery (finding)	4180186
44810982	Management of bowel preparation for surgery (procedure)	4180186
44810984	Radionuclide study of whole body for detection of liver to lung shunt using technetium 99m macroaggregated albumin (procedure)	4180186
44810986	Allocating named nurse (procedure)	4180186
44810987	South and Central American - ethnic category 2001 census (finding)	4180186
44810990	Subcutaneous injection of non-absorbable gel polymer (procedure)	4180186
44810991	Endoscopic radiofrequency ablation of gastro-oesophageal junction (procedure)	4180186
44810997	Diabetic foot screening invitation third letter (procedure)	4180186
44810999	Echocardiography report received (finding)	4180186
44811000	Education about pulmonary artery catheter care (procedure)	4180186
44811004	Confusion, urea, respiratory rate, blood pressure score	4180186
44811004	Confusion, urea, respiratory rate, blood pressure score (assessment scale)	4180186
44811005	Confusion, urea, respiratory rate, blood pressure score	4180186
44811005	Confusion, urea, respiratory rate, blood pressure score (observable entity)	4180186
44811006	Confusion, urea, respiratory rate, blood pressure, 65 years of age or older score	4180186
44811006	Confusion, urea, respiratory rate, blood pressure, 65 years of age or older score (observable entity)	4180186
44811008	Long term condition summary sent to patient (finding)	4180186
44811009	Number of wound sites (observable entity)	4180186
44811010	FEV1 (forced expiratory volume in one second)/VC (vital capacity) ratio after bronchodilator	4180186
44811010	Forced expiratory volume in one second/vital capacity ratio after bronchodilator (observable entity)	4180186
44811011	Education about coping skills (procedure)	4180186
44811012	Fluoroscopy guided percutaneous insertion of cannula for ECMO (extracorporeal membrane oxygenation)	4180186
44811012	Percutaneous insertion of cannula for extracorporeal membrane oxygenation using fluoroscopic guidance (procedure)	4180186
44811013	Excessive oral food intake for physiological needs (finding)	4180186
44811015	Education about interpreter and translator service (procedure)	4180186
44811016	Right thigh circumference (observable entity)	4180186
44811017	On examination left radial pulse present (finding)	4180186
44811023	Discussion about anticoagulation therapy (procedure)	4180186
44811025	O/E right arm pulses all present	4180186
44811025	On examination right upper limb pulses all present (finding)	4180186
44811026	Discussion about mental health crisis plan (procedure)	4180186
44811027	Eicosatrienoic acid level	4180186
44811027	Measurement of eicosatrienoic acid (procedure)	4180186
44811029	O/E right arm pulses all absent	4180186
44811029	On examination right upper limb pulses all absent (finding)	4180186
44811031	Did not attend optometrist ocular hypertension monitoring (finding)	4180186
44811032	History of genital warts (situation)	4180186
44811033	History of genital herpes (situation)	4180186
44811034	No history of vaccine allergy (situation)	4180186
44811035	Initial CAMHS (child and adolescent mental health service) assessment	4180186
44811035	Initial child and adolescent mental health service assessment (procedure)	4180186
44811036	Wagner ulcer classification system (assessment scale)	4180186
44811037	Discussion about heart failure care plan (procedure)	4180186
44811038	Wagner ulcer classification (observable entity)	4180186
44811041	Wagner ulcer classification grade 0 foot ulcer (disorder)	4180186
44811042	Power of left myotome of fourth lumbar nerve (observable entity)	4180186
44811048	Power of right myotome of second lumbar nerve (observable entity)	4180186
44811049	Power of left myotome of second sacral nerve (observable entity)	4180186
44811051	Power of left myotome of seventh cervical nerve (observable entity)	4180186
44811053	Power of left myotome of sixth cervical nerve (observable entity)	4180186
44811055	Power of left myotome of third cervical nerve (observable entity)	4180186
44811056	Power of right myotome of third cervical nerve (observable entity)	4180186
44811060	GMFCS (Gross Motor Function Classification System) for Cerebral Palsy level III	4180186
44811060	GMFCS (Gross Motor Function Classification System) level III	4180186
44811060	Gross Motor Function Classification System for Cerebral Palsy level III (finding)	4180186
44811061	GMFCS (Gross Motor Function Classification System) for Cerebral Palsy level IV	4180186
44811061	GMFCS (Gross Motor Function Classification System) level IV	4180186
44811061	Gross Motor Function Classification System for Cerebral Palsy level IV (finding)	4180186
44811062	GMFCS (Gross Motor Function Classification System) for Cerebral Palsy level V	4180186
44811062	GMFCS (Gross Motor Function Classification System) level V	4180186
44811062	Gross Motor Function Classification System for Cerebral Palsy level V (finding)	4180186
44811063	Did not attend counselling appointment (finding)	4180186
44811065	Did not attend second intranasal seasonal influenza vaccination (finding)	4180186
44811070	Non-union of joint of foot with infection (disorder)	4180186
44811074	Psychoeducation (procedure)	4180186
44811077	Behavioural parent training (regime/therapy)	4180186
44811081	Placement of Martius flap (procedure)	4180186
44811089	Education about sedation (procedure)	4180186
44811090	Laparoscopic nephrolithotomy (procedure)	4180186
44811091	Intravesical electrochemotherapy (procedure)	4180186
44811096	Assessment using podiatry objective clinical score (procedure)	4180186
44811096	Assessment using POCS (podiatry objective clinical score)	4180186
44811099	Identifying care coordinator (procedure)	4180186
44811100	Education about gait training (procedure)	4180186
44811103	Inadequate enteral nutrition infusion (finding)	4180186
44811105	Excessive enteral nutrition infusion (finding)	4180186
44811106	Peripheral vascular disease monitoring second letter (procedure)	4180186
44811108	Peripheral vascular disease monitoring verbal invitation (procedure)	4180186
44811110	Nocturnal hypertension (disorder)	4180186
44811118	Excessive dietary intake of magnesium (finding)	4180186
44811119	Wagner ulcer classification grade 1 foot ulcer (disorder)	4180186
44811120	Wagner ulcer classification grade 2 foot ulcer (disorder)	4180186
44811121	Wagner ulcer classification grade 3 foot ulcer (disorder)	4180186
44811125	Stenosis of venous side of dialysis arteriovenous shunt (disorder)	4180186
44811126	Application of external fixator on bone of upper limb using fluoroscopic guidance (procedure)	4180186
44811130	Referral to rapid access care of the elderly clinic (procedure)	4180186
44811131	Referral to rapid access temporal arteritis clinic (procedure)	4180186
44811132	Essential fatty acids profile	4180186
44811132	Measurement of essential fatty acids profile (procedure)	4180186
44811134	On ear nose and throat care pathway (situation)	4180186
44811136	Ear nose and throat care pathway (regime/therapy)	4180186
44811138	Scottish patients at risk of readmission and admission algorithm (assessment scale)	4180186
44811139	Vacuum assisted core needle biopsy of breast using magnetic resonance imaging guidance (procedure)	4180186
44811141	Musculoskeletal care pathway (regime/therapy)	4180186
44811142	Dermatology care pathway (regime/therapy)	4180186
44811144	Nutrition care (regime/therapy)	4180186
44811145	Unfit for activity (finding)	4180186
44811148	Heptacosanoic acid level	4180186
44811148	Measurement of heptacosanoic acid (procedure)	4180186
44811152	Rheumatoid arthritis monitoring invitation second letter (procedure)	4180186
44811154	Rheumatoid arthritis monitoring verbal invitation (procedure)	4180186
44811156	Counselling appointment cancelled by patient (finding)	4180186
44811157	Lymphoedema associated with obesity (disorder)	4180186
44811159	Computed tomography of lower limb for arthroplasty planning (procedure)	4180186
44811162	Referral for spirometry reversibility testing (procedure)	4180186
44811165	Internal practice referral for acupuncture (procedure)	4180186
44811170	Fluoroscopy guided percutaneous transluminal embolisation of uterine artery	4180186
44811170	Percutaneous transluminal embolisation of uterine artery using fluoroscopic guidance (procedure)	4180186
44811171	Insertion of antroduodenal manometry catheter using fluoroscopic guidance (procedure)	4180186
44811174	Benign bone tumour of foot and ankle	4180186
44811174	Benign neoplasm of bone of foot and ankle (disorder)	4180186
44811177	Consent given for sharing end of life care coordination record (finding)	4180186
44811178	Opioid substitution therapy monitoring (regime/therapy)	4180186
44811179	Breast screening incomplete (finding)	4180186
44811180	Glenoid superior labrum anterior to posterior tear	4180186
44811180	Glenoid superior labrum anterior to posterior tear (disorder)	4180186
44811180	SLAP (superior labrum anterior to posterior) tear	4180186
44811182	Referral to contraception and sexual health service (procedure)	4180186
44811184	Referral to adult speech and language therapy service (procedure)	4180186
44811185	Referral to tissue viability service (procedure)	4180186
44811186	Inadequate oral nutrition intake for physiological needs	4180186
44811186	Inadequate oral nutrition intake for physiological needs (finding)	4180186
44811191	Fast track referral for suspected lower gastrointestinal cancer (procedure)	4180186
44811192	Predicted malnutrition (finding)	4180186
44811194	Herpes zoster vaccination offered (situation)	4180186
44811195	Referral to healthy lifestyle programme (procedure)	4180186
44811196	Asthma management plan declined (situation)	4180186
44811197	Chronic obstructive pulmonary disease management plan declined (situation)	4180186
44811197	COPD (chronic obstructive pulmonary disease) management plan declined	4180186
44811198	Seen in community lymphoedema clinic (finding)	4180186
44811200	Pulmonary arterial hypertension drugs Band 1 (procedure)	4180186
44811201	Pulmonary arterial hypertension drugs Band 2 (procedure)	4180186
44811207	History of arterial lower limb ulcer	4180186
44811207	History of arterial lower limb ulcer (situation)	4180186
44811207	H/O: arterial leg ulcer	4180186
44811208	Excessive dietary intake of phosphorus (finding)	4180186
44811209	Inadequate dietary intake of magnesium (finding)	4180186
44811210	Able to sustain an erection (finding)	4180186
44811211	Allergy to soya (disorder)	4180186
44811212	QDiabetes risk calculator (assessment scale)	4180186
44811215	Sudden unexpected death in childhood rapid response team call out (procedure)	4180186
44811218	Provision of pelvic floor exercise indicator (procedure)	4180186
44811221	Pedobarography (procedure)	4180186
44811225	Transfers using standing hoist (finding)	4180186
44811226	Improved venous return in limb vein (finding)	4180186
44811227	Clinical stage A chronic lymphocytic leukaemia (disorder)	4180186
44811228	Clinical stage B chronic lymphocytic leukaemia (disorder)	4180186
44811229	Intrathecal injection of skeletal muscle relaxant into lumbar subarachnoid space (procedure)	4180186
44811235	Cognitive linguistic quick test memory domain (assessment scale)	4180186
44811236	Injection of hydrocortisone acetate into elbow joint (procedure)	4180186
44811237	Measurement of octacosanoic acid (procedure)	4180186
44811237	Octacosanoic acid level	4180186
44811240	Pentacosanoic acid (substance)	4180186
44811240	Pentacosylic acid	4180186
44811243	Measurement of tricosanoic acid (procedure)	4180186
44811243	Tricosanoic acid level	4180186
44811244	Tricosylic acid	4180186
44811244	Tricosanoic acid (substance)	4180186
44811246	Referral for participation in clinical trial (procedure)	4180186
44811247	Lost to clinical trial follow-up (finding)	4180186
44811249	Research study observation activity (regime/therapy)	4180186
44811250	Clinical trial observation activity (regime/therapy)	4180186
44811255	Blood glucose level after breakfast (observable entity)	4180186
44811256	Blood glucose level before breakfast (observable entity)	4180186
44811258	Inadequate dietary intake of sodium (finding)	4180186
44811260	Liverpool care pathway for the dying (regime/therapy)	4180186
44811262	Excessive parenteral nutrition infusion (finding)	4180186
44811265	Best interest decision taken (Mental Capacity Act 2005) for sharing end of life care coordination record (finding)	4180186
44811267	Consent given by appointed person with lasting power of attorney for personal welfare (Mental Capacity Act 2005) for sharing end of life care coordination record (finding)	4180186
44811269	Temporary implantation of left ventricular assist device (procedure)	4180186
44811270	Carer has sole parental responsibility (finding)	4180186
44811271	Father has sole parental responsibility (finding)	4180186
44811273	Discussion about Liverpool care pathway for the dying with family (procedure)	4180186
44811274	Non-functioning kidney (finding)	4180186
44811276	Genogram (record artifact)	4180186
44811279	DoloTest score (observable entity)	4180186
44811286	Unsuccessful urethral catheter insertion (situation)	4180186
44811288	History of abnormal cervical smear (situation)	4180186
44811290	Leeds Revised Acne Grading System score (observable entity)	4180186
44811291	Catheter-associated urinary tract infection (disorder)	4180186
44811291	CAUTI - catheter-associated urinary tract infection	4180186
44811292	Suspected non-accidental injury to child (situation)	4180186
44811293	Did not attend depression review (finding)	4180186
44811296	Hepatobiliary and pancreatic surgery service (qualifier value)	4180186
44811299	Maintenance of tube drain into pleural cavity	4180186
44811299	Maintenance of tube drain into pleural cavity (procedure)	4180186
44811300	Insertion of weight into upper eyelid (procedure)	4180186
44811301	Gynaecological oncology service (qualifier value)	4180186
44811303	Dental medicine service (qualifier value)	4180186
44811304	Clinical microbiology service (qualifier value)	4180186
44811306	Clinical haematology service (qualifier value)	4180186
44811307	Cardiothoracic transplantation service (qualifier value)	4180186
44811308	Burns care service (qualifier value)	4180186
44811309	Blood and marrow transplantation service (qualifier value)	4180186
44811313	General medical service (qualifier value)	4180186
44811314	Renewal of weight into upper eyelid	4180186
44811314	Replacement of weight into upper eyelid (procedure)	4180186
44811315	Removal of weight from upper eyelid (procedure)	4180186
44811317	Recession of upper eyelid (procedure)	4180186
44811320	Clinical physiology service (qualifier value)	4180186
44811321	Clinical pharmacology service (qualifier value)	4180186
44811322	CMHT - community mental health team	4180186
44811322	Community mental health team (qualifier value)	4180186
44811323	Extended right hemicolectomy and end to side anastomosis (procedure)	4180186
44811324	Clinical immunology service (qualifier value)	4180186
44811325	TIA (transient ischaemic attack) service	4180186
44811325	Transient ischaemic attack service (qualifier value)	4180186
44811326	Clinical allergy service (qualifier value)	4180186
44811329	Infectious diseases service (qualifier value)	4180186
44811330	Right hemicolectomy and end to side anastomosis (procedure)	4180186
44811331	Crisis prevention assessment and treatment team (qualifier value)	4180186
44811332	Spinal surgery service (qualifier value)	4180186
44811333	Injection of steroid into elbow joint (procedure)	4180186
44811335	Open fracture of thumb (disorder)	4180186
44811339	Number of previous attempts to stop smoking (observable entity)	4180186
44811341	Under care of CAMHS (child and adolescent mental health service)	4180186
44811341	Under care of child and adolescent mental health service (finding)	4180186
44811342	Recommendation to have child immunised against meningitis C (procedure)	4180186
44811344	Seen in SARC (sexual assault referral centre)	4180186
44811344	Seen in sexual assault referral centre (finding)	4180186
44811346	NEAD - non-epileptic attack disorder	4180186
44811346	Non-epileptic attack disorder (disorder)	4180186
44811347	Thrombosis of internal jugular vein (disorder)	4180186
44811350	Did not attend National Health Service Health Check annual review (finding)	4180186
44811352	National Health Service Health Check annual review declined (situation)	4180186
44811353	Thrombosis of vein of transplanted kidney (disorder)	4180186
44811354	Metal-on-metal hip prosthesis in situ (finding)	4180186
44811355	Assessment using Johns Hopkins ACG (adjusted clinical groups) system	4180186
44811355	Assessment using Johns Hopkins adjusted clinical groups system (procedure)	4180186
44811356	Bupa Health Dialog risk stratification tool (assessment scale)	4180186
44811359	Toe brachial pressure index (procedure)	4180186
44811362	Reason for delayed wound healing (observable entity)	4180186
44811363	Measurement of ratio of tetrahydrocorticosterone to creatinine (procedure)	4180186
44811363	Tetrahydrocorticosterone/creatinine ratio	4180186
44811364	Measurement of ratio of tetrahydrocortisone to creatinine (procedure)	4180186
44811364	Tetrahydrocortisone/creatinine ratio	4180186
44811365	5-alpha/5-beta tetrahydrocortisol ratio	4180186
44811365	Measurement of ratio of 5-alpha to 5-beta tetrahydrocortisol (procedure)	4180186
44811366	Measurement of ratio of tetrahydrocortisol to creatinine (procedure)	4180186
44811366	Tetrahydrocortisol/creatinine ratio	4180186
44811367	Measurement of ratio of tetrahydro-11-deoxycortisol to creatinine (procedure)	4180186
44811367	Tetrahydro-11-deoxycortisol/creatinine ratio	4180186
44811368	Good parenting skills (finding)	4180186
44811369	Intramedullary nailing system in situ (finding)	4180186
44811371	Transurethral administration of therapeutic substance (procedure)	4180186
44811372	Electronic brain stimulator in situ (finding)	4180186
44811373	Satisfactory sexual experience (finding)	4180186
44811378	Seen by paediatric trainee doctor (finding)	4180186
44811380	Seen by trainee psychologist (finding)	4180186
44811381	FEV6 - forced expired volume in 6 seconds	4180186
44811381	Forced expired volume in 6 seconds (observable entity)	4180186
44811385	Copy of clinical record sent to Criminal Injuries Compensation Authority (finding)	4180186
44811387	Copy of clinical record sent to Department of Work and Pensions (finding)	4180186
44811389	Post-chemotherapy monitoring (regime/therapy)	4180186
44811389	Post-chemotherapy observation	4180186
44811390	Stimulant drug therapy for attention deficit hyperactivity disorder (procedure)	4180186
44811392	Number of hours long-term oxygen therapy prescribed per day (observable entity)	4180186
44811395	Sure Start antenatal visit (regime/therapy)	4180186
44811396	Supplier reported volume of long-term oxygen prescribed per day (observable entity)	4180186
44811398	Supplier reported volume of short-burst oxygen prescribed per day (observable entity)	4180186
44811399	Supplier reported volume of ambulatory oxygen prescribed per day (observable entity)	4180186
44811401	Cognitive behavioural therapy parenting programme (regime/therapy)	4180186
44811402	Schinzel syndrome	4180186
44811402	Ulnar mammary syndrome (disorder)	4180186
44811404	Assessment using Lymphoedema Quality of Life Tool - arm (procedure)	4180186
44811407	Pre-admission assessment for day surgery (procedure)	4180186
44811411	Specific speech impairment (finding)	4180186
44811412	GDH (glutamate dehydrogenase) antigen positive	4180186
44811412	Glutamate dehydrogenase antigen positive (finding)	4180186
44811413	Genitourinary medicine service (qualifier value)	4180186
44811416	Neurology service (qualifier value)	4180186
44811421	Spinal injuries service (qualifier value)	4180186
44811423	Podiatric surgery service (qualifier value)	4180186
44811426	Mental health dual diagnosis service (qualifier value)	4180186
44811427	Medical virology service (qualifier value)	4180186
44811428	Transverse colectomy and end to side anastomosis (procedure)	4180186
44811429	Local specialist rehabilitation service (qualifier value)	4180186
44811430	Haemophilia service (qualifier value)	4180186
44811432	Dementia assessment service (qualifier value)	4180186
44811434	Complex specialised rehabilitation service (qualifier value)	4180186
44811438	Tropical medicine service (qualifier value)	4180186
44811439	Trauma and orthopaedics service (qualifier value)	4180186
44811440	Transplantation surgery service (qualifier value)	4180186
44811441	Respite care service (qualifier value)	4180186
44811446	Failed encounter - hospital appointment (finding)	4180186
44811450	Paediatric diabetic medicine service (qualifier value)	4180186
44811451	Palliative medicine service (qualifier value)	4180186
44811452	Paediatric clinical immunology and allergy service (qualifier value)	4180186
44811453	FP24A maternity claim family practitioner committee dispute fee due (finding)	4180186
44811454	Urine amphetamine concentration	4180186
44811454	Measurement of concentration of amphetamine in urine specimen (procedure)	4180186
44811455	Measurement of concentration of benzodiazepine in urine specimen (procedure)	4180186
44811455	Urine benzodiazepine concentration	4180186
44811460	Percentage of predicted forced vital capacity after bronchodilation (observable entity)	4180186
44811461	Poisoning due to redback spider venom (disorder)	4180186
44811464	Measurement of concentration of methadone in urine specimen (procedure)	4180186
44811464	Urine methadone concentration	4180186
44811465	Measurement of ratio of adrenaline to creatinine in urine specimen (procedure)	4180186
44811465	Urine adrenaline:creatinine ratio	4180186
44811466	Measurement of ratio of dopamine to creatinine in urine specimen (procedure)	4180186
44811466	Urine dopamine:creatinine ratio	4180186
44811472	X-ray of hand and wrist for metacarpal index (procedure)	4180186
44811473	Under care of autism assessment service (finding)	4180186
44811475	Referred by autism assessment service (finding)	4180186
44811478	Remote care monitoring enhanced services administration (procedure)	4180186
44811479	Long term condition care planning invitation (procedure)	4180186
44811481	Long term condition care planning invitation first letter (procedure)	4180186
44811482	Measurement of fasting concentration of beta carboxy terminal telopeptide of type I collagen in serum specimen (procedure)	4180186
44811482	Serum fasting beta C terminal telopeptide concentration	4180186
44811490	Gold Standards Framework After Death Analysis Audit Tool (assessment scale)	4180186
44811491	NOAC (novel oral anticoagulant) contraindicated	4180186
44811491	Novel oral anticoagulant contraindicated (situation)	4180186
44811494	Health of the Nation Outcome Scale interpretation (finding)	4180186
44811495	Urine prostate cancer antigen 3 targeted genetic test (procedure)	4180186
44811497	Dietary education for irritable bowel syndrome (procedure)	4180186
44811498	SSLM (Sure Start Language Measure) score	4180186
44811498	Sure Start Language Measure score (observable entity)	4180186
44811500	Ethnic category - 2001 census (finding)	4180186
44811501	British or mixed British - ethnic category 2001 census (finding)	4180186
44811503	White and Black Caribbean - ethnic category 2001 census (finding)	4180186
44811504	White and Black African - ethnic category 2001 census (finding)	4180186
44811505	White and Asian - ethnic category 2001 census (finding)	4180186
44811506	Checking adequacy of dialysis (procedure)	4180186
44811507	Sundanese language interpreter needed (finding)	4180186
44811510	Measurement of concentration of paraquat in urine specimen (procedure)	4180186
44811510	Urine paraquat concentration	4180186
44811514	Measurement of ratio of mandelic acid to creatinine in urine specimen (procedure)	4180186
44811514	Urine mandelic acid:creatinine ratio	4180186
44811515	Excision of basal encephalocele (procedure)	4180186
44811517	Excision of occipital encephalocele (procedure)	4180186
44811522	Intensive weight management programme commenced (situation)	4180186
44811524	Intensive weight management programme declined (situation)	4180186
44811531	SSLM-R (Sure Start Language Measure, revised) score	4180186
44811531	Sure Start Language Measure, revised score (observable entity)	4180186
44811534	Health of the Nation Outcome Scale score 0: no problem (finding)	4180186
44811535	Second measles mumps rubella immunisation first telephone invitation (procedure)	4180186
44811537	Second measles mumps rubella immunisation third telephone invitation (procedure)	4180186
44811540	Computed tomography of transplanted small intestine (procedure)	4180186
44811542	Health of the Nation Outcome Scale score 1: minor problem requiring no action (finding)	4180186
44811544	Open colposuspension (procedure)	4180186
44811545	Laparoscopic colposuspension (procedure)	4180186
44811550	Laparoscopic sacrohysteropexy (procedure)	4180186
44811551	Relatives willing to allow organ donation (finding)	4180186
44811558	Fluoroscopic venogram of transplanted small intestine with contrast	4180186
44811558	Fluoroscopic venography of transplanted small intestine with contrast (procedure)	4180186
44811559	Endoscopy of vagina using fluoroscopic guidance (procedure)	4180186
44811564	Education about chair based exercise programme (procedure)	4180186
44811569	Other Mixed background - ethnic category 2001 census (finding)	4180186
44811570	Pakistani or British Pakistani - ethnic category 2001 census (finding)	4180186
44811572	Other Asian background - ethnic category 2001 census (finding)	4180186
44811573	African - ethnic category 2001 census (finding)	4180186
44811576	Other - ethnic category 2001 census (finding)	4180186
44811577	Renal transplant recipient (finding)	4180186
44811579	Removed from kidney transplant waiting list (finding)	4180186
44811583	Patient actions in care plan not agreed	4180186
44811583	Service user actions in care plan not agreed	4180186
44811583	Subject actions in care plan not agreed (finding)	4180186
44811584	Measurement of ratio of pregnanetriol to creatinine in urine specimen (procedure)	4180186
44811584	Urine pregnanetriol:creatinine ratio	4180186
44811585	Measurement of ratio of proline to creatinine in urine specimen (procedure)	4180186
44811585	Urine proline:creatinine ratio	4180186
44811586	Measurement of ratio of retinol binding protein to creatinine in urine specimen (procedure)	4180186
44811586	Urine retinol binding protein:creatinine ratio	4180186
44811587	Measurement of ratio of serine to creatinine in urine specimen (procedure)	4180186
44811587	Urine serine:creatinine ratio	4180186
44811589	Measurement of ratio of tetrahydrocortisone to creatinine in urine specimen (procedure)	4180186
44811589	Urine tetrahydrocortisone:creatinine ratio	4180186
44811592	Measurement of ratio of urea to creatinine in urine specimen (procedure)	4180186
44811592	Urine urea:creatinine ratio	4180186
44811593	Agreeing on needs (procedure)	4180186
44811595	Need agreed (finding)	4180186
44811597	Healthcare professional actions in care plan not agreed (finding)	4180186
44811598	Healthcare professional actions in care plan agreed (finding)	4180186
44811599	Measurement of ratio of magnesium to creatinine in urine specimen (procedure)	4180186
44811599	Urine magnesium:creatinine ratio	4180186
44811600	Imbalanced dietary intake of carbohydrate (finding)	4180186
44811601	Inconsistent dietary intake of carbohydrate (finding)	4180186
44811603	Predicted inadequate dietary vitamin intake (finding)	4180186
44811604	Predicted inadequate dietary intake of vitamin D (finding)	4180186
44811606	Assessment using Childhood Asthma Control Test (procedure)	4180186
44811607	Childhood Asthma Control Test score (observable entity)	4180186
44811608	Acute pyrophosphate crystal arthropathy (disorder)	4180186
44811609	Calcific bursitis (disorder)	4180186
44811610	Chikungunya arthritis (disorder)	4180186
44811615	Measurement of anti-cyclic citrullinated peptide antibody in serum specimen (procedure)	4180186
44811615	Serum anti-cyclic citrullinated peptide antibody level	4180186
44811616	Measurement of anti-mutated citrullinated vimentin antibody in serum specimen (procedure)	4180186
44811616	Serum anti-mutated citrullinated vimentin antibody level	4180186
44811618	Form S2 - United Kingdom Border Agency (record artifact)	4180186
44811620	Health of the Nation Outcome Scale score 9: not known/no information available (finding)	4180186
44811621	Referral for multidisciplinary case management (procedure)	4180186
44811622	Admission avoidance care plan (record artifact)	4180186
44811623	Personal Independence Payment applied for (finding)	4180186
44811625	Admission avoidance care plan agreed (finding)	4180186
44811626	Admission avoidance care plan declined (situation)	4180186
44811627	Review of admission avoidance care plan (procedure)	4180186
44811631	Health of the Nation Outcome Scale for Children and Adolescents section A score (observable entity)	4180186
44811632	Health of the Nation Outcome Scale for Children and Adolescents section B score (observable entity)	4180186
44811633	Education about influenza vaccination (procedure)	4180186
44811636	Transfers using rotunda transfer platform (finding)	4180186
44811637	Uses orthotic shoes (finding)	4180186
44811639	Child in private foster care (finding)	4180186
44811643	Verification of post biopsy blood loss within expected range (procedure)	4180186
44811645	Scottish - ethnic category 2001 census (finding)	4180186
44811646	Welsh - ethnic category 2001 census (finding)	4180186
44811647	Northern Irish - ethnic category 2001 census (finding)	4180186
44811648	Cornish - ethnic category 2001 census (finding)	4180186
44811649	Black and Asian - ethnic category 2001 census (finding)	4180186
44811651	HSA1 therapeutic abortion green form (record artifact)	4180186
44811653	Greek - ethnic category 2001 census (finding)	4180186
44811657	Reactive arthritis after chlamydia trachomatis infection (disorder)	4180186
44811658	Reactive arthritis after clostridium difficile infection (disorder)	4180186
44811659	Reactive arthritis after escherichia coli infection (disorder)	4180186
44811661	Reactive arthritis after shigella infection (disorder)	4180186
44811662	Reactive arthritis after ureaplasma urealyticum infection (disorder)	4180186
44811664	Nonspecific polyarthritis (disorder)	4180186
44811668	At low risk of domestic violence (finding)	4180186
44811669	Assessment of risk of prisoner in-possession medication (procedure)	4180186
44811671	Excision of transcranial dermoid cyst (procedure)	4180186
44811672	Repair of post-traumatic meningoencephalocele (procedure)	4180186
44811674	Partial compliance with oral nutritional supplement regimen (finding)	4180186
44811676	Compliant with HMS (home made supplement) regimen	4180186
44811676	Compliant with home made oral nutritional supplement regimen (finding)	4180186
44811677	Partial compliance with HMS (home made supplement) regimen	4180186
44811677	Partial compliance with home made oral nutritional supplement regimen (finding)	4180186
44811678	Noncompliance with HMS (home made supplement) regimen	4180186
44811678	Noncompliance with home made oral nutritional supplement regimen (finding)	4180186
44811685	Removal of internal distraction device from skull (procedure)	4180186
44811688	Measurement of concentration of tetrahydrocorticosterone in urine specimen (procedure)	4180186
44811688	Urine tetrahydrocorticosterone concentration	4180186
44811690	Consent given to share CAF (Common Assessment Framework) for children and young people record	4180186
44811690	Consent given to share Common Assessment Framework for children and young people record (finding)	4180186
44811694	Measurement of concentration of cortisol binding globulin in serum specimen (procedure)	4180186
44811694	Serum cortisol binding globulin concentration	4180186
44811695	Impaired ability to recognise safety risks (finding)	4180186
44811697	Measurement of concentration of cortisol in plasma specimen at midday (procedure)	4180186
44811697	Plasma midday cortisol concentration	4180186
44811700	Wellness education (procedure)	4180186
44811701	Assessment using BASFI (Bath Ankylosing Spondylitis Functional Index)	4180186
44811701	Assessment using Bath Ankylosing Spondylitis Functional Index (procedure)	4180186
44811707	Imbalance of nutrients	4180186
44811707	Imbalance of nutrient intake (finding)	4180186
44811710	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification A.1.3 - disorder of organisation	4180186
44811710	Surveillance of Cerebral Palsy in Europe classification - predominant pattern A.1.3 - disorder of organisation (finding)	4180186
44811711	Obese class I (body mass index 30.0 - 34.9) (finding)	4180186
44811712	Obese class II (body mass index 35.0 - 39.9) (finding)	4180186
44811713	Asian and Chinese - ethnic category 2001 census (finding)	4180186
44811716	Punjabi - ethnic category 2001 census (finding)	4180186
44811718	East African Asian - ethnic category 2001 census (finding)	4180186
44811721	Transfer of care to a high security health care provider (procedure)	4180186
44811723	Bosnian - ethnic category 2001 census (finding)	4180186
44811726	Other republics which made up the former Yugoslavia - ethnic category 2001 census (finding)	4180186
44811728	Other mixed White - ethnic category 2001 census (finding)	4180186
44811729	Magnetic resonance imaging of prostate with contrast (procedure)	4180186
44811730	Computed tomography angiography of mesenteric artery (procedure)	4180186
44811730	CT angiogram of mesenteric artery	4180186
44811731	Ultrasonography of thymus (procedure)	4180186
44811731	Ultrasound of thymus	4180186
44811731	Ultrasound scan of thymus	4180186
44811732	Insertion of cardiac single chamber permanent pacemaker using fluoroscopic guidance (procedure)	4180186
44811733	Percutaneous radiofrequency ablation of long saphenous vein using ultrasonography guidance (procedure)	4180186
44811733	Ultrasound guided percutaneous radiofrequency ablation of long saphenous vein	4180186
44811734	Percutaneous radiofrequency ablation of short saphenous vein using ultrasonography guidance (procedure)	4180186
44811734	Ultrasound guided percutaneous radiofrequency ablation of short saphenous vein	4180186
44811736	Increased energy expenditure (finding)	4180186
44811737	Increased energy requirement (finding)	4180186
44811739	Pre-conception advice declined (situation)	4180186
44811740	Acute vascular insufficiency of small intestine (disorder)	4180186
44811742	Destruction of fetus (procedure)	4180186
44811744	Requires transport for appointments (finding)	4180186
44811746	Astrovirus nucleic acid detection assay (procedure)	4180186
44811749	Excessive growth rate (finding)	4180186
44811751	Herpes simplex virus type 2 nucleic acid detection assay (procedure)	4180186
44811753	Avian influenza virus nucleic acid detection assay (procedure)	4180186
44811754	Coxiella burnetii (Q fever) nucleic acid detection assay (procedure)	4180186
44811755	Human papilloma virus nucleic acid detection assay (procedure)	4180186
44811759	Bolus tube feeding (regime/therapy)	4180186
44811761	Change of tube feed ancillaries (procedure)	4180186
44811762	Anti-obesity drug therapy commenced (situation)	4180186
44811763	Anti-obesity drug therapy discontinued (situation)	4180186
44811764	Anticipatory care plan (record artifact)	4180186
44811768	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification B.2 - sequelae of intraventricular haemorrhage or periventricular infarction	4180186
44811768	Surveillance of Cerebral Palsy in Europe classification - predominant pattern B.2 - sequelae of intraventricular haemorrhage or periventricular infarction (finding)	4180186
44811773	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification C.3 - infarct of the middle cerebral artery	4180186
44811773	Surveillance of Cerebral Palsy in Europe classification - predominant pattern C.3 - infarct of the middle cerebral artery (finding)	4180186
44811775	Assessment using Schedule of Growing Skills II (procedure)	4180186
44811775	Assessment using SOGS II (Schedule of Growing Skills II)	4180186
44811777	Nutritional requirements partially supplied through enteral tube feed (finding)	4180186
44811779	Transbrachial abdominal angiogram	4180186
44811779	Transbrachial abdominal angiography (procedure)	4180186
44811782	Right posterior tibial pulse impalpable (finding)	4180186
44811783	Left posterior tibial pulse impalpable (finding)	4180186
44811784	Caribbean Asian - ethnic category 2001 census (finding)	4180186
44811785	Other Asian or Asian unspecified - ethnic category 2001 census (finding)	4180186
44811787	Mixed Black - ethnic category 2001 census (finding)	4180186
44811788	Nigerian - ethnic category 2001 census (finding)	4180186
44811789	Other Black or Black unspecified - ethnic category 2001 census (finding)	4180186
44811790	Vietnamese - ethnic category 2001 census (finding)	4180186
44811791	Other White European or European unspecified or Mixed European - ethnic category 2001 census (finding)	4180186
44811793	North African - ethnic category 2001 census (finding)	4180186
44811794	Middle Eastern (excluding Israeli, Iranian and Arab) - ethnic category 2001 census (finding)	4180186
44811797	Timed collection: specimen collection, 15 minutes post-dose (finding)	4180186
44811798	Timed collection: specimen collection, 30 minutes post-dose (finding)	4180186
44811802	Rubella virus nucleic acid detection assay (procedure)	4180186
44811803	West Nile fever virus nucleic acid detection assay (procedure)	4180186
44811804	Tropheryma whipplei nucleic acid detection assay (procedure)	4180186
44811806	Epstein-Barr virus nucleic acid detection assay (procedure)	4180186
44811807	Strengths and Difficulties Questionnaire - emotional symptoms score (observable entity)	4180186
44811808	Strengths and Difficulties Questionnaire - conduct problems score (observable entity)	4180186
44811809	Strengths and Difficulties Questionnaire - hyperactivity score (observable entity)	4180186
44811810	Strengths and Difficulties Questionnaire - peer problems score (observable entity)	4180186
44811813	Anti-oestrogen therapy (procedure)	4180186
44811818	Human herpes virus 6 nucleic acid detection assay (procedure)	4180186
44811819	Human herpes virus 7 nucleic acid detection assay (procedure)	4180186
44811820	Consent given for blood test (finding)	4180186
44811821	Seen by Parkinson's disease service (finding)	4180186
44811823	Genetics laboratory service (qualifier value)	4180186
44811824	Right dorsalis pedis pulse palpable (finding)	4180186
44811826	Left dorsalis pedis pulse palpable (finding)	4180186
44811827	Left dorsalis pedis pulse impalpable (finding)	4180186
44811829	Wire guided localisation of lesion using fluoroscopic guidance (procedure)	4180186
44811831	Redacted patient record (finding)	4180186
44811836	Measurement of concentration of methanol in plasma specimen (procedure)	4180186
44811836	Plasma methanol concentration	4180186
44811839	Wright and Ayre Stuttering Self-rating Profile score (observable entity)	4180186
44811840	On optimal heart failure therapy (finding)	4180186
44811841	Breast screening not done (situation)	4180186
44811842	No longer on clinical management plan (finding)	4180186
44811843	On NOLA (No One Left Alone) programme	4180186
44811843	On No One Left Alone programme (situation)	4180186
44811844	No One Left Alone programme (regime/therapy)	4180186
44811846	Filipino - ethnic category 2001 census (finding)	4180186
44811848	Cypriot (part not stated) - ethnic category 2001 census (finding)	4180186
44811850	Latin American - ethnic category 2001 census (finding)	4180186
44811852	Buddhist - ethnic category 2001 census (finding)	4180186
44811854	Nepali language interpreter needed (finding)	4180186
44811855	Human metapneumovirus nucleic acid detection assay (procedure)	4180186
44811856	National Health Service 111 service (qualifier value)	4180186
44811857	Influenza A nucleic acid detection assay (procedure)	4180186
44811858	Influenza B nucleic acid detection assay (procedure)	4180186
44811860	Declined to receive test result by telephone (finding)	4180186
44811862	Midwife episode - specialty (qualifier value)	4180186
44811862	Midwifery speciality	4180186
44811863	Finding of touch sensation of dermatome (finding)	4180186
44811863	Observation of touch sensation of dermatome	4180186
44811866	Declined to receive test result via message on telephone answering machine (finding)	4180186
44811868	Neisseria gonorrhoeae nucleic acid detection assay (procedure)	4180186
44811870	Fluid intake from tube feed (observable entity)	4180186
44811872	Parainfluenza type 1 nucleic acid detection assay (procedure)	4180186
44811875	Measurement of cobalt in plasma specimen (procedure)	4180186
44811875	Plasma cobalt level	4180186
44811876	Measurement of cobalt in urine specimen (procedure)	4180186
44811878	Referral for pre-bariatric surgery assessment (procedure)	4180186
44811879	Palpitations care pathway (regime/therapy)	4180186
44811881	Protein intake from tube feed (observable entity)	4180186
44811882	Pin prick sensation of left dermatome of first thoracic nerve reduced (finding)	4180186
44811883	Pin prick sensation of left dermatome of first thoracic nerve absent (finding)	4180186
44811894	Management of intermittent urethral catheterisation (procedure)	4180186
44811895	All nutritional requirements supplied through enteral tube feed (finding)	4180186
44811897	Peritonitis due to perforation of gastrointestinal tract (disorder)	4180186
44811899	All fluid requirements supplied through enteral tube feed (finding)	4180186
44811900	Measurement of uridine 1 small nuclear ribonucleoprotein antibody in serum specimen (procedure)	4180186
44811900	Serum uridine 1 small nuclear ribonucleoprotein antibody level	4180186
44811902	ECBI - Eyberg Child Behaviour Inventory	4180186
44811902	Eyberg Child Behaviour Inventory (assessment scale)	4180186
44811903	Concerned about appearance of toenails (finding)	4180186
44811904	Assessment using ECBI (Eyberg Child Behaviour Inventory)	4180186
44811904	Assessment using Eyberg Child Behaviour Inventory (procedure)	4180186
44811905	ECBI (Eyberg Child Behaviour Inventory) score	4180186
44811905	Eyberg Child Behaviour Inventory score (observable entity)	4180186
44811906	Rivermead Mobility Index (assessment scale)	4180186
44811906	RMI - Rivermead Mobility Index	4180186
44811908	Assessment using Rivermead Mobility Index (procedure)	4180186
44811908	Assessment using RMI (Rivermead Mobility Index)	4180186
44811914	Poliovirus type 3 nucleic acid detection assay (procedure)	4180186
44811915	Poxvirus nucleic acid detection assay (procedure)	4180186
44811918	Falls risk assessment complete (situation)	4180186
44811920	Rotavirus nucleic acid detection assay (procedure)	4180186
44811923	Severe acute respiratory syndrome virus nucleic acid detection assay (procedure)	4180186
44811925	Anxiety screening (procedure)	4180186
44811926	Nursing episode - specialty (qualifier value)	4180186
44811929	Roche Ro 2-6083 inhibition number in serum specimen (procedure)	4180186
44811929	Serum Roche number	4180186
44811935	Insertion of vacuum assisted peritoneal drainage catheter using fluoroscopic guidance (procedure)	4180186
44811936	Touch sensation of right dermatome of first thoracic nerve exaggerated (finding)	4180186
44811937	Touch sensation of left dermatome of first thoracic nerve exaggerated (finding)	4180186
44811938	Touch sensation of right dermatome of first thoracic nerve normal (finding)	4180186
44811939	Touch sensation of left dermatome of first thoracic nerve normal (finding)	4180186
44811941	Assessment using University of Washington Quality of Life questionnaire version 4 (procedure)	4180186
44811941	Assessment using UW-QOL (University of Washington Quality of Life) questionnaire version 4	4180186
44811944	Touch sensation of left dermatome of first thoracic nerve reduced (finding)	4180186
44811945	Wright and Ayre Stuttering Self-rating Profile (assessment scale)	4180186
44811946	Cardiovascular system examination abnormal (finding)	4180186
44811952	Assertive outreach team (qualifier value)	4180186
44811953	FP24A maternity claim paid by family practitioner committee checked (finding)	4180186
44811954	Breast cancer detected by national screening programme (disorder)	4180186
44811961	Assessment using Parents Evaluation of Developmental Status: Developmental Milestones (procedure)	4180186
44811961	Assessment using PEDS:DM (Parents Evaluation of Developmental Status: Developmental Milestones)	4180186
44811964	Child safeguarding report (record artifact)	4180186
44811965	Parents Evaluation of Developmental Status: Developmental Milestones score (observable entity)	4180186
44811965	PEDS:DM (Parents Evaluation of Developmental Status: Developmental Milestones) score	4180186
44811966	Measurement of ratio of dehydroepiandrostenedione to creatinine in urine specimen (procedure)	4180186
44811966	Urine dehydroepiandrostenedione:creatinine ratio	4180186
44811968	Measurement of ratio of cortisol metabolite to creatinine in urine specimen (procedure)	4180186
44811968	Urine cortisol metabolite:creatinine ratio	4180186
44811969	Measurement of cancer antigen 125 in serum specimen (procedure)	4180186
44811969	Serum CA 125 (cancer antigen 125) level	4180186
44811971	Measurement of tetrahydro-11-deoxycortisol in urine specimen (procedure)	4180186
44811971	Urine tetrahydro-11-deoxycortisol level	4180186
44811972	Measurement of ratio of 11 betahydroxy aetiocholanolone to creatinine in urine specimen (procedure)	4180186
44811972	Urine 11 betahydroxy aetiocholanolone:creatinine ratio	4180186
44811977	Removed from kidney transplant waiting list at patient request (finding)	4180186
44811978	Measurement of cancer antigen 15-3 in serum specimen (procedure)	4180186
44811978	Serum CA 15-3 (cancer antigen 15-3) level	4180186
44811981	Measurement of free prostate specific antigen in serum specimen (procedure)	4180186
44811981	Serum free prostate specific antigen level	4180186
44811982	Measurement of ratio of free to total prostate specific antigen in serum specimen (procedure)	4180186
44811982	Serum free:total prostate specific antigen ratio	4180186
44811983	Native American religion, follower of religion (person)	4180186
44811985	Community care assessment (regime/therapy)	4180186
44811986	Registered Primary Care Trust (finding)	4180186
44811988	Epilepsy restricts employment (finding)	4180186
44811989	Epilepsy prevents employment (finding)	4180186
44811990	GMS2 maternity claim status (finding)	4180186
44811999	Measurement of acetylcholinesterase in serum specimen (procedure)	4180186
44811999	Serum acetylcholinesterase level	4180186
44812002	Neuromuscular disorder (disorder)	4180186
44812005	Imaging of brain normal (finding)	4180186
44812007	Dietary education for inflammatory bowel disease (procedure)	4180186
44812012	Touch sensation of right dermatome of first sacral nerve reduced (finding)	4180186
44812014	Touch sensation of right dermatome of first sacral nerve exaggerated (finding)	4180186
44812016	Measurement of retinol binding protein in plasma specimen (procedure)	4180186
44812016	Plasma retinol binding protein level	4180186
44812017	Touch sensation of left dermatome of first sacral nerve exaggerated (finding)	4180186
44812018	Measurement of red blood cell 6-mercaptopurine (procedure)	4180186
44812018	Red blood cell 6-mercaptopurine level	4180186
44812020	Measurement of red blood cell 6-thioguanine nucleotides (procedure)	4180186
44812020	Red blood cell 6-thioguanine nucleotides level	4180186
44812022	Measurement of acylcarnitine in serum specimen (procedure)	4180186
44812022	Serum acylcarnitine level	4180186
44812023	Admission to medium secure unit (procedure)	4180186
44812024	Anti-dementia drug therapy (procedure)	4180186
44812025	Agreement of care programme approach care plan (procedure)	4180186
44812025	Agreement of CPA (care programme approach) care plan	4180186
44812028	Copy of care programme approach care plan with general practitioner (finding)	4180186
44812029	FP24A maternity claim underpaid by family practitioner committee (finding)	4180186
44812031	Timed collection: specimen collection, post-treatment (finding)	4180186
44812032	GMS2 claim signed by patient (finding)	4180186
44812034	Personal Independence Payment claim form (record artifact)	4180186
44812040	Assessment using GAS (Goal Attainment Scaling)	4180186
44812040	Assessment using Goal Attainment Scaling (procedure)	4180186
44812042	GAS - Goal Attainment Scaling	4180186
44812042	Goal Attainment Scaling (assessment scale)	4180186
44812045	Home visit request by district nurse (procedure)	4180186
44812046	National Obesity Observatory Standard Evaluation Framework for weight management interventions - participant satisfaction with intervention (assessment scale)	4180186
44812048	National Obesity Observatory Standard Evaluation Framework for weight management interventions - participant satisfaction with intervention (observable entity)	4180186
44812050	Care home enhanced services administration (procedure)	4180186
44812053	Assessment using SAS (Symptom Assessment Scale)	4180186
44812053	Assessment using Symptom Assessment Scale (procedure)	4180186
44812056	Notification to primary care out of hours service of end of life care plan in place (procedure)	4180186
44812057	Percutaneous embolisation of transfemoral intrahepatic portosystemic shunt using fluoroscopic guidance (procedure)	4180186
44812058	Percutaneous embolisation of intrahepatic portosystemic shunt by direct puncture using fluoroscopic guidance (procedure)	4180186
44812062	Copy of care programme approach care plan with relative (finding)	4180186
44812063	Mental health record sharing status (finding)	4180186
44812064	Mental health crisis resolution team (qualifier value)	4180186
44812067	FP24A maternity claim overpaid by family practitioner committee (finding)	4180186
44812068	Medication review of medical notes (procedure)	4180186
44812071	Eats unsafe food (finding)	4180186
44812073	Measurement of concentration of lorazepam in serum specimen (procedure)	4180186
44812073	Serum lorazepam concentration	4180186
44812074	Postoperative popliteal-great saphenous arteriovenous fistula (morphologic abnormality)	4180186
44812075	Psychologically prepared for childbirth (finding)	4180186
44812080	Diffusion weighted magnetic resonance imaging of liver (procedure)	4180186
44812081	Measurement of thiosulphate in serum specimen (procedure)	4180186
44812081	Serum thiosulphate level	4180186
44812083	Measurement of sulpiride in serum specimen (procedure)	4180186
44812083	Serum sulpiride level	4180186
44812084	Measurement of clozapine in serum specimen (procedure)	4180186
44812084	Serum clozapine level	4180186
44812085	Touch sensation of left dermatome of second cervical nerve normal (finding)	4180186
44812086	Touch sensation of right dermatome of second cervical nerve normal (finding)	4180186
44812089	History of non-vertebral fracture (situation)	4180186
44812089	H/O: non-vertebral fracture	4180186
44812090	Touch sensation of right dermatome of second cervical nerve reduced (finding)	4180186
44812091	Touch sensation of left dermatome of second cervical nerve reduced (finding)	4180186
44812095	Measurement of pregabalin in serum specimen (procedure)	4180186
44812095	Serum pregabalin level	4180186
44812096	Measurement of oxcarbazepine metabolite in serum specimen (procedure)	4180186
44812096	Serum oxcarbazepine metabolite level	4180186
44812098	Measurement of N-desmethyldiazepam in serum specimen (procedure)	4180186
44812098	Serum N-desmethyldiazepam level	4180186
44812100	Measurement of quetiapine in serum specimen (procedure)	4180186
44812100	Serum quetiapine level	4180186
44812101	Whole blood everolimus concentration	4180186
44812101	Measurement of concentration of everolimus in whole blood specimen (procedure)	4180186
44812102	Assessment using DDS17 (Diabetes Distress Scale 17)	4180186
44812102	Assessment using Diabetes Distress Scale 17 item (procedure)	4180186
44812104	Measurement of ganciclovir in serum specimen (procedure)	4180186
44812104	Serum ganciclovir level	4180186
44812105	No hot water in home (finding)	4180186
44812110	Discharged from parole (finding)	4180186
44812111	Disengagement of self from services (finding)	4180186
44812112	Early intervention in psychosis team (qualifier value)	4180186
44812116	Admission to psychiatric intensive care unit (procedure)	4180186
44812119	Did not attend epilepsy clinic (finding)	4180186
44812119	DNA (did not attend) epilepsy clinic	4180186
44812120	FP24A maternity claim family practitioner committee contacted regarding mistake (finding)	4180186
44812123	Measurement of concentration of methanol in serum specimen (procedure)	4180186
44812123	Serum methanol concentration	4180186
44812124	Measurement of concentration of midazolam in serum specimen (procedure)	4180186
44812124	Serum midazolam concentration	4180186
44812125	Assessment of risk of opioid medication storage at home (procedure)	4180186
44812127	Child not brought to appointment (finding)	4180186
44812131	Prescribed calorie intake (observable entity)	4180186
44812138	Measurement of concentration of imipramine in serum specimen (procedure)	4180186
44812138	Serum imipramine concentration	4180186
44812139	Measurement of concentration of itraconazole in serum specimen (procedure)	4180186
44812139	Serum itraconazole concentration	4180186
44812144	Measurement of concentration of nelfinavir in serum specimen (procedure)	4180186
44812144	Serum nelfinavir concentration	4180186
44812145	Screening test for benzodiazepine in urine specimen (procedure)	4180186
44812148	Touch sensation of right dermatome of second cervical nerve absent (finding)	4180186
44812149	Touch sensation of left dermatome of second cervical nerve absent (finding)	4180186
44812150	Touch sensation of right dermatome of second lumbar nerve normal (finding)	4180186
44812151	Touch sensation of left dermatome of second lumbar nerve normal (finding)	4180186
44812154	Insertion of permanent pacemaker ventricular lead using fluoroscopic guidance (procedure)	4180186
44812155	Clostridium difficile GDH (glutamate dehydrogenase) immunoassay	4180186
44812155	Clostridium difficile glutamate dehydrogenase immunoassay (procedure)	4180186
44812158	Remote care environment monitoring service	4180186
44812158	Remote care environment monitoring service (qualifier value)	4180186
44812163	Measurement of concentration of cortisol in serum specimen at 09.00 hours (procedure)	4180186
44812163	Serum 9am cortisol concentration	4180186
44812164	Measurement of concentration of thyroid peroxidase antibody in serum specimen (procedure)	4180186
44812164	Serum thyroid peroxidase antibody concentration	4180186
44812166	Consent given to receive test results by short message service text messaging (finding)	4180186
44812167	Telehealthcare service (qualifier value)	4180186
44812169	Declined consent to receive test results by short message service text messaging (finding)	4180186
44812173	Fluoroscopic angioplasty of transplanted liver (procedure)	4180186
44812178	Measurement of renin activity in plasma specimen, recumbent (procedure)	4180186
44812178	Plasma renin activity recumbent	4180186
44812179	Fluoroscopic angiography of transplanted hepatic artery using contrast with insertion of stent (procedure)	4180186
44812180	Fluoroscopic venography of transplanted portal vein using contrast with insertion of stent (procedure)	4180186
44812181	Permanent transfer from other mental health care provider (procedure)	4180186
44812184	Referral by approved social worker (procedure)	4180186
44812184	Referral by ASW (approved social worker)	4180186
44812186	Referral by police (procedure)	4180186
44812188	Multi-professional risk assessment default (finding)	4180186
44812189	FP24A maternity claim family practitioner committee make up payment (finding)	4180186
44812190	Creation of subcutaneous storage pocket and placement of autologous tissue (procedure)	4180186
44812191	Measurement of concentration of nevirapine in serum specimen (procedure)	4180186
44812191	Serum nevirapine concentration	4180186
44812192	Removal of autologous tissue from subcutaneous storage pocket (procedure)	4180186
44812193	Measurement of concentration of olanzapine in serum specimen (procedure)	4180186
44812193	Serum olanzapine concentration	4180186
44812194	Measurement of concentration of oxcarbazepine (procedure)	4180186
44812194	Serum oxcarbazepine concentration	4180186
44812195	Decompressive craniectomy (procedure)	4180186
44812196	Resource Utilisation Groups - Activities of Daily Living scale (assessment scale)	4180186
44812196	RUG-ADL (Resource Utilisation Groups - Activities of Daily Living) scale	4180186
44812200	Posterior calvarial release (procedure)	4180186
44812201	Resource Utilisation Groups - Activities of Daily Living Bed mobility score (observable entity)	4180186
44812201	RUG-ADL (Resource Utilisation Groups - Activities of Daily Living) Bed mobility score	4180186
44812202	Remodelling of calvarium (procedure)	4180186
44812204	Advancement and remodelling of cranium and orbits (procedure)	4180186
44812205	Resource Utilisation Groups - Activities of Daily Living Toileting score (observable entity)	4180186
44812205	RUG-ADL (Resource Utilisation Groups - Activities of Daily Living) Toileting score	4180186
44812207	Resource Utilisation Groups - Activities of Daily Living Eating score (observable entity)	4180186
44812207	RUG-ADL (Resource Utilisation Groups - Activities of Daily Living) Eating score	4180186
44812209	Measurement of concentration of procainamide in serum specimen (procedure)	4180186
44812209	Serum procainamide concentration	4180186
44812210	Palliative Care Problem Severity Score (assessment scale)	4180186
44812210	PCPSS - Palliative Care Problem Severity Score	4180186
44812213	Measurement of concentration of quinidine in serum specimen (procedure)	4180186
44812213	Serum quinidine concentration	4180186
44812215	Palliative Care Problem Severity Score - psychological/spiritual (observable entity)	4180186
44812215	PCPSS (Palliative Care Problem Severity Score) - psychological/spiritual	4180186
44812216	Palliative Care Problem Severity Score - family/carer (observable entity)	4180186
44812216	PCPSS (Palliative Care Problem Severity Score) - family/carer	4180186
44812218	Bipartition of facial bones and maxilla (procedure)	4180186
44812219	Measurement of concentration of risperidone in serum specimen (procedure)	4180186
44812219	Serum risperidone concentration	4180186
44812220	Fluoroscopy guided percutaneous thrombolysis of hepatic artery	4180186
44812220	Percutaneous thrombolysis of hepatic artery using fluoroscopic guidance (procedure)	4180186
44812221	Percutaneous thrombolysis of transplanted hepatic artery using fluoroscopic guidance (procedure)	4180186
44812224	Percutaneous transluminal angioplasty of transplanted portal vein using fluoroscopic guidance (procedure)	4180186
44812225	Biopsy of transplanted liver using ultrasonography guidance (procedure)	4180186
44812225	Ultrasound guided biopsy of transplanted liver	4180186
44812228	Advice to take oral nutritional supplements	4180186
44812228	Recommendation to take oral nutritional supplements (procedure)	4180186
44812229	Advice to take home made oral nutritional supplements	4180186
44812229	Recommendation to take home made oral nutritional supplements (procedure)	4180186
44812230	Computed tomography of transplanted liver (procedure)	4180186
44812231	Computed tomography of transplanted liver with contrast (procedure)	4180186
44812232	Biopsy of transplanted liver using computed tomography guidance (procedure)	4180186
44812234	Health of the Nation Outcome Scale for children and adolescents (assessment scale)	4180186
44812234	HoNOSCA - Health of the Nation Outcome Scale for children and adolescents	4180186
44812236	Diffusion weighted magnetic resonance imaging of internal auditory meatus (procedure)	4180186
44812239	Brachytherapy of prostate using ultrasonography guidance (procedure)	4180186
44812240	Brachytherapy of cervix using ultrasonography guidance (procedure)	4180186
44812243	Health of the Nation Outcome Scale for learning disabilities (assessment scale)	4180186
44812243	HoNOS-LD - Health of the Nation Outcome Scale for learning disabilities	4180186
44812244	Hospital discharge letter received (finding)	4180186
44812245	Outpatient clinic letter received (finding)	4180186
44812246	Measurement of ratio of aldosterone to renin activity in plasma specimen (procedure)	4180186
44812246	Plasma aldosterone:renin activity ratio	4180186
44812247	Measurement of ratio of aldosterone to renin concentration in plasma specimen (procedure)	4180186
44812247	Plasma aldosterone:renin concentration ratio	4180186
44812248	Measurement of ratio of monomeric to total prolactin in serum specimen (procedure)	4180186
44812248	Serum monomeric:total prolactin ratio	4180186
44812249	Measurement of 3 hydroxybutyrate in plasma specimen (procedure)	4180186
44812249	Plasma 3 hydroxybutyrate level	4180186
44812250	Measurement of 24 hour urine pentaporphyrin output (procedure)	4180186
44812250	Urine 24 hour pentaporphyrin output	4180186
44812253	Referral by voluntary agency (procedure)	4180186
44812254	Review of care programme approach care plan (procedure)	4180186
44812254	Review of CPA (care programme approach) care plan	4180186
44812256	Serum tiagabine concentration	4180186
44812256	Measurement of concentration of tiagabine in serum specimen (procedure)	4180186
44812257	Measurement of concentration of tipranavir in serum specimen (procedure)	4180186
44812257	Serum tipranavir concentration	4180186
44812258	Measurement of concentration of valproate in serum specimen (procedure)	4180186
44812258	Serum valproate concentration	4180186
44812261	Measurement of concentration of zonisamide in serum specimen (procedure)	4180186
44812261	Serum zonisamide concentration	4180186
44812262	Serum zopiclone concentration	4180186
44812262	Measurement of concentration of zopiclone in serum specimen (procedure)	4180186
44812265	History of female genital mutilation (situation)	4180186
44812266	Joint consultation (procedure)	4180186
44812267	Joint consultation - General Practitioner registrar and General Practitioner trainer (procedure)	4180186
44812268	Patient contact details verified (finding)	4180186
44812269	Female genital mutilation type I - World Health Organisation classification (disorder)	4180186
44812272	Diphtheria, tetanus, inactivated polio vaccination contraindicated (situation)	4180186
44812273	Diphtheria, tetanus, inactivated polio vaccination declined (situation)	4180186
44812274	SAS (Symptom Assessment Scale) - fatigue score	4180186
44812274	Symptom Assessment Scale - fatigue score (observable entity)	4180186
44812277	SAS (Symptom Assessment Scale) - breathing problems score	4180186
44812277	Symptom Assessment Scale - breathing problems score (observable entity)	4180186
44812280	Measurement of non high density lipoprotein in serum specimen (procedure)	4180186
44812280	Serum non high density lipoprotein cholesterol level	4180186
44812282	SAS (Symptom Assessment Scale) - appetite problems score	4180186
44812282	Symptom Assessment Scale - appetite problems score (observable entity)	4180186
44812284	Fibrillin 1 gene mutation positive (finding)	4180186
44812285	Health of the Nation Outcome Scale-secure: Rating scale B - potential self harm or neglect (assessment scale)	4180186
44812285	HoNOS (Health of the Nation Outcome Scale)-secure: Rating scale B - potential self harm or neglect	4180186
44812286	Measurement of procollagen type III amino-terminal propeptide in serum specimen (procedure)	4180186
44812286	Serum procollagen type III N-terminal propeptide level	4180186
44812287	Measurement of procollagen type I amino-terminal propeptide in serum specimen (procedure)	4180186
44812287	Serum procollagen type I N-terminal propeptide level	4180186
44812288	Lithotripsy of ureter using fluoroscopic guidance (procedure)	4180186
44812289	Percutaneous insertion of right atrial appendage closure device using fluoroscopic guidance (procedure)	4180186
44812290	Measurement of carboxy-terminal telopeptide of type I collagen in serum specimen (procedure)	4180186
44812290	Serum C-terminal telopeptide of type I collagen level	4180186
44812293	Computed tomography triple phase study of abdomen and pelvis with contrast (procedure)	4180186
44812296	Insertion of tunnelled drain into thorax using fluoroscopic guidance (procedure)	4180186
44812297	Computed tomography portal venography of abdomen and pelvis with contrast (procedure)	4180186
44812297	Computed tomography portal venography of abdomen and pelvis with contrast	4180186
44812300	Touch sensation of right dermatome of second lumbar nerve absent (finding)	4180186
44812302	Touch sensation of left dermatome of second lumbar nerve absent (finding)	4180186
44812303	Touch sensation of left dermatome of second lumbar nerve exaggerated (finding)	4180186
44812306	Touch sensation of right dermatome of second sacral nerve absent (finding)	4180186
44812309	Touch sensation of left dermatome of second sacral nerve reduced (finding)	4180186
44812310	Touch sensation of right dermatome of second sacral nerve reduced (finding)	4180186
44812318	GMS2 claim paid by HA (health authority) - checked	4180186
44812318	GMS2 claim paid by health authority, checked (finding)	4180186
44812321	FP1002 signed (finding)	4180186
44812323	FP1002 due next with new intrauterine device (finding)	4180186
44812323	FP1002 due next with new IUD (intrauterine device)	4180186
44812324	FP1003 signed (finding)	4180186
44812326	[X]Handgun discharge, occurrence at school, other institution and public administrative area (event)	4180186
44812327	[M]Fibromatous neoplasm NOS (morphologic abnormality)	4180186
44812328	[X]Neoplasm of uncertain and unknown behaviour of other digestive organs (disorder)	4180186
44812329	[X]Contact with other specified venomous animals, occurrence at unspecified place (event)	4180186
44812330	[M]Neoplasm morphology NOS (morphologic abnormality)	4180186
44812331	[M]Miscellaneous leukaemias (morphologic abnormality)	4180186
44812331	[M]Miscellaneous leukemias	4180186
44812333	[X]Malignant neoplasm without specification of site (disorder)	4180186
44812334	[M]Apocrine adenoma and adenocarcinomas (morphologic abnormality)	4180186
44812336	[M]Soft tissue tumor or sarcoma NOS	4180186
44812336	[M]Soft tissue tumour or sarcoma NOS (morphologic abnormality)	4180186
44812343	FP74 cervical cytology claim signed (finding)	4180186
44812344	FP74 - laboratory's technical request (finding)	4180186
44812346	Impaired vision due to diabetic retinopathy (finding)	4180186
44812348	[X]Chondropathies (disorder)	4180186
44812349	[X]Other chronic respiratory diseases originating in the perinatal period (disorder)	4180186
44812350	[X]Additional musculoskeletal and connective tissue disease classification terms (disorder)	4180186
44812352	[D]Abdominal pain NOS (situation)	4180186
44812353	[X]Other cysts of oral region, not elsewhere classified (disorder)	4180186
44812354	[X]Other complications following abortion and ectopic and molar pregnancy (disorder)	4180186
44812356	[X]Other specified congenital malformations of skull and face bones (disorder)	4180186
44812358	[D]Swelling, mass or lump of chest NOS (situation)	4180186
44812359	[X]Motorcycle rider injured in collision with fixed or stationary object, driver injured in traffic accident (event)	4180186
44812364	ANC5/6 to Family Practitioner Committee - end of March (finding)	4180186
44812365	ANC5/6 to Family Practitioner Committee - end of June (finding)	4180186
44812366	ANC5/6 to Family Practitioner Committee - end of September (finding)	4180186
44812368	Yiddish language interpreter needed (finding)	4180186
44812376	[M]Fibroepithelial neoplasm NOS (morphologic abnormality)	4180186
44812377	Cremation form part C completed (finding)	4180186
44812379	[X]Other and unspecified firearm discharge, undetermined intent, occurrence at industrial and construction area (event)	4180186
44812380	[X]Contact with hot air and gases, occurrence at home (event)	4180186
44812382	[X]Unintentional cut, puncture, perforation or haemorrhage during endoscopic examination (disorder)	4180186
44812383	GMS2 claim overpaid by health authority (finding)	4180186
44812384	Prem1 form requested from Family Practitioner Committee (finding)	4180186
44812386	Prem2 form requested from Family Practitioner Committee (finding)	4180186
44812390	SNOMED CT UK clinical extension reference set module	4180186
44812390	SNOMED CT United Kingdom clinical extension reference set module (core metadata concept)	4180186
44812392	UKTC maintained module	4180186
44812392	United Kingdom Terminology Center maintained module	4180186
44812392	United Kingdom Terminology Centre maintained module (core metadata concept)	4180186
44812394	Care planning assessments simple reference set (foundation metadata concept)	4180186
44812395	Care planning action context values simple reference set (foundation metadata concept)	4180186
44812396	Care planning intent context values simple reference set (foundation metadata concept)	4180186
44812397	Care planning discharge planning simple reference set (foundation metadata concept)	4180186
44812401	Care planning medication review simple reference set (foundation metadata concept)	4180186
44812402	Care planning needs simple reference set (foundation metadata concept)	4180186
44812409	Adverse reaction propensity simple reference set (foundation metadata concept)	4180186
44812410	Alcohol simple reference set (foundation metadata concept)	4180186
44812411	Allergy event simple reference set (foundation metadata concept)	4180186
44812413	Blood coagulation simple reference set (foundation metadata concept)	4180186
44812416	[X]Other non-thrombocytopenic purpura (disorder)	4180186
44812419	GMS2 claim health authority contacted regarding mistake (finding)	4180186
44812420	Blood pressure simple reference set (foundation metadata concept)	4180186
44812421	Clinical document architecture care setting type simple reference set	4180186
44812421	Clinical document architecture care setting type simple reference set (foundation metadata concept)	4180186
44812422	Clinical document architecture document type simple reference set	4180186
44812422	Clinical document architecture document type simple reference set (foundation metadata concept)	4180186
44812426	Correspondence care setting type simple reference set (foundation metadata concept)	4180186
44812429	Food allergen simple reference set (foundation metadata concept)	4180186
44812430	Baha'i religion simple reference set (foundation metadata concept)	4180186
44812432	Christian religion simple reference set (foundation metadata concept)	4180186
44812433	Declines religion simple reference set (foundation metadata concept)	4180186
44812434	Hindu religion simple reference set (foundation metadata concept)	4180186
44812435	Jain religion simple reference set (foundation metadata concept)	4180186
44812438	No religion simple reference set (foundation metadata concept)	4180186
44812439	Other religion simple reference set (foundation metadata concept)	4180186
44812443	Zoroastrian religion simple reference set (foundation metadata concept)	4180186
44812444	Non-food substance allergen simple reference set (foundation metadata concept)	4180186
44812447	Christian religion language reference set (foundation metadata concept)	4180186
44812448	Declines religion language reference set (foundation metadata concept)	4180186
44812449	Hindu religion language reference set (foundation metadata concept)	4180186
44812451	Jewish religion language reference set (foundation metadata concept)	4180186
44812452	Muslim religion language reference set (foundation metadata concept)	4180186
44812453	No religion language reference set (foundation metadata concept)	4180186
44812457	Sikh religion language reference set (foundation metadata concept)	4180186
44812460	Discharge simple reference set (foundation metadata concept)	4180186
44812462	Document type simple reference set (foundation metadata concept)	4180186
44812463	Encounter disposition simple reference set (foundation metadata concept)	4180186
44812465	Family history simple reference set (foundation metadata concept)	4180186
44812466	Finding simple reference set (foundation metadata concept)	4180186
44812467	Height simple reference set (foundation metadata concept)	4180186
44812468	Incidental location type simple reference set (foundation metadata concept)	4180186
44812469	Investigations simple reference set (foundation metadata concept)	4180186
44812471	Lifestyle simple reference set (foundation metadata concept)	4180186
44812472	Personal preferences simple reference set (foundation metadata concept)	4180186
44812473	Provision of advice simple reference set (foundation metadata concept)	4180186
44812474	Remote monitoring simple reference set (foundation metadata concept)	4180186
44812478	Social and personal circumstances simple reference set (foundation metadata concept)	4180186
44812479	Specimen material type simple reference set (foundation metadata concept)	4180186
44812480	Telehealth disposition simple reference set (foundation metadata concept)	4180186
44812481	Telehealth document type simple reference set (foundation metadata concept)	4180186
44812482	Telehealth temperature simple reference set (foundation metadata concept)	4180186
44812487	Messaging link assertion simple reference set (foundation metadata concept)	4180186
44812488	No consent for HPV (human papillomavirus) vaccination	4180186
44812488	No consent for human papillomavirus vaccination (finding)	4180186
44812489	[X]Agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use (disorder)	4180186
44812492	[X]Problem related to lifestyle, unspecified (situation)	4180186
44812493	[V]Personal history of exposure to radiation	4180186
44812493	[V]Personal history of irradiation (situation)	4180186
44812494	GMS2 claim health authority make up payment (finding)	4180186
44812499	Endoscopy procedures simple reference set (foundation metadata concept)	4180186
44812500	Renal clinical finding simple reference set (foundation metadata concept)	4180186
44812501	Public health simple reference set (foundation metadata concept)	4180186
44812502	Allergy and adverse reaction drug causative agent simple reference set (foundation metadata concept)	4180186
44812503	Allergy and adverse reaction food causative agent simple reference set (foundation metadata concept)	4180186
44812505	United Kingdom diagnostic imaging procedure simple reference set (foundation metadata concept)	4180186
44812507	Occupational therapy assessment scales simple reference set (foundation metadata concept)	4180186
44812509	National Health Service laboratory collection method simple reference set	4180186
44812509	National Health Service laboratory collection method simple reference set (foundation metadata concept)	4180186
44812510	National Health Service laboratory investigation method simple reference set	4180186
44812510	National Health Service laboratory investigation method simple reference set (foundation metadata concept)	4180186
44812511	National Health Service laboratory investigation simple reference set	4180186
44812511	National Health Service laboratory investigation simple reference set (foundation metadata concept)	4180186
44812517	National Health Service laboratory topography simple reference set	4180186
44812517	National Health Service laboratory topography simple reference set (foundation metadata concept)	4180186
44812519	United Kingdom Extension Great Britain English language reference set	4180186
44812519	United Kingdom Extension Great Britain English language reference set (foundation metadata concept)	4180186
44812522	UKTC module dependency reference set	4180186
44812522	United Kingdom Terminology Center module dependency reference set	4180186
44812522	United Kingdom Terminology Centre module dependency reference set (foundation metadata concept)	4180186
44812524	UK administrative ordered reference set	4180186
44812524	United Kingdom administrative ordered reference set (foundation metadata concept)	4180186
44812529	Activity of daily living simple reference set (foundation metadata concept)	4180186
44812530	Allergy or adverse reaction event simple reference set (foundation metadata concept)	4180186
44812532	Assessment procedure type simple reference set (foundation metadata concept)	4180186
44812533	Behavior finding simple reference set	4180186
44812533	Behaviour finding simple reference set (foundation metadata concept)	4180186
44812534	Breathing finding simple reference set (foundation metadata concept)	4180186
44812536	National Health Service continuing healthcare rejection message type simple reference set (foundation metadata concept)	4180186
44812536	NHS CHC (continuing healthcare) rejection message type simple reference set	4180186
44812538	Care plan type simple reference set (foundation metadata concept)	4180186
44812540	Communication finding simple reference set (foundation metadata concept)	4180186
44812544	General physical wellbeing finding simple reference set (foundation metadata concept)	4180186
44812545	Housing finding simple reference set (foundation metadata concept)	4180186
44812548	Occupation simple reference set (foundation metadata concept)	4180186
44812549	Pain finding simple reference set (foundation metadata concept)	4180186
44812551	Security, abuse or discrimination simple reference set (foundation metadata concept)	4180186
44812552	Consent given for HPV (human papillomavirus) vaccination	4180186
44812552	Consent given for human papillomavirus vaccination (finding)	4180186
44812556	[X]Accident to watercraft causing drowning and submersion, unspecified watercraft (event)	4180186
44812558	[X]Other secondary arthrosis of first carpometacarpal joints, bilateral (disorder)	4180186
44812559	[V]Personal history of respiratory system disease (situation)	4180186
44812563	GMS2 claim health authority dispute fee due (finding)	4180186
44812565	Sleep finding simple reference set (foundation metadata concept)	4180186
44812566	Swallowing and oral health simple reference set (foundation metadata concept)	4180186
44812569	National Health Service Data Model and Dictionary accident and emergency diagnosis simple map reference set (foundation metadata concept)	4180186
44812569	NHS Data Model and Dictionary accident and emergency diagnosis simple map reference set	4180186
44812569	NHS Data Model and Dictionary A & E (accident and emergency) diagnosis simple map reference set	4180186
44812569	NHS Data Model and Dictionary emergency department diagnosis simple map reference set	4180186
44812570	Complex map extended with map block type reference set (foundation metadata concept)	4180186
44812571	Occupational therapy assessment procedure simple reference set (foundation metadata concept)	4180186
44812572	Occupational therapy assessment observable simple reference set (foundation metadata concept)	4180186
44812573	Occupational therapy functional observable simple reference set (foundation metadata concept)	4180186
44812574	Action context values simple reference set (foundation metadata concept)	4180186
44812577	Gastroenterology outpatient diagnosis simple reference set (foundation metadata concept)	4180186
44812580	Ophthalmology adnexal diagnosis simple reference set (foundation metadata concept)	4180186
44812581	Ophthalmology cataract diagnosis simple reference set (foundation metadata concept)	4180186
44812583	Ophthalmology external diagnosis simple reference set (foundation metadata concept)	4180186
44812587	Ophthalmology refractive diagnosis simple reference set (foundation metadata concept)	4180186
44812588	Ophthalmology strabismus diagnosis simple reference set (foundation metadata concept)	4180186
44812589	Ophthalmology vitreoretinal diagnosis simple reference set (foundation metadata concept)	4180186
44812593	Rheumatology diagnosis language reference set (foundation metadata concept)	4180186
44812594	Office of Population Censuses and Surveys Classification of Interventions and Procedures Version 4.7 complex map reference set (foundation metadata concept)	4180186
44812594	OPCS (Office of Population Censuses and Surveys) Classification of Interventions and Procedures Version 4.7 complex map reference set	4180186
44812595	IG (improvement grant) forms requested from FPC (family practitioner committee)	4180186
44812595	Improvement grant forms requested from family practitioner committee (finding)	4180186
44812600	Excluded from national child measurement programme (finding)	4180186
44812604	Pandemic influenza vaccination not indicated (situation)	4180186
44812607	[V] Screening for trachoma (situation)	4180186
44812609	[X]Myositis in protozoal and parasitic infections classified elsewhere (disorder)	4180186
44812610	FP1001 status (finding)	4180186
44812612	Patient advised of anticoagulant dose (situation)	4180186
44812614	Post-operative keloid scar (disorder)	4180186
44812618	[X]Other waiting period for investigation and treatment (situation)	4180186
44812620	[X]Examination and observation following other accident (situation)	4180186
44812622	[M]Papillary cystadenocarcinoma, NOS (morphologic abnormality)	4180186
44812625	[M]Cystic, mucinous and serous neoplasms (morphologic abnormality)	4180186
44812628	Twi language interpreter needed (finding)	4180186
44812629	DAS-CRP (Disease activity score using C-reactive protein)	4180186
44812629	Disease activity score using C-reactive protein (observable entity)	4180186
44812633	[X]Gastroenterology and urology devices associated with adverse incidents, prosthetic and other implants, materials and accessory devices (disorder)	4180186
44812636	[M]Malignant lymphoma, follicular center cell, non-cleaved, follicular	4180186
44812636	[M]Malignant lymphoma, follicular centre cell, non-cleaved, follicular (morphologic abnormality)	4180186
44812638	[M]Granular cell tumor or alveolar soft part sarcoma NOS	4180186
44812638	[M]Granular cell tumour or alveolar soft part sarcoma NOS (morphologic abnormality)	4180186
44812641	[X]Early syphilis, unspecified (disorder)	4180186
44812642	FP1001 sent to family practitioner committee (finding)	4180186
44812645	Seen in infectious diseases clinic (finding)	4180186
44812647	QPCR (quantitative polymerase chain reaction)	4180186
44812647	Quantitative polymerase chain reaction analysis (procedure)	4180186
44812648	Cardiovascular disease risk assessment indicated (situation)	4180186
44812649	[X]Personal history of major surgery, not elsewhere classified (situation)	4180186
44812652	[X]Other pulmonary aspergillosis (disorder)	4180186
44812654	Electronic general practitioner medical record received (finding)	4180186
44812654	Electronic GP (general practitioner) medical record received	4180186
44812657	[X]Morbidity and mortality classifications (disorder)	4180186
44812658	[X]Unspecified event, undetermined intent, occurrence at industrial and construction area (event)	4180186
44812659	EPUAP (European pressure ulcer advisory panel) grade 4 ulcer	4180186
44812659	European pressure ulcer advisory panel grade 4 ulcer (disorder)	4180186
44812661	FP1001 claim due (finding)	4180186
44812664	[X]Drowning and submersion following fall into bath-tub, occurrence at other specified place (event)	4180186
44812665	Endocervical swab culture negative (finding)	4180186
44812666	FP1001 claim due next visit (finding)	4180186
44812668	Other digital signal (record artifact)	4180186
44812669	GMS2 claim checked by staff (finding)	4180186
44812674	Bowel cancer screening programme faecal occult blood test normal (finding)	4180186
44812678	Prison sickness certificate issued (finding)	4180186
44812680	[X]Malignant neoplasm of connective and soft tissue of trunk, unspecified (disorder)	4180186
44812682	[M]Gastrinoma and carcinomas (morphologic abnormality)	4180186
44812685	[X]Persons encountering health services for examination and investigation (situation)	4180186
44812687	[X]Isolated proteinuria, with other specified morphological changes (disorder)	4180186
44812688	[V]Acquired absence of organs (situation)	4180186
44812689	[X]Plasmodium vivax malaria without complication (disorder)	4180186
44812690	ANC5/6 to Health Board - end of September (finding)	4180186
44812692	[X]Unspecified mental retardation with the statement of no, or minimal, impairment of behaviour (disorder)	4180186
44812694	[V]Unspecified encounter with person who has no complaint or sickness (situation)	4180186
44812700	[D]Musculoskeletal X-ray or scan abnormality NOS (situation)	4180186
44812701	[X]Meningitis due to other specified causes (disorder)	4180186
44812702	[X]Puerperal mental disorder, unspecified (disorder)	4180186
44812703	[X]Other/unspecified symptoms and signs involving cognitive functions and awareness	4180186
44812703	[X]Other/unspecified symptoms & signs involving cognitive functions & awareness (finding)	4180186
44812705	[X]Open multiple fractures unspecified (morphologic abnormality)	4180186
44812706	[X]Episodic and paroxysmal disorders (disorder)	4180186
44812710	[X]Other instability of joint (finding)	4180186
44812711	RAF (Royal Air Force) chef	4180186
44812711	Royal Air Force chef (occupation)	4180186
44812712	[X]Cerebral arteritis in other diseases classified elsewhere (disorder)	4180186
44812713	[X]Mental and behavioural disorders due to use of other stimulants, including caffeine (disorder)	4180186
44812714	[X]Systemic atrophy affecting the central nervous system in other diseases classified elsewhere (disorder)	4180186
44812719	[X]Sequelae of unspecified external cause (disorder)	4180186
44812721	[X]Other cerebral infarction (disorder)	4180186
44812722	[X]Leprosy, unspecified (disorder)	4180186
44812723	[X]Yaws, unspecified (disorder)	4180186
44812724	[X]Pinta, unspecified (disorder)	4180186
44812725	[V]Educational handicap	4180186
44812725	[V]Educational problems (situation)	4180186
44812726	[V]Observation following alleged rape	4180186
44812726	[V]Observation following alleged rape or seduction (situation)	4180186
44812726	[V]Observation following alleged seduction	4180186
44812729	[X]Periostitis in other infectious diseases classified elsewhere (disorder)	4180186
44812735	[V]Other specified contraceptive management (situation)	4180186
44812737	[V]Observation for unspecified condition (situation)	4180186
44812739	[X] Hepatomegaly with splenomegaly, not elsewhere classified (disorder)	4180186
44812746	[X]Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances: residual and late-onset psychotic (disorder)	4180186
44812747	[X]Dislocation of other and unspecified parts of the neck (disorder)	4180186
44812748	[V]Other specified elective cosmetic or ritual surgery (situation)	4180186
44812750	[X]Esophageal varices in diseases classified elsewhere (disorder)	4180186
44812752	[X]Injury of other nerves at ankle and foot level (disorder)	4180186
44812753	[X]Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts (disorder)	4180186
44812754	[V]Acquired absence of upper and lower limbs, any level (situation)	4180186
44812755	[D]Syncope and collapse NOS (situation)	4180186
44812758	[X]Malignant neoplasm of male genital organ, unspecified (disorder)	4180186
44812759	[X]Other nonspecific lymphadenitis (disorder)	4180186
44812760	[V]Psychiatric patient - not previously admitted (situation)	4180186
44812762	[V]Potential health hazards related to family history (FH)	4180186
44812762	[V]Potential health hazards related to personal history (PH)	4180186
44812762	[V]Potential health hazards related to personal history (PH) and family history (FH) (situation)	4180186
44812763	[V]Family history of cerebrovascular accident (CVA)	4180186
44812763	[V]Family history of stroke (cerebrovascular) (situation)	4180186
44812766	[V]No able carer in household (situation)	4180186
44812768	[V]Measles-mumps-rubella (MMR) vaccination (situation)	4180186
44812771	[V]Fitting or adjustment of other specified device (situation)	4180186
44812775	[V]Other specified antenatal screening (situation)	4180186
44812776	[X]Unspecified multiple injuries (disorder)	4180186
44812777	[M]Sebaceous adenoma or adenocarcinoma NOS (morphologic abnormality)	4180186
44812781	[X]Mechanical complication of internal fixation device of other bones (disorder)	4180186
44812782	Detained in hospital under Section 3 of the Mental Health Act 1983 (England and Wales) (finding)	4180186
44812782	Detained in hospital under Section 3 of the MHA (Mental Health Act) 1983 (England and Wales)	4180186
44812782	Formally detained under hospital-treatment order - under Section 3 of the Mental Health Act 1983	4180186
44812783	[X]Toxic effect of unspecified seafood (disorder)	4180186
44812785	[X]Intentional self harm by other and unspecified firearm discharge, occurrence on street and highway (event)	4180186
44812786	[X]Kaposi's sarcoma of multiple organs (disorder)	4180186
44812788	[V]Unspecified constitutional state in development (situation)	4180186
44812790	[X]Sequelae of other specified injury of head (disorder)	4180186
44812791	[X]Other superficial injuries of other and unspecified parts of ankle and foot (disorder)	4180186
44812792	[X]Other specified osteochondrodysplasias (disorder)	4180186
44812793	[X]Obesity and other hyperalimentation (disorder)	4180186
44812794	[X]Schizophrenia, schizotypal and delusional disorders (disorder)	4180186
44812796	[V]Boarding school resident	4180186
44812796	[V]Institution resident (situation)	4180186
44812797	[V]Other sex counselling (situation)	4180186
44812799	[X]Other disorders of tooth development (disorder)	4180186
44812802	[V]Other or unspecified general psychiatric examination (situation)	4180186
44812804	[X]Occupant of heavy transport vehicle injured in collision with pedestrian or animal (event)	4180186
44812807	[X]Disorder of muscle tone of newborn, unspecified (disorder)	4180186
44812808	[X]Other epidermolysis bullosa (disorder)	4180186
44812809	[V]Screening for nephropathy (situation)	4180186
44812810	[M]Ovarian serous tumor	4180186
44812810	[M]Ovarian serous tumour (morphologic abnormality)	4180186
44812812	Landing craft personnel - Royal Marines (occupation)	4180186
44812813	RAF (Royal Air Force) student environmental health technician	4180186
44812813	Royal Air Force student environmental health technician (occupation)	4180186
44812814	[V]Speech therapy (situation)	4180186
44812815	GP79 - seniority pay claim (record artifact)	4180186
44812816	[X]Victim of earthquake, occurrence on street and highway (finding)	4180186
44812819	[X]Mental and behavioural disorders due to use of cannabinoids: residual and late-onset psychotic disorder (disorder)	4180186
44812823	[X]Other congenital viral diseases (disorder)	4180186
44812827	[X]Contact with plant thorns and spines and sharp leaves, occurrence at sports and athletics area (event)	4180186
44812829	[Q] Moderate slip(30-60) (qualifier value)	4180186
44812830	[X]Other acute renal failure (disorder)	4180186
44812831	[X]Family history of other malignant neoplasms of lymphoid, haematopoietic and related tissues (situation)	4180186
44812831	[X]Family history of other malignant neoplasms of lymphoid, hematopoietic and related tissues	4180186
44812833	[X]Contact with hornets, wasps and bees, occurrence at other specified place (event)	4180186
44812834	[M]Acute myelofibrosis (morphologic abnormality)	4180186
44812836	[X]Succinimides causing adverse effects in therapeutic use (disorder)	4180186
44812839	[X]Deaf mutism, not elsewhere classified (disorder)	4180186
44812840	[X]Mental and behavioural disorders due to use of volatile solvents: harmful use (disorder)	4180186
44812841	[X]Sequelae of burn and corrosion classifiable only according to extent of body surface involved (disorder)	4180186
44812849	[X]Bus occupant injured in collision with railway train or railway vehicle, unspecified bus occupant injured in nontraffic accident (event)	4180186
44812850	[X]Unspecified drowning and submersion, occurrence at trade and service area (event)	4180186
44812851	[X]Unspecified privation, occurrence on farm (event)	4180186
44812852	[X]Motorcycle rider injured in noncollision transport accident, driver injured in nontraffic accident (event)	4180186
44812853	[X]Poisoning by and exposure to sedative hypnotics, occurrence at sports and athletics area, undetermined intent (event)	4180186
44812854	[X]Sequelae of unspecified injury of neck and trunk (disorder)	4180186
44812855	Care for mentally disordered offenders - Part day: day care (procedure)	4180186
44812860	[X]Special screening examination for certain developmental disorders in childhood (situation)	4180186
44812861	[X]Failure in dosage during unspecified surgical and medical care (disorder)	4180186
44812863	[V]Family history of psychiatric condition (situation)	4180186
44812871	[X]Motorcycle rider injured in collision with car, pick-up truck or van, person injured whilst boarding or alighting (event)	4180186
44812874	[D]Brain and central nervous system abnormal function study NOS (situation)	4180186
44812880	[X]Melanocytic nevi, unspecified (disorder)	4180186
44812884	[X]Personal history of long-term (current) use of other medicaments (situation)	4180186
44812887	[X]Other specified coagulation defects (disorder)	4180186
44812891	[X]Injury of unspecified nerve at shoulder and upper arm level (disorder)	4180186
44812902	[X]Injury of unspecified blood vessel of leg, level unspecified (disorder)	4180186
44812903	[X]Poisoning by other and unspecified hormone antagonists (disorder)	4180186
44812904	[V]Unspecified vaccination against single bacterial disease (situation)	4180186
44812905	[V]Poliomyelitis vaccination (situation)	4180186
44812908	[X]Assault by corrosive substance, occurrence at trade and service area (event)	4180186
44812909	[X]Occupant of three-wheeled motor vehicle injured in collision with other nonmotor vehicle, passenger injured in traffic accident (event)	4180186
44812910	[M]Comedocarcinoma NOS (morphologic abnormality)	4180186
44812911	[X]Intentional self poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours, halogens, occurrence at unspecified place (event)	4180186
44812913	[X]Otorhinolaryngological devices associated with adverse incidents, miscellaneous devices, not elsewhere classified (disorder)	4180186
44812916	[D]Death less than 24 hours from onset of illness NOS (situation)	4180186
44812919	[X]Mental and behavioural disorder due to use of tobacco (disorder)	4180186
44812921	[V]Sheltered housing (situation)	4180186
44812922	[X]Polyneuropathy in nutritional deficiency classified elsewhere (disorder)	4180186
44812924	[X]Other congenital malformations of ribs (disorder)	4180186
44812925	[V]Problem related to care-provider dependency, unspecified (situation)	4180186
44812928	[X]Unspecified frostbite involving multiple body regions (disorder)	4180186
44812938	[V]Low income (situation)	4180186
44812943	[D]Palpitations NOS (situation)	4180186
44812944	[D]Hallucinations NOS (situation)	4180186
44812945	[X]Injury of muscles and tendons of unspecified body region (disorder)	4180186
44812949	[V]Acquired absence of both lower limbs, any level except toes alone (situation)	4180186
44812950	[X]Panic disorder [episodic paroxysmal anxiety] (disorder)	4180186
44812952	[X]Occupant of pick-up truck or van injured in collision with heavy transport vehicle or bus, person on outside of vehicle injured in nontraffic accident (event)	4180186
44812953	[X]Confined to or trapped in a low-oxygen environment, occurrence at industrial and construction area (event)	4180186
44812956	[X]Obstetric death of unspecified cause (event)	4180186
44812958	Pharmacy technician - Royal Army Medical Corps (occupation)	4180186
44812961	[X]Other specified carcinomas of liver (disorder)	4180186
44812962	[X]Glaucoma in other diseases classified elsewhere (disorder)	4180186
44812963	[X]Other specified nutritional deficiencies (disorder)	4180186
44812966	[V]Other specified administrative encounter (situation)	4180186
44812967	[V]Unspecified infertility management (situation)	4180186
44812968	[X]Persons encountering health services for specific procedures and health care (situation)	4180186
44812972	[V]Other urinary problems (situation)	4180186
44812973	[V]Assessment for procedure NOS (situation)	4180186
44812974	[X]Assault by pesticides, occurrence at home (event)	4180186
44812975	[M]Trophoblastic neoplasm NOS (morphologic abnormality)	4180186
44812980	[X]Other problems related to lifestyle (situation)	4180186
44812981	[X]Mechanical complication of other devices, implants and grafts of genital tract (disorder)	4180186
44812983	[X]Other serum reactions (disorder)	4180186
44812984	Electrical and mechanical draughtsman - Royal Engineers (occupation)	4180186
44812985	Royal Army Veterinary Corps Warrant Officer (occupation)	4180186
44812992	[V]Unspecified birth, born outside hospital and not hospitalised (situation)	4180186
44812993	[D]Nonspecific abnormal finding NOS (situation)	4180186
44812996	[D]Dependent oedema	4180186
44812996	[D]Edema NOS (situation)	4180186
44812997	[X]Exposure to ionising radiation, occurrence at trade and service area (event)	4180186
44813000	[V]Normal level of neonatal care (situation)	4180186
44813001	[X]Other and unspecified disorders of lactation (disorder)	4180186
44813003	[V]Personal history of mental disorder (situation)	4180186
44813005	Request form or letter sent by mail/email (record artifact)	4180186
44813006	Excepted from smoking quality indicators - informed dissent (finding)	4180186
44813009	Canteen (qualifier value)	4180186
44813010	Central government (qualifier value)	4180186
44813011	Monitoring (qualifier value)	4180186
44813012	GMS3 claim - temporary contraceptive (non IUCD) signed (finding)	4180186
44813014	GPC claim - registration examination paid (finding)	4180186
44813019	[V]Social exclusion and rejection (situation)	4180186
44813020	RAF (Royal Air Force) avionics mechanic, technical	4180186
44813020	Royal Air Force avionics mechanic, technical (occupation)	4180186
44813022	[V]Routine child health examination (situation)	4180186
44813023	[X]Bus occupant injured in collision with heavy transport vehicle or bus, driver injured in traffic accident (event)	4180186
44813027	Assessment using health of the nation outcome scale for secure services (regime/therapy)	4180186
44813027	Assessment using HoNOS-secure (health of the nation outcome scale - secure)	4180186
44813030	[D]Nonspecific chromosomal abnormality found on analysis (situation)	4180186
44813031	[D]Nonspecific positive culture findings (situation)	4180186
44813032	[D]Positive culture findings in sputum (situation)	4180186
44813034	[D]Nonspecific tuberculin test reaction (situation)	4180186
44813035	[D]False positive serological syphilis test (situation)	4180186
44813036	[D]Other nonspecific immunological finding (situation)	4180186
44813039	[D]Instantaneous death (situation)	4180186
44813041	[D]Found dead (situation)	4180186
44813043	[D]Respiratory failure (situation)	4180186
44813045	[D]Nerves	4180186
44813045	[D]Nervousness (situation)	4180186
44813045	[D]Nervous tension	4180186
44813047	[D]Bizarre personal appearance (situation)	4180186
44813049	Use of spectacles education (procedure)	4180186
44813049	Wearing of glasses education	4180186
44813050	On end of life care register (finding)	4180186
44813051	PULHHEEMS - L6R (finding)	4180186
44813053	Slovak (ethnic group)	4180186
44813057	Influenza vaccination invitation short message service text message sent (finding)	4180186
44813057	Influenza vaccination invitation SMS (short message service) text message sent	4180186
44813061	GP/PS3 form not approved by Health Board (finding)	4180186
44813063	[X]Toxic effect of contact with other marine animals (disorder)	4180186
44813065	[V]Other multiple birth, mates live born (situation)	4180186
44813067	[V]Dietary counselling	4180186
44813067	[V]Dietary counselling in colitis	4180186
44813067	[V]Dietary counselling in diabetes mellitus	4180186
44813067	[V]Dietary counselling in food intolerance	4180186
44813067	[V]Dietary counselling in gastritis	4180186
44813067	[V]Dietary counselling in hypoglycaemia	4180186
44813067	[V]Dietary counselling in obesity	4180186
44813067	[V]Dietary surveillance	4180186
44813067	[V]Dietary surveillance and counselling (situation)	4180186
44813067	[V]Dietary surveillance in hypercholesterolaemia	4180186
44813070	Father has physical disability (situation)	4180186
44813071	Disease modifying antirheumatic drug monitored in primary care (finding)	4180186
44813073	Scleroderma health assessment questionnaire (assessment scale)	4180186
44813073	SHAQ - scleroderma health assessment questionnaire	4180186
44813074	Quick DASH (disabilities of the arm shoulder and hand) outcome measurement	4180186
44813074	Quick disabilities of the arm shoulder and hand outcome measurement (assessment scale)	4180186
44813076	[D]Incoordination (situation)	4180186
44813078	[D]Icterus (situation)	4180186
44813078	Icterus [D]	4180186
44813081	[D]Heart sounds, abnormal (situation)	4180186
44813082	[D]Retrosternal pain (situation)	4180186
44813082	Retrosternal pain [D]	4180186
44813084	[D]Alcohol blood elevated (situation)	4180186
44813086	[D]Immunoglobulin level raised (situation)	4180186
44813091	Child not present at encounter (finding)	4180186
44813093	Medication monitored in secondary care (finding)	4180186
44813098	[D]Other nonspecific function test abnormal (situation)	4180186
44813100	[D]Lump stomach (situation)	4180186
44813101	[D]Sleep apnoea syndrome (situation)	4180186
44813102	[D]God only knows (situation)	4180186
44813106	Other specified excision of organ NOC (procedure)	4180186
44813111	National Health Service Continuing Healthcare Checklist Assessment Acceptance (record artifact)	4180186
44813114	Hepatitis A vaccination not indicated (situation)	4180186
44813115	[X]Arthropod-borne viral fevers and viral haemorrhagic fevers (disorder)	4180186
44813116	[X]Need for immunisation against other specified single infectious diseases (situation)	4180186
44813118	[V]Other problems related to upbringing (situation)	4180186
44813119	[V]Failed examinations (situation)	4180186
44813120	Discharge by associate general practitioner (procedure)	4180186
44813120	Discharge by associate GP (general practitioner)	4180186
44813126	[D]Hallucinations, tactile (situation)	4180186
44813129	[D]Micturition syncope (situation)	4180186
44813130	[D]Convulsions, febrile (situation)	4180186
44813130	[D]Pyrexial convulsion	4180186
44813131	[D]Reflex anoxic seizure (situation)	4180186
44813133	[D]Light-headedness (situation)	4180186
44813138	FP78 vocational training claim status (finding)	4180186
44813140	[D]Hypothermia, of non-environmental cause (situation)	4180186
44813145	[D]Abnormal involuntary movements (situation)	4180186
44813146	[D]Fasciculation (situation)	4180186
44813149	[D]Parageusia (situation)	4180186
44813152	Referral for physical activity service offered (finding)	4180186
44813156	English oak RAST test	4180186
44813156	Oak pollen RAST test	4180186
44813156	Quercus robur specific immunoglobulin E antibody measurement (procedure)	4180186
44813157	BODE (body mass, airflow obstruction, dyspnoea and exercise capacity) index score	4180186
44813157	Body mass, airflow obstruction, dyspnoea and exercise capacity index score (observable entity)	4180186
44813159	Active insulin time (observable entity)	4180186
44813161	DS1500 Disability living allowance report declined (situation)	4180186
44813162	Has heart failure management plan (finding)	4180186
44813163	Primary care management (procedure)	4180186
44813165	Referral to respiratory clinic declined (situation)	4180186
44813166	[X]Undifferentiated schizophrenia (disorder)	4180186
44813167	[X]Streptococcus pneumoniae as the cause of diseases classified to other chapters (disorder)	4180186
44813169	[X]Pneumonia in other diseases classified elsewhere (disorder)	4180186
44813172	[D]Dysgraphia (situation)	4180186
44813173	[D]Transient paralysis of a limb (situation)	4180186
44813175	Measles mumps rubella catch-up vaccination programme enhanced services administration (procedure)	4180186
44813175	MMR (measles mumps rubella) catch-up vaccination programme enhanced services administration	4180186
44813177	Choice and booking appointment cancelled by patient (finding)	4180186
44813182	[D]Localised swelling, mass and lump, upper limb (situation)	4180186
44813183	[D]Localised swelling, mass and lump, multiple sites (situation)	4180186
44813184	[D]Foot lump (situation)	4180186
44813186	[D]Lump on knee (situation)	4180186
44813188	[D]Finger lump (situation)	4180186
44813190	[D]Anasarca (situation)	4180186
44813191	[D]Peripheral oedema (situation)	4180186
44813196	Dialysate temperature (observable entity)	4180186
44813199	Lipid disorder treatment changed (situation)	4180186
44813200	Assessment for sterilisation procedure (procedure)	4180186
44813202	Child in need referral rejected by social services (finding)	4180186
44813204	Unable to perform spirometry (situation)	4180186
44813205	Anomalous posteromedial muscle bands of left ventricle (disorder)	4180186
44813206	Subpulmonary right ventricular outflow tract obstruction (disorder)	4180186
44813210	Goal partially achieved (finding)	4180186
44813211	Not progressing towards goal (finding)	4180186
44813213	[X]Occupant of pick-up truck or van injured in noncollision transport accident, unspecified occupant of pick-up truck or van injured in nontraffic accident (event)	4180186
44813215	[D]Failure to gain weight (situation)	4180186
44813218	[D]Polydipsia (situation)	4180186
44813219	[D]Excessive thirst (situation)	4180186
44813220	[D]Polyphagia (situation)	4180186
44813222	[D]Headache (situation)	4180186
44813224	[D]Swelling in head or neck (situation)	4180186
44813226	[D]Tongue mass (situation)	4180186
44813227	[D]Lump on nose (situation)	4180186
44813228	[D]Submental lump (situation)	4180186
44813232	Avestan language (qualifier value)	4180186
44813233	[D]Agnosia (situation)	4180186
44813235	[D]Other symptoms affecting head and neck (situation)	4180186
44813243	[D]Cardiac dullness decreased (situation)	4180186
44813246	Other attention to repair of organ NOC (procedure)	4180186
44813249	On examination - inspiratory wheeze (finding)	4180186
44813252	Referral to erectile dysfunction clinic declined (situation)	4180186
44813253	Post transfusion, repeat test four months after last transfusion (finding)	4180186
44813256	Referral to Benefits Agency (procedure)	4180186
44813257	Discharge from advanced primary nurse care (procedure)	4180186
44813261	Cholesterol/phospholipid ratio measurement (procedure)	4180186
44813264	Hepatitis A nucleic acid detection (procedure)	4180186
44813265	Cognitive linguistic quick test (assessment scale)	4180186
44813266	[X]Gastroenterology and urology devices associated with adverse incidents, miscellaneous devices, not elsewhere classified (disorder)	4180186
44813267	[X]Unspecified systemic anti-infectives and antiparasitics causing adverse effects in therapeutic use (disorder)	4180186
44813268	[X]Intentional self harm by sharp object, occurrence at home (event)	4180186
44813269	Seen in consultant led community clinic (finding)	4180186
44813272	[D]Wheezing (situation)	4180186
44813273	[D]Dyspnoea (situation)	4180186
44813274	[D]Snoring (situation)	4180186
44813275	[D]Stridor (situation)	4180186
44813279	[D]Sputum abnormal - colour (situation)	4180186
44813281	[D]Pleurodynia (situation)	4180186
44813282	[D]Chest discomfort (situation)	4180186
44813284	[D]Parasternal chest pain (situation)	4180186
44813289	Medical follow-up - normal (record artifact)	4180186
44813290	Private account (record artifact)	4180186
44813292	Solicitors court allowance (record artifact)	4180186
44813293	Fast track heart failure referral for transthoracic two dimensional echocardiogram (procedure)	4180186
44813294	Hepatitis C viral ribonucleic acid polymerase chain reaction positive (finding)	4180186
44813294	Hepatitis C viral RNA PCR (ribonucleic acid polymerase chain reaction) positive	4180186
44813295	Place of occurrence of accident or poisoning, playground (environment)	4180186
44813296	Referral to general practitioner out of hours service (procedure)	4180186
44813296	Referral to GP (general practitioner) out of hours service	4180186
44813300	Bypass of aorta by anastomosis of axillary artery to bilateral femoral arteries (procedure)	4180186
44813301	Endoscopic placement of intrafallopian implant into remaining solitary fallopian tube (procedure)	4180186
44813304	Bilateral neurological deficit (finding)	4180186
44813310	Difficulty heating home (finding)	4180186
44813311	Difficulty preparing snack (finding)	4180186
44813312	Difficulty swimming (finding)	4180186
44813317	[V]Examination for participation in sport (situation)	4180186
44813318	[X]Recurrent depressive disorder (disorder)	4180186
44813319	Tailor - Royal Armoured Corps (occupation)	4180186
44813321	[X]Other specified sex chromosome abnormalities, female phenotype (disorder)	4180186
44813326	Referral to community ear, nose and throat service (procedure)	4180186
44813328	Consent given by person with parental responsibility (finding)	4180186
44813329	Coeliac disease monitoring invitation first letter (procedure)	4180186
44813330	Seen by general practitioner of choice (finding)	4180186
44813331	Finding related to ability to cool home (finding)	4180186
44813335	Blood glucose range before evening meal (observable entity)	4180186
44813336	Blood glucose range after evening meal (observable entity)	4180186
44813338	Left quadriceps lag (observable entity)	4180186
44813339	Left mid upper arm circumference (observable entity)	4180186
44813341	Neurodegenerative condition drugs Band 1 (procedure)	4180186
44813343	Second Haemophilus influenzae type B and meningitis C vaccination	4180186
44813343	Second Haemophilus influenzae type B and Neisseria meningitidis serotype C combination vaccination (procedure)	4180186
44813347	[V]Has artificial larynx	4180186
44813347	[V]Other specified organ or tissue replacement (situation)	4180186
44813349	[D]Skin symptoms NOS (situation)	4180186
44813350	[V]Family history of consanguinity (situation)	4180186
44813355	[M]Specialized gonadal neoplasms	4180186
44813355	[M]Specialized gonadal neoplasms (morphologic abnormality)	4180186
44813357	[X]Acute polymorphic psychotic disorder without symptoms of schizophrenia (disorder)	4180186
44813363	[M]Sweat gland tumour NOS (morphologic abnormality)	4180186
44813366	[D]Hemoptysis NOS (situation)	4180186
44813369	[V]Acquired absence of leg at or below knee (situation)	4180186
44813370	[V]Supervision of pregnancy with history of insufficient antenatal care (situation)	4180186
44813373	[X]Other abnormal finding from diagnostic imaging of central nervous system	4180186
44813373	[X]Other abnormal findings from diagnostic imaging of central nervous system (finding)	4180186
44813376	[X]Other obesity (disorder)	4180186
44813378	PULHHEEMS - P2R (finding)	4180186
44813381	HTLV (human T-cell lymphotropic virus) type 1 IgG antibody measurement	4180186
44813381	Measurement of human T-cell lymphotropic virus type 1 immunoglobulin G antibody (procedure)	4180186
44813382	Bronchoscopic radiofrequency cauterisation of lower lobe bronchus (procedure)	4180186
44813382	Endoscopic radiofrequency cauterisation of lower lobe bronchus	4180186
44813387	Critical care medical care plan for major complex surgery (record artifact)	4180186
44813389	First stage osseointegrated implantation into jaw (procedure)	4180186
44813390	Change in medication declined (situation)	4180186
44813393	Multidisciplinary assessment record (record artifact)	4180186
44813396	Lipoprotein profile (procedure)	4180186
44813397	Epimerase measurement (procedure)	4180186
44813398	Alpha-neuraminidase measurement (procedure)	4180186
44813402	Multidisciplinary note (record artifact)	4180186
44813405	Prealbumin measurement (procedure)	4180186
44813406	IDTS (integrated drug treatment system) group therapy declined	4180186
44813406	Integrated drug treatment system group therapy declined (situation)	4180186
44813411	[X]Toxic effect of other metals (disorder)	4180186
44813412	[X]Hyperglycemia, unspecified (finding)	4180186
44813414	[X]Dislocation, sprain and strain of unspecified joint and ligament of trunk (disorder)	4180186
44813415	[X]Self mutilation (finding)	4180186
44813417	[X]Symptoms and signs involving the skin and subcutaneous tissue (finding)	4180186
44813419	[V]Contraceptive management (situation)	4180186
44813421	Doctor approved by the Secretary of State under section 12 of the Mental Health Act 1983 (England and Wales) (occupation)	4180186
44813422	[X]Special screening examination for neoplasms of other sites (situation)	4180186
44813426	[X]Chronic and other pulmonary manifestations due to radiation (disorder)	4180186
44813427	Non NHS registered nursing home mental health care for older adults - 24 hour not intensive (procedure)	4180186
44813429	[X]Pseudomonas as the cause of diseases classified to other chapters (disorder)	4180186
44813434	Accident to manned kite in collision with other aircraft (event)	4180186
44813435	Liver transplant planned (situation)	4180186
44813436	Alpha-1 microglobulin measurement (procedure)	4180186
44813437	Collagen type II immunoglobulin G antibody measurement (procedure)	4180186
44813438	Rodent epithelium mix specific immunoglobulin E antibody measurement (procedure)	4180186
44813448	Injury inconsistent with history given (finding)	4180186
44813450	Insulin dose changed (situation)	4180186
44813451	Automated oto-acoustic emission test clear response (finding)	4180186
44813452	Automated oto-acoustic emission test incomplete (finding)	4180186
44813453	Verbal advice about long acting reversible contraception (situation)	4180186
44813455	[V]Diphtheria-tetanus-pertussis, combined (DTP) vaccination (situation)	4180186
44813456	[V]Family history of eye and ear disorders (situation)	4180186
44813458	[X]Disorders of vitreous body and globe (disorder)	4180186
44813460	[V]Screening for other inborn errors of metabolism (situation)	4180186
44813464	[M]Mycosis fungoides NOS (morphologic abnormality)	4180186
44813466	[X]Complications predominantly related to the puerperium (disorder)	4180186
44813468	[X]Subarachnoid haemorrhage from other intracranial arteries (disorder)	4180186
44813470	[X]Other diseases of urinary system (disorder)	4180186
44813472	[M]Myomatous neoplasms (morphologic abnormality)	4180186
44813473	[D]Insomnia NOS (situation)	4180186
44813474	[V]Screening for malignant neoplasm of oral cavity (situation)	4180186
44813476	[D]Body substance abnormal NOS (situation)	4180186
44813478	[X]Melanoma in situ of other sites (disorder)	4180186
44813484	Avionics technician - Royal Electrical and Mechanical Engineers (occupation)	4180186
44813485	[X]Osteopathy in other diseases classified elsewhere (disorder)	4180186
44813487	[X]Fetus and newborn affected by other specified complications of labour and delivery (disorder)	4180186
44813488	[X]Liver disorders in other diseases classified elsewhere (disorder)	4180186
44813491	[V]Contraceptive cap fitting	4180186
44813491	[V]Contraceptive cream prescription	4180186
44813491	[V]Contraceptive foam fitting	4180186
44813491	[V]Diaphragm fitting	4180186
44813491	[V]General contraceptive advice and counselling (situation)	4180186
44813491	[V]Oral contraceptive prescription	4180186
44813492	[V]Blood donor (situation)	4180186
44813497	Provision of written information on inhaler technique (procedure)	4180186
44813498	Nondependent antidepressant type drug abuse (disorder)	4180186
44813500	Pathology report received (finding)	4180186
44813501	Looked after child (finding)	4180186
44813505	Did not attend walk in centre (finding)	4180186
44813507	Tunnelled central venous catheter education (procedure)	4180186
44813508	Erectile dysfunction unresponsive to phosphodiesterase-5 inhibitor (situation)	4180186
44813509	Non-organic psychosis in remission (disorder)	4180186
44813517	[X]Other forms of scoliosis (disorder)	4180186
44813522	[M]Skin appendage adenoma (morphologic abnormality)	4180186
44813523	[X]Fracture of other parts of forearm (disorder)	4180186
44813524	[X]Other specified mental disorder due to brain damage and dysfunction and to physical disease (disorder)	4180186
44813526	Reconnaissance leader - Royal Marines (occupation)	4180186
44813527	National Health Service (NHS) mental health nursing home/residential care	4180186
44813527	National Health Service (NHS) mental health nursing home/residential care (regime/therapy)	4180186
44813529	[V]Family history of physical abuse to sibling by family member (situation)	4180186
44813530	[V]Screening for rheumatoid arthritis (situation)	4180186
44813532	[V]Tobacco abuse counselling (situation)	4180186
44813533	HS22X form (record artifact)	4180186
44813534	[V]Unspecified administrative encounter (situation)	4180186
44813537	[V]Attention to cystostomy (situation)	4180186
44813540	[V]Inappropriate diet and eating habits (situation)	4180186
44813541	RM2 Department of Health and Social Security district medical officer report status (finding)	4180186
44813543	Renal function monitoring invitation (procedure)	4180186
44813545	Measurement of rubella virus immunoglobulin G antibody (procedure)	4180186
44813547	Assessment using Rockall acute upper gastrointestinal haemorrhage risk score (procedure)	4180186
44813549	Deficit between central and peripheral pulse rate (observable entity)	4180186
44813551	Kappa light chain output measurement (procedure)	4180186
44813552	Injection of thrombin (procedure)	4180186
44813554	Hepatitis C antigen negative (finding)	4180186
44813555	EQ-5D-5L (EuroQol five dimension five level) usual activities score	4180186
44813555	EuroQol five dimension five level usual activities score (observable entity)	4180186
44813556	EQ-5D-5L (EuroQol five dimension five level) anxiety depression score	4180186
44813556	EuroQol five dimension five level anxiety depression score (observable entity)	4180186
44813557	Free adrenaline output measurement (procedure)	4180186
44813558	Collection of breath (procedure)	4180186
44813560	Specimen collection by excision (procedure)	4180186
44813561	Cycle of change stage, healthy eating (qualifier value)	4180186
44813564	Acute meningitis (disorder)	4180186
44813565	Acute infectious hepatitis (disorder)	4180186
44813566	Clinical syndrome due to Escherichia coli O157 infection (disorder)	4180186
44813569	[X]Victim of lightning, occurrence in residential institution (finding)	4180186
44813571	[X]Superficial injury of abdomen, lower back and pelvis, part unspecified (disorder)	4180186
44813572	[X]Mental and behavioural disorders due to use of cocaine: harmful use (disorder)	4180186
44813573	[X]Other and unspecified diseases of pulp and periapical tissues (disorder)	4180186
44813574	[V]Drug use (situation)	4180186
44813576	[X]Other symptoms and signs involving emotional state (finding)	4180186
44813577	Completion of arrest of dental haemorrhage claim (procedure)	4180186
44813579	[D]Vertigo NEC (situation)	4180186
44813579	Vertigo NEC [D]	4180186
44813582	[V]Screening for other specified condition (situation)	4180186
44813583	[X]Unspecified viral infection of the central nervous system (disorder)	4180186
44813585	Lumbar spina bifida without mention of hydrocephalus (disorder)	4180186
44813587	[X]Mental and behavioural disorders due to use of opioids: residual and late onset psychotic disorder (disorder)	4180186
44813590	[M]Cystadenoma or carcinoma NOS (morphologic abnormality)	4180186
44813593	[X]Congenital malformations of genital organs (disorder)	4180186
44813594	FP1001 form (record artifact)	4180186
44813596	[X]Other disorders of kidney and ureter in other diseases classified elsewhere (disorder)	4180186
44813599	Regimental senior artisan - Royal Engineers (occupation)	4180186
44813600	[X]Other derangements of patella (disorder)	4180186
44813602	[X]Antenatal screening for malformations using ultrasonics and other physical methods (situation)	4180186
44813604	[V]Deficiencies of head (situation)	4180186
44813605	[X]Schizophrenia, unspecified (disorder)	4180186
44813606	[X]Other mental and behavioural disorders associated with the puerperium, not elsewhere classified (disorder)	4180186
44813608	Referral for manual lymphatic drainage (procedure)	4180186
44813609	No previous bacillus Calmette-Guerin vaccination (finding)	4180186
44813610	[D]Gas pain (abdominal) (situation)	4180186
44813611	[D]Tympanites (abdominal) (situation)	4180186
44813612	[D]Bowel sounds abnormal (situation)	4180186
44813613	[D]Bowel sounds hyperactive (situation)	4180186
44813617	[D]Tenesmus (situation)	4180186
44813621	Court certification payment claim (procedure)	4180186
44813629	[X]Other specified assisted single delivery (finding)	4180186
44813630	[V]Personal or family history NOS (situation)	4180186
44813633	[X]Obstructive and reflux uropathy, unspecified (disorder)	4180186
44813634	[V]Pregnancy with history of infertility (situation)	4180186
44813635	[D]Dysuria (situation)	4180186
44813639	[D]Acute retention of urine (situation)	4180186
44813640	Nebivolol contraindicated (situation)	4180186
44813642	Carvedilol not indicated (situation)	4180186
44813643	Ambulation with assistance of two people (regime/therapy)	4180186
44813643	Mobilisation with assistance of two people	4180186
44813646	[D]Other urinary system symptom (situation)	4180186
44813646	[D]Prostadynia	4180186
44813648	[D]Vesical tenesmus (situation)	4180186
44813649	[D]Abdominal pain (situation)	4180186
44813650	[D]Abdominal colic (situation)	4180186
44813653	[D]Pain in right iliac fossa (situation)	4180186
44813657	Anal prolapse (disorder)	4180186
44813658	Follicular mucinosis (disorder)	4180186
44813660	Smoking cessation leaflet given (situation)	4180186
44813661	Amendment of general practitioner maternity claim (procedure)	4180186
44813661	Amendment of GP (general practitioner) maternity claim	4180186
44813662	Confinement payment claim status (finding)	4180186
44813663	Immunisation claim status (finding)	4180186
44813664	Mat B2 - certificate of confinement (record artifact)	4180186
44813665	Tricuspid valve atresia (disorder)	4180186
44813665	Tricuspid valve atretic	4180186
44813665	Tricuspid valve imperforate	4180186
44813667	Hormone replacement monitoring administration (record artifact)	4180186
44813668	Hypertension clinic administration (record artifact)	4180186
44813671	Congenital pulmonary venous confluence remote from left atrium (disorder)	4180186
44813678	Patient recall administration (record artifact)	4180186
44813678	Recall administration - general	4180186
44813681	[X]Dislocations, sprains and strains involving other combinations of body regions (disorder)	4180186
44813685	[V]Other multiple birth, mates live born, NOS (situation)	4180186
44813686	[V]Acquired absence of leg above knee (situation)	4180186
44813687	[D]Red blood cell abnormality (situation)	4180186
44813688	[D]Red cell volume abnormal (situation)	4180186
44813689	[D]Elevated sedimentation rate (situation)	4180186
44813693	[D]Other blood chemistry abnormality (situation)	4180186
44813694	[D]Copper, blood level abnormal (situation)	4180186
44813695	[D]Lithium, blood level abnormal (situation)	4180186
44813697	[D]Abnormality of albumin (situation)	4180186
44813702	[D]Raised urine 17-ketosteroid (situation)	4180186
44813703	[D]Raised urine catecholamines (situation)	4180186
44813704	[D]Raised urine VMA (situation)	4180186
44813705	[D]Cerebrospinal fluid abnormality (situation)	4180186
44813706	[D]Abnormal level of hormones in cerebrospinal fluid (situation)	4180186
44813707	[D]Abnormal level of substances of chiefly non-medicinal source in cerebrospinal fluid (situation)	4180186
44813711	[D]Semen abnormal (situation)	4180186
44813712	[D]Saliva abnormal (situation)	4180186
44813714	Staff employment contract status (finding)	4180186
44813715	No cutaneous lymphangioma (situation)	4180186
44813716	No history of cutaneous cellulitis (situation)	4180186
44813719	Normal position of thoracoabdominal organ (finding)	4180186
44813722	Prevention administration (record artifact)	4180186
44813723	Immunisation administration (record artifact)	4180186
44813724	Contraception administration (record artifact)	4180186
44813724	Contraceptive administration	4180186
44813725	Oral contraceptive administration (record artifact)	4180186
44813725	Pill contraceptive administration	4180186
44813728	Peer group (qualifier value)	4180186
44813729	Screening invitation medium (record artifact)	4180186
44813730	Disabled driver certificate administration (record artifact)	4180186
44813730	Orange badge administration	4180186
44813733	[X]Other specified diabetes mellitus (disorder)	4180186
44813735	[V]Other specified aftercare (situation)	4180186
44813736	[X]Other specified noninflammatory disorders of uterus (disorder)	4180186
44813737	[X]Manic episode, unspecified (disorder)	4180186
44813738	Moderate lymphoedema of limb (disorder)	4180186
44813739	Attended ACCT (Assessment, Care in Custody and Teamwork) review	4180186
44813739	Attended Assessment, Care in Custody and Teamwork review (finding)	4180186
44813740	Referral to eczema clinic (procedure)	4180186
44813746	[D]Abnormal findings in specimens from female genital organs (situation)	4180186
44813747	[D]Abnormal level of hormones in specimens from female genital organs (situation)	4180186
44813749	Main spoken language Hindko (finding)	4180186
44813750	Private referral to chiropractor (procedure)	4180186
44813751	Referral for exercise on prescription declined (situation)	4180186
44813760	[D]Electroretinogram abnormal (situation)	4180186
44813761	[D]Visually evoked potentials abnormal (situation)	4180186
44813763	Antibiotic treatment indicated (situation)	4180186
44813764	Awaiting chemotherapy (finding)	4180186
44813765	History of developmental disorder (situation)	4180186
44813769	Excepted from palliative care quality indicators - patient unsuitable (finding)	4180186
44813770	Stroke/transient ischaemic attack monitoring telephone invitation (finding)	4180186
44813772	Actions (record artifact)	4180186
44813773	Medical Research Council muscle power score of right knee flexion (observable entity)	4180186
44813774	National Health Service 111 Interim Ambulance Request (record artifact)	4180186
44813776	Physiological measurement - specialty (qualifier value)	4180186
44813783	QCancer colorectal cancer risk calculator (assessment scale)	4180186
44813784	Assessment using QCancer risk calculator (procedure)	4180186
44813785	Application of alginate dressing (procedure)	4180186
44813787	Application of wound drainage pouch (procedure)	4180186
44813789	Acute renal failure induced by cisplatin (disorder)	4180186
44813792	FES (functional electrical stimulation) of common peroneal nerve	4180186
44813792	Functional electrical stimulation of common peroneal nerve (procedure)	4180186
44813794	Error on published operating list (finding)	4180186
44813798	INR (international normalised ratio) above target range	4180186
44813798	International normalised ratio above target range (finding)	4180186
44813799	Insertion of fiducial marker into prostate using ultrasonography guidance (procedure)	4180186
44813799	Ultrasound guided insertion of fiducial marker into prostate	4180186
44813800	Assessment using ageing males' symptoms scale (procedure)	4180186
44813800	Assessment using AMS (ageing males' symptoms) scale	4180186
44813801	Physiotherapy service (qualifier value)	4180186
44813804	Open traumatic dislocation of shoulder joint (disorder)	4180186
44813805	Measurement of concentration of indinavir in serum specimen (procedure)	4180186
44813805	Serum indinavir concentration	4180186
44813806	Measurement of concentration of lopinavir in serum specimen (procedure)	4180186
44813806	Serum lopinavir concentration	4180186
44813807	Palliative Care Problem Severity Score (observable entity)	4180186
44813807	PCPSS - Palliative Care Problem Severity Score	4180186
44813808	Palliative Care Problem Severity Score - other symptoms (observable entity)	4180186
44813808	PCPSS (Palliative Care Problem Severity Score) - other symptoms	4180186
44813811	SAS (Symptom Assessment Scale) - pain score	4180186
44813811	Symptom Assessment Scale - pain score (observable entity)	4180186
44813814	Prescribed medication to be delivered to patient by pharmacy (finding)	4180186
44813816	Measurement of alpha-mannosidase activity (procedure)	4180186
44813818	Telehealth Referral (record artifact)	4180186
44813819	Assessment using NEWS (national early warning score)	4180186
44813819	Assessment using RCP (Royal College of Physicians) NEWS (national early warning score)	4180186
44813819	Assessment using Royal College of Physicians national early warning score (procedure)	4180186
44813820	Preparation of outpatient summary (procedure)	4180186
44813825	Failed trial without catheter (situation)	4180186
44813825	Failed TWOC (trial without catheter)	4180186
44813826	Education about neurological critical care (procedure)	4180186
44813831	Assessment of sexual function (procedure)	4180186
44813836	Expected date of discharge from service (observable entity)	4180186
44813838	Provision of written information about radiation therapy (procedure)	4180186
44813839	Major colorectal surgery inpatient care plan (record artifact)	4180186
44813840	Endoscopic retrograde cholangiopancreatography with balloon dilatation of sphincter of pancreatic duct using fluoroscopic guidance (procedure)	4180186
44813844	CT guided insertion of fiducial marker into thorax	4180186
44813844	Insertion of fiducial marker into chest using computed tomography guidance (procedure)	4180186
44813845	Well hydrated (finding)	4180186
44813846	Intrathecal infusion test	4180186
44813846	Lumbar infusion test (procedure)	4180186
44813848	Contact assessment (procedure)	4180186
44813849	Specialist assessment (procedure)	4180186
44813852	Did not attend Mantoux test (finding)	4180186
44813853	[V]Personal history of cervical intraepithelial neoplasia, grade III (situation)	4180186
44813854	At risk of drug misuse (finding)	4180186
44813855	Suprascapular nerve block using ultrasonography guidance (procedure)	4180186
44813855	Ultrasound guided suprascapular nerve block	4180186
44813856	SNOMED CT UK Edition reference set module	4180186
44813856	SNOMED CT United Kingdom Edition reference set module (core metadata concept)	4180186
44813857	Care planning goal context values simple reference set (foundation metadata concept)	4180186
44813860	Adverse reaction event simple reference set (foundation metadata concept)	4180186
44813864	Has socially isolated carer (finding)	4180186
44813865	Minimum prothrombin time (observable entity)	4180186
44813866	Target activated partial thromboplastin time (observable entity)	4180186
44813874	Medical Research Council muscle power score of left shoulder abduction (observable entity)	4180186
44813875	Active range of left elbow supination (observable entity)	4180186
44813877	Not eligible for aftercare under Section 117 of Mental Health Act 1983 (England and Wales) (finding)	4180186
44813878	History of amaurosis fugax (situation)	4180186
44813880	DOSE (dyspnoea, airflow obstruction, smoking status, exacerbation frequency) index	4180186
44813880	Dyspnoea, airflow obstruction, smoking status, exacerbation frequency index (assessment scale)	4180186
44813881	Cultural and spiritual wishes honoured (finding)	4180186
44813883	Active range of right wrist adduction (observable entity)	4180186
44813884	Medical Research Council muscle power score of right ankle eversion (observable entity)	4180186
44813885	Medical Research Council muscle power score of right ankle dorsiflexion (observable entity)	4180186
44813887	Patient health questionnaire 2 score (observable entity)	4180186
44813888	Generalised anxiety disorder 2 scale score (observable entity)	4180186
44813889	Gold standards framework prognostic indicator stage B (green) - months prognosis (finding)	4180186
44813890	Gold standards framework prognostic indicator stage D (red) - days prognosis (finding)	4180186
44813892	Thrombosis of dialysis vascular access (disorder)	4180186
44813896	Impaired fasting glycaemia resolved (finding)	4180186
44813897	GMS2 claim completed by doctor (finding)	4180186
44813898	Parenteral nutrition at 6 weeks (finding)	4180186
44813899	Vascular surgery inpatient care plan (record artifact)	4180186
44813900	Education about management of vomiting (procedure)	4180186
44813901	Application of burn compression garment (procedure)	4180186
44813902	Delayed reconstruction of breast with extended latissimus dorsi flap and insertion of prosthesis (procedure)	4180186
44813903	Transvaginal and transabdominal ultrasonography of pelvis (procedure)	4180186
44813903	Transvaginal and transabdominal ultrasound scan of pelvis	4180186
44813905	Hypoglycaemia fear survey (assessment scale)	4180186
44813908	Provision of written information about asthma (procedure)	4180186
44813910	Fistulography of arteriovenous fistula with contrast	4180186
44813910	Fluoroscopic angiography of arteriovenous fistula using contrast (procedure)	4180186
44813911	Intraoperative fluid balance monitoring (regime/therapy)	4180186
44813911	Intraoperative fluid monitoring	4180186
44813913	Bowel Cancer Screening Programme bowel scope screening test (procedure)	4180186
44813915	Receiving learning support (finding)	4180186
44813916	Planned stop date for clopidogrel therapy (observable entity)	4180186
44813917	Clopidogrel therapy stopped (situation)	4180186
44813918	Endoscopic retrograde diathermy probe pyelotomy and insertion of stent using fluoroscopic guidance (procedure)	4180186
44813920	Health of the Nation Outcome Scale for Children and Adolescents item 6 - physical illness or disability problems (observable entity)	4180186
44813921	Mental Health Act 1983 (England and Wales) form 2 passed to social worker (finding)	4180186
44813923	Discharge from school medical centre (procedure)	4180186
44813924	Self-monitoring of blood ketone (regime/therapy)	4180186
44813925	Preferred place of care - home of relative (finding)	4180186
44813926	Female genital mutilation (disorder)	4180186
44813930	Finding of upper body strength (finding)	4180186
44813930	Observation of upper body strength	4180186
44813935	Left Hoffman reflex equivocal (finding)	4180186
44813935	Left Hoffman's reflex equivocal	4180186
44813936	Outpatient care plan (record artifact)	4180186
44813938	Non-union of joint of ankle without infection (disorder)	4180186
44813942	Emergency contraception declined (situation)	4180186
44813943	Constant wheezing (finding)	4180186
44813945	Respiratory syncytial virus monoclonal antibody prophylaxis (procedure)	4180186
44813948	Seen in weight management clinic (finding)	4180186
44813949	Insulin passport not checked (situation)	4180186
44813950	Handover details (record artifact)	4180186
44813953	Reason for contact (record artifact)	4180186
44813954	Measurement of ratio of valine to creatinine in urine specimen (procedure)	4180186
44813954	Urine valine:creatinine ratio	4180186
44813956	Replacement of appliance declined (situation)	4180186
44813958	QAdmissions emergency admission risk calculator (assessment scale)	4180186
44813959	QAdmissions risk of emergency hospital admission in next 30 days (observable entity)	4180186
44813961	Ventriculoperitoneal shunt catheter in situ (finding)	4180186
44813962	Left biceps reflex exaggerated (finding)	4180186
44813963	Right biceps reflex exaggerated (finding)	4180186
44813965	Hormone releasing intrauterine contraceptive device fitted by other healthcare provider (situation)	4180186
44813965	Hormone releasing IUCD (intrauterine contraceptive device) fitted by other healthcare provider	4180186
44813965	Intrauterine system fitted by other healthcare provider	4180186
44813966	Faecal heptaporphyrin content	4180186
44813966	Measurement of heptaporphyrin content in faeces specimen (procedure)	4180186
44813968	First rotavirus vaccination (procedure)	4180186
44813971	Referral to memory clinic declined (situation)	4180186
44813972	Cone beam computed tomography of chest (procedure)	4180186
44813972	Cone beam CT of thorax	4180186
44813973	Cone beam computed tomography of pelvis (procedure)	4180186
44813974	Laparoscopic hand assisted repair of abdominal aortic aneurysm (procedure)	4180186
44813976	Tube feeding completed (situation)	4180186
44813976	Tube feeding ended	4180186
44813979	Referred by National Health Service 111 service (finding)	4180186
44813980	Aspiration of ectopic pregnancy from cornual segment of fallopian tube (procedure)	4180186
44813980	Aspiration of interstitial ectopic pregnancy	4180186
44813981	Assessment of care needs by multidisciplinary team (procedure)	4180186
44813984	Predicted drug interaction with food (finding)	4180186
44813985	On urinary tract infection care pathway (situation)	4180186
44813986	Acquired deformity of lesser toe (disorder)	4180186
44813987	Victim of sexual grooming (finding)	4180186
44813989	Advice about long acting reversible contraception not indicated (situation)	4180186
44813991	Urgent appointment letter sent to patient (finding)	4180186
44813992	Follow-up CAMHS (child and adolescent mental health service) assessment	4180186
44813992	Follow-up child and adolescent mental health service assessment (procedure)	4180186
44813996	Arterial cannula care assessment (procedure)	4180186
44813997	Arab - ethnic category 2001 census (finding)	4180186
44813998	Family aware of prognosis (situation)	4180186
44814000	On examination left brachial pulse present (finding)	4180186
44814002	Power of right myotome of eighth cervical nerve (observable entity)	4180186
44814003	Power of right myotome of fifth lumbar nerve (observable entity)	4180186
44814004	Power of right myotome of first sacral nerve (observable entity)	4180186
44814007	Possibly eligible for participation in clinical trial (finding)	4180186
44814008	Arterial leg ulcer	4180186
44814008	Arterial lower limb ulcer (disorder)	4180186
44814009	First rotavirus vaccination declined (situation)	4180186
44814010	Delayed union of joint of foot (disorder)	4180186
44814015	Excessive dietary intake of vitamin B6 (finding)	4180186
44814018	On musculoskeletal care pathway (situation)	4180186
44814019	On dermatology care pathway (situation)	4180186
44814020	Patient reports no current disability (situation)	4180186
44814021	Referral to general practitioner for medication review (procedure)	4180186
44814022	Withdrawal of consent for sharing end of life care coordination record (finding)	4180186
44814026	Clinical stage C chronic lymphocytic leukaemia (disorder)	4180186
44814027	Injury within last 48 hours (finding)	4180186
44814028	Cognitive linguistic quick test visuospatial domain (assessment scale)	4180186
44814029	Cognitive linguistic quick test attention domain (assessment scale)	4180186
44814031	Excessive dietary intake of sodium (finding)	4180186
44814032	Lower limb ulcer care pathway (regime/therapy)	4180186
44814033	Inadequate parenteral nutrition infusion (finding)	4180186
44814034	Inadequate bioactive substance intake (finding)	4180186
44814036	Leeds Revised Acne Grading System (assessment scale)	4180186
44814037	Referral to voluntary agency declined (situation)	4180186
44814039	Postnatal listening visit (procedure)	4180186
44814041	Cardiology service (qualifier value)	4180186
44814042	Johns Hopkins ACG (adjusted clinical groups) system	4180186
44814042	Johns Hopkins adjusted clinical groups system (assessment scale)	4180186
44814044	Viraemia due to BK polyomavirus (finding)	4180186
44814045	History of pre-eclampsia (situation)	4180186
44814047	Sigmoid colectomy and end to side anastomosis (procedure)	4180186
44814049	Paediatric metabolic disease service (qualifier value)	4180186
44814054	Advice given about access to emergency appointment (situation)	4180186
44814058	Intensive weight management programme ended (situation)	4180186
44814060	Measurement of ratio of pregnanediol to creatinine in urine specimen (procedure)	4180186
44814060	Urine pregnanediol:creatinine ratio	4180186
44814062	Chronic pyrophosphate crystal arthropathy (disorder)	4180186
44814065	Percutaneous injection of sclerosing agent into short saphenous vein using ultrasonography guidance (procedure)	4180186
44814065	Ultrasound guided injection of sclerosing agent into short saphenous vein	4180186
44814066	Black and Chinese - ethnic category 2001 census (finding)	4180186
44814067	Chinese and White - ethnic category 2001 census (finding)	4180186
44814068	Turkish Cypriot - ethnic category 2001 census (finding)	4180186
44814069	Analgesic abuse	4180186
44814069	Analgesic misuse (disorder)	4180186
44814070	End of life care assessment (procedure)	4180186
44814071	Education for infection control isolation (procedure)	4180186
44814073	Early discharge from critical care (finding)	4180186
44814075	Aortic aneurysm monitoring (regime/therapy)	4180186
44814079	Systemic inflammatory response syndrome of non-infectious origin with organ failure (disorder)	4180186
44814080	Assessment using congestive heart failure, hypertension, age 2, diabetes mellitus, stroke 2 - vascular disease, age, sex category score (procedure)	4180186
44814081	Infant weaning intervention offered (situation)	4180186
44814083	Family member to be contacted to make appointment (finding)	4180186
44814084	Requires loud verbal communication (finding)	4180186
44814090	Attention to external distraction device of skull (procedure)	4180186
44814091	Removal of external distraction device from skull (procedure)	4180186
44814092	Discussion about previous experience in baby care (procedure)	4180186
44814094	Left posterior tibial pulse palpable (finding)	4180186
44814096	Percutaneous decompression using coblation to intervertebral disc using fluoroscopic guidance	4180186
44814096	Percutaneous decompression using plasma mediated ablation to intervertebral disc using fluoroscopic guidance (procedure)	4180186
44814097	Conversion from previous hybrid prosthetic replacement of shoulder joint using cement (procedure)	4180186
44814100	Pulsed dye laser therapy to skin (procedure)	4180186
44814102	Significant disorder identified by screening (finding)	4180186
44814104	Active range of left ankle dorsiflexion	4180186
44814104	Active range of left ankle flexion (observable entity)	4180186
44814106	Active range of left ankle eversion (observable entity)	4180186
44814109	Requires contact via telephone interpreting line (finding)	4180186
44814110	Urea/creatinine ratio	4180186
44814110	Urea/creatinine ratio measurement (procedure)	4180186
44814112	Case management of long term condition (procedure)	4180186
44814113	Any other group - ethnic category 2001 census (finding)	4180186
44814114	Pin prick sensation of left dermatome of first thoracic nerve normal (finding)	4180186
44814117	Rivermead Mobility Index score (observable entity)	4180186
44814117	RMI (Rivermead Mobility Index) score	4180186
44814119	Measurement of adenovirus immunoglobulin G antibody/total antibody (procedure)	4180186
44814121	Provision of personal protective equipment (procedure)	4180186
44814123	Right posterior tibial pulse absent (finding)	4180186
44814124	Normal light touch sensation left foot (finding)	4180186
44814127	Patient handover (procedure)	4180186
44814128	Lysis of adhesions of extensor tendon of hand (procedure)	4180186
44814131	Ghrelin measurement (procedure)	4180186
44814132	Seen by respiratory nurse specialist (finding)	4180186
44814133	Measurement of phosphorylase b kinase (procedure)	4180186
44814135	Cytoplasmic CD11b count (procedure)	4180186
44814137	Cytoplasmic CD19 count (procedure)	4180186
44814138	Mother hepatitis B positive (situation)	4180186
44814139	Abdominal aortic aneurysm screen ultrasound scan report received (finding)	4180186
44814140	HSV (herpes simplex virus) type 1 and 2 antiviral resistance measurement by DNA (deoxyribonucleic acid) analysis	4180186
44814140	Measurement of Herpes simplex virus type 1 and 2 antiviral resistance by deoxyribonucleic acid analysis (procedure)	4180186
44814141	Touch sensation of right dermatome of first thoracic nerve reduced (finding)	4180186
44814142	Touch sensation of left dermatome of first sacral nerve absent (finding)	4180186
44814144	Dissent from secondary use of general practitioner patient identifiable data (finding)	4180186
44814145	Suicide risk increased from previous level (finding)	4180186
44814148	Optical coherence tomography assessment of thickness of arterial wall using fluoroscopic guidance	4180186
44814148	OCT (optical coherence tomography) assessment of thickness of arterial wall using fluoroscopic guidance	4180186
44814148	Optical coherence tomography assessment of thickness of arterial wall using fluoroscopic guidance (procedure)	4180186
44814151	Medical Research Council muscle power score of wrist flexion (observable entity)	4180186
44814153	Referred by residential home (finding)	4180186
44814154	Measurement of famciclovir (procedure)	4180186
44814155	Discussion about deactivation of automatic implantable cardioverter defibrillator (procedure)	4180186
44814156	Follicular lymphoma grade 2 (disorder)	4180186
44814158	Dental surgery assistance service (qualifier value)	4180186
44814162	General nursing (qualifier value)	4180186
44814164	Measurement of lamivudine (procedure)	4180186
44814165	Discharge from family nurse partnership team (procedure)	4180186
44814166	QFracture risk calculator (assessment scale)	4180186
44814170	Perinatal mental health service (qualifier value)	4180186
44814171	DDS17 (Diabetes Distress Scale 17) score	4180186
44814171	Diabetes Distress Scale 17 item score (observable entity)	4180186
44816523	C16:0; Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Erythrocytes; Hexadecanoate; Hexadecanoic acid; i; Palmitic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Scrto; Substance concentration ratio; Substance ratio	4180186
44816523	DMA 16:0/C16:0 RBC-sRto	4180186
44816523	1,1-二甲氧基十六烷/棕榈酸:物质的量比率:时间点:红细胞:定量型	4182948
44816527	3-hydroxy-isovalerylcarnitine; 3OH-Isovalerylcarn; C4DC; C4-DC; C4DC+C5OH; C4-DC+C5-OH; C4-DCC; C5OH; C5-OH; Chemistry; Dicarboxylic carnitine; III; Level; Me-malonylcarn; nonderivatized; non-derivatized; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; underivatized	4180186
44816527	C4-DC+C5-OH SerPl-sCnc	4180186
44816527	甲基丙二酰肉碱 (C4-DC)+3-羟基异戊酰肉碱 (C5-OH):物质的量浓度:时间点:血清/血浆:定量型	4182948
44816533	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bact; BV DNA Pnl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
44816533	BV DNA Pnl Vag NAA+probe	4180186
44816533	细菌性阴道病 DNA 组套:-:时间点:阴道:-:探针法.基因扩增.靶向	4182948
44816534	1 day; 24 hours; 24HR; AE1 Anion Exchanger; Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; III; Kidney; M Protein; M Protein 3; Mass Rate; M-band; Monoclonal band; Monoclonal spike; M-protein; mRate; M-spike; Nephrology; Para protein; Paraprotein; PEUR; PR; Prot; QNT; Quan; Quant; Quantitative; Renal; UA; UPEP; UR; Urn	4180186
44816534	M Protein 3 24h Ur Elph-mRate	4180186
44816534	蛋白质.单克隆型 区带 3:质量速率:24小时:尿液:定量型:电泳	4182948
44816537	Bands; bnd; Chemistry; Hematology; Heme; Identity or presence; IFE; Ifix; II; Immunofixation electrophoresis; Monoclon Band 2 Obs; Nominal; Point in time; Random; UA; UR; Urn	4180186
44816537	Monoclon Band 2 Obs Ur IFE	4180186
44816537	已观察到的单克隆区带 2:存在与否或特征标识:时间点:尿液:名义型:免疫固定电泳分析法	4182948
44816538	AE1 Anion Exchanger; Bands; bnd; Chemistry; Identity or presence; IFE; Ifix; III; Immunofixation electrophoresis; Monoclon Band 3 Obs; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816538	Monoclon Band 3 Obs SerPl IFE	4180186
44816538	已观察到的单克隆区带 3:存在与否或特征标识:时间点:血清/血浆:名义型:免疫固定电泳分析法	4182948
44816539	Bands; bnd; Chemistry; Identity or presence; IFE; Ifix; II; Immunofixation electrophoresis; Monoclon Band 2 Obs; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816539	Monoclon Band 2 Obs SerPl IFE	4180186
44816539	已观察到的单克隆区带 2:存在与否或特征标识:时间点:血清/血浆:名义型:免疫固定电泳分析法	4182948
44816540	1,3DCB SerPl-mCnc	4180186
44816540	1,3-D; 1,3DCB; 3,3'-dichlorobenzidine; DCB; DRUG/TOXICOLOGY; Drugs; i; III; Level; Mass concentration; m-Dichlorobenzene; m-dichlorobenzol; Metadichlorobenzene; m-Phenylenedichloride; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Telone	4180186
44816540	1,3-二氯苯:质量浓度:时间点:血清/血浆:定量型	4182948
44816543	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydromorphinone; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816543	HYDROmorphone Sal Ql Cfm	4180186
44816543	二氢吗啡酮:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816544	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Methamphet; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816544	Methamphet Sal Ql Cfm	4180186
44816544	甲基苯丙胺:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816546	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; MDA; Methylenedioxymethamphetamine metabolite; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816546	MDA Sal Ql Cfm	4180186
44816546	亚甲基二氧苯丙胺:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816547	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; MDEA; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
44816547	MDEA Sal Cfm-mCnc	4180186
44816547	亚甲基二乙氧基苯丙胺:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
44816548	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; MDEA; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816548	MDEA Sal Ql Cfm	4180186
44816548	亚甲基二乙氧基苯丙胺:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816550	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; Level; Mass concentration; MDMA; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
44816550	MDMA SerPlBld-mCnc	4180186
44816550	亚甲基二氧甲基苯丙胺:质量浓度:时间点:血清/血浆/全血:定量型	4182948
44816552	Addiction; c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Morphine sulfate; MS; MSO4; OMPH; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816552	Morphine Sal Ql Cfm	4180186
44816552	吗啡:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816553	Norsertraline Ur-mCnc	4180186
44816553	Desmeth; Desmethylsertraline; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sertraline metabolite; Setralinemetab; UA; UR; Urn	4180186
44816553	去甲基舍曲林:质量浓度:时间点:尿液:定量型	4182948
44816558	Addiction; Angel dust; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Oral fluid; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Sernylan	4180186
44816558	PCP Sal Ql Cfm	4180186
44816558	苯环利定:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816560	Sertraline Ur-mCnc	4180186
44816560	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Zoloft	4180186
44816560	舍曲林:质量浓度:时间点:尿液:定量型	4182948
44816562	Addiction; Adormix; Ambien; Ambien CR; Blood; Damixan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Edluar; Hypnogen; Illicit; Ivedal; Level; Lioran; Mass concentration; Myslee; Nasen; Nytamel; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sanval; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; WB; Whole blood; Zoldem; Zolpihexal; Zolpimist	4180186
44816562	Zolpidem Bld-mCnc	4180186
44816562	唑吡坦:质量浓度:时间点:全血:定量型	4182948
44816563	Monoclon Band Obs SerPl IFE	4180186
44816563	Bands; bnd; Chemistry; Identity or presence; IFE; Ifix; Immunofixation electrophoresis; Monoclon Band Obs; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816563	已观察到的单克隆区带:存在与否或特征标识:时间点:血清/血浆:名义型:免疫固定电泳分析法	4182948
44816564	Bands; bnd; Chemistry; Hematology; Heme; Identity or presence; IFE; Ifix; Immunofixation electrophoresis; Monoclon Band Obs; Nominal; Point in time; Random; UA; UR; Urn	4180186
44816564	Monoclon Band Obs Ur IFE	4180186
44816564	已观察到的单克隆区带:存在与否或特征标识:时间点:尿液:名义型:免疫固定电泳分析法	4182948
44816568	Addiction; Benzoylmethylecgonine; Cfm; CNFR; CNFRM; Coc+Met; COCM; Coke; Conf; Confirmation; Confirmatory; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; GCMS; Illicit; Metabolite; Metb; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Snow	4180186
44816568	Coc+Met Sal Ql Cfm	4180186
44816568	可卡因+代谢产物:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816569	Addiction; Benzoylmethylecgonine; Cfm; CNFR; CNFRM; Coke; Conf; Confirmation; Confirmatory; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Snow	4180186
44816569	Cocaine Sal Ql Cfm	4180186
44816569	可卡因:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816571	Alc; Alcohol; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Ethyl alcohol; EtOH; GCMS; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816571	Ethanol Sal Ql Cfm	4180186
44816571	乙醇:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816572	Chlorinated solvents Ur Ql	4180186
44816572	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
44816572	含氯溶剂:存在情况或阈值:时间点:尿液:序数型	4182948
44816573	Addiction; c260; C300; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Methylmorphine; Morphine methyl ether; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816573	Codeine Sal Ql Cfm	4180186
44816573	可待因:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816574	carbapenem-resistant Klebsiella pneumoniae; CRE; CRKP; Hodge test; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Typ	4180186
44816574	Carbapenemase Islt	4180186
44816574	碳青霉烯酶:类型:时间点:分离株:名义型:碳青霉烯酶 Nordmann-Poirel 试验	4182948
44816575	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin metabolite; Illicit; MAM; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816575	6MAM Sal Ql Cfm	4180186
44816575	6-单乙酰吗啡:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816576	11-nor-9-carboxy-delta-9-THC; 11-nor-9-carboxy-THC; 11-nor-delta-9-THC-9-COOH; 9-carboxy-11-nor-delta-9-tetrahydrocannabinol; Addiction; Carboxytetrahydrocannabinol; CarboxyTHC; Carboxy-THC-delta-9; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Marijuana; Nabilone; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; THC; THCA; THCC; THCCOOH; THC-COOH	4180186
44816576	CarboxyTHC Sal Ql Cfm	4180186
44816576	羧基四氢大麻酚:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816577	BZE Sal Ql Cfm	4180186
44816577	BEC; BEG; Benz; Benzoylec; BZE; Cfm; CNFR; CNFRM; Cocaine degradation production; Cocaine metabolite; Conf; Confirmation; Confirmatory; Crack metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816577	苯甲酰芽子碱:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816578	Addiction; Amph; Amphet; Amphetam; Amphetamines; Ampht; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Speed	4180186
44816578	Amphet Sal Ql Cfm	4180186
44816578	苯丙胺:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816579	Addiction; Amph; Amphetam; Amphetamine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Speed	4180186
44816579	Amphetamines Sal Ql Cfm	4180186
44816579	苯丙胺类:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816580	Blood; DRUG/TOXICOLOGY; Drugs; FR; Level; Mass concentration; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; TCOH.free; WB; Whole blood	4180186
44816580	TCOH.free Bld-mCnc	4180186
44816580	三氯乙醇.游离型:质量浓度:时间点:全血:定量型	4182948
44816583	240 minutes; 4 hours; 4.0Hr; 4HR; Chemistry; Level; Na; Na+; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
44816583	Sodium 4h Ur-sCnc	4180186
44816583	钠:物质的量浓度:4小时:尿液:定量型	4182948
44816584	Glucose 12h Ur-sRate	4180186
44816584	12 hours; 12HR; Chemistry; Glu; Gluc; Glucoseur; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
44816584	葡萄糖:物质的量速率:12小时:尿液:定量型	4182948
44816586	After; Chemistry; Dialy; Level; Na; Na+; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816586	Sodium p dialysis SerPl-sCnc	4180186
44816586	钠^在透析之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816587	Nuc cell # Fld Manual	4180186
44816587	#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Manl; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816587	有核细胞类:计数型浓度:时间点:体液:定量型:手工计数方法	4182948
44816588	弱 D 抗原:存在情况或阈值:时间点:脐带血红细胞:序数型	4182948
44816588	Weak D Ag RBCCo Ql	4180186
44816588	Antigen; Antigens; BLOOD BANK; Dextro; Gyn; Gynecology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Rh; Rhesus; Screen	4180186
44816589	#/area; Cell; Cellularity; Ejaculate; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnd Cells; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
44816589	Rnd Cells #/area Smn HPF	4180186
44816589	圆形细胞:单位面积数量或计数:时间点:精液:定量型:显微镜检查.光学.高倍视野	4182948
44816590	A72V; Ala72Val; Blood; G14459A; Genetics; Heredity; Heritable; Inherited; Mitochondrially encoded NADH dehydrogenase 6; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MTND6; MT-ND6 m.14459G&gt;A; NADH dehydrogenase, subunit 6 (complex I) gene; NADH-ubiquinone oxidoreductase chain 6 gene; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
44816590	MT-ND6 m.14459G>A Bld/T Ql	4180186
44816590	MT-ND6 基因.m.14459G>A:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
44816591	Agency for Healthcare Research and Quality; Ethnicity; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44816592	Agency for Healthcare Research and Quality; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44816593	Nur Nm Provider	4180186
44816593	CLIN; Nominal; Nur Nm; nursing; Person name; Point in time; Random	4180186
44816593	护士姓名:人员姓名:时间点:服务提供者:名义型	4182948
44816596	Agency for Healthcare Research and Quality; Gender; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44816597	ANTIBIOTIC SUSCEPTIBILITIES; AST; c308; C33; Ceftin; Cefuroxime Axetil; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zinacef	4180186
44816597	Cefuroxime Islt KB	4180186
44816597	头孢呋辛:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
44816599	Agency for Healthcare Research and Quality; FCN; Func; Funct; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44816601	Agency for Healthcare Research and Quality; EHR system; HER; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44816602	Admin or billing system; Agency for Healthcare Research and Quality; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44816603	Agency for Healthcare Research and Quality; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44816605	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Subs; Survey; SURVEY.AHRQ	4180186
44816608	Ident; Identifier; No; Nominal; Num; Point in time; Random	4180186
44816608	资产标签编号:标识符:时间点:{装置}:名义型	4182948
44816610	Exp; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816610	有效日期:日期:时间点:{装置}:定量型	4182948
44816612	Ident; Identifier; Lot or batch no.; No; Nominal; Num; Point in time; Random	4180186
44816612	Lot or batch no.	4180186
44816612	批号:标识符:时间点:{装置}:名义型	4182948
44816613	Ident; Identifier; No; Nominal; Num; Point in time; Random; Serial #	4180186
44816613	Serial #	4180186
44816613	厂商序列号:标识符:时间点:{装置}:名义型	4182948
44816615	Model #	4180186
44816615	Ident; Identifier; Model #; No; Nominal; Num; Point in time; Random	4180186
44816615	厂商型号:标识符:时间点:{装置}:名义型	4182948
44816616	Device ID	4180186
44816616	Nominal; Point in time; Random; Typ	4180186
44816616	装置标识符:类型:时间点:{装置}:名义型	4182948
44816617	Ident; Identifier; Nominal; Point in time; Random	4180186
44816617	制造商名称:标识符:时间点:{装置}:名义型	4182948
44816618	Ident; Identifier; Nominal; Point in time; Random	4180186
44816618	装置名称:标识符:时间点:{装置}:名义型	4182948
44816619	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44816620	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.AHRQ	4180186
44816623	Agency for Healthcare Research and Quality; AHRQ survey Pnl; Hosp; Pan; Panel; Panl; Pnl; Point in time; Pt safety event; Random; Surg; Survey; SURVEY.AHRQ	4180186
44816625	bod; Bodies; Body Score; H+P; H+P.PX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Scale; Screen; Vet; Veterinary	4180186
44816625	Body Score	4180186
44816625	身体情况评分:评分:时间点:^患者:序数型:杰富瑞斯法	4182948
44816627	ALDP Fib Ql ImStn	4180186
44816627	Adrenoleukodystrophy; ALD protein; ALDP; Fib; Fibr; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; X-ALD; X-linked adrenoleukodystrophy; Zellweger disease	4180186
44816627	肾上腺脑白质营养不良蛋白:存在情况或阈值:时间点:成纤维细胞:序数型:免疫染色法	4182948
44816628	Oligosaccharide Pattern 24h Ur-Imp	4180186
44816628	1 day; 24 hours; 24HR; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Oligosaccharide Pattern; Oligosaccharidoses; Report; UA; UR; Urn	4180186
44816628	低聚糖模式:印象:24小时:尿液:叙述型	4182948
44816631	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Myco; Mycobact; Nominal; Point in time; Prb Mag; Random; ribosomal RNA; species; spp; Tuberculosis; WB; Whole blood	4180186
44816631	Deprecated Mycobacterium rRNA Bld Pos Prb Mag	4180186
44816632	Death cert detail; Document; Finding; Findings; Point in time; Random; Survey; SURVEY.CDC	4180186
44816633	Ident; Identifier; MISC; Nominal; Point in time; Random; Registry; shared health data	4180186
44816633	Health data repository ID	4180186
44816633	健康数据存储库:标识符:时间点:存储库:名义型	4182948
44816634	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; S pyogenes; Screen; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; WB; Whole blood	4180186
44816634	Deprecated S pyogenes hsp60 Bld Pos Ql Prb Mag	4180186
44816638	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; Screen; species; spp; Strep; Strept; WB; Whole blood	4180186
44816638	Deprecated Streptococcus sp tuf Bld Pos Ql Prb Mag	4180186
44816639	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; c162; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; VANC; Vancocin; Vancomycin resistance gene; Vancor; WB; Whole blood	4180186
44816639	Deprecated vanB Bld Pos Ql Prb Mag	4180186
44816641	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; E faecalis; E faecalis hsp60; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
44816641	Deprecated E faecalis hsp60 Bld Pos Ql Prb Mag	4180186
44816643	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; Celbenin; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Metacillin; Methicillin resistance gene; Metin; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Staficyn; Staphicillin; WB; Whole blood	4180186
44816643	Deprecated mecA Bld Pos Ql Prb Mag	4180186
44816645	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; o71; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; S aureus; Screen; Staph; WB; Whole blood	4180186
44816645	Deprecated S aureus gyrB Bld Pos Ql Prb Mag	4180186
44816646	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; Screen; species; spp; Staph; Staph sp tuf; WB; Whole blood	4180186
44816646	Deprecated Staph sp tuf Bld Pos Ql Prb Mag	4180186
44816647	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GP Bld Culture Pnl; ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Pos; Prb Mag; Random; WB; Whole blood	4180186
44816647	Deprecated GP Bld Culture Pnl Bld Pos Prb Mag	4180186
44816650	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PEDv; PEDv RNA; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
44816650	PEDv RNA Ct Spec Qn NAA+probe	4180186
44816650	猪流行性腹泻病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
44816652	Antigens Present Bld Imm Spin	4180186
44816652	Ag; Blood; BLOOD BANK; Identity or presence; Imm Spin; IS; Nominal; Point in time; Random; WB; Whole blood	4180186
44816652	存在血型抗原:存在与否或特征标识:时间点:全血:名义型:立即离心法	4182948
44816656	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EtG; ETG EtS; Ethanol metabolite; ethyl hydrogen sulfate; EtS; GCMS; Gluc; Glucouronide; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid; UA; UR; Urn	4180186
44816656	ETG EtS Ur Ql Cfm	4180186
44816656	硫酸乙酯+乙基葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
44816659	100 RBC; Blood; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Microcyte; Microcytosis; Micros; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood	4180186
44816659	Microcytes/100 RBC NFr Bld	4180186
44816659	小红细胞/100 个红细胞:计数型分数:时间点:全血:定量型	4182948
44816661	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anus; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV E6+E7; HPV E6+E7 mRNA; HPV I/H Risk 4; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 12; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectal specimen; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
44816661	HPV E6+E7 mRNA Anal Ql NAA+probe	4180186
44816661	人乳头瘤病毒 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 型 mRNA:存在情况或阈值:时间点:肛门:序数型:探针法.基因扩增.靶向	4182948
44816664	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B pert; B pert.PT; B pert.PT 100; B pert.PT 100 Ab; B pert.PT 100 IgG; B pertussis; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pertussis; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Whooping cough	4180186
44816664	B pert.PT 100 IgG Ser Ql Line blot	4180186
44816664	百日咳博德特菌.百日咳毒素 100 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
44816670	Agency for Healthcare Research and Quality; AHRQ survey Pnl; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44816671	Imm hevylite Pnl SerPl	4180186
44816671	Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Imm hevylite Pnl; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816671	免疫球蛋白轻链与重链组套:-:时间点:血清/血浆:-	4182948
44816674	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV6; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Papilloma virus low risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
44816674	HPV6 DNA Spec NAA+probe-Log#	4180186
44816674	人乳头瘤病毒 6 型 DNA:对数型数量或计数浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
44816675	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV6; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; Papilloma virus low risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
44816675	HPV6 DNA # Spec NAA+probe	4180186
44816675	人乳头瘤病毒 6 型 DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
44816676	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV11; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Papilloma virus low risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
44816676	HPV11 DNA Spec NAA+probe-Log#	4180186
44816676	人乳头瘤病毒 11 型 DNA:对数型数量或计数浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
44816678	Blood; carnitine palmitoyltransferase 1A (liver); CPT1; CPT1A c.1436C&gt;T; CPT1-L; DBS; Dried blood spot; Filter paper; FP; Genetics; Heredity; Heritable; Inherited; L-CPT1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T prime; WB; Whole blood	4180186
44816678	CPT1A c.1436C>T DBS Ql	4180186
44816678	CPT1A 基因.c.1436C>T:存在情况或阈值:时间点:全血.斑点:序数型:分子遗传学类实验室方法	4182948
44816680	Art; Cardio; Cardiology; Dors pedal a; Dors pedal a-R; Feet; Foot; Heart Disease; Heart Rate; HEART RATE.MOLEC; Mechanical force; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen	4180186
44816680	Pulse intensity Dors pedal a-R Palpation	4180186
44816680	动脉脉搏强度:机械力:时间点:右足背动脉:序数型:触诊法	4182948
44816685	FLUB; FLUBV; FLUBV Vic + Yam RNA Pnl; FLUBV Victoria; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Misc; Miscellaneous; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Ribonucleic acid; Spec; To be specified in another part of the message; Unspecified	4180186
44816685	FLUBV Vic + Yam RNA Pnl Spec	4180186
44816685	流感病毒 B 型 Yamagata 与 Victoria 谱系 RNA 组套:-:时间点:XXX:-	4182948
44816686	Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Lactulose HBT; Lactulose HBT Pnl; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816686	Lactulose HBT Pnl ExG	4180186
44816686	乳果糖刺激组套:-:时间点:呼出的气体:定量型	4182948
44816687	Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Fructose HBT; Fructose HBT Pnl; Gases; Levulose; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Revulose	4180186
44816687	Fructose HBT Pnl ExG	4180186
44816687	果糖刺激组套:-:时间点:呼出的气体:定量型	4182948
44816688	Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Glu; Glu tol; Gluc; Glucose HBT; Glucose HBT Pnl; Glucose tolerance; Glucoseur; GTT; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816688	Glucose HBT Pnl ExG	4180186
44816688	葡萄糖刺激组套:-:时间点:呼出的气体:定量型	4182948
44816689	Lactulose HBT ExG-Imp	4180186
44816689	Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lactulose HBT; Nominal; Point in time; Random	4180186
44816689	乳果糖刺激:印象:时间点:呼出的气体:名义型	4182948
44816691	Chemistry; Horm; Number fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T3 uptake; T3U; T4; Thyroxine Uptake; Triiodothyroinine uptake; T-uptake	4180186
44816691	T-uptake NFr SerPl	4180186
44816691	甲状腺激素摄取:计数型分数:时间点:血清/血浆:定量型	4182948
44816695	Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lactose HBT; LTT; Nominal; Point in time; Random	4180186
44816695	Lactose HBT ExG-Imp	4180186
44816695	乳糖刺激:印象:时间点:呼出的气体:名义型	4182948
44816696	Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Fructose HBT; Gases; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Levulose; Nominal; Point in time; Random; Revulose	4180186
44816696	Fructose HBT ExG-Imp	4180186
44816696	果糖刺激:印象:时间点:呼出的气体:名义型	4182948
44816697	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Gm27; IAA; Immune globulin G; Immunoglobulin G; Level; m27; Mass concentration; MEIA; Penicillium spp; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; RGm27; Rm217; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; SUDS	4180186
44816697	Penicillium IgG IA-mCnc	4180186
44816697	青霉属单个未知种 抗体.IgG:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
44816700	Act/Nor; Activ; Actvty; COAGULATION; Control; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Hematology; Heme; i; IAA; imm 1:1 NP; MEIA; Movements; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SUDS; Von will; Vonwillebrand; vWf; vWf:Ac	4180186
44816700	vWf:Ac Act/Nor imm 1:1 NP PPP IA	4180186
44816700	von Willebrand 因子.活性 实际的/正常的^紧接着在添加1:1正常血浆之后:相对比率:时间点:贫血小板血浆:定量型:免疫测定法	4182948
44816703	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DF-118; DHC; DHCPlus; Drocode; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
44816703	DHC Sal Cfm-mCnc	4180186
44816703	二氢可待因:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
44816704	Mirtazapine Ur Ql	4180186
44816704	Avanza; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Reflex; Remeron; Screen; UA; UR; Urn; Zispin	4180186
44816704	米氮平:存在情况或阈值:时间点:尿液:序数型	4182948
44816708	Aerobe; Aerobe Cult; Aerobed; Anaerobe+Aerobe Cult; Bact; C&S; Cult; Cultures; Eyeball; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Vision; Visual	4180186
44816708	Bacteria Eye Anaerobe+Aerobe Cult	4180186
44816708	细菌 已鉴定的:存在与否或特征标识:时间点:眼睛:名义型:厌氧微生物培养+需氧微生物培养	4182948
44816711	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sparine; Tranquazine; UA; UR; Urn	4180186
44816711	Promazine Ur Ql Scn	4180186
44816711	丙嗪:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
44816714	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C diff; C diff Tox; C diff Tox B; C diff Tox B tcdB; C difficile; Clostridium difficile; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
44816714	C diff Tox B tcdB Stl Ql NAA+probe	4180186
44816714	艰难梭菌毒素 B tcdB 基因:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
44816716	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; POWV; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
44816716	POWV Ab Ser Ql HAI	4180186
44816716	Powassan 病毒 抗体:存在情况或阈值:时间点:血清:序数型:红细胞凝集抑制试验法	4182948
44816718	ABS; Aby; Alphaviruses; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SFV; SR	4180186
44816718	SFV Ab Ser Ql HAI	4180186
44816718	塞姆利基森林病毒 抗体:存在情况或阈值:时间点:血清:序数型:红细胞凝集抑制试验法	4182948
44816719	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SSHV	4180186
44816719	SSHV Ab Ser Ql HAI	4180186
44816719	雪鞋野兔病毒 抗体:存在情况或阈值:时间点:血清:序数型:红细胞凝集抑制试验法	4182948
44816723	Chemistry; Level; Metaneph; Metaneph+Normetaneph; Metaneph+Normetaneph Pnl; Metanephrine fractionated; Metanephrines panel; Metanephrne; Metenephrine; Normeta; Normetaneph; Normetanephrn; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Substance concentration; UA; UR; Urn	4180186
44816723	Deprecated Metaneph+Normetaneph Pnl Ur-sCnc	4180186
44816724	Dose med or substance; DRUG DOSES; Lanzek; Point in time; QNT; Quan; Quant; Quantitative; Random; Zypadhera; Zyprexa	4180186
44816724	OLANZapine Dose	4180186
44816724	奥氮平:质量:时间点:剂量药物或剂量物质:定量型	4182948
44816726	Blood; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Identity or presence; Inherited; MARS2 full mut analysis; methionyl-tRNA synthetase 2, mitochondrial; MetRS; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; mtMetRS; Mut; Mutations; Next generation sequencing; NGS; Nominal; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
44816726	MARS2 Full Mut Anl Bld/T Seq	4180186
44816726	MARS2 基因 全面突变分析:存在与否或特征标识:时间点:全血/组织:名义型:序列测定	4182948
44816727	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Percent; Pnl; Point in time; Porphyrin Fract Pnl; Random; Stl; Stool = Fecal; Substance Fraction	4180186
44816727	Porphyrin Fract Pnl SFr Stl	4180186
44816727	卟啉类成分组套:物质的量分数:时间点:大便:-	4182948
44816729	#; ABS; absolute; absolutes; B1; B-1; Bp35; CD20 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Leu16; Leu-16; Misc; Miscellaneous; Number concentration; Number Concentration (count/vol); Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
44816729	CD20 Cells # Spec	4180186
44816729	细胞.CD20:计数型浓度:时间点:XXX:定量型	4182948
44816730	#; ABS; absolute; absolutes; CD34 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; gp105-120; Hematopoietic stem cell; HSC; Misc; Miscellaneous; My10; My-10; Number concentration; Number Concentration (count/vol); Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Stem cells; To be specified in another part of the message; Unspecified	4180186
44816730	CD34 Cells # Spec	4180186
44816730	细胞.CD34:计数型浓度:时间点:XXX:定量型	4182948
44816731	CD3 Cells; CD3+CD4+ Cells; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Gated cells; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; T3; T4; T-4; T4 helper/inducer cells; To be specified in another part of the message; Unspecified; W3/25	4180186
44816731	CD3-CD4+ NFr Spec	4180186
44816731	细胞.CD3-CD4+/100 个细胞:计数型分数:时间点:XXX:定量型	4182948
44816736	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Baylis sp; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; round worm; Screen; Serum; species; spp; SR; SUDS	4180186
44816736	Baylis sp IgG Ser Ql IA	4180186
44816736	贝利蛔线虫属单个未知种 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
44816737	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SINV; SR	4180186
44816737	SINV Ab Ser Ql HAI	4180186
44816737	辛德毕斯病毒 抗体:存在情况或阈值:时间点:血清:序数型:红细胞凝集抑制试验法	4182948
44816739	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin E; Immunoglobulin E; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T gondii; Toxo; Toxoplasmosis	4180186
44816739	T gondii IgE Ser Ql IA	4180186
44816739	刚地弓形虫 抗体.IgE:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
44816742	Cell; Cellularity; Gated cells; HEMATOLOGY/CELL COUNTS; LN; Lymphoblast; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816742	Lymphoblasts NFr LN Manual	4180186
44816742	淋巴母细胞/100 个细胞:计数型分数:时间点:淋巴结:定量型:手工计数方法	4182948
44816743	Blasts NFr LN Manual	4180186
44816743	Blast; Cell; Cellularity; Gated cells; HEMATOLOGY/CELL COUNTS; LN; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816743	幼稚细胞/100 个细胞:计数型分数:时间点:淋巴结:定量型:手工计数方法	4182948
44816744	Mesothl Cell NFr LN Manual	4180186
44816744	Cell; Cellularity; Gated cells; HEMATOLOGY/CELL COUNTS; LN; Manl; Mesothl; Mesothl Cell; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816744	间皮细胞/100 个细胞:计数型分数:时间点:淋巴结:定量型:手工计数方法	4182948
44816746	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; AIDS; Amplif; Amplification; Amplified; Blood; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
44816746	HIV 1 pro DNA # Bld NAA+probe	4180186
44816746	HIV 1 型 前病毒 DNA:计数型浓度:时间点:全血:定量型:探针法.基因扩增.靶向	4182948
44816747	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
44816747	HIV 1 pro DNA Spec NAA+probe-Log#	4180186
44816747	HIV 1 型 前病毒 DNA:对数型数量或计数浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
44816751	Bld Ethanol Est from SerPl-mCnc	4180186
44816751	Alc; Alcohol; Blood; DRUG/TOXICOLOGY; Drugs; Est; Est from SerPl; estimation; Ethyl alcohol; EtOH; Level; Levels; Levl; LV; LVL; Mass concentration; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random; Ser; SR; WB; Whole blood	4180186
44816751	乙醇:质量浓度:时间点:全血:定量型:基于血清或血浆水平的估计法	4182948
44816754	IgG Kappa SerPl-mCnc	4180186
44816754	Chemistry; heavy chain; IgG Kappa; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816754	IgG.kappa:质量浓度:时间点:血清/血浆:定量型	4182948
44816756	IgA kappa SerPl-mCnc	4180186
44816756	Chemistry; heavy chain; IgA kappa; Immune globulin A; Immunoglobulin A; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816756	IgA.kappa:质量浓度:时间点:血清/血浆:定量型	4182948
44816757	IgA lamba SerPl-mCnc	4180186
44816757	Chemistry; heavy chain; IgA lamba; Immune globulin A; Immunoglobulin A; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816757	IgA.lambda:质量浓度:时间点:血清/血浆:定量型	4182948
44816758	Chemistry; IgM kappa; Immune globulin M; Immunoglobulin M; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816758	IgM kappa SerPl-mCnc	4180186
44816758	IgM.kappa:质量浓度:时间点:血清/血浆:定量型	4182948
44816759	IgM lambda SerPl-mCnc	4180186
44816759	Chemistry; IgM lambda; Immune globulin M; Immunoglobulin M; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816759	IgM.lambda:质量浓度:时间点:血清/血浆:定量型	4182948
44816761	IgA kappa/A lambda SerPl	4180186
44816761	A lambda; Chemistry; heavy chain; IgA kappa; IgA lamba; Immune globulin A; Immunoglobulin A; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816761	IgA.kappa/IgA.lambda:质量比率:时间点:血清/血浆:定量型	4182948
44816762	IgM kappa/M lambda SerPl	4180186
44816762	Chemistry; IgM kappa; IgM lambda; Immune globulin M; Immunoglobulin M; M lambda; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816762	IgM.kappa/IgM.lambda:质量比率:时间点:血清/血浆:定量型	4182948
44816763	Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Level; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Xarelto	4180186
44816763	Rivaroxaban PPP Chro-mCnc	4180186
44816763	利伐沙班:质量浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
44816764	21DC SerPl-mCnc	4180186
44816764	21DC; 21-DF; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816764	21-脱氧皮质醇:质量浓度:时间点:血清/血浆:定量型	4182948
44816768	After; Arg; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood	4180186
44816768	Arginine p diet DBS-sCnc	4180186
44816768	精氨酸^在治疗性饮食之后:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816769	After; Argininosuccinic acid; arginosuccinate; Arginosuccinic acid; ASA; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood	4180186
44816769	Argininosuccinate p diet DBS-sCnc	4180186
44816769	精氨基琥珀酸^在治疗性饮食之后:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816770	After; Blood; C0; Carnitine Free; Carnitine.total; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; FC; Filter paper; FP; FR; Level; Non-protein bound; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood	4180186
44816770	Carnitine Free p diet DBS-sCnc	4180186
44816770	肉碱.游离型 (C0)^在治疗性饮食之后:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816772	After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Level; Ohpro; OH-Proline; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood	4180186
44816772	OH-Proline p diet DBS-sCnc	4180186
44816772	羟基脯氨酸^在治疗性饮食之后:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816773	Isoleucine p diet DBS-sCnc	4180186
44816773	After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Ile; Level; Maple syrup urine disease; MSUD (Maple Syrup Urine Disease); p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood	4180186
44816773	异亮氨酸^在治疗性饮食之后:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816774	After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Leu; Level; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood	4180186
44816774	Leucine p diet DBS-sCnc	4180186
44816774	亮氨酸^在治疗性饮食之后:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816775	After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; Orn; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood	4180186
44816775	Ornithine p diet DBS-sCnc	4180186
44816775	鸟氨酸^在治疗性饮食之后:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816780	DRUG/TOXICOLOGY; Drugs; Level; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sterols Pnl; Substance Concentration	4180186
44816780	Sterols Pnl SerPl-sCnc	4180186
44816780	甾醇类组套:物质的量浓度:时间点:血清/血浆:-	4182948
44816782	Inositol Free/Creat Ur-sRto	4180186
44816782	Chemistry; CR; Crea; Creat; Cyclohexane-1,2,3,4,5,6-hexol; FR; Inositol Free; Myoinositol; myo-inositol; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44816782	肌醇.游离型/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44816789	Chemistry; Level; Lithocholic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816789	Lithocholate SerPl-sCnc	4180186
44816789	石胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816793	Gamma tocopherol EntSub RBC	4180186
44816793	Chemistry; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Vit E; Vitamin E	4180186
44816793	Gamma 生育酚:实体物质的量:时间点:红细胞:定量型	4182948
44816794	Catalytic Content; Cerebrose; Chemistry; GAL-1-P; Gal1PO4; GAL-1-PO4; GAL1PTS; Gal1PUT; GAL-1-PUT; Galactose 1 Phosphate Uridyltransferase; Galactosemia; GALT; GPUT; Hexose-1-phosphate uridyltransferase; i; i Phos; Inorganic phosphate; Leukocytes; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
44816794	Gal1PUT WBC-cCnt	4180186
44816794	半乳糖-1-磷酸尿苷酰转移酶:催化含量:时间点:白细胞:定量型	4182948
44816796	DOPamine CSF-sCnc	4180186
44816796	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44816796	多巴胺:物质的量浓度:时间点:脑脊液:定量型	4182948
44816797	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816797	Desmosterol SerPl-sCnc	4180186
44816797	链甾醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816798	Bili; Bilirubins; Billirubin; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; TBIL	4180186
44816798	Bilirub CSF-sCnc	4180186
44816798	胆红素:物质的量浓度:时间点:脑脊液:定量型	4182948
44816799	B-sitosterol SerPl-sCnc	4180186
44816799	B; B-sitosterol; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816799	Beta 谷甾醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816801	Ca; CaC2O4; Cal; Calc; Calculi; CaOx; Chemistry; Ethanedioate; Ethanedioic acid; Gastro; Gastroenterology; GI; Kidney; Mass Fraction; Nephrology; Oxal; Oxalic acid; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones; Tot; Totl	4180186
44816801	Calcium Oxalate Dihydrate MFr Stone	4180186
44816801	二水草酸钙/总计:质量分数:时间点:结石:定量型	4182948
44816803	Primidone Trough SerPl-mCnc	4180186
44816803	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mysoline; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816803	扑米酮^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816805	Acylglycines Pnl; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UR; Urn	4180186
44816805	Acylglycines Pnl Ur-sRto	4180186
44816805	酰基甘氨酸类组套:物质的量比率:时间点:尿液:-	4182948
44816806	Dolmatil; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SULP; Sulparex; Sulpitil	4180186
44816806	Sulpiride Trough SerPl-mCnc	4180186
44816806	舒必利^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816807	DRUG/TOXICOLOGY; Drugs; Level; LO; Lopressor; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816807	Metoprolol Trough SerPl-mCnc	4180186
44816807	美多洛尔^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816809	1 day; 24 hours; 24HR; Acd; Acid; Bowel movement; Chemistry; Faecal; Faeces; Fatty acid; Fecal; Feces; Lipid; Mass content; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
44816809	FA 24h Stl-mCnt	4180186
44816809	脂肪酸类:质量含量:24小时:大便:定量型	4182948
44816811	G-OH-Butyr Bld-sCnc	4180186
44816811	4-hydroxybutyrate; 4-hydroxybutyric acid; Blood; Chemistry; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Level; Liquidx; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
44816811	Gamma 羟基丁酸:物质的量浓度:时间点:全血:定量型	4182948
44816812	Clobazam metabolite; Desmeth; Desmethylclobazam; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; N-desmethylclobazam; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816812	Deprecated Norclobazam Trough SerPl-mCnc	4180186
44816813	Asp; Aspartic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Left; Level; Levo; NAA; N-Ac-L-Asp; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44816813	N-Ac-L-Asp CSF-sCnc	4180186
44816813	N-乙酰-L-天门冬氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
44816814	Deprecated Temazepam Trough SerPl-mCnc	4180186
44816814	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Normison; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Restoril; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816816	Depixol; DRUG/TOXICOLOGY; Drugs; Fluanxol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816816	Deprecated Flupenthixol Trough SerPl-mCn	4180186
44816817	Barbiturate; c417; DRUG/TOXICOLOGY; Drugs; Level; Luminal; Mass concentration; Nirvonal; PHBR; Phenobarb; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816817	Phenobarb Trough SerPl-mCnc	4180186
44816817	苯巴比妥^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816819	Allopurinol Trough SerPl-mCnc	4180186
44816819	DRUG/TOXICOLOGY; Drugs; Level; Lopurin; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zyloprim	4180186
44816819	别嘌呤醇^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816820	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816820	Deprecated Fluspirilene Trough SerPl-mCn	4180186
44816821	3OH-kynurenin; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44816821	3OH-kynurenin CSF-sCnc	4180186
44816821	3-羟基犬尿氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
44816823	Celexa; Cipramil; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816823	Deprecated Citalopram Trough SerPl-mCnc	4180186
44816824	Deprecated Desalkylfluraz Trough SerPl-m	4180186
44816824	Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Level; Mass concentration; norfludiazepam; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816825	DRUG/TOXICOLOGY; Drugs; Fluphenazine Hydrochloride; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Prolixin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816825	fluPHENAZine Trough SerPl-mCnc	4180186
44816825	氟奋乃静^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816828	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tarasan; Truxal; Truxaletten; Turactan	4180186
44816828	Deprecated Chlorprothixene Trough SerPl-	4180186
44816832	Moclobemide SerPl-mCnc	4180186
44816832	Aurorix; DRUG/TOXICOLOGY; Drugs; Level; Manerix; Mass concentration; MOC; Moclamine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816832	吗氯贝胺:质量浓度:时间点:血清/血浆:定量型	4182948
44816833	Kynurenin CSF-sCnc	4180186
44816833	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Kynurenine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44816833	犬尿氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
44816838	Clomipramine metabolite; Desmeth; Desmethylclomip; Desmethylclomipramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816838	Deprecated Norclomipramine Trough SerPl-	4180186
44816839	FLUoxetine+Nor Trough SerPl-mCnc	4180186
44816839	(S)-Norfluoxetine; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; Level; Mass concentration; Norfluoxetin; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Prozac; QNT; Quan; Quant; Quantitative; Random; Seproxetine; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816839	氟西汀+去甲基氟西汀^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816841	Catalytic Content; Chemistry; Galactosylceramidase; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
44816841	Deprecated Galactocerebrosidase WBC-cCnt	4180186
44816842	DRUG/TOXICOLOGY; Drugs; E-10-OH-NT; Level; Mass concentration; Nortriptyline metabolite; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816842	Deprecated E-10-OH-NT Trough SerPl-mCnc	4180186
44816850	Deprecated fluvoxaMINE Trough SerPl-mCnc	4180186
44816850	DRUG/TOXICOLOGY; Drugs; Level; Luvox; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816853	Maprotiline Trough SerPl-mCnc	4180186
44816853	DRUG/TOXICOLOGY; Drugs; Level; Ludiomil; Mass concentration; Novartis; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816853	马普替林^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816856	DRUG/TOXICOLOGY; Drugs; Haldol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Serenace; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816856	Haloperidol Trough SerPl-mCnc	4180186
44816856	氟哌啶醇^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816860	Deprecated Methotrimeprazine Trough SerP	4180186
44816860	DRUG/TOXICOLOGY; Drugs; Hirnamin; Lepurin; Lerium; Levamin; Level; Levohalte; Levomazine; Levomeprazine; Levomeproma; Levomepromazin; Levomepromazina; Levomepromazine; Levomezine; Levonormal; Levopromazine; Levoprome; Levotomin; Levozan; Levozin; Mass concentration; Methotrimeprazine; Milezin; Minozinan; Neozine; Neuractil; Neurocil; Neurozil; Novo-Meprazine; Nozinan; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Procrazine; QNT; Quan; Quant; Quantitative; Random; Ronexine; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinogan; Sofmin; Specia 246; SR; Tisercin; Tisercine; Tisercinetta; Tisercinettes; Veractil	4180186
44816861	Acetylsalicylate Trough SerPl-mCnc	4180186
44816861	Acetylsalicylic acid; ASA; Aspirin; c207; c217; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816861	乙酰水杨酸^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816862	Ciatyl; Cisordinol; Clopixol; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Sedanxol; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sordinol; SR; Zuclopenthixol	4180186
44816862	Deprecated Clopenthixol Trough SerPl-mCn	4180186
44816863	9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; DRUG/TOXICOLOGY; Drugs; Invega; Level; Mass concentration; Paliperidone; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Risperidone metabolite; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816863	Deprecated 9OH-risperiDONE Trough SerPl-	4180186
44816864	Carbamazapine; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; Level; Mass concentration; Neuro; Neurology; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril	4180186
44816864	carBAMazepine Trough SerPl-mCnc	4180186
44816864	卡马西平^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816865	Carbamazapine; carBAMazepine free; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; FR; Level; Mass concentration; Neuro; Neurology; Non-protein bound; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril	4180186
44816865	carBAMazepine free Trough SerPl-mCnc	4180186
44816865	卡马西平.游离型^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816866	Nordiazepam Trough SerPl-mCnc	4180186
44816866	Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Pl; Plasma; Plsm; Point in time; Praxadium; Prazepam metabolite; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stilny; Tranxilium N; Vegesan	4180186
44816866	去甲基安定^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816869	Aryl sulfatase A; Aryl sulfatase B; Arylsulfatase A; Arylsulfatase A+ B Pnl; Arylsulfatase A+B; Arylsulfatase B; Catalytic Content; Chemistry; GalNAc6S sulfatase; Leukocytes; Maroteaux-Lamy disease; Metachromatic leucodystrophy; MPS VI; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; rh4S; rhASB; WBCs; White blood cells	4180186
44816869	Arylsulfatase A+ B Pnl WBC-cCnt	4180186
44816869	脑苷脂硫酸酯酶与N-乙酰半乳糖胺-4-硫酸酯酶组套:催化含量:时间点:白细胞:-	4182948
44816870	Bronchial alveolar lavage; Bronchoalveolar lavage; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; Urates; Uric acid	4180186
44816870	Urate BAL-sCnc	4180186
44816870	尿酸:物质的量浓度:时间点:支气管肺泡灌洗液:定量型	4182948
44816871	Ativan; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816871	LORazepam Trough SerPl-mCnc	4180186
44816871	氯羟安定^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816873	FLUoxetine Trough SerPl-mCnc	4180186
44816873	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Prozac; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816873	氟西汀^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816875	Catalytic Content; Chemistry; FADH2; Ferredoxin; Lymphblst; MTHFR; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816875	MTHFR Lymphblst-cCnt	4180186
44816875	5,10-亚甲基四氢叶酸还原酶:催化含量:时间点:淋巴母细胞:定量型	4182948
44816876	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Niravam; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xanax	4180186
44816876	Alpraz Trough SerPl-mCnc	4180186
44816876	阿普唑仑^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816878	Deprecated Pericyazine Trough SerPl-mCnc	4180186
44816878	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Neulactil; Periciazine; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Propericiazine; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816884	Chloride+sodium Pnl Sweat-sCnc	4180186
44816884	Chemistry; Chloride+sodium Pnl; Cl; Cl-; Level; Na; Na+; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; SWT	4180186
44816884	氯化物与钠组套:物质的量浓度:时间点:汗液:定量型	4182948
44816885	Beta crosslaps; Carboxyterminal cross-linking telopeptide of bone collagen; Chemistry; Collagen CTx; CrossLaps; C-Telopeptide of Type I Collagen; CTx; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Standard score; Z score; Z value; Z-score	4180186
44816885	Collagen CTx Z-score SerPl	4180186
44816885	胶原交联 C-末端肽:Z评分:时间点:血清/血浆:定量型	4182948
44816886	Osteocalcin Z-score SerPl	4180186
44816886	Chemistry; OC; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPARC; SR; Standard score; Z score; Z value; Z-score	4180186
44816886	骨钙素:Z评分:时间点:血清/血浆:定量型	4182948
44816888	A1; A1A; A1AT; A-1-AT; A1-AT; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Hepatology; i; Liver; Lung; Mass Content; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Stl; Stool = Fecal	4180186
44816888	A1AT Stool.dried-mCnt	4180186
44816888	Alpha 1 抗胰蛋白酶:质量含量:时间点:大便.干:定量型	4182948
44816889	MTHFR Fib-cCnt	4180186
44816889	Catalytic Content; Chemistry; FADH2; Ferredoxin; Fib; Fibr; MTHFR; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816889	5,10-亚甲基四氢叶酸还原酶:催化含量:时间点:成纤维细胞:定量型	4182948
44816890	Catalytic Content; Chemistry; FADH2; Ferredoxin; Leukocytes; MTHFR; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
44816890	MTHFR WBC-cCnt	4180186
44816890	5,10-亚甲基四氢叶酸还原酶:催化含量:时间点:白细胞:定量型	4182948
44816895	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bos spp; f026; f027; f083; f088; f26; f27; f83; f88; Food Allergen Mix fp73; Food Allergen Mix fx73; FP73; fx73; Gallus spp; Immune globulin E; Immunoglobulin E; Mutton; Ovis spp; Pig; Point in time; Porcine; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sus spp; Swine	4180186
44816895	Food Allergen Mix fp73 IgE Qn	4180186
44816895	(牛肉+鸡肉+猪肉+羊肉) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
44816897	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Buchwheat; Buckwheat; Corn; Crab; f008; f010; f011; f023; f024; f10; f11; f141; f23; f24; f74; f8; Food Allerg Mix E; FP8; Immune globulin E; Immunoglobulin E; Maize; Point in time; Prawns; QNT; Quan; Quant; Quantitative; Random; Serum; Sesame Seed; Sesamum orientale; Shrimp; SR	4180186
44816897	Food Allerg Mix E IgE Qn	4180186
44816897	(黄道蟹+荞麦+长额虾+芝麻籽+玉蜀黍) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
44816901	Acute myeloid leukemia; AML; BM; BON; Bone marrow; DNA; gene fusion; gene translocation; inv(16)(CBFB,MYH11) gene inversion; inv(16)(p13;q22); Inversion 16; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.INV; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; translocation	4180186
44816901	inv(16)(p13;q22) Mar Ql	4180186
44816901	inv(16)(p13.1;q22.1)(MYH11,CBFB) 融合转录物:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
44816903	AF4; ALL1; ALL-1; BM; BON; Bone marrow; DNA; FEL; gene fusion; gene translocation; Homolog of trithorax; HRX; HTRX; HTRX1; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; MLLT2; Molecular genetics; Molecular pathology; MOLPATH; myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); Myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila)); Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(4,11)(MLLT2,MLL) gene translocation; t(4;11)(AFF1,MLL); translocation; TRX1	4180186
44816903	t(4;11)(AFF1,MLL) Mar Ql	4180186
44816903	t(4;11)(q21.3;q23)(AFF1,MLL) 融合转录物:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
44816905	ABL; BM; BON; Bone marrow; DNA; ets variant gene 6; gene fusion; gene translocation; JTK7; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; p150; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(9;12)(ABL1,ETV6); TEL; Tel oncogene; TEL1; translocation; Translocation ets leukemia; v-abl Abelson murine leukemia viral oncogene homolog 1	4180186
44816905	t(9;12)(ABL1,ETV6) Mar Ql	4180186
44816905	t(9;12)(q34.1;p13)(ABL1,ETV6) 融合转录物:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
44816908	ABL; ALL; bcr/abl; BCR1; bcr-abl1; BM; BON; Bone marrow; Breakpoint cluster region; Chronic myeloid leukemia; CML; D22S11; D22S662; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; major breakpoints; MAR; Marrow (bone); Mbr; Mcr; minimal angle of resolution; Minimum angle of resolution; minor breakpoints; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; p150; PCR; Ph chromosome; Philadelphia chromosome; PHL; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(9,22)(ABL1,BCR) gene translocation; t(9,22)(ABL1,BCR) p230 gene translocation; t(9,22)(ABL1,BCR) Translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(ABL1,BCR); t(ABL1,BCR)e19a2; translocation; v-abl Abelson murine leukemia viral oncogene homolog 1	4180186
44816908	t(ABL1,BCR)e19a2 Mar Ql	4180186
44816908	t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 融合转录物:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
44816909	ABL; ALL; bcr/abl; BCR1; bcr-abl1; Blood; Breakpoint cluster region; Chronic myeloid leukemia; CML; D22S11; D22S662; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; major breakpoints; Mbr; Mcr; minor breakpoints; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; p150; PCR; Ph chromosome; Philadelphia chromosome; PHL; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(9,22)(ABL1,BCR) gene translocation; t(9,22)(ABL1,BCR) p230 gene translocation; t(9,22)(ABL1,BCR) Translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(ABL1,BCR); t(ABL1,BCR)e19a2; Tissue; Tissue, unspecified; translocation; v-abl Abelson murine leukemia viral oncogene homolog 1; WB; Whole blood; Whole blood or Tissue	4180186
44816909	t(ABL1,BCR)e19a2 Bld/T Ql	4180186
44816909	t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 融合转录物:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
44816911	ABL; ALL; bcr/abl; BCR1; bcr-abl1; BM; BON; Bone marrow; Breakpoint cluster region; Chronic myeloid leukemia; CML; D22S11; D22S662; DNA; Document; Finding; Findings; gene fusion; gene translocation; JTK7; major breakpoints; MAR; Marrow (bone); Mbr; Mcr; minimal angle of resolution; Minimum angle of resolution; minor breakpoints; Molecular genetics; Molecular pathology; MOLPATH; p150; PCR; Ph chromosome; Philadelphia chromosome; PHL; Point in time; Random; RNA; T prime; t(9,22)(ABL1,BCR) gene translocation; t(9,22)(ABL1,BCR) Translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(ABL1,BCR); translocation; v-abl Abelson murine leukemia viral oncogene homolog 1	4180186
44816911	t(9;22)(ABL1,BCR) Mar	4180186
44816911	t(9;22)(q34.1;q11)(ABL1,BCR) 融合转录物:发现:时间点:骨髓:文档型:分子遗传学类实验室方法	4182948
44816912	OLANZapine Pnl SerPl	4180186
44816912	DRUG/TOXICOLOGY; Drugs; Lanzek; OLANZapine Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zypadhera; Zyprexa	4180186
44816912	奥氮平组套:-:时间点:血清/血浆:-	4182948
44816914	Baso; Basophil; Basophil activation test; Basos; BAT; Blood; Bph; CD63 Basophils; CELL MARKERS; Dynamic; FC; gp53; gp55; Granulophysin; LAMP-3; LIMP; lysosomal-membrane-associated glycoprotein 3; ME491; Melanoma-associated antigen; MLA1; Neuroglandular antigen; NGA; Number fraction; Percent; Point in time; PTLGP40; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
44816914	CD63 Basophils NFr Bld FC	4180186
44816914	嗜碱性粒细胞.CD63/100 个嗜碱性粒细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
44816915	Bowel movement; Chemistry; Copro; Copro1; Coproporph; Coproporphyrin I; Coproporphyrins; Faecal; Faeces; Fecal; Feces; Hematology; Heme; i; Percent; Point in time; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Fraction; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; Tot; Totl	4180186
44816915	Copro1 SFr Stl	4180186
44816915	粪卟啉 I/卟啉.总计:物质的量分数:时间点:大便:定量型	4182948
44816917	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Percent; Point in time; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Fraction; Tot; Totl	4180186
44816917	Deuteropor SFr Stl	4180186
44816917	次卟啉/卟啉.总计:物质的量分数:时间点:大便:定量型	4182948
44816919	Bowel movement; Chemistry; Dicarboxyl porphyrin; Dicarboxylporphyrin; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Percent; Point in time; Porph; Porphyrin; Protoporph; Protoporphrn; Protoporphyrins; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Fraction; Tot; Totl	4180186
44816919	Protopor SFr Stl	4180186
44816919	原卟啉/卟啉.总计:物质的量分数:时间点:大便:定量型	4182948
44816921	FDA label Whlsale drg dist+3rd prty reg	4180186
44816921	3rd; DOCUMENT.REGULATORY; Drugs; FDA label; Narrative; Report; Whlsale drg dist+3rd prty reg	4180186
44816921	药物批发分销商与第三方物流设施注册:-:-:^FDA 产品标签:叙述型	4182948
44816922	DOCUMENT.REGULATORY; Drugs; FDA label; Human comp drug label; Narrative; Report	4180186
44816922	FDA label Human comp drug label	4180186
44816922	人类复方药物标签:-:-:^FDA 产品标签:叙述型	4182948
44816923	BM; BON; Bone marrow; C/EBP-alpha; CCAAT/enhancer binding protein (C/EBP), alpha; CEBP; Document; Familial AML; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region	4180186
44816923	CEBPA gene Full Mut Anl Mar Seq	4180186
44816923	CEBPA 基因 全面突变分析:发现:时间点:骨髓:文档型:序列测定	4182948
44816925	B23; BM; BON; Bone marrow; Genetics; Heredity; Heritable; Identity or presence; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; NPM; Nucleolar phosphoprotein b23; nucleophosmin (nucleolar phosphoprotein B23, numatrin); Numatrin; PCR; Point in time; Random	4180186
44816925	NPM1 gene Mut Anl Mar	4180186
44816925	NPM1 基因 突变分析:存在与否或特征标识:时间点:骨髓:名义型:分子遗传学类实验室方法	4182948
44816926	Oxytocin Sal-sCnc	4180186
44816926	DRUG/TOXICOLOGY; Drugs; Level; Ocytocin; Oral fluid; OXT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
44816926	催产素:物质的量浓度:时间点:唾液:定量型	4182948
44816928	2OH-gluterate DBS-sCnc	4180186
44816928	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
44816928	2-羟基戊二酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816929	Acd; Acids; Bile Ac Pattern; Bile acid.total; Bile salt; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816929	Bile Ac Pattern SerPl-Imp	4180186
44816929	胆汁酸模式:印象:时间点:血清/血浆:叙述型	4182948
44816930	BIOPT; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816930	Biopterin SerPl-sCnc	4180186
44816930	生物蝶呤:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816931	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dextro; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44816931	D-Lactate CSF-sCnc	4180186
44816931	D-乳酸:物质的量浓度:时间点:脑脊液:定量型	4182948
44816932	Pyridoxal SerPl-sCnc	4180186
44816932	C8H9NO3; Chemistry; Level; Pl; Plasma; Plsm; Point in time; Pyridoxaldehyde; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit B6; Vitamin B6; Vitamin B6 hydrochloride	4180186
44816932	吡哆醛:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816933	C8H9NO3; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; Pyridoxaldehyde; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Vit B6; Vitamin B6; Vitamin B6 hydrochloride	4180186
44816933	Pyridoxal CSF-sCnc	4180186
44816933	吡哆醛:物质的量浓度:时间点:脑脊液:定量型	4182948
44816935	Sepiapterin/Creat Ur-sRto	4180186
44816935	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Sepiapterine; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44816935	墨蝶呤/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44816936	Sialate Amn-sCnc	4180186
44816936	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Level; N-Acetylneuraminic Acid; Point in time; QNT; Quan; Quant; Quantitative; Random; SA; Sialic acid; Substance concentration	4180186
44816936	唾液酸:物质的量浓度:时间点:羊水:定量型	4182948
44816939	THfolate CSF-sCnc	4180186
44816939	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; FH4; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Tetrahydrofolic acid; THF; THFA; THfolate	4180186
44816939	四氢叶酸:物质的量浓度:时间点:脑脊液:定量型	4182948
44816940	Thiosulfate Ur-sCnc	4180186
44816940	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Thiosulphate; UA; UR; Urn	4180186
44816940	硫代硫酸盐:物质的量浓度:时间点:尿液:定量型	4182948
44816941	Chemistry; Coenzyme Q10; CoQ10; CO-Q10; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Ubiquinone10	4180186
44816941	Ubiquinone10 SerPl-sCnc	4180186
44816941	泛醌 10:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816944	A-L-Iduronidase SerPl-cCnc	4180186
44816944	Alfa; Catalytic Concentration; Chemistry; Hurler disease; Left; Levo; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scheie disease; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816944	Alpha-L-艾杜糖苷酶:催化浓度:时间点:血清/血浆:定量型	4182948
44816947	C8H10NO6P; C8H9NO3; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Codecarboxylase; i Phos; Inorganic phosphate; Level; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PLP; PO4; Point in time; Pyridoxal 5-Phosphate; Pyridoxaldehyde; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Vit B6; Vit B6 coenzyme; Vitamin B6; Vitamin B6 coenzyme; Vitamin B6 hydrochloride	4180186
44816947	Pyridoxal Phos CSF-sCnc	4180186
44816947	磷酸吡哆醛:物质的量浓度:时间点:脑脊液:定量型	4182948
44816950	Catalytic Content; Chemistry; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816950	Transaldolase Fib-cCnt	4180186
44816950	转醛醇酶:催化含量:时间点:成纤维细胞:定量型	4182948
44816951	Pantothenate/Creat Ur-sRto	4180186
44816951	Chemistry; CR; Crea; Creat; Pantothenic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn; Vit B5; Vitamin B5	4180186
44816951	泛酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44816952	Malonate SerPl-sCnc	4180186
44816952	Chemistry; Level; Malonic acid; Pl; Plasma; Plsm; Point in time; Propanedioate; Propanedioic acid; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816952	丙二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816954	Glycerate SerPl-sCnc	4180186
44816954	Chemistry; Glyceric acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816954	甘油酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816957	Chemistry; Level; Pantothenic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit B5; Vitamin B5	4180186
44816957	Pantothenate SerPl-sCnc	4180186
44816957	泛酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816958	Indole-3-acetate SerPl-sCnc	4180186
44816958	Acetic acid; Chemistry; Ethanoate; Ethanoic acid; IA; IAA; III; Indole-3-acetic acid; Indoleacetate; Indoleacetic acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816958	吲哚-3-乙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816960	Benzyl alcohol metabolite; Chemistry; Hipp; Hippramine; Hippuran; Hippuric acid; Hiprex; HIP-REX; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Toluene metabolite; Urex; Urotractan	4180186
44816960	Hippurate SerPl-sCnc	4180186
44816960	马尿酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816962	ACET; Acetamidophenol; Acetaminoph; Acetominophen; APAP; c209; C55; Chemistry; CR; Crea; Creat; Hydroxyacetanilide; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tylenol; u209; UA; UCr; UR; Urn	4180186
44816962	APAP/Creat Ur-sRto	4180186
44816962	对乙酰氨基酚/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44816964	Chemistry; Level; Octanedioate; Octanedioic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Suberic acid; Substance concentration	4180186
44816964	Suberate SerPl-sCnc	4180186
44816964	辛二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816966	Vanillate SerPl-sCnc	4180186
44816966	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vanillic acid	4180186
44816966	香子兰酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816971	Fumarate SerPl-sCnc	4180186
44816971	Chemistry; Fumaric acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816971	延胡索酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816972	1-Propene-1,2,3-tricarboxylic acid; Aconitic acid; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816972	Aconitate SerPl-sCnc	4180186
44816972	乌头酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816973	Sebacate SerPl-sCnc	4180186
44816973	Chemistry; Decanedioate; Decanedioic acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sebacic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816973	癸二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816974	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; HGA; Homogen; Homogentisic acid; Homogentistic acid; Melanate; Melanic acid; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44816974	Homogentisate/Creat 24h Ur-sRto	4180186
44816974	尿黑酸/肌酐:物质的量比率:24小时:尿液:定量型	4182948
44816980	Catechol/Creat Ur-sRto	4180186
44816980	1,2-benzenediol; 1,2-dihydroxybenzene; 2-hydroxyphenol; Benzene, o-dihydroxy-; Chemistry; CR; Crea; Creat; O-diphenol; Ortho-benzenediol; Ortho-dihydroxybenzene; Ortho-dioxybenzene; Ortho-hydroquinone; Ortho-hydroxyphenol; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44816980	儿茶酚/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44816981	Birthdate; Date of birth; DOB; Fetal; Gyn; Gynecology; OB; ObGyn; Obstetrics; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816981	Birth Date Act Fetus	4180186
44816981	出生日期:日期:时间点:^胎儿:定量型	4182948
44816982	After; Blood; Cerebrose; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Galactose tolerance test; Level; Mass concentration; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ther; WB; Whole blood	4180186
44816982	Galactose p diet DBS-mCnc	4180186
44816982	半乳糖^在治疗性饮食之后:质量浓度:时间点:全血.斑点:定量型	4182948
44816983	After; Blood; Catalytic Concentration; Cerebrose; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; GAL-1-P; Gal1PO4; GAL-1-PO4; GAL1PTS; Gal1PUT; GAL-1-PUT; Galactose 1 Phosphate Uridyltransferase; Galactose tolerance test; Galactosemia; GALT; GPUT; Hexose-1-phosphate uridyltransferase; i; i Phos; Inorganic phosphate; p diet; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ther; WB; Whole blood	4180186
44816983	Gal1PUT p diet DBS-cCnc	4180186
44816983	半乳糖-1-磷酸尿苷酰转移酶^在治疗性饮食之后:催化浓度:时间点:全血.斑点:定量型	4182948
44816986	C20:5w3; Chemistry; Eicosapentaenoic acid; Entitic substance; EPA; Erythrocytes; Icosapentaenoate; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Timnodonate; Timnodonic Acid	4180186
44816986	EPA EntSub RBC	4180186
44816986	二十碳五烯酸:实体物质的量:时间点:红细胞:定量型	4182948
44816988	Laurate EntSub RBC	4180186
44816988	C12:0; Chemistry; Dodecanoate; Dodecanoic acid; Entitic substance; Erythrocytes; Lauric acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44816988	月桂酸:实体物质的量:时间点:红细胞:定量型	4182948
44816989	FA EntSub RBC	4180186
44816989	Acd; Acid; Chemistry; Entitic substance; Erythrocytes; Fatty acid; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44816989	脂肪酸类:实体物质的量:时间点:红细胞:定量型	4182948
44816991	C18:1w9; Chemistry; Entitic substance; Erythrocytes; Oleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44816991	Oleate EntSub RBC	4180186
44816991	油酸:实体物质的量:时间点:红细胞:定量型	4182948
44816992	Myristate EntSub RBC	4180186
44816992	C14:0; Chemistry; Entitic substance; Erythrocytes; Myristic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Tetradecanoate; Tetradecanoic acid	4180186
44816992	肉豆蔻酸:实体物质的量:时间点:红细胞:定量型	4182948
44816995	5,8,11-Eicosatrienoic acid; 5,8,11-Icosatrienoic acid; Acd; Acids; C20:3w9; Chemistry; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44816995	Mead acid EntSub RBC	4180186
44816995	蜜酒酸:实体物质的量:时间点:红细胞:定量型	4182948
44816997	Arachidic acid; C20:0; Chemistry; Eicosanoate; Eicosanoic acid; Entitic substance; Erythrocytes; Icosanoate; Icosanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44816997	Arachidate EntSub RBC	4180186
44816997	二十烷酸:实体物质的量:时间点:红细胞:定量型	4182948
44816998	Acd; Acid; Aliphatic carboxylate; Chains; Chemistry; Chn; Entitic substance; Erucate; Erucic acid; Erythrocytes; Fatty acid; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; VLC; VLCF; VLCFA; VLCFA.C22:1n9	4180186
44816998	VLCFA.C22:1n9 EntSub RBC	4180186
44816998	脂肪酸类.极长链型.C22:1n9:实体物质的量:时间点:红细胞:定量型	4182948
44817004	Palmitate EntSub RBC	4180186
44817004	C16:0; Chemistry; Entitic substance; Erythrocytes; Hexadecanoate; Hexadecanoic acid; Palmitic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44817004	棕榈酸:实体物质的量:时间点:红细胞:定量型	4182948
44817006	C18:2w6; Chemistry; cis-9, cis-12-octadecadienoate; cis-9, cis-12-octadecadienoic acid; Entitic substance; Erythrocytes; Linoleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44817006	Linoleate EntSub RBC	4180186
44817006	亚油酸:实体物质的量:时间点:红细胞:定量型	4182948
44817007	Octadecanoate EntSub RBC	4180186
44817007	1-Heptadecanecarboxylic acid; C18:0; C18H36O2; Cetylacetic acid; Chemistry; Elaidate; Entitic substance; Erythrocytes; Octadecanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Stearate; Stearic acid	4180186
44817007	十八烷酸:实体物质的量:时间点:红细胞:定量型	4182948
44817009	Octanoate EntSub RBC	4180186
44817009	C8:0; Caprylic acid; Capryloate; Chemistry; Entitic substance; Erythrocytes; Octanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44817009	辛酸:实体物质的量:时间点:红细胞:定量型	4182948
44817010	5-Methyluracil; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817010	Thymine SerPl-sCnc	4180186
44817010	胸腺嘧啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817011	Deoxyadenosine SerPl-sCnc	4180186
44817011	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817011	脱氧腺嘌呤核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817012	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817012	Hypoxanthine CSF-sCnc	4180186
44817012	次黄嘌呤:物质的量浓度:时间点:脑脊液:定量型	4182948
44817013	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817013	Deoxyadenosine CSF-sCnc	4180186
44817013	脱氧腺嘌呤核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817014	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817014	Orotidine SerPl-sCnc	4180186
44817014	乳清酸核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817017	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817017	Uracil CSF-sCnc	4180186
44817017	尿嘧啶:物质的量浓度:时间点:脑脊液:定量型	4182948
44817020	Adenine SerPl-sCnc	4180186
44817020	B4 Hemosan; Chemistry; Leuco-4; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit B4; Vitamin B4	4180186
44817020	腺嘌呤:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817022	B4 Hemosan; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Leuco-4; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Vit B4; Vitamin B4	4180186
44817022	Adenine CSF-sCnc	4180186
44817022	腺嘌呤:物质的量浓度:时间点:脑脊液:定量型	4182948
44817023	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817023	Deoxyguanosine SerPl-sCnc	4180186
44817023	脱氧鸟嘌呤核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817025	ADO CSF-sCnc	4180186
44817025	ADO; ANED; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Medication stress; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817025	腺苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817028	Urate CSF-sCnc	4180186
44817028	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; UA; Urates; Uric acid	4180186
44817028	尿酸:物质的量浓度:时间点:脑脊液:定量型	4182948
44817029	Allantoine CSF-sCnc	4180186
44817029	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817029	尿囊素:物质的量浓度:时间点:脑脊液:定量型	4182948
44817030	5-amino imidazole carboxamide riboside; AICAR; AICA-riboside; Amino imidazole carboxamide riboside; Aminoimidazole carboxamide riboside; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817030	Acadesine CSF-sCnc	4180186
44817030	阿卡地新:物质的量浓度:时间点:脑脊液:定量型	4182948
44817031	ADO SerPl-sCnc	4180186
44817031	ADO; ANED; Chemistry; Level; Medication stress; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817031	腺苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817032	Deoxyuridine CSF-sCnc	4180186
44817032	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; dU; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817032	脱氧尿嘧啶核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817033	Xanthine SerPl-sCnc	4180186
44817033	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817033	黄嘌呤:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817034	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; S-Ado; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817034	Succinyladenosine SerPl-sCnc	4180186
44817034	琥珀酰腺苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817035	SAICAR SerPl-sCnc	4180186
44817035	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SAICAR; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817035	琥珀酰氨基咪唑氨甲酰核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817036	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SAICAR; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817036	SAICAR CSF-sCnc	4180186
44817036	琥珀酰氨基咪唑氨甲酰核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817037	Orotidine CSF-sCnc	4180186
44817037	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817037	乳清酸核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817038	Deoxyguanosine CSF-sCnc	4180186
44817038	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817038	脱氧鸟嘌呤核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817039	Inosine SerPl-sCnc	4180186
44817039	Chemistry; Hypoxanthosine; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817039	次黄嘌呤核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817040	5-amino imidazole carboxamide riboside; AICAR; AICA-riboside; Amino imidazole carboxamide riboside; Aminoimidazole carboxamide riboside; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44817040	Acadesine/Creat Ur-sRto	4180186
44817040	阿卡地新/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44817042	Thymine CSF-sCnc	4180186
44817042	5-Methyluracil; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817042	胸腺嘧啶:物质的量浓度:时间点:脑脊液:定量型	4182948
44817044	Allantoine/Creat Ur-sRto	4180186
44817044	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44817044	尿囊素/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44817045	Thymidine CSF-sCnc	4180186
44817045	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Deoxythymidine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817045	胸腺嘧啶脱氧核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817046	Deoxyinosine CSF-sCnc	4180186
44817046	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817046	脱氧肌苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817048	Uridine SerPl-sCnc	4180186
44817048	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817048	尿嘧啶核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817049	ADO; ANED; Chemistry; CR; Crea; Creat; Medication stress; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44817049	ADO/Creat Ur-sRto	4180186
44817049	腺苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44817050	Activ; Actvty; bi-level positive airway pressure; continuous positive airway pressure; Finding; Findings; Lung; Movements; Ordinal; Point in time; PULMONARY; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
44817050	BPAP activity Vent	4180186
44817050	BPAP 活动性:发现:时间点:呼吸机:序数型	4182948
44817051	Activ; Actvty; biphasic positive airway pressure; Finding; Findings; Lung; Movements; Ordinal; PeV+; Point in time; PULMONARY; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
44817051	BIPAP activity Vent	4180186
44817051	BIPAP 活动:发现:时间点:呼吸机:序数型	4182948
44817052	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Mat; Maternal; Matnl; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC; Tri first prenatal visit	4180186
44817053	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
44817054	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
44817056	Mat; Maternal; Matnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
44817057	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
44817058	Dilution factor; Dilution Factor (Titer); Mat; Maternal; Matnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC; Titer; Titered; Titre; Ttr	4180186
44817059	Mat; Maternal; Matnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
44817060	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
44817061	Dilution factor; Dilution Factor (Titer); Mat; Maternal; Matnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC; Titer; Titered; Titre; Ttr	4180186
44817063	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Mat; Maternal; Matnl; Nominal; Point in time; Random; Survey; SURVEY.CDC; Typ	4180186
44817065	Mat; Maternal; Matnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
44817066	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Mat; Maternal; Matnl; Nominal; Point in time; Random; Survey; SURVEY.CDC; Typ	4180186
44817068	AIDS; Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Gestation; Gestations; Gravida; Human immunodeficiency virus; Mat; Maternal; Matnl; Nominal; Point in time; Pregnancies; Random; Survey; SURVEY.CDC	4180186
44817070	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Gestation; Gestations; Gravida; Mat; Maternal; Matnl; Nominal; Point in time; Pregnancies; Random; Survey; SURVEY.CDC	4180186
44817071	Gestation; Gestations; Gravida; Mat; Maternal; Matnl; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC; Tx	4180186
44817072	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Ordinal; PCN; Pen; Penicilloyl; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC; Wycillin	4180186
44817073	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Nominal; PCN; Pen; Penicilloyl; Point in time; Random; Survey; SURVEY.CDC; Tx; Wycillin	4180186
44817075	Birth status; Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
44817076	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Reac; React; Screen; Survey; SURVEY.CDC	4180186
44817077	Point in time; QNT; Quan; Quant; Quantitative; Random; Reac; React; Survey; SURVEY.CDC	4180186
44817079	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Reac; React; Screen; Survey; SURVEY.CDC	4180186
44817080	Point in time; QNT; Quan; Quant; Quantitative; Random; Reac; React; Survey; SURVEY.CDC	4180186
44817081	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Nominal; Point in time; Random; St; Stains; Stn; Survey; SURVEY.CDC	4180186
44817083	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
44817086	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.CDC; Tx	4180186
44817087	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
44817088	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Pan; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC; Treponema pallidum	4180186
44817089	Mat; Maternal; Matnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
44817092	Before; LMP; LMP Start date; Mat; Maternal; Matnl; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
44817093	Arbitrary; Centers for Disease Control and Prevention; Mat; Maternal; Matnl; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
44817096	Arbitrary; Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
44817097	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Mat; Maternal; Maternal Info Sec; Matnl; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
44817099	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
44817100	C3+C16 DBS-sCnc	4180186
44817100	Blood; C16; C3; C3+C16; C3-carntitine; Chemistry; DBS; Dried blood spot; Filter paper; FP; Hexadecanoylcarnitine; Level; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
44817100	丙酰肉碱 (C3)+棕榈酰肉碱 (C16):物质的量浓度:时间点:全血.斑点:定量型	4182948
44817101	Malonylcarn/C10 DBS-sRto	4180186
44817101	Blood; C10; C3DC; C3-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
44817101	丙二酰肉碱 (C3-DC)/癸酰肉碱 (C10):物质的量比率:时间点:全血.斑点:定量型	4182948
44817102	3-Hydroxy butyrylcarnitine; 3-hydroxybutylcarnitine; 3-hydroxy-butylcarnitine; 3OH-Butyrcarn; Blood; C10; C3DC; C3-DC; C3DC+C4OH; C3-DC+C4-OH; C4OH; C4-OH; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; III; Malonyl+3OHbutyrylcarn; nonderivatized; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; underivatized; WB; Whole blood	4180186
44817102	Malonyl+3OHbutyrylcarn/C10 DBS-sRto	4180186
44817102	丙二酰肉碱 (C3-DC)+3-羟基异丁酰肉碱 (C4-OH)/癸酰肉碱 (C10):物质的量比率:时间点:全血.斑点:定量型	4182948
44817107	Case rprt; DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
44817107	Case rprt	4180186
44817107	案例报告:发现:时间点:{环境}:文档型:{角色}	4182948
44817108	DOC.ONT; Document; Finding; Findings; Point in time; Random; Registry rpt	4180186
44817108	摘要登记报告:发现:时间点:{环境}:文档型:{角色}	4182948
44817109	Urology Prog note	4180186
44817109	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; URO; Urology; Visit note	4180186
44817109	病程记录:发现:时间点:{环境}:文档型:泌尿外科学	4182948
44817110	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; Neurology; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
44817110	Neurology Prog note	4180186
44817110	病程记录:发现:时间点:{环境}:文档型:神经病学	4182948
44817112	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; Breakbone fever; Denv; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; IAA; ID; Identity or presence; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Nominal; Pl; PlasBld; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; SUDS; WB; Whole blood	4180186
44817112	DENV IgG+IgM SerPlBld IA.rapid	4180186
44817112	登革热病毒 抗体.IgG 与 IgM:存在与否或特征标识:时间点:血清/血浆/全血:名义型:免疫测定法.快速	4182948
44817114	Glutarylcarn/C0 DBS-sRto	4180186
44817114	Blood; C5DC; C5-DC; Carnitine.total; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
44817114	戊二酰肉碱 (C5-DC)/肉碱 (C0):物质的量比率:时间点:全血.斑点:定量型	4182948
44817115	8OH-Amoxapine Ur Ql	4180186
44817115	8-Hydroxy amoxapine; 8OH-Amoxapine; Amoxapine metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
44817115	8-羟基阿莫沙平:存在情况或阈值:时间点:尿液:序数型	4182948
44817116	Addiction; Baclosan; Beklo; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Gablofen; Illicit; Kemstro; Level; Liofen; Lioresal; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
44817116	Baclofen Ur-mCnc	4180186
44817116	巴氯芬:质量浓度:时间点:尿液:定量型	4182948
44817117	Addiction; Carisoma; Carisoprodol metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; Flexartal; GCMS; Illicit; Isopropylmeprobamate; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Rela; Sanoma; Soma; Somadril; Somalgit; UA; UR; Urn	4180186
44817117	Carisoprodol+Meprob Ur Cfm-mCnc	4180186
44817117	异丙基甲丁双脲+氨甲丙二酯:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
44817118	DULoxetine Ur Ql	4180186
44817118	Cymbalta; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Yentreve	4180186
44817118	度洛西汀:存在情况或阈值:时间点:尿液:序数型	4182948
44817122	Desmeth; Desmethylsertraline; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sertraline metabolite; Setralinemetab; UA; UR; Urn	4180186
44817122	Norsertraline Ur Ql	4180186
44817122	去甲基舍曲林:存在情况或阈值:时间点:尿液:序数型	4182948
44817123	O-去甲基文拉法新:存在情况或阈值:时间点:尿液:序数型	4182948
44817123	Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Ordinal; Point in time; PR; Pristiq; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Venlafaxine metabolite	4180186
44817123	ODV Ur Ql	4180186
44817124	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Viibryd	4180186
44817124	Vilaz Ur Ql	4180186
44817124	维拉佐酮:存在情况或阈值:时间点:尿液:序数型	4182948
44817125	#/area; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Crys; Cryst; Crystal; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817125	Crystals #/area Fld Micro	4180186
44817125	结晶:单位面积数量或计数:时间点:体液:定量型:显微镜检查.光学	4182948
44817126	#/area; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
44817126	RBC #/area Snv HPF	4180186
44817126	红细胞:单位面积数量或计数:时间点:滑液:定量型:显微镜检查.光学.高倍视野	4182948
44817127	IR Procedure note	4180186
44817127	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; Point in time; Random; Visit note	4180186
44817127	操作记录:发现:时间点:{环境}:文档型:介入放射医学	4182948
44817128	IMA Ser-aCnc	4180186
44817128	Alb; Arbitrary concentration; Chemistry; IMA; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
44817128	白蛋白.缺血修饰型:任意型浓度:时间点:血清:定量型	4182948
44817131	Antipsychotic; DRUG/TOXICOLOGY; Drugs; neuroleptics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
44817131	Antipsychotics Ur Ql Scn	4180186
44817131	抗精神病药:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
44817133	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON	4180186
44817136	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON	4180186
44817139	Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS	4180186
44817140	Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS	4180186
44817141	Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS	4180186
44817142	Arterial Stenosis; Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.HHS	4180186
44817143	Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; LMTED; LTD; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS	4180186
44817147	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
44817149	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.PROMIS	4180186
44817150	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
44817152	Ab; Bld gp Ab Scn; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44817152	Bld gp Ab Scn SerPl Ql GEL	4180186
44817152	血型抗体筛查:存在情况或阈值:时间点:血清/血浆:序数型:GEL 抗体检测法	4182948
44817155	Glutarylcarn/C8+C10 DBS-sRto	4180186
44817155	Blood; C5DC; C5-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
44817155	戊二酰肉碱 (C5-DC)/辛酰肉碱+癸酰肉碱 (C8+C10):物质的量比率:时间点:全血.斑点:定量型	4182948
44817156	Glutarylcarn/C16 DBS-sRto	4180186
44817156	Blood; C16; C5DC; C5-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Hexadecanoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
44817156	戊二酰肉碱 (C5-DC)/棕榈酰肉碱 (C16):物质的量比率:时间点:全血.斑点:定量型	4182948
44817157	Leucine/Phe DBS-sRto	4180186
44817157	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Leu; Phe; PKU; Point in time; PPA; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
44817157	亮氨酸/苯丙氨酸:物质的量比率:时间点:全血.斑点:定量型	4182948
44817158	Aerobe; Aerobe Cult; Aerobed; Anaerobe+Aerobe Cult; Bact; C&S; Cult; Cultures; Gen; Genital tract; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Urogenit; Urogenital	4180186
44817158	Bacteria Genital Anaerobe+Aerobe Cult	4180186
44817158	细菌 已鉴定的:存在与否或特征标识:时间点:生殖器:名义型:厌氧微生物培养+需氧微生物培养	4182948
44817159	CD3+CD20 Ag Tiss ImStn	4180186
44817159	Antigen; Antigens; B1; B-1; Bp35; CD3+CD20; CD3+CD20 Ag; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Leu16; Leu-16; Leu4; Leu-4; Nominal; Pathology; Point in time; Random; St; Stains; Stn; T3; Tissue; Tissue, unspecified; Tumor marker	4180186
44817159	CD3 与 CD20 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817160	Antigen; Antigens; Autoimmune hepatitis; CK; CK5; CK5+p63+CK AE1; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; LMW; Nominal; Pathology; Point in time; Random; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
44817160	CK5+p63+CK AE1 Ag Tiss ImStn	4180186
44817160	细胞角蛋白 5 与 p63 与 细胞角蛋白 AE1 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817161	Antigen; Antigens; Autoimmune hepatitis; CK; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Nominal; P504S+p63+CK903; PATHOLOGY; Point in time; Random; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
44817161	P504S+p63+CK903 Ag Tiss ImStn	4180186
44817161	P504S 与 p63 与 细胞角蛋白 903 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817162	Antigen; Antigens; Autoimmune hepatitis; Chains; Chn; CK; CK8; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; K8; Keratin, type II cytoskeletal 8; Musc; Muscl; Nominal; p63 + SM-MHC + CK8; PATHOLOGY; Point in time; Random; SM; SM-MHC; St; Stains; Stn; Tissue; Tissue, unspecified; Type-II keratin Kb8	4180186
44817162	p63 + SM-MHC + CK8 Ag Tiss ImStn	4180186
44817162	p63 与平滑肌肌球蛋白重链与细胞角蛋白 8 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817165	Antigen; Antigens; Autoimmune hepatitis; CK; CK 7; CK7; CK7+TTF-1; Fac; Fact; i; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Keratin 7; NK2 homeobox 1; NKX2-1; Nominal; Pathology; Point in time; Random; St; Stains; Stn; Tissue; Tissue, unspecified; TTF1; TTF-1	4180186
44817165	CK7+TTF-1 Ag Tiss ImStn	4180186
44817165	细胞角蛋白 7 与 甲状腺转录因子 1 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817167	PAX5+CD5 Ag Tiss ImStn	4180186
44817167	Antigen; Antigens; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Leu1; Leu-1; Ly-1; Nominal; Pathology; PAX5+CD5; Point in time; Random; St; Stains; Stn; T1; Tissue; Tissue, unspecified; Tp67	4180186
44817167	PAX5 与 CD5 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817168	CD34+Fac XIII Ag Tiss ImStn	4180186
44817168	Antigen; Antigens; CD34+Fac XIII; Coag; Fac; Fact; Fact XIII; Factor 13; Fibrin stabilizing factor; Fibrinase laki-lorand factor; Fibrinoligase; FXIII; gp105-120; Hematopoietic stem cell; HSC; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; My10; My-10; Nominal; Pathology; Plasma transamidase; Plasma transglutaminase; Point in time; Protransglutaminase; Random; St; Stains; Stem cells; Stn; Tissue; Tissue, unspecified	4180186
44817168	CD34 与凝血因子 XIII 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817171	Echography; Finding; Findings; Med Examiner/Coroner contacted; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US Death Certificate	4180186
44817172	Echography; Finding; Findings; Ordinal; Placent; Placenta; Placntl; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US fetal death	4180186
44817174	Agency for Healthcare Research and Quality; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44817175	Agency for Healthcare Research and Quality; AHRQ survey Pnl; Hosp; Pan; Panel; Panl; Pnl; Point in time; Pt safety event; Random; SIR v1.2; Survey; SURVEY.AHRQ	4180186
44817177	16B,18-diOH-DHEA; 3 beta Hydroxysteroid Dehydrogenase; 3-Beta Hydroxysteroid dehydrogenase deficiency; B; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
44817177	16B,18-diOH-DHEA Ur-sCnc	4180186
44817177	16-Beta,18-二羟基脱氢表雄甾酮:物质的量浓度:时间点:尿液:定量型	4182948
44817179	1 day; 16B,18-diOH-DHEA; 24 hours; 24HR; 3 beta Hydroxysteroid Dehydrogenase; 3-Beta Hydroxysteroid dehydrogenase deficiency; B; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
44817179	16B,18-diOH-DHEA 24h Ur-sRate	4180186
44817179	16-Beta,18-二羟基脱氢表雄甾酮:物质的量速率:24小时:尿液:定量型	4182948
44817180	1 day; 16 alphaOH-Preg; 16A OH-Preg; 16-Alpha hydroxy pregnenolone; 24 hours; 24HR; 3 beta,16 alpha-dihydroxypregn-5-en-20-one; Alfa; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
44817180	16A OH-Preg 24h Ur-sRate	4180186
44817180	16-alpha 羟基孕烯醇酮:物质的量速率:24小时:尿液:定量型	4182948
44817181	16 alphaOH-Preg; 16A OH-Preg; 16-Alpha hydroxy pregnenolone; 3 beta,16 alpha-dihydroxypregn-5-en-20-one; Alfa; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
44817181	16A OH-Preg Ur-sCnc	4180186
44817181	16-alpha 羟基孕烯醇酮:物质的量浓度:时间点:尿液:定量型	4182948
44817182	16A OH-Preg 24h Ur-sCnc	4180186
44817182	1 day; 16 alphaOH-Preg; 16A OH-Preg; 16-Alpha hydroxy pregnenolone; 24 hours; 24HR; 3 beta,16 alpha-dihydroxypregn-5-en-20-one; Alfa; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
44817182	16-alpha 羟基孕烯醇酮:物质的量浓度:24小时:尿液:定量型	4182948
44817184	3-OH-eicosanoylcarn SerPl-sCnc	4180186
44817184	3-[(3-hydroxyicosanoyl)oxy]-4-(trimethylazaniumyl)butanoate; 3-hydroxyarachidoylcarnitine; 3-OH-eicosanoylcarn; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817184	3-羟基二十酰肉碱 (C20-OH):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817185	472G&gt;A; Blood; c.472G&gt;A; Catechol-O-Methyltransferase; COMT c.1947G&gt;A; G1947A; G472A; Genetics; HEL-S-98n; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; PCR; Point in time; Random; rs4680; Tissue; Tissue, unspecified; Val108Met; Val158Met; WB; Whole blood; Whole blood or Tissue	4180186
44817185	COMT c.1947G>A Geno Bld/T	4180186
44817185	COMT 基因.c.1947G>A:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
44817186	CCL18; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
44817186	CCL18 Ser-mCnc	4180186
44817186	趋化因子 (C-C 基元) 配体 18:质量浓度:时间点:血清:定量型	4182948
44817187	A-Tocopherol Vit E EntSub RBC	4180186
44817187	Alfa; A-Tocopherol Vit E; Chemistry; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Tocopherols; Vit E; Vitamin E	4180186
44817187	Alpha 生育酚:实体物质的量:时间点:红细胞:定量型	4182948
44817189	Bile Ac 24h Stl-sCnt	4180186
44817189	1 day; 24 hours; 24HR; Acd; Acids; Bile acid.total; Bile salt; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal; Substance Content	4180186
44817189	胆汁酸:物质的量含量:24小时:大便:定量型	4182948
44817192	CC16 Ser-mCnc	4180186
44817192	CC10; CC16; Chemistry; clara cell secretory protein; Level; Mass concentration; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SCGB1A1; Secretoglobin Family 1A Member 1; Serum; SR; Uteroglobin	4180186
44817192	克拉拉细胞蛋白 16:质量浓度:时间点:血清:定量型	4182948
44817195	Act/Nor; Comp; Complement CH50; Complmt; Control; EIA; ELFA; ELISA; Enzyme immunoassay; HEMATOLOGY/CELL COUNTS; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Serum; SR; SUDS; Tot; Total Hem Comp; Totl	4180186
44817195	CH50 Act/Nor Ser IA	4180186
44817195	补体总溶血活性 Ch50 实际的/正常的:相对任意型浓度:时间点:血清:定量型:免疫测定法	4182948
44817196	Act/Nor; Comp; Comp activity.lectin; Complement functional activity.lectin pathway; Complement screening; Complmt; Control; EIA; ELFA; ELISA; Enzyme immunoassay; HEMATOLOGY/CELL COUNTS; IAA; MBL; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Serum; SR; SUDS	4180186
44817196	Comp activity.lectin Act/Nor Ser IA	4180186
44817196	补体凝集素途径 实际的/正常的:相对任意型浓度:时间点:血清:定量型:免疫测定法	4182948
44817197	C9; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817197	Nonanoylcarn SerPl-sCnc	4180186
44817197	壬酰肉碱 (C9):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817199	C10:1DC; C10:1-DC; Chemistry; Dicarboxylic carnitine; i; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817199	Dehydrosebacylcarn SerPl-sCnc	4180186
44817199	脱氢癸二酰肉碱 (C10:1-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817200	D-ALA+PBG+creat Pnl 24h Ur	4180186
44817200	1 day; 24 hours; 24HR; 5-ALA; 5-aminolevulinate; 5-aminolevulinic acid; ALA; Aminolevulinic acid; Amnolev; Amnolevuunc; Chemistry; CR; Crea; Creat; Creat Pnl; D-ALA; D-ALA+PBG+creat Pnl; Delta-ala; Delta-aminolevulinic acid; Pan; PANEL.CHEMISTRY; Panl; PBG; Pnl; Porph; Porphobili; Porphoblngn; Porpoblngn; UA; UCr; UR; Urn	4180186
44817200	Delta 氨基酮戊酸、 胆色素原与肌酐组套:-:24小时:尿液:-	4182948
44817203	Dicarboxyhexenoylcarn SerPl-sCnc	4180186
44817203	3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency; 3-methylglutarylcarnitine; Chemistry; i; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817203	二羧基己烯酰肉碱 (C6:1-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817204	Dicarboxypalmitoleylcarn SerPl-sCnc	4180186
44817204	C16:1DC; C16:1-DC; Chemistry; i; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817204	二羧基棕榈烯酰肉碱 (C16:1-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817205	Dicarboxytetradecanoylcarn SerPl-sCnc	4180186
44817205	C14DC; C14-DC; Chemistry; Dicarboxylic carnitine; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817205	二羧基十四烷酰肉碱 (C14-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817206	Energy content 24h Stool.wet	4180186
44817206	1 day; 24 hours; 24HR; Bowel movement; Energy content; Faecal; Faeces; Fecal; Feces; QNT; Quan; Quant; Quantitative; SPEC; Stl; Stool = Fecal	4180186
44817206	能量含量:能量含量:24小时:大便.湿:定量型	4182948
44817207	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg DNA; N men sg Y; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group Y; Neisseria meningitidis type Y; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44817207	N men sg Y DNA Spec Ql NAA+probe	4180186
44817207	脑膜炎奈瑟菌 Y 血清群 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
44817209	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg W135; N men sg w135 DNA; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group w135; Neisseria meningitidis type w135; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44817209	N men sg W135 DNA Spec Ql NAA+probe	4180186
44817209	脑膜炎奈瑟菌 w135 血清群 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
44817210	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg C; N men sg C DNA; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group C; Neisseria meningitidis type C; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44817210	N men sg C DNA Spec Ql NAA+probe	4180186
44817210	脑膜炎奈瑟菌 C 血清群 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
44817211	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Group B; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg B; N men sg B DNA; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group B; Neisseria meningitidis type B; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44817211	N men sg B DNA Spec Ql NAA+probe	4180186
44817211	脑膜炎奈瑟菌 B 血清群 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
44817214	Assoc; Chemistry; Dextro; Level; Mass concentration; Point in time; PR; Prot; Pulm; QNT; Quan; Quant; Quantitative; Random; Serum; SFTPD; SP-D; SR	4180186
44817214	SFTPD Ser-mCnc	4180186
44817214	肺表面活性物质相关蛋白 D:质量浓度:时间点:血清:定量型	4182948
44817216	Tocopherols EntSub RBC	4180186
44817216	Chemistry; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Vit E; Vitamin E	4180186
44817216	生育酚:实体物质的量:时间点:红细胞:定量型	4182948
44817220	No; Nominal; Num; Phone #; Point in time; Random; Reporter phone #; Survey; SURVEY.AHRQ; Telecommunication number; Telephone number	4180186
44817221	AE; Nominal; Person name; Point in time; Random; Reporter adverse event; Survey; SURVEY.AHRQ	4180186
44817222	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44817223	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44817224	Agency for Healthcare Research and Quality; Assoc; Finding; Findings; Nominal; Point in time; Pt safety event; Random; Survey; SURVEY.AHRQ	4180186
44817228	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44817230	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44817232	Agency for Healthcare Research and Quality; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44817237	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44817239	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44817241	Agency for Healthcare Research and Quality; Finding; Findings; Near miss prevention action; Nominal; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44817242	Add; Agency for Healthcare Research and Quality; Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.AHRQ	4180186
44817243	Agency for Healthcare Research and Quality; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44817244	AE; Agency for Healthcare Research and Quality; Nominal; Point in time; Random; Reporter adverse event; Survey; SURVEY.AHRQ; Typ	4180186
44817246	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
44817246	Macroscopic obs Spec-Imp	4180186
44817246	大体观察:印象:时间点:XXX:叙述型	4182948
44817247	PDH E1 Tiss-cCnt	4180186
44817247	Catalytic Content; Chemistry; Dehydrog; Dehyrdogenase; PDH; PDH E1; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
44817247	丙酮酸脱氢酶 E1:催化含量:时间点:组织与涂片:定量型	4182948
44817248	Tripeptidyl peptidase I Fib-cCnt	4180186
44817248	Catalytic Content; Chemistry; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817248	三肽基肽酶 I:催化含量:时间点:成纤维细胞:定量型	4182948
44817252	Catalytic Content; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
44817252	Fumarase Tiss-cCnt	4180186
44817252	延胡索酸酶:催化含量:时间点:组织与涂片:定量型	4182948
44817255	Acd; Acid; Aliphatic carboxylate; C24:0; Chains; Chemistry; Chn; Fatty acid; Fib; Fibr; Lignocerate; Lignoceric acid; Lipid; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Tetracosanoate; Tetracosanoic acid; VLC; VLCF; VLCFA; VLCFA C24:0; VLCFA C24:0/C22:0	4180186
44817255	VLCFA C24:0/C22:0 Fib	4180186
44817255	脂肪酸类.极长链型.C24:0/C22:0:质量比率:时间点:成纤维细胞:定量型	4182948
44817257	Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Cit Syn; Citric acid; Complex III; CoQ CyC Reduct; cyt; Cytochrome bc1 complex; Cytochrome C reductase; Enzymatic activity ratio; Point in time; Q-cytochrome c oxidoreductase; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
44817257	CoQ CyC Reduct/Cit Syn Tiss-cRto	4180186
44817257	辅酶 Q 细胞色素 C 还原酶/柠檬酸合酶:催化比率:时间点:组织与涂片:定量型	4182948
44817261	Succinate Dehydrog/Cit Syn Tiss-cRto	4180186
44817261	Butanedioate; Butanedioic acid; Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Cit Syn; Citric acid; Dehydrog; Dehyrdogenase; Enzymatic activity ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Succinic acid; Tissue; Tissue, unspecified	4180186
44817261	琥珀酸脱氢酶/柠檬酸合酶:催化比率:时间点:组织与涂片:定量型	4182948
44817264	C8; Catalytic Content; Chemistry; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817264	Octanoylcarn Fib-cCnt	4180186
44817264	辛酰肉碱 (C8):催化含量:时间点:成纤维细胞:定量型	4182948
44817265	Adipylcarnitine; C6DC; C6-DC; Catalytic Content; Chemistry; Dicarboxylic carnitine; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817265	Adipoylcarn Fib-cCnt	4180186
44817265	已二酰肉碱 (C6-DC):催化含量:时间点:成纤维细胞:定量型	4182948
44817266	Hexanoylcarn Fib-cCnt	4180186
44817266	C6; Catalytic Content; Chemistry; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817266	己酰肉碱 (C6):催化含量:时间点:成纤维细胞:定量型	4182948
44817267	3-Hydroxy butyrylcarnitine; 3-hydroxybutylcarnitine; 3-hydroxy-butylcarnitine; 3OH-Butyrcarn; C4OH; C4-OH; Catalytic Content; Chemistry; Fib; Fibr; III; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817267	3OH-Butyrcarn Fib-cCnt	4180186
44817267	3-羟基丁酰肉碱 (C4-OH):催化含量:时间点:成纤维细胞:定量型	4182948
44817272	Palmitoleylcarn Fib-cCnt	4180186
44817272	C16:1; Catalytic Content; Chemistry; Fib; Fibr; Hexadecenoylcarnitine; i; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817272	棕榈烯酰肉碱 (C16:1):催化含量:时间点:成纤维细胞:定量型	4182948
44817274	3-hydroxymyristoylcarnitine; 3-hydroxy-tetradecanoylcarnitine; 3OH-Tdecanoylcarn; C14OH; C14-OH; Catalytic Content; Chemistry; Fib; Fibr; III; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817274	3OH-Tdecanoylcarn Fib-cCnt	4180186
44817274	3-羟基十四烷酰肉碱 (C14-OH):催化含量:时间点:成纤维细胞:定量型	4182948
44817278	C14; Catalytic Content; Chemistry; Fib; Fibr; Myristoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Tdecanoylcarn	4180186
44817278	Tdecanoylcarn Fib-cCnt	4180186
44817278	十四烷酰肉碱 (C14):催化含量:时间点:成纤维细胞:定量型	4182948
44817279	C12:1; Catalytic Content; Chemistry; Fib; Fibr; i; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817279	Dodecenoylcarn Fib-cCnt	4180186
44817279	十二烯酰肉碱 (C12:1):催化含量:时间点:成纤维细胞:定量型	4182948
44817282	C10:2; Catalytic Content; Chemistry; Fib; Fibr; II; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817282	Decadienoylcarn Fib-cCnt	4180186
44817282	癸二烯酰肉碱 (C10:2):催化含量:时间点:成纤维细胞:定量型	4182948
44817283	Decenoylcarn Fib-cCnt	4180186
44817283	C10:1; Catalytic Content; Chemistry; Fib; Fibr; i; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817283	癸烯酰肉碱 (C10:1):催化含量:时间点:成纤维细胞:定量型	4182948
44817287	VLCFA C22:0 Fib-mCnt	4180186
44817287	Acd; Acid; Aliphatic carboxylate; Behenate; Behenic acid; C22:0; Chains; Chemistry; Chn; Docosanoate; Docosanoic acid; Fatty acid; Fib; Fibr; Lipid; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; VLC; VLCF; VLCFA; VLCFA C22:0	4180186
44817287	脂肪酸类.极长链型.C22:0:质量含量:时间点:成纤维细胞:定量型	4182948
44817289	1-Heptadecanecarboxylic acid; C18:0; C18H36O2; Cetylacetic acid; Chemistry; DMA 18:0; DMA C18:0; Elaidate; Erythrocytes; i; Octadecanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Scrto; Stearaldehyde, dimethyl acetal; Stearate; Stearic acid; Substance concentration ratio; Substance ratio	4180186
44817289	DMA 18:0/C18:0 RBC-sRto	4180186
44817289	1,1-二甲氧基十八碳烷/十八碳酯:物质的量比率:时间点:红细胞:定量型	4182948
44817290	Chemistry; DMA 18:0; DMA C18:0; Fib; Fibr; i; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Stearaldehyde, dimethyl acetal	4180186
44817290	DMA 18:0 Fib-mCnt	4180186
44817290	1,1-二甲氧基十八碳烷:质量含量:时间点:成纤维细胞:定量型	4182948
44817292	C18:1w9; Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Fib; Fibr; i; Mass concentration ratio; Mass ratio; MCRto; Oleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817292	DMA 18:1/Oleate Fib	4180186
44817292	1,1-二甲氧基-(9Z)十八碳烯/油酸:质量比率:时间点:成纤维细胞:定量型	4182948
44817295	Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Erythrocytes; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance content	4180186
44817295	DMA 18:1 RBC-sCnt	4180186
44817295	1,1-二甲氧基-(9Z)十八碳烯:物质的量含量:时间点:红细胞:定量型	4182948
44817310	von Willebrand factor.activity	4180186
44817586	COMT gene.c.1947G>A	4180186
44817643	Sebacate	4180186
44817654	Lymphocytes.clefted	4180186
44817655	Laurate	4180186
44817657	Gamma linolenate	4180186
44817659	Arachidate	4180186
44817661	Mead acid	4180186
44817662	Eicosapentaenoate	4180186
44817663	Docosahexaenoate	4180186
44817706	1,1-Dimethoxyoctadecane	4180186
44817710	CPT1A gene.c.1436C>T	4180186
44817712	Soluble fms-like tyrosine kinase-1 & placental growth factor panel	4180186
44817715	Baylisascaris sp Ab.igG	4180186
44817740	Fatty acids.very long chain.C22:1n9	4180186
44818751	Has method (SNOMED)	4180186
44818774	Has time aspect (SNOMED)	4180186
44818871	Scale type of (SNOMED)	4180186
44818900	SNOMED to ICD9 procedure equivalent (OMOP)	4180186
44818908	RxNorm to ATC (FDB)	4180186
44818992	Clinical Pack	4180186
44819020	Clinical Drug Form	4180186
44819023	Visit	4180186
44819041	Branded Drug Form	4180186
44819138	Medicare provider/supplier specialty codes (CMS)	4180186
44819144	Gemscript NHS dictionary of medicine and devices (NHS)	4180186
44819148	PCORNet	4180186
44819245	APC	4180186
44819256	HCPCS	4180186
44819263	LOINC	4180186
44819269	NUCC	4180186
44819271	OXMIS	4180186
44819283	ATC 2nd	4180186
44819285	ATC 4th	4180186
45610008	5,5-diphenyl-2-(beta-N-piperidinoethyl)-1,3-dioxolan-4-one	4180186
45610008	BR 18	4180186
45610008	BR-18	4180186
45610008	pipoxolan monohydrochloride	4180186
45610008	Rowapraxin	4180186
45610010	Ceflatonin	4180186
45610010	homoharringtonine, 3H-labeled, (3(R))-isomer	4180186
45610010	omacetaxine mepesuccinate	4180186
45610012	parthenolide, (1aR-(1aR*,4E,7aS*,10aS*,10bR*))-isomer	4180186
45610013	(9R,9R)-5,5-bis(beta-d-glucopyranosyloxy)-9,9,10,10-tetrahydro-4,4-dihydroxy-10,10-dioxo(9,9-bianthracene)-2,2-dicarboxylic acid	4180186
45610013	(9R,9'S)-5,5'-bis(beta-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo(9,9'-bianthracene)-2,2'-dicarboxylic acid	4180186
45610013	ND 10	4180186
45610013	ND-10	4180186
45610013	Pursennid	4180186
45610013	sennoside	4180186
45610013	sennoside A	4180186
45610013	sennoside A+B calcium	4180186
45610013	sennoside A&B, calcium salt	4180186
45610013	sennoside A calcium	4180186
45610013	sennoside A calcium and sennoside B calcium	4180186
45610013	sennoside A, calcium salt	4180186
45610013	sennoside A, calcium salt (1:1)	4180186
45610013	sennoside B	4180186
45610013	sennoside b calcium	4180186
45610013	sennoside B, calcium salt	4180186
45610013	sennosides	4180186
45610013	sennosides A and B	4180186
45610013	sennosides A and B acids	4180186
45610013	sennosides sennoside a	4180186
45610013	sennosides sennoside B	4180186
45610013	Senokot	4180186
45610014	Anaflex	4180186
45610014	methylene-N,N'-bis(hydroxymethyl)urea polymer	4180186
45610015	7-(2-((alpha-methylphenethyl)amino)ethyl)theophylline	4180186
45610015	7-ethyltheophyllineamphetamine	4180186
45610015	Biocapton	4180186
45610015	Captagon	4180186
45610015	fenethylline monohydrochloride	4180186
45610015	fenetylline	4180186
45610017	colistimethate	4180186
45610017	colistimethate, disodium salt	4180186
45610017	colistimethate sodium	4180186
45610017	colistin sodium methanesulfonate	4180186
45610018	1-(2-methoxyphenyl)-2-methylaminopropane	4180186
45610018	2-methoxy-N,alpha-dimethylphenethylamine	4180186
45610018	methoxyphenamine hydrochloride	4180186
45610018	methoxyphenamine hydrochloride, (+-)-isomer	4180186
45610018	methoxyphenamine hydrochloride, (R)-isomer	4180186
45610018	methoxyphenamine, (S)-isomer	4180186
45610018	mimexina	4180186
45610018	Orthoxine	4180186
45610019	6-(2-methyleneamino-2-phenylacetamido)penicillanic acid	4180186
45610019	Magnipen	4180186
45610019	Metakes	4180186
45610019	metampicillin	4180186
45610019	metampicillin sodium	4180186
45610019	methampicillin, calcium salt (2:1), (2S-(2alpha,5alpha,6beta(S*)))-isomer	4180186
45610019	methampicillin, monosodium salt, (2S-(2alpha,5alpha,6beta(S*)))-isomer	4180186
45610019	methampicillin, sodium salt	4180186
45610019	Serfabiotic	4180186
45610019	Suvipen	4180186
45610021	2-(5,6,7,8-tetrahydro-1-naphthylamino)-2-imidazoline	4180186
45610021	4,5-dihydro-N-(5,6,7,8- tetrahydro-1-naphthalenyl)-1H-imidazol-2-amine	4180186
45610021	Biciron	4180186
45610021	Bisolnasal	4180186
45610021	Ellatun	4180186
45610021	KB 227	4180186
45610021	Rhinospray	4180186
45610021	Spray-Tish	4180186
45610021	tramazoline hydrochloride	4180186
45610021	tramazoline monohydrochloride	4180186
45610022	benzeneacetamide, N-(aminocarbonyl)-	4180186
45610022	phenuron	4180186
45610022	(phenylacetyl)urea	4180186
45610026	(4-(4-(diethylamino)-alpha-phenylbenzylidene)-2,5-cyclohexadien-1-ylidene)diethylammonium sulfate	4180186
45610026	(4-(p-(diethylamino)-alpha-phenylbenzylidene)-2,5-cyclohexadien-1-ylidene)diethylammonium sulfate	4180186
45610026	benzenaminium, 4-((4-(dimethylamino)phenyl)(4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene)methyl)-N-ethyl-N,N-dimethyl-, bromide chloride (1:1:1)	4180186
45610026	ethyl green	4180186
45610027	2-(2-diethylaminoethoxy)ethyl-2-phenylbutamyrate dihydrogen citrate	4180186
45610027	2-(2-(diethylamino)ethoxy)ethyl-2-phenylbutyrate citrate	4180186
45610027	alpha-ethylbenzeneacetic acid, 2-(2-(diethylamino)ethoxy)ethyl ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)	4180186
45610027	butamirate citrate	4180186
45610027	butamyrate citrate	4180186
45610027	HH 197	4180186
45610027	Sinecod	4180186
45610028	beta-diethylaminoethyl-2-phenylbutyrate	4180186
45610028	phenethylaminecitrate	4180186
45610029	Catrix	4180186
45610029	Catrix s	4180186
45610031	Acetocaustin	4180186
45610031	chloroacetic acid, aluminum salt	4180186
45610031	SODIUM CHLOROACETATE	4180186
45610031	chloroacetic acid, potassium salt	4180186
45610031	chloroacetic acid, potassium (2:1) salt	4180186
45610031	chloroacetic acid, ammonium salt	4180186
45610031	chloroacetic acid, ammonium (2:1) salt	4180186
45610031	monochloroacetic acid	4180186
45610031	chloroacetate	4180186
45610031	chloroacetic acid, sodium (5:2) salt	4180186
45610031	chloroacetic acid, sodium salt	4180186
45610031	chloroacetic acid, sodium (2:1) salt	4180186
45610031	chloroacetic acid, calcium salt	4180186
45610031	chloroacetic acid, silver salt	4180186
45610031	chloroacetic acid, calcium (3:1) salt	4180186
45610033	2-chloro-5-hydroxy-1,3-dimethylbenzene	4180186
45610033	3,5-dimethyl-4-chlorophenol	4180186
45610033	4-chloro-3,5-dimethylphenol	4180186
45610033	4-chloro-3,5-dimethylphenol sulfonate	4180186
45610033	chloroxylenol, potassium salt	4180186
45610033	chloroxylenol, sodium salt	4180186
45610033	Dettol	4180186
45610033	Ice-O-Derm	4180186
45610033	Micro-Guard	4180186
45610033	parachlorometaxylenol	4180186
45610033	p-chloro-m-xylenol	4180186
45610033	PCMX	4180186
45610033	Sween Prep	4180186
45610034	clomocycline sodium salt, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-isomer	4180186
45610034	N-2-hydroxymethylchlortetracycline	4180186
45610037	1-methyl-4-(1-methylethenyl)cyclohexene	4180186
45610037	4-mentha-1,8-diene	4180186
45610037	(4R)-1-methyl-4-(1-methylethenyl)cyclohexene	4180186
45610037	(4S)-1-methyl-4-isopropenylcyclohex-1-ene	4180186
45610037	AISA 5203-L (+)limonene	4180186
45610037	cyclohexene, 1-methyl-4-(1-methylethenyl)-, (4R)-	4180186
45610037	dipentene	4180186
45610037	d-limonene	4180186
45610037	(D)-limonene	4180186
45610037	(-)-limonene	4180186
45610037	(+)-limonene	4180186
45610037	limonene, (+-)-	4180186
45610037	limonene, (+)-	4180186
45610037	limonene, (+-)-isomer	4180186
45610037	limonene, (R)-isomer	4180186
45610037	limonene, (S)-isomer	4180186
45610037	(+)-(R)-4-isopropenyl-1-methylcyclohexene	4180186
45610037	(R)-4-isopropenyl-1-methylcyclohexene	4180186
45610037	(R)-(+)-limonene	4180186
45610039	Plasmanate	4180186
45610039	PLASMA PROTEIN FRACTION (HUMAN)	4180186
45610039	Plasmatein plasma protein fraction	4180186
45610040	4'-(2-thiazolylsulfamoyl)succinanilic acid	4180186
45610040	succinylsulfathiazole monohydrate	4180186
45610040	sulfasuccithiazole	4180186
45610041	sulfacarbamide	4180186
45610041	Urosulfan	4180186
45610048	1-(o-chlorophenyl)-2-tert-butylaminoethanol	4180186
45610048	2-chloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol	4180186
45610048	alpha-((tert-butylamino)methyl)-o-chlorobenzyl alcohol	4180186
45610048	Atenos	4180186
45610048	Brelomax	4180186
45610048	C-78	4180186
45610048	HN-078	4180186
45610048	tulobuterol hydrochloride	4180186
45610050	CHP phenobarbital	4180186
45610050	Maliasin	4180186
45610050	phenobarbital propylhexedrine salt	4180186
45610051	17 alpha- methyl-19-demethylpregna-4,9-diene-3,20-dione	4180186
45610051	17 alpha-methyl-19-norprogesterone	4180186
45610053	2,7-dimethylthianthrene	4180186
45610053	Citemul S	4180186
45610053	dimethyldiphenylenedisulfide	4180186
45610053	thiotal	4180186
45610054	steviol glycoside	4180186
45610057	Curcuma longa extract	4180186
45610057	Curcuma longa root	4180186
45610057	Curcuma longa root extract	4180186
45610057	oils, curcuma	4180186
45610057	turmeric root	4180186
45610057	turmeric root extract	4180186
45610057	rhizoma curcumae longae	4180186
45610057	curcumae longae rhizoma	4180186
45610062	2,3,4-triethoxy-gamma-oxobenzenebutanoic acid	4180186
45610062	3-(2',4',5'-triethoxybenzoyl)propionic acid, sodium salt	4180186
45610062	AA 149	4180186
45610063	urapidil, 5-(14)C-labeled	4180186
45610063	urapidil monohydrochloride	4180186
45610063	6-((3-(4- (2-methoxyphenyl)-1-piperazinyl)propyl)amino)- 1,3-dimethyl-2,4(1H,3H)-pyrimidinedione	4180186
45610063	6-(3-(4-(o-methoxyphenyl)-1-piperazinyl)propylamino)-1,3-dimethyluracil	4180186
45610063	Ebrantil	4180186
45610063	urapidil, 2,3-(14)C2-labeled	4180186
45610064	2-acetoxy-4-trifluoromethylbenzoic acid	4180186
45610064	2- (acetyloxy)-4-(trifluoromethyl)benzoic acid	4180186
45610064	Disgren	4180186
45610066	aluminum hydroxychloride	4180186
45610066	dihydrate of aluminum chlorhydrate	4180186
45610066	pentahydroxy dialuminum chloride	4180186
45610066	pentahydroxydialuminum chloride	4180186
45610067	3-(4-chlorophenyl)-1-phenylpyrazole-4-acetic acid	4180186
45610067	Argun	4180186
45610067	Irriten	4180186
45610067	lonazolac calcium	4180186
45610067	lonazolac calcium salt	4180186
45610068	3-((O beta-D-glucopyranosyl-(1-4)-O-3 beta-O-acetyl- 2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6- dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6- dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12 beta,14-dihydroxy-5 beta-card-20(22)-enolide	4180186
45610068	Allocor	4180186
45610068	Cedilanid	4180186
45610068	Ceglunat	4180186
45610068	Celanide	4180186
45610068	isolanid	4180186
45610068	lanatigen C	4180186
45610068	Lanocide	4180186
45610069	6-acetamidohexanoic acid	4180186
45610069	6-acetylaminocaproic acid, calcium salt	4180186
45610069	6-acetylaminocaproic acid, monosodium salt	4180186
45610069	6-(acetylamino)hexanoic acid	4180186
45610069	acexamic acid	4180186
45610069	Celuton	4180186
45610069	CY168E	4180186
45610069	epsilon-acetylaminocaproic acid	4180186
45610069	Hexanoic acid, 6-(acetylamino)-	4180186
45610069	N-acetylamino-6-hexanoic acid	4180186
45610069	NAS-501	4180186
45610069	Plastenan	4180186
45610069	sodium acexamate	4180186
45610069	zinc acexamate	4180186
45610070	1-phenylcyclopentanecarboxylic acid,2-(2-(diethylamino)ethoxy)ethyl ester	4180186
45610070	2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate	4180186
45610070	carbetapentane 1,5-napthalenedisulfonate (2:1)	4180186
45610070	carbetapentane 2,6-napthalenedisulfonate (2:1)	4180186
45610070	carbetapentane citrate	4180186
45610070	carbetapentane tannate	4180186
45610070	pentoxyverine	4180186
45610071	cicloxilic acid, sodium salt, (cis)-isomer	4180186
45610071	cis-2-hydroxy-2-phenyl- cyclohexanecarboxylic acid	4180186
45610071	cycloxilic acid	4180186
45610071	Plecton	4180186
45610074	Aktiferrin	4180186
45610074	Apo-Ferrous Sulfate	4180186
45610074	biofer	4180186
45610074	Ceferro	4180186
45610074	Conferon	4180186
45610074	Eisendragees-ratiopharm	4180186
45610074	Eisensulfat Stada	4180186
45610074	Feospan	4180186
45610074	Feratab	4180186
45610074	Fer-Gen-Sol	4180186
45610074	Fer-in-Sol	4180186
45610074	Ferodan	4180186
45610074	Ferogradumet	4180186
45610074	Fero-Gradumet	4180186
45610074	Ferrogamma	4180186
45610074	Ferrograd	4180186
45610074	Ferro-Gradumet	4180186
45610074	FERROinfant	4180186
45610074	ferrous sulfate, heptahydrate	4180186
45610074	ferrous sulphate	4180186
45610074	Haemoprotect	4180186
45610074	Hämatopan	4180186
45610074	Hemobion	4180186
45610074	Hemofer	4180186
45610074	iron(II) sulfate heptahydrate	4180186
45610074	Kendural	4180186
45610074	Mol-Iron	4180186
45610074	Plastufer	4180186
45610074	Slow-Fe	4180186
45610074	sulfuric acid, iron(2+) salt (1:1)	4180186
45610074	Vitaferro Kapseln	4180186
45610075	ONO-802	4180186
45610075	16,16-dimethyl-delta(2)-PGE1 methyl ester	4180186
45610075	16,16-dimethyl-delta(2)-prostaglandin E1 methyl ester	4180186
45610075	16,16-dimethyl-trans-delta(2)-PGE(1) methyl ester	4180186
45610075	16,16-dimethyl-trans-delta(2)-prostaglandin E(1) methyl ester	4180186
45610075	16,16-DMTDPGEME	4180186
45610075	(2E,11 alpha,13E,15R)-11,15-dihydroxy-16,16- dimethyl-9-oxoprosta-2,13-dien-1-oic acid, methyl ester	4180186
45610075	Cergem	4180186
45610075	Cervagem	4180186
45610075	Cervagème	4180186
45610075	gemeprost, (2E,11alpha,13E,15R)-isomer	4180186
45610075	ONO 802	4180186
45610075	PG802	4180186
45610075	Preglandin	4180186
45610078	4-methoxy-7H-furo(3,2-g)(1)benzopyran-7-one	4180186
45610078	bergapten	4180186
45610078	Pentaderm	4180186
45610083	KHCO3	4180186
45610083	potassium hydrocarbonate	4180186
45610084	5-methylpyrazine-2-carboxylic acid 4-oxide	4180186
45610084	5-methylpyrazinecarboxylic acid 4-oxide	4180186
45610084	Nedios	4180186
45610084	Olbemox	4180186
45610084	Olbetam	4180186
45610085	dolomite	4180186
45610085	CaMg(CO(3))(2)	4180186
45610085	calcium magnesium dicarbonate	4180186
45610086	quinupramine, L-(+)-tartrate	4180186
45610086	quinupramine monohydrochloride	4180186
45610088	2-ketoglutarate	4180186
45610088	2-ketoglutaric acid	4180186
45610088	2-oxoglutarate	4180186
45610088	2-oxoglutaric acid	4180186
45610088	alpha-ketoglutarate	4180186
45610088	alpha-ketoglutaric acid, calcium salt (2:1)	4180186
45610088	alpha-ketoglutaric acid, diammonium salt	4180186
45610088	alpha-ketoglutaric acid, dipotassium salt	4180186
45610088	alpha-ketoglutaric acid, disodium salt	4180186
45610088	alpha-ketoglutaric acid, monopotassium salt	4180186
45610088	alpha-ketoglutaric acid, monosodium salt	4180186
45610088	alpha-ketoglutaric acid, potassium salt	4180186
45610088	alpha-ketoglutaric acid, sodium salt	4180186
45610088	alpha-oxoglutarate	4180186
45610088	calcium alpha-ketoglutarate	4180186
45610088	calcium ketoglutarate	4180186
45610088	oxogluric acid	4180186
45610091	1,2-benzopyrone	4180186
45610091	5,6-benzo-alpha-pyrone	4180186
45610093	1,2-diaminoethane	4180186
45610093	1,2-ethanediamine	4180186
45610093	edamine	4180186
45610093	ethane-1,2-diamine	4180186
45610093	ethyl diamine	4180186
45610093	ethylenediamine (1:1) sulfate	4180186
45610093	ethylenediamine (1:1) sulfite	4180186
45610093	ethylenediamine, 3H-labeled cpd	4180186
45610093	ethylenediamine conjugate acid	4180186
45610093	ethylenediamine dihydrobromide	4180186
45610093	ethylenediamine dihydrochloride	4180186
45610093	ethylenediamine dihydrogen iodide	4180186
45610093	ethylenediamine dihydroiodide	4180186
45610093	ethylenediamine dinitrate	4180186
45610093	ethylenediamine hydrochloride	4180186
45610093	ethylenediamine monohydrochloride	4180186
45610093	ethylenediamine phosphate	4180186
45610093	ethylenediamine sulfate	4180186
45610094	caprylic acid	4180186
45610094	caprylic acid, 14C-labeled	4180186
45610094	caprylic acid, aluminum salt	4180186
45610094	caprylic acid, ammonia salt	4180186
45610094	caprylic acid, barium salt	4180186
45610094	caprylic acid, cadmium salt	4180186
45610094	caprylic acid, calcium salt	4180186
45610094	caprylic acid, cesium salt	4180186
45610094	caprylic acid, chromium(+2) salt	4180186
45610094	caprylic acid, cobalt salt	4180186
45610094	caprylic acid, copper(+2) salt	4180186
45610094	caprylic acid, copper salt	4180186
45610094	caprylic acid, iridum(+3) salt	4180186
45610094	caprylic acid, iron(+3) salt	4180186
45610094	caprylic acid, lanthanum(+3) salt	4180186
45610094	caprylic acid, lead(+2) salt	4180186
45610094	caprylic acid, lithium salt	4180186
45610094	caprylic acid, manganese salt	4180186
45610094	caprylic acid, nickel(+2) salt	4180186
45610094	caprylic acid, potassium salt	4180186
45610094	caprylic acid, ruthenium(+3) salt	4180186
45610094	caprylic acid, sodium salt	4180186
45610094	caprylic acid, sodium salt, 11C-labeled	4180186
45610094	caprylic acid, tin(+2) salt	4180186
45610094	caprylic acid, tin salt	4180186
45610094	caprylic acid, zinc salt	4180186
45610094	caprylic acid, zirconium(+4) salt	4180186
45610094	caprylic acid, zirconium salt	4180186
45610094	lithium octanoate	4180186
45610094	octanoate	4180186
45610094	sodium caprylate	4180186
45610094	sodium octanoate	4180186
45610095	1-(5'-oxohexyl)-3-methyl-7-propylxanthine	4180186
45610095	1H-Purine-2,6-dione, 3,7-dihydro-3-methyl-1-(5-oxohexyl)-7-propyl-	4180186
45610095	HWA 285	4180186
45610095	HWA-285	4180186
45610096	azodisalicylate	4180186
45610096	azodisal sodium	4180186
45610096	Benzoic acid, 3,3'-azobis(6-hydroxy)-,	4180186
45610096	CJ-91B	4180186
45610096	Dipentum	4180186
45610096	disodium 5,5'-azodisalicylate	4180186
45610096	disodium azodisalicylate	4180186
45610096	olsalazine, disodium salt	4180186
45610096	olsalazine sodium	4180186
45610096	Rasal	4180186
45610096	sodium diazosalicylate	4180186
45610097	boron oxide hydroxide	4180186
45610097	orthoboric acid	4180186
45610099	1-(2,4-dichloro-beta-((p-(phenylthio)benzyl)oxy)phenethyl)imidazole	4180186
45610099	Fenizolan	4180186
45610099	fenticonazole mononitate	4180186
45610099	Laurimic	4180186
45610099	Lomexin	4180186
45610099	Micofulvin	4180186
45610099	Rec 15-1476	4180186
45610099	Terlomexin	4180186
45610102	1-(4-methoxybenzoyl)-2-pyrrolidinone	4180186
45610102	1-anisoyl-2-pyrrolidinone	4180186
45610102	Ro 13-5057	4180186
45610102	Ro-13-5057	4180186
45610103	1-(1-(2-((3-chlorobenzyl)oxy)phenyl)vinyl)-1H-imidazole	4180186
45610103	cloconazole	4180186
45610103	croconazole hydrochloride	4180186
45610105	adrenalone hydrochloride	4180186
45610105	Stryphnasal	4180186
45610107	lapyrium chloride	4180186
45610110	2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)-	4180186
45610110	BW825C	4180186
45610110	BW 825C	4180186
45610110	BW-825C	4180186
45610110	Semprex	4180186
45610114	Dopacard	4180186
45610114	dopexamine dihydrobromide	4180186
45610114	dopexamine dihydrochloride	4180186
45610114	dopexamine hydrochloride	4180186
45610114	FPL 60278	4180186
45610115	1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid	4180186
45610115	Bilina	4180186
45610115	levocabastine hydrochloride	4180186
45610115	levophta	4180186
45610115	lévophta	4180186
45610115	livocab	4180186
45610115	livostin	4180186
45610116	5-(2-(tert-butylamino)-1-hydroxyethyl)-3-phenylene bis(dimethylcarbamate)	4180186
45610116	bambuterol hydrochloride	4180186
45610118	acetorphan	4180186
45610118	acetorphan, (R)-isomer	4180186
45610118	acetorphan, (S)-isomer	4180186
45610118	ecadotril	4180186
45610118	Glycine, N-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)-, phenylmethyl ester, (+-)-	4180186
45610118	N-(3-acetylmercapto-2-benzylpropanoyl)glycine benzyl ester	4180186
45610118	retorphan	4180186
45610118	sinorphan	4180186
45610121	CIFN (interferon)	4180186
45610121	consensus IFN-alpha	4180186
45610121	IFN-alpha Con 1	4180186
45610121	Inferax	4180186
45610121	Infergen	4180186
45610121	interferon-alpha Con(1)	4180186
45610121	recombinant consensus interferon alpha	4180186
45610121	rIFN-con-1	4180186
45610124	ceftiofur hydrochloride	4180186
45610124	ceftiofur sodium	4180186
45610124	Naxcel	4180186
45610124	U 64279A	4180186
45610124	U-64279E	4180186
45610125	rosmarini aetheroleum	4180186
45610126	(9S)-9-deoxo-11-deoxy-9,11-(imino((1R)-2-(2-methoxyethoxy)ethylidene)oxy)erythromycin	4180186
45610126	Dynabac	4180186
45610126	erythromycin, 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethylidene)oxy)-, (9S(R))-	4180186
45610126	LY 237216	4180186
45610126	LY-237216	4180186
45610126	Nortron	4180186
45610131	Caldine	4180186
45610131	diethyl 2,6-dimethyl-4-(2-((E)-2-((2-methylpropan-2-yl)oxycarbonyl)ethenyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate	4180186
45610131	GR 43659X	4180186
45610131	GR-43659X	4180186
45610131	Lacimen	4180186
45610131	Lacipil	4180186
45610131	Motens	4180186
45610132	Lercadip	4180186
45610132	lercanidipine hydrochloride	4180186
45610132	Lerdip	4180186
45610132	methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	4180186
45610132	REC 15-2375	4180186
45610132	REC-15-2375	4180186
45610132	Zanidip	4180186
45610133	Cellcept	4180186
45610133	Mycophenolate Sodium	4180186
45610133	Myfortic	4180186
45610133	RS 61443	4180186
45610133	RS-61443	4180186
45610133	Sodium Mycophenolate	4180186
45610133	mycophenolate mofetil hydrochloride	4180186
45610133	mycophenolic acid morpholinoethyl ester	4180186
45610135	A 64077	4180186
45610135	A-64077	4180186
45610135	Abbot 64077	4180186
45610135	N-(1-benzo(b)thien-2-ylethyl)-N-hydroxyurea	4180186
45610135	Zyflo	4180186
45610136	3-((5-oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylic acid	4180186
45610136	3-pyroglutamylthiazolidine-4-carboxylic acid	4180186
45610136	3-pyroglutamylthiazolidine-4-carboxylic acid, (R-(R*,S*))-isomer	4180186
45610136	Adimod	4180186
45610136	PGT-1A	4180186
45610138	6-Trp-10-N-Et-GlyNH2-LHRH	4180186
45610138	deslorelin acetate	4180186
45610138	D-Trp(6)-N-Et-D-GlyNH2(10)-LHRH	4180186
45610138	GnRh, Trp(6)-N-Et-GlyNH2(10)-	4180186
45610138	LHRH, Trp(6)-N-Et-GlyNH2(10)-	4180186
45610138	LHRH, tryptophyl(6)-N-ethylglycinamide(10)-	4180186
45610138	Ovuplant	4180186
45610138	Somagard	4180186
45610139	Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester	4180186
45610139	docetaxel anhydrous	4180186
45610139	docetaxel hydrate	4180186
45610139	docetaxel trihydrate	4180186
45610139	docetaxol	4180186
45610139	N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol	4180186
45610139	NSC 628503	4180186
45610139	RP 56976	4180186
45610139	RP-56976	4180186
45610139	Taxoltere metro	4180186
45610139	Taxotere	4180186
45610141	whortleberry leaf	4180186
45610141	Vaccinium myrtillus leaf	4180186
45610141	myrtillus leaf	4180186
45610141	myrtilli folium	4180186
45610141	fructus myrtilli extract	4180186
45610141	fructus myrtilli	4180186
45610141	bilberry fruit extract	4180186
45610141	bilberry fruit	4180186
45610141	Myrtocyan	4180186
45610141	VMA extract	4180186
45610146	1,3-Diazaspiro(4.4)non-1-en-4-one, 2-butyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-	4180186
45610146	2-n-butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one	4180186
45610146	Aprovel	4180186
45610146	Avapro	4180186
45610146	BMS 186295	4180186
45610146	BMS-186295	4180186
45610146	Karvea	4180186
45610146	SR 47436	4180186
45610146	SR-47436	4180186
45610149	1-Propanone, 1-(10-(2-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-	4180186
45610149	Largon	4180186
45610150	2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid	4180186
45610150	5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-	4180186
45610150	TEI 6720	4180186
45610150	TEI-6720	4180186
45610150	Uloric	4180186
45610154	Adnexol	4180186
45610154	Aknederm Salbe Neu	4180186
45610154	Aknichthol	4180186
45610154	ammonium bituminosulfonate	4180186
45610154	Crino Cordes N	4180186
45610154	Daroderm	4180186
45610154	Dermichthol	4180186
45610154	Egoderm	4180186
45610154	ichthammonium	4180186
45610154	Ichtho-Bad	4180186
45610154	Ichthoderm	4180186
45610154	Ichtholan	4180186
45610154	Ichtholan T	4180186
45610154	Ichthosin	4180186
45610154	ichthosulfol	4180186
45610154	Ichthraletten	4180186
45610154	Ichthyol	4180186
45610154	Ichthyol-Natrium	4180186
45610154	Ichthyol-Natrium Hell	4180186
45610154	Ichthyol Sodium	4180186
45610154	Lavichthol	4180186
45610154	Prid	4180186
45610154	Schwarze-Salbe	4180186
45610154	Solutio Cordes	4180186
45610154	Thiobitum	4180186
45610157	Fungitrol	4180186
45610160	N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide	4180186
45610160	PNU-100766	4180186
45610160	U 100766	4180186
45610160	U-100766	4180186
45610160	Zyvox	4180186
45610160	linezolide	4180186
45610161	(5-benzyl-3-furyl)methyl 2,2-dimethyl-3-(2-methylpropenyl)cyclopropemecarboxylate	4180186
45610161	Scourge	4180186
45610165	iodoxamic acid, calcium salt	4180186
45610165	3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-dily)diimino)bis(2,4,6-triiodobenzoic acid)	4180186
45610165	BC 17	4180186
45610165	B-10610	4180186
45610165	BC-17	4180186
45610165	iodoxamic acid, magnesium salt	4180186
45610165	B 10610	4180186
45610165	Endobil	4180186
45610165	iodoxamid	4180186
45610165	iodoxaminic acid	4180186
45610165	iodoxamate	4180186
45610165	iodoxamidic acid	4180186
45610167	D 20443	4180186
45610167	D-20443	4180186
45610167	D 23129	4180186
45610167	D-23129	4180186
45610167	ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride	4180186
45610167	N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester	4180186
45610167	Potiga	4180186
45610167	retigabine	4180186
45610174	(1S,2S,3R,4R)-3-((1S)-1-acetamido-2-ethylbutyl)-4-((amino(imino)methyl)amino)-2-hydroxycyclopentanecarboxylic acid trihydrate	4180186
45610174	3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic acid	4180186
45610174	BCX1812	4180186
45610174	BCX 1812	4180186
45610174	BCX-1812	4180186
45610174	peramivir trihydrate	4180186
45610174	Rapivab	4180186
45610174	RWJ270201	4180186
45610174	RWJ 270201	4180186
45610174	RWJ-270201	4180186
45610177	degarelix acetate	4180186
45610177	degarelix	4180186
45610177	uglypeptide1	4180186
45610177	Gonax	4180186
45610177	FE200486	4180186
45610177	Ac-2Nal-4Cpa-3Pal-Ser-4Aph(hydroorotyl)-4Aph(carbamoyl)-Leu-ILys-pro-Ala-NH2	4180186
45610177	FE-200486	4180186
45610177	Firmagon	4180186
45610177	FE 200486	4180186
45610179	ZD-64	4180186
45610179	N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine	4180186
45610179	Caprelsa	4180186
45610179	Zactima	4180186
45610179	ZD6474	4180186
45610179	ZD 6474	4180186
45610179	ZD-6474	4180186
45610180	2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-	4180186
45610180	3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione	4180186
45610180	CC5013	4180186
45610180	CC 5013	4180186
45610180	CC-5013	4180186
45610180	IMiD3 cpd	4180186
45610180	Revimid	4180186
45610180	Revlimid	4180186
45610182	insulin, ultralente, human	4180186
45610182	insulin, lente, human	4180186
45610182	insulin, protamine zinc, human	4180186
45610184	ceftaroline	4180186
45610184	T91825	4180186
45610184	T-91825	4180186
45610194	(Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide	4180186
45610194	RS 61980	4180186
45610194	HMR-1726	4180186
45610194	Aubagio	4180186
45610194	A77 1726	4180186
45610194	A-771726	4180186
45610194	A 771726	4180186
45610194	A771726	4180186
45610194	A 1726	4180186
45610194	(2Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide	4180186
45610194	2-hydroxyethylidene-cyanoacetic acid-4-trifluoromethyl anilide	4180186
45610194	2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide	4180186
45610194	HMR1726	4180186
45610197	Afibrinogenemia, Congenital	4180186
45610197	Congenital afibrinogenaemia	4180186
45610197	Hypofibrinogenemia, Congenital	4180186
45610201	Enlarged tongue	4180186
45610201	Giant tongue	4180186
45610203	Atriodigital dysplasia	4180186
45610203	Atrio-Digital Syndrome	4180186
45610203	Cardiac-Limb Syndrome	4180186
45610203	Cervico-Oculo-Acoustic Syndrome	4180186
45610203	Heart-hand syndrome	4180186
45610203	Heart-Hand Syndrome, Type 1	4180186
45610203	Ventriculo-Radial Syndrome	4180186
45610203	Wildervanck syndrome	4180186
45610205	Perinuclear cataract	4180186
45610205	Cataract, lamellar	4180186
45610205	Cataract, Marner Type	4180186
45610207	Cystathioninuria	4180186
45610208	Avellino corneal dystrophy	4180186
45610208	Combined granular-lattice corneal dystrophies	4180186
45610208	Combined Granular-Lattice Corneal Dystrophy	4180186
45610208	Corneal Dystrophy, Avellino Type	4180186
45610208	Granular and lattice corneal dystrophies	4180186
45610208	Granular corneal dystrophy type 2	4180186
45610208	Granular Corneal Dystrophy, Type II	4180186
45610208	Granular-lattice (Avellino) corneal dystrophy	4180186
45610209	Arthrogryposis, Distal, Type 2A	4180186
45610209	Craniocarpotarsal Dysplasia	4180186
45610209	Craniocarpotarsal dystrophy	4180186
45610209	Distal Arthrogryposis, Type 2A	4180186
45610209	Whistling Face Syndrome	4180186
45610209	Whistling Face-Windmill Vane Hand Syndrome	4180186
45610215	Dyggve-Melchior-Clausen Disease	4180186
45610215	Dyggve-Melchior-Clausen syndrome X linked	4180186
45610215	Dyggve-Melchior-Clausen Syndrome, X-Linked	4180186
45610215	X-linked Dyggve-Melchior-Clausen syndrome	4180186
45610219	Hashimoto-Pritzker disease	4180186
45610219	Hashimoto-Pritzker histiocytosis	4180186
45610220	Dwarfism ichthyosiform erythroderma mental deficiency syndrome	4180186
45610220	Ichthyosis hypogonadism mental retardation epilepsy syndrome	4180186
45610220	Ichthyosis male hypogonadism syndrome	4180186
45610220	Ichthyosis mental retardation-epilepsy hypogonadism syndrome	4180186
45610220	Ichthyosis oligophrenia epilepsy syndrome	4180186
45610220	Neuroichthyosis hypogonadism syndrome	4180186
45610220	Rud's syndrome	4180186
45610222	Levator ani spasm syndrome	4180186
45610222	Levator ani syndrome	4180186
45610223	Cartilage Hair Syndrome	4180186
45610223	McKusick Metaphyseal Chondrodysplasia Syndrome	4180186
45610223	Metaphyseal chondrodysplasia, McKusick type	4180186
45610223	Metaphyseal Chondrodysplasia, Recessive Type	4180186
45610224	Galactocoele	4180186
45610224	Galactocoele of childhood	4180186
45610224	Lacteal cyst	4180186
45610224	Lactocele	4180186
45610226	OI, type 2B Osteogenesis imperfecta, type 2B	4180186
45610226	OI, type IIB Osteogenesis imperfecta, type IIB	4180186
45610226	Osteogenesis imperfecta, perinatal lethal, autosomal recessive	4180186
45610226	Osteogenesis Imperfecta, Type IIB	4180186
45610228	Fairbank-Keats syndrome	4180186
45610228	Osteoglophonic dysplasia	4180186
45610230	Osteogenesis imperfecta, ocular form	4180186
45610230	Pseudoglioma with bone fragility	4180186
45610231	Opd Syndrome, Type 1	4180186
45610231	Otopalatodigital syndrome, type 1	4180186
45610231	Otopalatodigital Syndrome Type 1	4180186
45610231	Otopalatodigital Syndrome, Type I	4180186
45610231	Taybi syndrome	4180186
45610232	Kynureninase deficiency	4180186
45610232	Xanthurenic aciduria	4180186
45610237	Retinol Deficiency	4180186
45610237	Xerotic Keratitis	4180186
45610238	Brittle cornea syndrome	4180186
45610238	Corneal fragility, keratoglobus, blue sclerae, joint hyperextensibility	4180186
45610238	Dysgenesis Mesodermalis Corneae et Sclerae	4180186
45610238	Ehlers-Danlos syndrome 6B	4180186
45610238	Ehlers-Danlos Syndrome, Type VIB	4180186
45610238	Fragilitas oculi with joint hyperextensibility	4180186
45610239	Ehlers-Danlos syndrome, kyphoscoliotic type	4180186
45610239	Ehlers-Danlos syndrome, oculoscoliotic type	4180186
45610239	Ehlers-Danlos syndrome, type 6	4180186
45610239	Ehlers-Danlos syndrome, type 6 A	4180186
45610239	Ehlers-Danlos Syndrome, Type VI	4180186
45610239	Ehlers-Danlos Syndrome, Type VIA	4180186
45610241	Angioedema, vibratory	4180186
45610246	Phosphoenolpyruvate carboxykinase-1 (PCK1) deficiency	4180186
45610246	Phosphoenolpyruvate Carboxykinase Deficiency, Cytosolic	4180186
45610246	Phosphoenolpyruvate carboxylase deficiency	4180186
45610246	Phosphopyruvate carboxylase deficiency	4180186
45610247	Dysplasia of nails with hypodontia	4180186
45610247	Nail Dysplasia With Hypodontia	4180186
45610247	Tooth and nail syndrome	4180186
45610247	Tooth-And-Nail Syndrome	4180186
45610248	Primary syphilis	4180186
45610249	Chromosome 3, deletion 3p	4180186
45610249	Deletion 3p	4180186
45610249	Monosomy 3p	4180186
45610251	Idiopathic thrombotic thrombocytopenic purpura	4180186
45610251	Moschowitz syndrome	4180186
45610252	Follicular thyroid cancer, Hurthle cell type	4180186
45610252	Hurthle cell carcinoma of the thyroid	4180186
45610252	Hurthle Cell Thyroid Neoplasia	4180186
45610252	Thyroid cancer, follicular, Hurthle cell type	4180186
45610252	Thyroid carcinoma, Hurthle cell	4180186
45610253	Congenital Nongoitrous Hypothyroidism-4	4180186
45610253	Pituitary cretinism	4180186
45610253	Thyroid-Stimulating Hormone Deficiency	4180186
45610253	Thyroid-stimulating hormone, deficiency of	4180186
45610253	Thyrotropin deficiency, isolated	4180186
45610253	Tsh Deficiency	4180186
45610254	Bull teeth	4180186
45610254	Large pulp chambers, in the molars	4180186
45610255	Familial Gonadotrophin-Independent Sexual Precocity	4180186
45610255	Familial Male-Limited Precocious Puberty	4180186
45610255	Gonadotrophin-Independent Precocious Puberty	4180186
45610255	Precocious Pseudopuberty	4180186
45610255	Sexual precocity, familial, gonadotropin-independent	4180186
45610255	Testotoxicosis, Familial	4180186
45610256	Anal-Ear-Renal-Radial Malformation Syndrome	4180186
45610256	Anus, Imperforate, with Hand, Foot, and Ear Anomalies	4180186
45610256	Deafness-Imperforate Anus-Hypoplastic Thumbs Syndrome	4180186
45610256	Deafness, sensorineural, with imperforate anus and hypoplastic thumbs	4180186
45610256	Deafness, Sensorineural, With Imperforate Anus And Thumb Anomalies	4180186
45610256	Imperforate Anus-Hand and Foot Anomalies Syndrome	4180186
45610256	REAR syndrome	4180186
45610256	Renal-ear-anal-radial syndrome	4180186
45610256	Renal-Ear-Anal-Radial Syndrome (Rear)	4180186
45610256	Sensorineural Deafness-Imperforate Anus-Hypoplastic Thumbs Syndrome	4180186
45610256	Townes Syndrome	4180186
45610258	Littoral cell angioma	4180186
45610259	Primitive renal tubule syndrome	4180186
45610259	Renal tubular dysgenesis	4180186
45610259	Renotubular dysgenesis	4180186
45610262	Glomerular basement membrane disease, nail-patella syndrome type	4180186
45610262	Nail patella like renal disease	4180186
45610262	Nail-Patella-Like Renal Disease	4180186
45610263	Congenital koilonychia	4180186
45610263	Familial koilonychia	4180186
45610263	Koilonychia, Hereditary	4180186
45610265	Early-onset regressive form of metaphyseal dysplasia	4180186
45610266	Acylcholine acylhydrolase deficiency	4180186
45610266	Apnea, Postanesthetic	4180186
45610266	Cholinesterase 2 Deficiency	4180186
45610266	Pseudocholinesterase deficiency	4180186
45610266	Pseudocholinesterase E1 deficiency	4180186
45610266	Succinylcholine Sensitivity	4180186
45610266	Suxamethonium Sensitivity	4180186
45610268	Huriez syndrome	4180186
45610268	Scleroatrophic and keratotic dermatosis of limbs	4180186
45610269	Acads Deficiency	4180186
45610269	Acyl-Coa Dehydrogenase, Short-Chain, Deficiency Of	4180186
45610269	Deficiency of Butyryl-Coa Dehydrogenase	4180186
45610269	Lipid-Storage Myopathy Secondary to Short-Chain Acyl-Coa Dehydrogenase Deficiency	4180186
45610269	Scad Deficiency	4180186
45610269	Scadh Deficiency	4180186
45610269	Short-Chain Acyl-Coa Dehydrogenase Deficiency	4180186
45610269	Short-Chain Acyl-Coenzyme A Dehydrogenase Deficiency	4180186
45610272	Tumor-induced osteomalacia	4180186
45610274	Corneal dystrophy, macular type	4180186
45610274	Groenouw type II corneal dystrophy	4180186
45610274	Macular corneal dystrophy type 1	4180186
45610274	Macular Corneal Dystrophy, Type I	4180186
45610274	Macular Dystrophy, Corneal, 1	4180186
45610274	Mcd	4180186
45610274	Mcdc1	4180186
45610276	Essential benign fructosuria	4180186
45610276	Hepatic fructokinase deficiency	4180186
45610276	Ketohexokinase deficiency	4180186
45610277	Bowing, congenital, with short bones	4180186
45610279	18p deletion syndrome	4180186
45610279	18p minus syndrome	4180186
45610279	18p- syndrome	4180186
45610279	Del(18p) syndrome	4180186
45610279	Deletion 18p syndrome	4180186
45610281	Vertebral artery syndrome	4180186
45610286	OFDS III	4180186
45610286	Brachydactyly of the hands and feet with duplication of the first toes	4180186
45610286	Brachydactyly with major proximal phalangeal shortening	4180186
45610286	Oral-facial-digital syndrome 3	4180186
45610286	Oral-Facial-Digital Syndrome, Type III	4180186
45610286	Orofaciodigital syndrome III	4180186
45610286	Sugarman brachydactyly	4180186
45610286	Sugarman syndrome	4180186
45610288	Chinese Restaurant Syndrome	4180186
45610291	Familial Intestinal Polyatresia Syndrome	4180186
45610298	Xeroderma Pigmentosum, Group B	4180186
45610304	Nasal Cartilages, Agenesis of	4180186
45610311	CFH Deficiency	4180186
45610311	Factor H Deficiency	4180186
45610311	C3G1 C3 glomerulopathy 1	4180186
45610311	C3G-1 Complement 3 Glomerulopathy 1	4180186
45610311	Glomerulonephritis With Isolated C3 Deposits And Factor H Deficiency	4180186
45610311	Membranoproliferative Glomerulonephritis, Type II, With Complement Factor H Deficiency	4180186
45610311	MPGN II with Complement Factor H Deficiency	4180186
45610313	Infertility Associated with Multi-Tailed Spermatozoa and Excessive DNA	4180186
45610316	Glaucoma, Pigment-Dispersion Type	4180186
45610316	GPDS1 Glaucoma-Related Pigment Dispersion Syndrome	4180186
45610316	Pigment-Dispersion Syndrome	4180186
45610318	Ataxia, Episodic, with Myokymia	4180186
45610318	Episodic Ataxia with Myokymia	4180186
45610318	Myokymia 1 With Or Without Hypomagnesemia	4180186
45610318	Myokymia with Periodic Ataxia	4180186
45610318	Paroxysmal Ataxia with Neuromyotonia, Hereditary	4180186
45610322	Abruption, Placental	4180186
45610322	Abruptions, Placental	4180186
45610322	Placental Abruption	4180186
45610322	Placental Abruptions	4180186
45610323	Accommodation, Lens	4180186
45610323	Ocular Distance Accommodation	4180186
45610323	Accommodation, Ocular Distance	4180186
45610323	Ocular Accommodation	4180186
45610323	Distance Accommodation, Ocular	4180186
45610323	Ocular Distance Accommodations	4180186
45610323	Lens Accommodation	4180186
45610324	Acebutolol Hydrochloride	4180186
45610324	Acetobutolol	4180186
45610324	ApoAcebutolol	4180186
45610324	Apo Acebutolol	4180186
45610324	Apo-Acebutolol	4180186
45610324	Butanamide, N-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-, (+-)-	4180186
45610324	M & B 17803A	4180186
45610324	M&B 17803 A	4180186
45610324	M&B-17803 A	4180186
45610324	M&B17803 A	4180186
45610324	Monitan	4180186
45610324	Neptal	4180186
45610324	NovoAcebutolol	4180186
45610324	Novo Acebutolol	4180186
45610324	Novo-Acebutolol	4180186
45610324	Prent	4180186
45610324	Rhotral	4180186
45610324	Sectral	4180186
45610328	Acrodynic Erythema	4180186
45610328	Childhood Mercurialism, Chronic	4180186
45610328	Childhood Mercurialisms, Chronic	4180186
45610328	Chronic Childhood Mercurialism	4180186
45610328	Chronic Childhood Mercurialisms	4180186
45610328	Erythema, Acrodynic	4180186
45610328	Feer Disease	4180186
45610328	Feer's Disease	4180186
45610328	Feers Disease	4180186
45610328	Mercurialism, Chronic Childhood	4180186
45610328	Pink Disease	4180186
45610328	Swift Disease	4180186
45610328	Swift's Disease	4180186
45610328	Swifts Disease	4180186
45610330	Adams Stokes Syndrome	4180186
45610330	Adam Stokes Attacks	4180186
45610330	Adam-Stokes Attacks	4180186
45610330	Attacks, Adam-Stokes	4180186
45610330	Attacks, Stokes-Adams	4180186
45610330	Stokes Adams Attacks	4180186
45610330	Stokes-Adams Attacks	4180186
45610330	Stokes Adams Syndrome	4180186
45610330	Stokes-Adams Syndrome	4180186
45610330	Syndrome, Adams-Stokes	4180186
45610330	Syndrome, Stokes-Adams	4180186
45610336	Addison Disease and Cerebral Sclerosis	4180186
45610336	Adrenoleukodystrophy, X-Linked	4180186
45610336	Adrenomyeloneuropathy	4180186
45610336	ALD (Adrenoleukodystrophy)	4180186
45610336	Bronze Schilder Disease	4180186
45610336	Leukodystrophies, Melanodermic	4180186
45610336	Leukodystrophy, Melanodermic	4180186
45610336	Melanodermic Leukodystrophy	4180186
45610336	Schilder Addison Complex	4180186
45610336	Schilder-Addison Complex	4180186
45610336	Siemerling Creutzfeldt Disease	4180186
45610336	Siemerling-Creutzfeldt Disease	4180186
45610336	X ALD	4180186
45610336	X-ALD	4180186
45610336	X ALD (X Linked Adrenoleukodystrophy)	4180186
45610336	X-ALD (X-Linked Adrenoleukodystrophy)	4180186
45610336	X Linked Adrenoleukodystrophy	4180186
45610336	X-Linked Adrenoleukodystrophy	4180186
45610337	Affective Disorder, Psychotic	4180186
45610337	Affective Psychoses	4180186
45610337	Depression, Reactive, Psychotic	4180186
45610337	Disorder, Psychotic Affective	4180186
45610337	Disorders, Psychotic Affective	4180186
45610337	Mood Disorder, Psychotic	4180186
45610337	Mood Disorders, Psychotic	4180186
45610337	Psychoses, Affective	4180186
45610337	Psychotic Affective Disorder	4180186
45610337	Psychotic Affective Disorders	4180186
45610337	Psychotic Mood Disorder	4180186
45610337	Psychotic Mood Disorders	4180186
45610338	Agammaglobulinemias	4180186
45610338	Hypogammaglobulinemia	4180186
45610338	Hypogammaglobulinemias	4180186
45610340	Abufène	4180186
45610340	Alanine, L Isomer	4180186
45610340	Alanine, L-Isomer	4180186
45610340	(L)-Alanine	4180186
45610340	L Alanine	4180186
45610340	L-Alanine	4180186
45610340	L-Isomer Alanine	4180186
45610343	Allyloestrenol	4180186
45610343	Estr-4-en-17-ol, 17-(2-propenyl)-, (17beta)-	4180186
45610343	Gestanin	4180186
45610343	Gestanon	4180186
45610343	Turinal	4180186
45610347	Amblyopia, Anisometropic	4180186
45610347	Amblyopia, Developmental	4180186
45610347	Amblyopias	4180186
45610347	Amblyopias, Anisometropic	4180186
45610347	Amblyopias, Developmental	4180186
45610347	Amblyopias, Stimulus Deprivation-Induced	4180186
45610347	Amblyopias, Suppression	4180186
45610347	Amblyopia, Stimulus Deprivation Induced	4180186
45610347	Amblyopia, Stimulus Deprivation-Induced	4180186
45610347	Amblyopia, Suppression	4180186
45610347	Anisometropic Amblyopia	4180186
45610347	Anisometropic Amblyopias	4180186
45610347	Deprivation-Induced Amblyopias, Stimulus	4180186
45610347	Deprivation-Induced Amblyopia, Stimulus	4180186
45610347	Developmental Amblyopia	4180186
45610347	Developmental Amblyopias	4180186
45610347	Eye, Lazy	4180186
45610347	Eyes, Lazy	4180186
45610347	Lazy Eye	4180186
45610347	Lazy Eyes	4180186
45610347	Stimulus Deprivation Induced Amblyopia	4180186
45610347	Stimulus Deprivation-Induced Amblyopia	4180186
45610347	Stimulus Deprivation-Induced Amblyopias	4180186
45610347	Suppression Amblyopia	4180186
45610347	Suppression Amblyopias	4180186
45610350	3H-Pyrazol-3-one, 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-	4180186
45610350	Amidazophen	4180186
45610350	Amidophen	4180186
45610350	Amidophenazon	4180186
45610350	Amidopyrine	4180186
45610350	Aminofenazone	4180186
45610350	Aminophenazone	4180186
45610350	Dimethylaminoantipyrine	4180186
45610350	Dimethylaminophenazone	4180186
45610350	Dimethyl N aminoantipyrine	4180186
45610350	Dimethyl-N-aminoantipyrine	4180186
45610350	Dipyrine	4180186
45610350	Eufibron	4180186
45610351	Amnesia, Dissociative	4180186
45610351	Amnesia, Global	4180186
45610351	Amnesia, Hysterical	4180186
45610351	Amnesia Memory Loss	4180186
45610351	Amnesia-Memory Loss	4180186
45610351	Amnesia-Memory Losses	4180186
45610351	Amnesias	4180186
45610351	Amnesias, Dissociative	4180186
45610351	Amnesias, Global	4180186
45610351	Amnesias, Hysterical	4180186
45610351	Amnesias, Tactile	4180186
45610351	Amnesias, Temporary	4180186
45610351	Amnesia, Tactile	4180186
45610351	Amnesia, Temporary	4180186
45610351	Amnestic State	4180186
45610351	Amnestic States	4180186
45610351	Dissociative Amnesia	4180186
45610351	Dissociative Amnesias	4180186
45610351	Global Amnesia	4180186
45610351	Global Amnesias	4180186
45610351	Hysterical Amnesia	4180186
45610351	Hysterical Amnesias	4180186
45610351	State, Amnestic	4180186
45610351	States, Amnestic	4180186
45610351	Tactile Amnesia	4180186
45610351	Tactile Amnesias	4180186
45610351	Temporary Amnesia	4180186
45610351	Temporary Amnesias	4180186
45610352	Amniotic Band	4180186
45610352	Amniotic Bands	4180186
45610352	Amputation, Intrauterine	4180186
45610352	Amputations, Intrauterine	4180186
45610352	Annular Groove	4180186
45610352	Annular Grooves	4180186
45610352	Band, Amniotic	4180186
45610352	Bands, Amniotic	4180186
45610352	Constriction, Intrauterine Ring	4180186
45610352	Constrictions, Intrauterine Ring	4180186
45610352	Groove, Annular	4180186
45610352	Grooves, Annular	4180186
45610352	Intrauterine Amputation	4180186
45610352	Intrauterine Amputations	4180186
45610352	Intrauterine Ring Constriction	4180186
45610352	Intrauterine Ring Constrictions	4180186
45610352	Ring Constriction, Intrauterine	4180186
45610352	Ring Constrictions, Intrauterine	4180186
45610352	Streeter Syndrome	4180186
45610352	Syndrome, Amniotic Band	4180186
45610352	Syndrome, Streeter	4180186
45610353	2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine	4180186
45610353	Asendin	4180186
45610353	Asendis	4180186
45610353	CL 67,772	4180186
45610353	CL-67,772	4180186
45610353	CL67,772	4180186
45610353	Défanyl	4180186
45610353	Demolox	4180186
45610353	Desmethylloxapine	4180186
45610353	Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(1-piperazinyl)-	4180186
45610354	Amputations, Traumatic	4180186
45610354	Traumatic Amputation	4180186
45610354	Traumatic Amputations	4180186
45610356	Anemia, Congenital Dyserythropoietic	4180186
45610356	Anemia, Congenital Dyserythropoietic, Type II	4180186
45610356	Anemia, Dyserythropoietic, Congenital Type 1	4180186
45610356	Anemia, Dyserythropoietic, Congenital Type 2	4180186
45610356	Anemia, Dyserythropoietic Congenital, Type I	4180186
45610356	Anemia, Dyserythropoietic, Congenital, Type I	4180186
45610356	Anemia, Dyserythropoietic Congenital, Type II	4180186
45610356	Anemia, Dyserythropoietic, Congenital, Type II	4180186
45610356	Anemia, Dyserythropoietic Congenital, Type III	4180186
45610356	Anemia, Dyserythropoietic, Congenital, Type III	4180186
45610356	Anemias, Congenital Dyserythropoietic	4180186
45610356	Anemia With Multinucleated Erythroblasts	4180186
45610356	Congenital Dyserythropoietic Anemia	4180186
45610356	Congenital Dyserythropoietic Anemias	4180186
45610356	Congenital Dyserythropoietic Anemia Type 1	4180186
45610356	Congenital Dyserythropoietic Anemia, Type I	4180186
45610356	Congenital Dyserythropoietic Anemia Type II	4180186
45610356	Congenital Dyserythropoietic Anemia, Type III	4180186
45610356	Dyserythropoietic Anemia, Congenital	4180186
45610356	Dyserythropoietic Anemia, Congenital Type 1	4180186
45610356	Dyserythropoietic Anemia, Congenital Type 2	4180186
45610356	Dyserythropoietic Anemia, Congenital, Type I	4180186
45610356	Dyserythropoietic Anemia, Congenital, Type II	4180186
45610356	Dyserythropoietic Anemia, Congenital, Type III	4180186
45610356	Dyserythropoietic Anemia, HEMPAS Type	4180186
45610356	Dyserythropoietic Anemias, Congenital	4180186
45610356	HEMPAS	4180186
45610356	HEMPAS Anemia	4180186
45610356	HEMPAS Anemias	4180186
45610356	Hereditary Erythroblastic Multinuclearity with Positive Acidified-Serum Test	4180186
45610356	Hereditary Erythroblast Multinuclearity with Positive Acidified Serum	4180186
45610356	Type I Congenital Dyserythropoietic Anemia	4180186
45610357	Refractory Anemia	4180186
45610357	Anemias, Refractory	4180186
45610357	Refractory Anemias	4180186
45610359	3H-1,2-Dithiole-3-thione, 5-(4-methoxyphenyl)-	4180186
45610359	Anethol Dithiolthione	4180186
45610359	Anetholetrithione	4180186
45610359	Anetholtrithion	4180186
45610359	Anetholtrithione	4180186
45610359	Anisyldithiolthionine	4180186
45610359	Dithiolthione, Anethol	4180186
45610359	Felviten	4180186
45610359	Heporal	4180186
45610359	Mucinol	4180186
45610359	Sialor	4180186
45610359	SL 25	4180186
45610359	SL-25	4180186
45610359	Sonicur	4180186
45610359	Sulfarlem	4180186
45610359	Sulfralem	4180186
45610359	Tiotrifar	4180186
45610359	Trithio	4180186
45610359	Trithioanethol	4180186
45610359	Trithione, Anethole	4180186
45610359	Trithioparamethoxyphenylpropene	4180186
45610360	Angiomatoses	4180186
45610361	Welfare, Animal	4180186
45610361	Cruelty, Animal	4180186
45610361	Animal Cruelty	4180186
45610363	Bacillus anthracis Infection	4180186
45610363	Bacillus anthracis Infections	4180186
45610364	Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4))di-, dipotassium, trihydrate, stereoisomer	4180186
45610364	Antimonyltartrate, Potassium	4180186
45610364	Antimony, Tartrated	4180186
45610364	Emetic, Tartar	4180186
45610364	Potassium Antimonyltartrate	4180186
45610364	Potassium Tartrate, Antimony	4180186
45610364	Tartar Emetic	4180186
45610364	Tartrate, Antimony Potassium	4180186
45610364	Tartrated Antimony	4180186
45610376	Athetoid Movement	4180186
45610376	Athetoid Movements	4180186
45610376	Athetoses	4180186
45610376	Disease, Hammond	4180186
45610376	Disease, Hammond's	4180186
45610376	Diseases, Hammond	4180186
45610376	Diseases, Hammond's	4180186
45610376	Hammond Disease	4180186
45610376	Hammond Diseases	4180186
45610376	Hammond's Disease	4180186
45610376	Hammonds Disease	4180186
45610376	Hammond's Diseases	4180186
45610376	Movement, Athetoid	4180186
45610376	Movements, Athetoid	4180186
45610378	1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-	4180186
45610378	Azathioprine Sodium	4180186
45610378	Azathioprine Sodium Salt	4180186
45610378	Azathioprine Sulfate	4180186
45610378	Azothioprine	4180186
45610378	Immuran	4180186
45610378	Imuran	4180186
45610378	Imurel	4180186
45610378	Sodium, Azathioprine	4180186
45610380	ApoBaclofen	4180186
45610380	Apo Baclofen	4180186
45610380	Apo-Baclofen	4180186
45610380	Atrofen	4180186
45610380	AWD, Baclofen	4180186
45610380	Ba34647	4180186
45610380	Ba-34647	4180186
45610380	Ba-34,647	4180186
45610380	Ba34,647	4180186
45610380	Baclofen AWD	4180186
45610380	BaclofèneIrex	4180186
45610380	Baclofène Irex	4180186
45610380	Baclofène-Irex	4180186
45610380	Baclophen	4180186
45610380	Baclospas	4180186
45610380	Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-	4180186
45610380	beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid	4180186
45610380	beta-(p-Chlorophenyl)-gamma-aminobutyric Acid	4180186
45610380	Chlorophenyl GABA	4180186
45610380	CIBA-34,647-BA	4180186
45610380	CIBA34,647BA	4180186
45610380	Clofen	4180186
45610380	GABA, Chlorophenyl	4180186
45610380	GenBaclofen	4180186
45610380	Gen Baclofen	4180186
45610380	Gen-Baclofen	4180186
45610380	Genpharm	4180186
45610380	Lebic	4180186
45610380	Lioresal	4180186
45610380	Liorésal	4180186
45610380	NuBaclo	4180186
45610380	Nu Baclo	4180186
45610380	Nu-Baclo	4180186
45610380	PCP-GABA	4180186
45610380	PMSBaclofen	4180186
45610380	PMS Baclofen	4180186
45610380	PMS-Baclofen	4180186
45610381	Phage Typing	4180186
45610381	Typing, Bacteriophage	4180186
45610381	Typing, Phage	4180186
45610382	Bacteriurias	4180186
45610383	Bacteroides Infection	4180186
45610383	Infection, Bacteroides	4180186
45610383	Infections, Bacteroides	4180186
45610384	Balantidiases	4180186
45610384	Balantidium coli Infection	4180186
45610384	Balantidium coli Infections	4180186
45610384	Balantidium Infection	4180186
45610384	Balantidium Infections	4180186
45610384	B. coli Infection	4180186
45610384	B. coli Infections	4180186
45610384	Infection, B. coli	4180186
45610387	NBCCS	4180186
45610387	Fifth Phacomatoses	4180186
45610387	Fifth Phacomatosis	4180186
45610387	Gorlin Goltz Syndrome	4180186
45610387	Gorlin-Goltz Syndrome	4180186
45610387	Gorlin Syndrome	4180186
45610387	Multiple Basal Cell Nevi, Odontogenic Keratocysts, and Skeletal Anomalies	4180186
45610387	Nevoid Basal Cell Carcinoma Syndrome	4180186
45610387	Nevus Syndrome, Basal Cell	4180186
45610387	Syndrome, Gorlin	4180186
45610387	Syndrome, Gorlin-Goltz	4180186
45610393	1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-	4180186
45610393	Benzidamine	4180186
45610393	Benzindamine	4180186
45610393	Benzydamine Hydrochloride	4180186
45610393	Benzydamine Monohydrochloride	4180186
45610393	Difflam	4180186
45610393	Hydrochloride, Benzydamine	4180186
45610393	Lonol	4180186
45610393	Monohydrochloride, Benzydamine	4180186
45610393	Novo Benzydamine	4180186
45610393	Novo-Benzydamine	4180186
45610393	Opalgyne	4180186
45610393	PMS Benzydamine	4180186
45610393	PMS-Benzydamine	4180186
45610393	Ratio Benzydamine	4180186
45610393	Ratio-Benzydamine	4180186
45610393	Rosalgin	4180186
45610393	Sun Benz	4180186
45610393	Sun-Benz	4180186
45610393	Tantum	4180186
45610393	Tantum Topico	4180186
45610394	Scorbo-bétaïne	4180186
45610394	Scorbo bétaïne	4180186
45610394	Scorbobétaïne	4180186
45610394	Citrate de Bétaïne UPSA	4180186
45610394	Citrate de Bétaïne Beaufour	4180186
45610394	Novobetaine	4180186
45610394	AcidinPepsin	4180186
45610394	Acidin Pepsin	4180186
45610394	Acidin-Pepsin	4180186
45610394	Betaine, Glycine	4180186
45610394	Betaine Hydrochloride	4180186
45610394	C.B.B.	4180186
45610394	Cystadane	4180186
45610394	Glycine Betaine	4180186
45610394	Hepastyl	4180186
45610394	Hydrochloride, Betaine	4180186
45610394	Lycine	4180186
45610394	Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt	4180186
45610394	Oxyneurine	4180186
45610394	Stea16	4180186
45610394	Stea 16	4180186
45610394	Stea-16	4180186
45610397	Bladder Exstrophies	4180186
45610397	Bladder Extrophies	4180186
45610397	Bladder Extrophy	4180186
45610397	Exstrophies, Bladder	4180186
45610397	Exstrophies, Urinary Bladder	4180186
45610397	Exstrophy, Bladder	4180186
45610397	Exstrophy Of Bladder	4180186
45610397	Exstrophy of the Bladder	4180186
45610397	Exstrophy, Urinary Bladder	4180186
45610397	Extrophies, Bladder	4180186
45610397	Extrophy, Bladder	4180186
45610397	Urinary Bladder Exstrophies	4180186
45610397	Urinary Bladder Exstrophy	4180186
45610400	Blebs	4180186
45610400	Bullous Lesions	4180186
45610400	Bullae	4180186
45610400	Bulla	4180186
45610400	Blisters	4180186
45610400	Vesications	4180186
45610400	Lesions, Bullous	4180186
45610400	Lesion, Bullous	4180186
45610400	Bullous Lesion	4180186
45610400	Vesication	4180186
45610400	Bleb	4180186
45610405	Benign Brain Neoplasm	4180186
45610405	Benign Brain Neoplasms	4180186
45610405	Benign Neoplasm, Brain	4180186
45610405	Benign Neoplasms, Brain	4180186
45610405	Brain Benign Neoplasm	4180186
45610405	Brain Benign Neoplasms	4180186
45610405	Brain Cancer	4180186
45610405	Brain Cancers	4180186
45610405	Brain Malignant Neoplasm	4180186
45610405	Brain Malignant Neoplasms	4180186
45610405	Brain Metastase	4180186
45610405	Brain Metastases	4180186
45610405	Brain Neoplasm	4180186
45610405	Brain Neoplasm, Benign	4180186
45610405	Brain Neoplasm, Malignant	4180186
45610405	Brain Neoplasm, Primary	4180186
45610405	Brain Neoplasms, Benign	4180186
45610405	Brain Neoplasms, Malignant	4180186
45610405	Brain Neoplasms, Malignant, Primary	4180186
45610405	Brain Neoplasms, Primary	4180186
45610405	Brain Neoplasms, Primary Malignant	4180186
45610405	Brain Tumor	4180186
45610405	Brain Tumor, Primary	4180186
45610405	Brain Tumor, Recurrent	4180186
45610405	Brain Tumors	4180186
45610405	Brain Tumors, Recurrent	4180186
45610405	Cancer, Brain	4180186
45610405	Cancer of Brain	4180186
45610405	Cancer of the Brain	4180186
45610405	Intracranial Neoplasm	4180186
45610405	Intracranial Neoplasms	4180186
45610405	Malignant Brain Neoplasm	4180186
45610405	Malignant Brain Neoplasms	4180186
45610405	Malignant Neoplasm, Brain	4180186
45610405	Malignant Neoplasms, Brain	4180186
45610405	Malignant Primary Brain Neoplasms	4180186
45610405	Malignant Primary Brain Tumors	4180186
45610405	Neoplasm, Brain	4180186
45610405	Neoplasm, Intracranial	4180186
45610405	Neoplasms, Brain	4180186
45610405	Neoplasms, Brain, Benign	4180186
45610405	Neoplasms, Brain, Malignant	4180186
45610405	Neoplasms, Brain, Primary	4180186
45610405	Neoplasms, Intracranial	4180186
45610405	Primary Brain Neoplasm	4180186
45610405	Primary Brain Neoplasms	4180186
45610405	Primary Brain Tumor	4180186
45610405	Primary Brain Tumors	4180186
45610405	Primary Malignant Brain Neoplasms	4180186
45610405	Primary Malignant Brain Tumors	4180186
45610405	Recurrent Brain Tumor	4180186
45610405	Recurrent Brain Tumors	4180186
45610405	Tumor, Brain	4180186
45610407	2 Bromo alpha ergocryptine	4180186
45610407	2-Bromo-alpha-ergocryptine	4180186
45610407	2 Bromo alpha ergokryptine	4180186
45610407	2-Bromo-alpha-ergokryptine	4180186
45610407	2 Bromoergocryptine	4180186
45610407	2-Bromoergocryptine	4180186
45610407	2 Bromoergocryptine Mesylate	4180186
45610407	2-Bromoergocryptine Mesylate	4180186
45610407	2 Bromoergocryptine Methanesulfonate	4180186
45610407	2-Bromoergocryptine Methanesulfonate	4180186
45610407	2 Bromoergokryptine	4180186
45610407	2-Bromoergokryptine	4180186
45610407	Bromocriptin	4180186
45610407	Bromocriptine Mesylate	4180186
45610407	Bromocryptin	4180186
45610407	CB154	4180186
45610407	CB 154	4180186
45610407	CB-154	4180186
45610407	Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-	4180186
45610407	Mesylate, 2-Bromoergocryptine	4180186
45610407	Mesylate, Bromocriptine	4180186
45610407	Methanesulfonate, 2-Bromoergocryptine	4180186
45610407	Parlodel	4180186
45610409	Novo Buspirone	4180186
45610409	8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-	4180186
45610409	Anxut	4180186
45610409	Apo Buspirone	4180186
45610409	Apo-Buspirone	4180186
45610409	Bespar	4180186
45610409	Busp	4180186
45610409	Buspar	4180186
45610409	Buspirone Hydrochloride	4180186
45610409	Gen Buspirone	4180186
45610409	Gen-Buspirone	4180186
45610409	Hydrochloride, Buspirone	4180186
45610409	Lin Buspirone	4180186
45610409	Lin-Buspirone	4180186
45610409	MJ90221	4180186
45610409	MJ 9022 1	4180186
45610409	MJ-9022-1	4180186
45610409	N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide	4180186
45610409	Neurosine	4180186
45610409	Novo-Buspirone	4180186
45610409	Nu Buspirone	4180186
45610409	Nu-Buspirone	4180186
45610409	PMS Buspirone	4180186
45610409	PMS-Buspirone	4180186
45610409	Ratio Buspirone	4180186
45610409	Ratio-Buspirone	4180186
45610411	5-Isopropoxycarbonylamino-2-(4-thiazoyl)benzimidazole	4180186
45610411	Carbamic acid, (2-(4-thiazolyl)-1H-benzimidazol-5-yl)-, 1-methylethyl ester	4180186
45610411	Noviben	4180186
45610413	4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxyphenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-	4180186
45610413	Anabactyl	4180186
45610413	Carbapen	4180186
45610413	Carbecin	4180186
45610413	Carbenicillin Disodium	4180186
45610413	Carboxybenzyl Penicillin	4180186
45610413	Disodium, Carbenicillin	4180186
45610413	Geopen	4180186
45610413	Microcillin	4180186
45610413	Penicillin, Carboxybenzyl	4180186
45610413	Pyopen	4180186
45610415	Carcinoma, Non Small Cell Lung	4180186
45610415	Carcinoma, Non-Small Cell Lung	4180186
45610415	Carcinomas, Non-Small-Cell Lung	4180186
45610415	Lung Carcinoma, Non-Small-Cell	4180186
45610415	Lung Carcinomas, Non-Small-Cell	4180186
45610415	Nonsmall Cell Lung Cancer	4180186
45610415	Non-Small Cell Lung Cancer	4180186
45610415	Non Small Cell Lung Carcinoma	4180186
45610415	Non-Small Cell Lung Carcinoma	4180186
45610415	Non-Small-Cell Lung Carcinoma	4180186
45610415	Non-Small-Cell Lung Carcinomas	4180186
45610418	Causalgia Syndrome	4180186
45610418	Causalgia Syndromes	4180186
45610418	Complex Regional Pain Syndrome Type II	4180186
45610418	CRPS Type II	4180186
45610418	Deafferentation Pain	4180186
45610418	Pain, Deafferentation	4180186
45610418	Syndrome, Causalgia	4180186
45610418	Syndromes, Causalgia	4180186
45610418	Type II Complex Regional Pain Syndrome	4180186
45610419	4 Hydroxycephalexin	4180186
45610419	4-Hydroxycephalexin	4180186
45610419	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-	4180186
45610419	Bidocef	4180186
45610419	BLS578	4180186
45610419	BL S578	4180186
45610419	BL S 578	4180186
45610419	BL-S578	4180186
45610419	BL-S 578	4180186
45610419	BLS 578	4180186
45610419	Cefadroxil Anhydrous	4180186
45610419	Cefadroxil Monohydrate	4180186
45610419	Cephadroxyl	4180186
45610419	Duricef	4180186
45610419	S578	4180186
45610419	S 578	4180186
45610419	S-578	4180186
45610419	Ultracef	4180186
45610420	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1H-1,2,3-triazol-4-ylthio)methyl)-, (6R-(6alpha,7beta(R*)))-	4180186
45610420	BLS640	4180186
45610420	BL S640	4180186
45610420	BL S 640	4180186
45610420	BL-S640	4180186
45610420	BL-S 640	4180186
45610420	BLS 640	4180186
45610420	S640P	4180186
45610420	S 640P	4180186
45610420	S 640 P	4180186
45610420	S 640-P	4180186
45610420	S-640P	4180186
45610420	SKF60771	4180186
45610420	SK&F60771	4180186
45610420	SK&F 60771	4180186
45610420	SK&F-60771	4180186
45610420	SKF 60771	4180186
45610420	SKF-60771	4180186
45610421	Cell Counts	4180186
45610421	Cell Densities	4180186
45610421	Cell Density	4180186
45610421	Cell Number	4180186
45610421	Cell Numbers	4180186
45610421	Count, Cell	4180186
45610421	Counts, Cell	4180186
45610421	Densities, Cell	4180186
45610421	Density, Cell	4180186
45610421	Number, Cell	4180186
45610421	Numbers, Cell	4180186
45610422	1,4-(1,3;1,4)-beta-D-Glucan-4-glucanohydrolase	4180186
45610422	beta 1,4 Glucan 4 Glucanohydrolase	4180186
45610422	beta-1,4-Glucan-4-Glucanohydrolase	4180186
45610422	Cellulysin	4180186
45610422	Endo 1,4 beta Glucanase	4180186
45610422	Endo-1,4-beta-Glucanase	4180186
45610422	Endoglucanase	4180186
45610422	Endoglucanase A	4180186
45610422	Endoglucanase C	4180186
45610422	Endoglucanase E	4180186
45610422	Endoglucanase IV	4180186
45610422	Endoglucanase Y	4180186
45610423	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, (6R-trans)-	4180186
45610423	Cefalotin	4180186
45610423	Cefalotina Normon	4180186
45610423	Cefalotina Sodica Spaly	4180186
45610423	Ceftina	4180186
45610423	Cephalothin Monosodium Salt	4180186
45610423	Cephalothin, Sodium	4180186
45610423	Keflin	4180186
45610423	Monosodium Salt, Cephalothin	4180186
45610423	Salt, Cephalothin Monosodium	4180186
45610423	Seffin	4180186
45610423	Sodium Cephalothin	4180186
45610424	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-	4180186
45610424	Anspor	4180186
45610424	Cefradine	4180186
45610424	Cephradine Dihydrate	4180186
45610424	Cephradine, Non Stoichiometric Hydrate	4180186
45610424	Cephradine, Non-Stoichiometric Hydrate	4180186
45610424	Dexef	4180186
45610424	Dihydrate, Cephradine	4180186
45610424	Kelsef	4180186
45610424	Maxisporin	4180186
45610424	Nicef	4180186
45610424	Non-Stoichiometric Hydrate Cephradine	4180186
45610424	Sefril	4180186
45610424	Septacef	4180186
45610424	SQ11436	4180186
45610424	SQ 11436	4180186
45610424	SQ-11436	4180186
45610424	Velocef	4180186
45610424	Velosef	4180186
45610424	Zeefra Gé	4180186
45610427	Angiographies, Cerebral	4180186
45610427	Angiography, Cerebral	4180186
45610427	Cerebral Angiographies	4180186
45610428	Alper Disease	4180186
45610428	Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis	4180186
45610428	Alper's Disease	4180186
45610428	Alpers Disease	4180186
45610428	Alpers' Disease	4180186
45610428	Alpers Huttenlocher Syndrome	4180186
45610428	Alpers-Huttenlocher Syndrome	4180186
45610428	Alpers Progressive Infantile Poliodystrophy	4180186
45610428	Alper's Syndrome	4180186
45610428	Alpers Syndrome	4180186
45610428	Alpers' Syndrome	4180186
45610428	Alper Syndrome	4180186
45610428	Balo Concentric Sclerosis	4180186
45610428	Balo's Concentric Sclerosis	4180186
45610428	Cerebral Sclerosis, Diffuse	4180186
45610428	Concentric Sclerosis, Balo	4180186
45610428	Concentric Sclerosis, Balo's	4180186
45610428	Diffuse Cerebral Scleroses	4180186
45610428	Diffuse Cerebral Sclerosis	4180186
45610428	Diffuse Scleroses, Myelinoclastic	4180186
45610428	Diffuse Sclerosis, Myelinoclastic	4180186
45610428	Disease, Alpers'	4180186
45610428	Disease, Schilder	4180186
45610428	Disease, Schilder's	4180186
45610428	Encephalitis Periaxialis	4180186
45610428	Encephalitis Periaxialis Concentrica	4180186
45610428	Encephalitis Periaxialis Diffusa	4180186
45610428	Myelinoclastic Diffuse Scleroses	4180186
45610428	Myelinoclastic Diffuse Sclerosis	4180186
45610428	Neuronal Degeneration Of Childhood With Liver Disease, Progressive	4180186
45610428	Poliodystrophia Cerebri	4180186
45610428	Progressive Neuronal Degeneration of Childhood with Liver Disease	4180186
45610428	Progressive Sclerosing Poliodystrophies	4180186
45610428	Progressive Sclerosing Poliodystrophy	4180186
45610428	Schilder Disease	4180186
45610428	Schilder's Disease	4180186
45610428	Schilders Disease	4180186
45610428	Scleroses, Balo's Concentric	4180186
45610428	Scleroses, Myelinoclastic Diffuse	4180186
45610428	Sclerosis, Diffuse Cerebral	4180186
45610428	Sclerosis, Myelinoclastic Diffuse	4180186
45610428	Sudanophilic Cerebral Sclerosis	4180186
45610428	Syndrome, Alpers	4180186
45610428	Syndrome, Alpers-Huttenlocher	4180186
45610433	Syndrome, Roussy-Levy	4180186
45610433	Charcot-Marie-Tooth Neuropathy, Type 1A	4180186
45610433	Hereditary Type I Motor and Sensory Neuropathy	4180186
45610433	Dystasia, Hereditary Areflexic	4180186
45610433	Charcot-Marie-Tooth Disease, Autosomal Dominant, With Focally Folded Myelin Sheaths, Type 1A	4180186
45610433	Areflexic Dystasia, Hereditary	4180186
45610433	Hereditary Areflexic Dystasia	4180186
45610433	Charcot-Marie-Tooth Disease, Autosomal Dominant, with Focally Folded Myelin Sheaths, Type 1B	4180186
45610433	Charcot-Marie-Tooth Hereditary Neuropathy	4180186
45610433	Muscular Atrophies, Peroneal	4180186
45610433	Charcot-Marie-Tooth Disease, Demyelinating, Type 1B	4180186
45610433	Charcot Marie Tooth Neuropathy, Type 1B	4180186
45610433	Muscular Atrophy, Peroneal	4180186
45610433	Roussy Levy Syndrome	4180186
45610433	Charcot Marie Tooth Disease, Type II	4180186
45610433	HMSN1B	4180186
45610433	Roussy-Levy Syndrome	4180186
45610433	Hereditary Areflexic Dystasias	4180186
45610433	HMSN IA	4180186
45610433	Hereditary Neuropathy, Charcot-Marie-Tooth	4180186
45610433	Roussy-Levy Disease	4180186
45610433	Charcot-Marie-Tooth Disease, Type IB	4180186
45610433	Atrophy, Peroneal Muscular	4180186
45610433	Neuropathy, Type II Hereditary Motor and Sensory	4180186
45610433	Charcot-Marie Disease	4180186
45610433	Charcot-Marie-Tooth Disease, Type II	4180186
45610433	HMSN IB	4180186
45610433	Charcot Marie Tooth Disease, Type IB	4180186
45610433	Areflexic Dystasias, Hereditary	4180186
45610433	Syndrome, Charcot-Marie-Tooth	4180186
45610433	Charcot Marie Disease	4180186
45610433	Dystasias, Hereditary Areflexic	4180186
45610433	Charcot Marie Tooth Syndrome	4180186
45610433	Charcot Marie Tooth Neuropathy, Type 1A	4180186
45610433	Charcot Marie Tooth Disease, Type 1B	4180186
45610433	Charcot Marie Tooth Disease, Type IA	4180186
45610433	Hereditary Motor and Sensory Neuropathy Type II	4180186
45610433	Charcot-Marie-Tooth Disease, Slow Nerve Conduction Type, Linked To Duffy	4180186
45610433	HMSN Type I	4180186
45610433	Hereditary Motor and Sensory Neuropathy 1B	4180186
45610433	Charcot-Marie-Tooth Disease, Type IA	4180186
45610433	Peroneal Muscular Atrophies	4180186
45610433	Charcot-Marie-Tooth Disease, Type I	4180186
45610433	HMSN II	4180186
45610433	Charcot-Marie-Tooth Syndrome	4180186
45610433	Charcot-Marie-Tooth Disease, Demyelinating, Type 1A	4180186
45610433	Roussy Levy Disease	4180186
45610433	Roussy Levy Hereditary Areflexic Dystasia	4180186
45610433	HMN Distal Type I	4180186
45610433	HMSN I	4180186
45610433	HMSN Type II	4180186
45610433	Charcot Marie Tooth Hereditary Neuropathy	4180186
45610433	Charcot-Marie-Tooth Neuropathy, Type 1B	4180186
45610433	HMSN1A	4180186
45610433	HMSN 1B	4180186
45610433	Peroneal Muscular Atrophy	4180186
45610433	Hereditary Motor and Sensory-Neuropathy Type II	4180186
45610433	Charcot-Marie-Tooth Disease, Type 1A	4180186
45610433	Charcot Marie Tooth Disease	4180186
45610433	Charcot Marie Tooth Disease, Type I	4180186
45610433	Neuropathy, Type I Hereditary Motor and Sensory	4180186
45610433	Charcot-Marie-Tooth Disease, Type 1B	4180186
45610433	Hereditary Motor, and Sensory Neuropathy Type I	4180186
45610433	Hereditary Motor and Sensory Neuropathy IA	4180186
45610433	Atrophies, Peroneal Muscular	4180186
45610433	Charcot Marie Tooth Disease, Type 1A	4180186
45610433	Hereditary Motor And Sensory Neuropathy IB	4180186
45610433	HMSN 1A	4180186
45610433	Atrophy, Muscular, Peroneal	4180186
45610433	Roussy-Levy Hereditary Areflexic Dystasia	4180186
45610433	Hereditary Motor and Sensory Neuropathy 1A	4180186
45610435	Bigumal	4180186
45610435	Chlorguanid	4180186
45610435	Chloriguane	4180186
45610435	Chloroguanide	4180186
45610435	Chloroguanide Hydrochloride	4180186
45610435	Hydrochloride, Chloroguanide	4180186
45610435	Hydrochloride, Proguanil	4180186
45610435	Imidodicarbonimidic diamide, N-(4-chlorophenyl)-N'-(1-methylethyl)-	4180186
45610435	Paludrin	4180186
45610435	Paludrine	4180186
45610435	Proguanil Hydrochloride	4180186
45610436	Chlorophyll 740	4180186
45610436	Chlorophylls	4180186
45610436	Phyllobilins	4180186
45610441	Cholecystostomies	4180186
45610443	Liquid Chromatography	4180186
45610446	Cleidocranial Digital Dysostoses	4180186
45610446	Cleidocranial Digital Dysostosis	4180186
45610446	Cleidocranial Dysostoses	4180186
45610446	Cleidocranial Dysostosis	4180186
45610446	Cleidocranial Dysplasias	4180186
45610446	Dysostoses, Cleidocranial	4180186
45610446	Dysostoses, Cleidocranial Digital	4180186
45610446	Dysostosis, Cleidocranial	4180186
45610446	Dysostosis, Cleidocranial Digital	4180186
45610446	Dysplasia, Cleidocranial	4180186
45610446	Dysplasias, Cleidocranial	4180186
45610446	Marie Sainton Syndrome	4180186
45610446	Marie-Sainton Syndrome	4180186
45610446	Scheuthauer Marie Sainton Syndrome	4180186
45610446	Scheuthauer-Marie-Sainton Syndrome	4180186
45610446	Syndrome, Marie-Sainton	4180186
45610446	Syndrome, Scheuthauer-Marie-Sainton	4180186
45610449	Clinitar	4180186
45610449	Estar	4180186
45610449	Tar, coal	4180186
45610449	Tar, Coal	4180186
45610451	Coccidioides immitis Infection	4180186
45610451	Coccidioides immitis Infections	4180186
45610451	Coccidioidomycoses	4180186
45610451	Infection, Coccidioides immitis	4180186
45610451	Infections, Coccidioides immitis	4180186
45610451	San Joaquin Valley Fever	4180186
45610451	Valley Fever	4180186
45610451	Valley Fevers	4180186
45610456	Conditionings, Operant	4180186
45610456	Instrumental Learning	4180186
45610456	Instrumental Learnings	4180186
45610456	Learning, Instrumental	4180186
45610456	Learnings, Instrumental	4180186
45610456	Operant Conditioning	4180186
45610456	Operant Conditionings	4180186
45610457	Conjunctival Disease	4180186
45610457	Disease, Conjunctival	4180186
45610457	Diseases, Conjunctival	4180186
45610458	Conjunctival Neoplasm	4180186
45610458	Neoplasm, Conjunctival	4180186
45610458	Neoplasms, Conjunctival	4180186
45610459	Fertility Control	4180186
45610459	Female Contraception	4180186
45610459	Contraception, Male	4180186
45610459	Contraceptions, Female	4180186
45610459	Fertilization Inhibition	4180186
45610459	Female Contraceptions	4180186
45610459	Contraception, Female	4180186
45610459	Inhibition of Fertilization	4180186
45610459	Male Contraceptions	4180186
45610459	Contraceptive Method	4180186
45610459	Contraceptive Methods	4180186
45610459	Contraceptions, Male	4180186
45610459	Male Contraception	4180186
45610459	Birth Control	4180186
45610460	Ring, Vaginal	4180186
45610460	Shield, Vaginal	4180186
45610460	Vaginal Rings	4180186
45610460	Sponges, Vaginal	4180186
45610460	Spring, Coiled	4180186
45610460	Female Contraceptive Device	4180186
45610460	Vaginal Ring	4180186
45610460	Sponge, Vaginal	4180186
45610460	Device, Female Contraceptive	4180186
45610460	Vaginal Diaphragms	4180186
45610460	Contraceptive Device, Female	4180186
45610460	Devices, Female Contraceptive	4180186
45610460	Coiled Spring	4180186
45610460	Springs, Coiled	4180186
45610460	Vaginal Sponges	4180186
45610460	Vaginal Shield	4180186
45610460	Caps, Cervical	4180186
45610460	Rings, Vaginal	4180186
45610460	Vaginal Sponge	4180186
45610460	Cap, Cervical	4180186
45610460	Vaginal Shields	4180186
45610460	Female Contraceptive Devices	4180186
45610460	Coiled Springs	4180186
45610460	Cervical Caps	4180186
45610460	Vaginal Diaphragm	4180186
45610460	Diaphragms, Vaginal	4180186
45610460	Diaphragm, Vaginal	4180186
45610460	Shields, Vaginal	4180186
45610460	Cervical Cap	4180186
45610461	Contractures	4180186
45610465	Coronaviridae Infection	4180186
45610465	Infection, Coronaviridae	4180186
45610465	Infections, Coronaviridae	4180186
45610466	17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate	4180186
45610466	Adreson	4180186
45610466	Cortisone Acetate	4180186
45610466	Cortone Acetate	4180186
45610466	Pregn-4-ene-3,11,20-trione, 17,21-dihydroxy-	4180186
45610470	Craniofacial Dysarthroses	4180186
45610470	Craniofacial Dysarthrosis	4180186
45610470	Craniofacial Dysostoses	4180186
45610470	Craniofacial Dysostosis, Crouzon	4180186
45610470	Craniofacial Dysostosis Syndrome	4180186
45610470	Craniofacial Dysostosis Syndromes	4180186
45610470	Craniofacial Dysostosis Type 1	4180186
45610470	Craniofacial Dysostosis, Type I	4180186
45610470	Crouzon Craniofacial Dysostosis	4180186
45610470	Crouzon Disease	4180186
45610470	Crouzon's Disease	4180186
45610470	Crouzons Disease	4180186
45610470	Crouzon Syndrome	4180186
45610470	Dysarthroses, Craniofacial	4180186
45610470	Dysarthrosis, Craniofacial	4180186
45610470	Dysostoses, Craniofacial	4180186
45610470	Dysostosis, Craniofacial	4180186
45610471	Craniectomies	4180186
45610471	Craniectomy	4180186
45610471	Craniotomies	4180186
45610473	Cryoglobulinemias	4180186
45610474	Cyanoses	4180186
45610475	4-((4-(Acetyloxy)phenyl)cyclohexylidenemethyl)phenol Acetate	4180186
45610475	Cyclophenil	4180186
45610475	F6066	4180186
45610475	F 6066	4180186
45610475	F-6066	4180186
45610475	Ondogyne	4180186
45610475	Phenol, 4-((4-(acetyloxy)phenyl)cyclohexylidenemethyl)-, acetate	4180186
45610477	Cystic Fibrosis of Pancreas	4180186
45610477	Cystic Fibrosis, Pancreatic	4180186
45610477	Cystic Fibrosis, Pulmonary	4180186
45610477	Fibrocystic Disease of Pancreas	4180186
45610477	Fibrosis, Cystic	4180186
45610477	Mucoviscidosis	4180186
45610477	Pancreas Fibrocystic Disease	4180186
45610477	Pancreas Fibrocystic Diseases	4180186
45610477	Pancreatic Cystic Fibrosis	4180186
45610477	Pulmonary Cystic Fibrosis	4180186
45610481	Breakbone Fever	4180186
45610481	Break Bone Fever	4180186
45610481	Break-Bone Fever	4180186
45610481	Classical Dengue	4180186
45610481	Classical Dengue Fever	4180186
45610481	Classical Dengue Fevers	4180186
45610481	Classical Dengues	4180186
45610481	Dengue, Classical	4180186
45610481	Dengue Fever	4180186
45610481	Dengue Fever, Classical	4180186
45610481	Fever, Breakbone	4180186
45610481	Fever, Break-Bone	4180186
45610481	Fever, Dengue	4180186
45610485	Desoxyribonuclease	4180186
45610485	Deoxyribonuclease	4180186
45610485	Acid DNase	4180186
45610485	Alkaline DNase	4180186
45610485	Desoxyribonucleases	4180186
45610485	DNAase	4180186
45610485	DNA Nucleases	4180186
45610485	DNase	4180186
45610485	DNase, Acid	4180186
45610485	DNase, Alkaline	4180186
45610485	Nucleases, DNA	4180186
45610486	Dermatitides	4180186
45610488	Allergen Immunotherapies	4180186
45610488	Allergen Immunotherapy	4180186
45610488	Allergy Shot	4180186
45610488	Allergy Shots	4180186
45610488	Desensitizations, Immunologic	4180186
45610488	Hyposensitization Therapies	4180186
45610488	Hyposensitization Therapy	4180186
45610488	Immunologic Desensitization	4180186
45610488	Immunologic Desensitizations	4180186
45610488	Immunotherapy, Allergen	4180186
45610488	Immunotherapy, Venom	4180186
45610488	Shot, Allergy	4180186
45610488	Therapy, Hyposensitization	4180186
45610488	Venom Immunotherapies	4180186
45610488	Venom Immunotherapy	4180186
45610491	Cholera, Pancreatic	4180186
45610491	Diarrheogenic Islet Cell Tumor	4180186
45610491	Diarrheogenic Tumor	4180186
45610491	Diarrheogenic Tumors	4180186
45610491	Pancreatic Cholera	4180186
45610491	Pancreatic VIPoma	4180186
45610491	Pancreatic VIPomas	4180186
45610491	Syndrome, Verner-Morrison	4180186
45610491	Syndrome, Vipoma	4180186
45610491	Tumor, Diarrheogenic	4180186
45610491	Tumors, Diarrheogenic	4180186
45610491	Tumors, VIP-Secreting (VIPoma)	4180186
45610491	Tumor, VIP-Secreting (VIPoma)	4180186
45610491	Vasoactive Intestinal Peptide Producing Tumor	4180186
45610491	Vasoactive Intestinal Peptide-Producing Tumor	4180186
45610491	Vasoactive Intestinal Peptide (VIP) Tumor	4180186
45610491	Verner Morrison Syndrome	4180186
45610491	Verner-Morrison Syndrome	4180186
45610491	VIPoma, Pancreatic	4180186
45610491	Vipomas	4180186
45610491	VIPomas, Pancreatic	4180186
45610491	Vipoma Syndrome	4180186
45610491	VIP-Secreting Tumors (VIPoma)	4180186
45610491	VIP Secreting Tumor (VIPoma)	4180186
45610491	VIP-Secreting Tumor (VIPoma)	4180186
45610491	Watery Diarrhea, Hypokalemia, and Achlorhydria Syndrome	4180186
45610491	Watery Diarrhea Syndrome	4180186
45610491	Watery Diarrhea with Hypokalemic Alkalosis	4180186
45610491	WDHA	4180186
45610491	WDHA Syndrome	4180186
45610491	WDHA Syndromes	4180186
45610491	WDHH	4180186
45610498	9,10-Secoergosta-5,7,22-trien-3-ol, (3beta,5E,7E,10alpha,22E)-	4180186
45610498	AT10	4180186
45610498	AT 10	4180186
45610498	AT-10	4180186
45610498	Calcamine	4180186
45610498	Dihydrotachysterin	4180186
45610498	Tachystin	4180186
45610499	Antitoxin, Diphtheria	4180186
45610500	4H-1-Benzopyran-2-carboxylic acid, 5,5'-((2-hydroxy-1,3-propanediyl)bis(oxy))bis(4-oxo-, disodium salt)	4180186
45610500	FPL-670	4180186
45610500	FPL670	4180186
45610500	Vicrom	4180186
45610500	Intal	4180186
45610500	Lomudal	4180186
45610500	Opticrom	4180186
45610500	Acid, Cromoglicic	4180186
45610500	Bicromat Spray	4180186
45610500	Cromoglicic Acid	4180186
45610500	Cromoglycic Acid	4180186
45610500	Disodium Cromoglycate	4180186
45610500	Cromoglycate, Sodium	4180186
45610500	Nasalcrom	4180186
45610500	Aarane	4180186
45610500	Cromoglycate, Disodium	4180186
45610500	Cromoglycate	4180186
45610500	Nalcrom	4180186
45610500	FPL 670	4180186
45610500	Acid, Cromoglycic	4180186
45610500	Cromolyn	4180186
45610500	Sodium Cromoglycate	4180186
45610507	Drug Tolerances	4180186
45610507	Tolerance, Drug	4180186
45610507	Tolerances, Drug	4180186
45610508	Syndrome, Dumping	4180186
45610508	Dumping Syndromes	4180186
45610508	Syndromes, Dumping	4180186
45610509	Duodenitis, Erosive	4180186
45610509	Erosive Duodenitis	4180186
45610510	Duodenostomies	4180186
45610514	Acquired Ear Deformities	4180186
45610514	Acquired Ear Deformity	4180186
45610514	Deformities, Acquired Ear	4180186
45610514	Deformity, Acquired Ear	4180186
45610514	Ear Deformity, Acquired	4180186
45610515	Auricular Cancer	4180186
45610515	Auricular Cancers	4180186
45610515	Auricular Neoplasms	4180186
45610515	Cancer, Auricular	4180186
45610515	Cancer of Ear	4180186
45610515	Cancer of Ear Auricle	4180186
45610515	Cancer of the Ear	4180186
45610515	Cancers, Auricular	4180186
45610515	Ear Auricle Cancer	4180186
45610515	Ear Auricle Cancers	4180186
45610515	Ear Auricle Neoplasm	4180186
45610515	Ear Auricle Neoplasms	4180186
45610515	Ear Cancer	4180186
45610515	Ear Neoplasm	4180186
45610515	Neoplasm, Ear	4180186
45610515	Neoplasms, Auricular	4180186
45610515	Neoplasms, Ear	4180186
45610515	Neoplasms of Ear Auricle	4180186
45610518	Echoencephalographies	4180186
45610519	Contagious Ecthyma	4180186
45610519	Contagious Pustular Dermatitides	4180186
45610519	Contagious Pustular Dermatitis	4180186
45610519	Dermatitides, Contagious Pustular	4180186
45610519	Dermatitis, Contagious Pustular	4180186
45610519	Infection, Orf Virus	4180186
45610519	Infections, Orf Virus	4180186
45610519	Orf Virus Infection	4180186
45610519	Orf Virus Infections	4180186
45610519	Pustular Dermatitides, Contagious	4180186
45610519	Pustular Dermatitis, Contagious	4180186
45610519	Virus Infection, Orf	4180186
45610519	Virus Infections, Orf	4180186
45610520	Mousepox	4180186
45610520	Mouse Pox	4180186
45610520	Infectious Ectromelia	4180186
45610521	Cardiac Edema	4180186
45610521	Cardiac Edemas	4180186
45610521	Edemas, Cardiac	4180186
45610522	Level, Maternal Educational	4180186
45610522	Maternal Educational Attainments	4180186
45610522	Maternal Educational Levels	4180186
45610522	Maternal Educational Level	4180186
45610522	Paternal Education Levels	4180186
45610522	Paternal Education Level	4180186
45610522	Attainment, Maternal Educational	4180186
45610522	Attainment, Paternal Educational	4180186
45610522	Educational Levels	4180186
45610522	Level, Education	4180186
45610522	Level, Educational	4180186
45610522	Education Level, Maternal	4180186
45610522	Achievement, Educational	4180186
45610522	Educational Attainments	4180186
45610522	Education Levels	4180186
45610522	Maternal Education Levels	4180186
45610522	Maternal Educational Status	4180186
45610522	Levels, Maternal Educational	4180186
45610522	Paternal Educational Attainment	4180186
45610522	Educational Attainment, Maternal	4180186
45610522	Status, Maternal Educational	4180186
45610522	Education Level	4180186
45610522	Status, Educational	4180186
45610522	Level, Maternal Education	4180186
45610522	Paternal Educational Attainments	4180186
45610522	Educational Status, Paternal	4180186
45610522	Attainment, Educational	4180186
45610522	Educational Level, Maternal	4180186
45610522	Status, Paternal Educational	4180186
45610522	Educational Level	4180186
45610522	Educational Attainment, Paternal	4180186
45610522	Educational Achievement	4180186
45610522	Educational Status, Maternal	4180186
45610522	Maternal Educational Attainment	4180186
45610522	Paternal Educational Level	4180186
45610522	Level, Paternal Education	4180186
45610522	Educational Level, Paternal	4180186
45610522	Educational Achievements	4180186
45610522	Paternal Educational Status	4180186
45610522	Level, Paternal Educational	4180186
45610522	Educational Attainment	4180186
45610522	Level of Education	4180186
45610522	Paternal Educational Levels	4180186
45610522	Education Level, Paternal	4180186
45610522	Maternal Education Level	4180186
45610523	Cardiac Electroversion	4180186
45610523	Cardiac Electroversions	4180186
45610523	Cardioversion	4180186
45610523	Cardioversion, Electrical	4180186
45610523	Cardioversions	4180186
45610523	Cardioversions, Electrical	4180186
45610523	Countershock, Electric	4180186
45610523	Countershocks, Electric	4180186
45610523	Defibrillation, Electric	4180186
45610523	Defibrillations, Electric	4180186
45610523	Electrical Cardioversion	4180186
45610523	Electrical Cardioversions	4180186
45610523	Electric Countershocks	4180186
45610523	Electric Defibrillation	4180186
45610523	Electric Defibrillations	4180186
45610523	Electroversion, Cardiac	4180186
45610523	Electroversions, Cardiac	4180186
45610523	Electroversion Therapies	4180186
45610523	Electroversion Therapy	4180186
45610523	Therapies, Electroversion	4180186
45610523	Therapy, Electroversion	4180186
45610526	Dihydrochloride, Emetine	4180186
45610526	Emetan, 6',7',10,11-tetramethoxy-	4180186
45610526	Emetine Dihydrochloride	4180186
45610526	Emetine Hydrochloride	4180186
45610526	Hydrochloride, Emetine	4180186
45610526	Ipecine	4180186
45610526	Methylcephaeline	4180186
45610527	Precarious Employment	4180186
45610527	Termination, Employment	4180186
45610527	Status, Employment	4180186
45610527	Employment Termination	4180186
45610527	Occupational Status	4180186
45610527	Underemployment	4180186
45610527	Labor Force	4180186
45610527	Marginal Employment	4180186
45610527	Employment Insecurity	4180186
45610527	Labor Forces	4180186
45610527	Insecurity, Employment	4180186
45610527	Employment, Marginal	4180186
45610527	Employment, Precarious	4180186
45610527	Employment Insecurities	4180186
45610527	Status, Occupational	4180186
45610527	Employment Status	4180186
45610528	Enalapril Maleate	4180186
45610528	L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)-	4180186
45610528	Maleate, Enalapril	4180186
45610528	MK421	4180186
45610528	MK 421	4180186
45610528	MK-421	4180186
45610528	Renitec	4180186
45610528	Renitek	4180186
45610530	Encephalitis, Saint Louis	4180186
45610530	Encephalitis, Viral, St. Louis	4180186
45610530	Lethargic Encephalitis, Type C	4180186
45610530	Louis Meningoencephalitides, St.	4180186
45610530	Meningoencephalitides, St. Louis	4180186
45610530	Meningoencephalitis, St. Louis	4180186
45610530	Saint Louis Encephalitis	4180186
45610530	St. Louis Encephalitis	4180186
45610530	St. Louis Meningoencephalitides	4180186
45610530	St. Louis Meningoencephalitis	4180186
45610530	St. Louis Viral Encephalitis	4180186
45610530	Type C Lethargic Encephalitis	4180186
45610532	Convulsion Disorders, Tonic-Clonic	4180186
45610532	Convulsion Disorder, Tonic-Clonic	4180186
45610532	Convulsion, Grand Mal	4180186
45610532	Convulsions, Grand Mal	4180186
45610532	Convulsions, Tonic Clonic	4180186
45610532	Convulsion Syndromes, Tonic-Clonic	4180186
45610532	Convulsion Syndrome, Tonic-Clonic	4180186
45610532	Convulsion, Tonic Clonic	4180186
45610532	Cryptogenic Tonic-Clonic Epilepsies	4180186
45610532	Cryptogenic Tonic Clonic Epilepsy	4180186
45610532	Cryptogenic Tonic-Clonic Epilepsy	4180186
45610532	Disorders, Tonic-Clonic Convulsion	4180186
45610532	Disorders, Tonic-Clonic Seizure	4180186
45610532	Disorder, Tonic-Clonic Convulsion	4180186
45610532	Disorder, Tonic-Clonic Seizure	4180186
45610532	Epilepsies, Cryptogenic Tonic-Clonic	4180186
45610532	Epilepsies, Familial Tonic-Clonic	4180186
45610532	Epilepsies, Symptomatic Tonic-Clonic	4180186
45610532	Epilepsies, Tonic-Clonic	4180186
45610532	Epilepsy, Cryptogenic Tonic-Clonic	4180186
45610532	Epilepsy, Familial Tonic-Clonic	4180186
45610532	Epilepsy, Grand Mal	4180186
45610532	Epilepsy, Major	4180186
45610532	Epilepsy, Symptomatic Tonic-Clonic	4180186
45610532	Epilepsy, Tonic Clonic	4180186
45610532	Epilepsy, Tonic-Clonic, Cryptogenic	4180186
45610532	Epilepsy, Tonic-Clonic, Familial	4180186
45610532	Epilepsy, Tonic-Clonic, Symptomatic	4180186
45610532	Familial Tonic-Clonic Epilepsies	4180186
45610532	Familial Tonic Clonic Epilepsy	4180186
45610532	Familial Tonic-Clonic Epilepsy	4180186
45610532	Grand Mal Convulsion	4180186
45610532	Grand Mal Convulsions	4180186
45610532	Grand Mal Epilepsy	4180186
45610532	Grand Mal Seizure Disorder	4180186
45610532	Major Epilepsies	4180186
45610532	Major Epilepsy	4180186
45610532	Major Motor Seizure Disorder	4180186
45610532	Seizure Disorder, Grand Mal	4180186
45610532	Seizure Disorder, Major Motor	4180186
45610532	Seizure Disorders, Tonic-Clonic	4180186
45610532	Seizure Disorder, Tonic Clonic	4180186
45610532	Seizure Disorder, Tonic-Clonic	4180186
45610532	Seizure Syndromes, Tonic-Clonic	4180186
45610532	Seizure Syndrome, Tonic-Clonic	4180186
45610532	Symptomatic Tonic-Clonic Epilepsies	4180186
45610532	Symptomatic Tonic Clonic Epilepsy	4180186
45610532	Symptomatic Tonic-Clonic Epilepsy	4180186
45610532	Syndromes, Tonic-Clonic Convulsion	4180186
45610532	Syndromes, Tonic-Clonic Seizure	4180186
45610532	Syndrome, Tonic-Clonic Convulsion	4180186
45610532	Syndrome, Tonic-Clonic Seizure	4180186
45610532	Tonic Clonic Convulsion	4180186
45610532	Tonic Clonic Convulsion Disorder	4180186
45610532	Tonic-Clonic Convulsion Disorder	4180186
45610532	Tonic-Clonic Convulsion Disorders	4180186
45610532	Tonic Clonic Convulsions	4180186
45610532	Tonic Clonic Convulsion Syndrome	4180186
45610532	Tonic-Clonic Convulsion Syndrome	4180186
45610532	Tonic-Clonic Convulsion Syndromes	4180186
45610532	Tonic-Clonic Epilepsies	4180186
45610532	Tonic-Clonic Epilepsies, Cryptogenic	4180186
45610532	Tonic-Clonic Epilepsies, Familial	4180186
45610532	Tonic-Clonic Epilepsies, Symptomatic	4180186
45610532	Tonic-Clonic Epilepsy	4180186
45610532	Tonic-Clonic Epilepsy, Cryptogenic	4180186
45610532	Tonic-Clonic Epilepsy, Familial	4180186
45610532	Tonic-Clonic Epilepsy, Symptomatic	4180186
45610532	Tonic Clonic Seizure Disorder	4180186
45610532	Tonic-Clonic Seizure Disorder	4180186
45610532	Tonic-Clonic Seizure Disorders	4180186
45610532	Tonic Clonic Seizure Syndrome	4180186
45610532	Tonic-Clonic Seizure Syndrome	4180186
45610532	Tonic-Clonic Seizure Syndromes	4180186
45610533	Burkitt Herpesvirus	4180186
